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ABSTRACT 
A series of core and core-shell nanoparticles with superparamagnetic properties were 
synthesised and surface functionalised using three different amino-silanes by a chemical 
conjugation method. The functionalised nanoparticles were characterised and further 
modified by chemical conjugation with two different classes of bio-molecules; (i) enzymes 
and (ii) single stranded DNA primers.  The resultant nanoparticles (nano-bio conjugates) 
were used for applications in (i) enzyme catalysis and (ii) bio-separation / bio-sensing.   
Magnetite and amorphous silica-coated core-shell nanoparticles were synthesised on both 
small (5 g) and large (20 g) scales and were characterised using transmission electron 
microscopy (TEM), X-ray diffraction (XRD), Brunauer-Emmett-Teller (BET) surface area 
measurement and vibrating sample magnetometry (VSM). Silica-coated core-shell 
nanoparticles were functionalised by silanisation with three different aminosilanes [3-
aminopropyl tri-ethoxysilane (APTS), 3-aminopropyl di-ethoxymethylsilane (APDS) and 3-
aminopropyl mono-ethoxydimethylsilane (APMS)] and two different methods: water 
(classical method) or a Tri-phasic Reverse Emulsion (TPRE) using toluene and a surfactant 
(Triton X-100). It was observed that the materials prepared using the TPRE method produced 
higher surface amine density values on average. 
The first application involved bio-catalysis where lipases [Pseudomonas Fluorescens lipase 
(PFL) and Candida Rugosa lipase (CRL)] were chemically conjugated (covalently linked) via 
glutaraldehyde-modification onto the amino-functionalised nanoparticles for applications 
such as: (i) hydrolysis of p-nitrophenyl palmitate to produce palmitic acid and p-nitrophenol 
(model reaction), (ii) transesterification of ethyl butyrate with n-butanol to produce butyl 
butyrate and (iii) partial and selective hydrolysis of cis-3,5-diacetoxy-1-cyclopentene to 
produce pharmaceutically important and expensive chiral intermediate molecules. Various 
reaction parameters such as (a) water concentration in a bi-phasic solvent mixture and (b) 
temperature were investigated to determine the optimum conditions. All reactions were 
carried out using free lipases and the physically adsorbed lipases in order to compare the 
performance with chemically conjugated nano-biomaterials.  
It was observed from the bio-catalytic reaction (i) that the conversion values given by lipase-
immobilised materials were comparable to those given by free lipases with the added 
advantage of being re-usable for further catalytic cycles. PFL-immobilised nanoparticles 
were shown to be more effective catalysts than CRL-immobilised materials.  In the bio-
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catalytic reaction (ii), Lipase-immobilised materials were shown to exhibit reasonable 
conversion values (maximum 53%) along with easy separability by one-step magnetic 
separation from the reaction mixture and re-usability. Finally, in the bio-catalytic reaction 
(iii), lipase-immobilised materials were shown to give lower total conversion values 
compared to free enzymes, but a higher proportion of desired products [(1S,4R)-cis-4-
acetoxy-2-cyclopenten-1-ol and (1R,4S)-cis-4-acetoxy-2-cyclopenten-1-ol]. PFL (both free 
and immobilised) materials were shown to give higher conversion and enantioselectivity 
towards the desired (1S,4R)-enantiomer (93-100% ee) than CRL materials (30-40% ee). 
The second application involved bio-separation and bio-sensing where 5ʹ-NH2-modified 
oligonucleotide sequences specific to either Listeria Monocytogenes (LM) or Escherichia 
Coli (EC) were immobilised onto the surface of glutaraldehyde modified nanoparticles to 
assess the specific capture and enhance the sensitivity of detection of pathogenic bacterial 
DNAs from food samples. Firstly, the oligonucleotide-grafted nanoparticles were used in a 
hybrid capture assay (model assay) at UCLan using specific single stranded DNA primers of 
our interest followed by the application in real food samples at Q-Bioanalytic GmbH, 
Germany. Capture of the complementary sequences was reasonably high (48-70% for LM-
specific materials and 48-55% for EC-specific materials) when calculated as a molar ratio of 
conjugated oligonucleotides to complementary oligonucleotides captured. Specific capture 
was determined to be 33-52% for LM-specific oligonucleotide-grafted nano-materials and 
59-60% for EC-specific oligonucleotide-grafted nano-materials. Dehybridisation of captured 
sequences was shown to be efficient for all oligonucleotide-grafted materials (72-97% for 
LM-specific materials and 86-87% for EC-specific materials), indicating that the materials 
were ready for real applications using food matrices at Q-Bioanalytic GmbH, Germany.  
Nucleic acid DNA was extracted from a real food sample inoculated with either LM or EC 
and the extracted DNA was used for specific capture using the oligonucleotide-grafted 
materials tested at UCLan. Dehybridised oligonucleotides were amplified and analysed using 
quantitative real-time PCR (qPCR). The results showed that using a one-step hybrid capture 
assay, LM-specific oligonucleotide-grafted materials were successful at detecting LM from 
an undiluted solution of LM only and from a 1:1 mixture of LM and EC. Using a two-step 
assay where the forward and reverse oligonucleotide-grafted materials were applied for 
capture separately, only EC-specific materials were successful for the detection of EC from 
an undiluted solution, and also from a 1:1 mixture of LM and EC.  
Page 5 of 250 
 
MOTIVATION FOR THE PROJECT 
The motivation for this project was to overcome the current problems associated with the 
applications in industrial bio-catalysis using enzymes and easy separation / rapid detection of 
microbial contamination in food / water samples. Transesterification of large molecular 
weight fatty acid esters to low molecular weight alkyl esters is important for the production 
of bio-diesels and flavouring agents. Similarly, partial and selective hydrolysis of cis-3,5-
diacetoxy-1-cyclopentene is a powerful reaction to produce pharmaceutically important and 
expensive chiral intermediate molecules. The above reactions were carried out either by free 
enzymes or by enzymes supported on a solid matrix as the recovery of expensive enzymes 
and recycling of enzymes supported on solid matrices are challenging steps for industry.  In 
this context, recent development of nano-materials / nano-technology at UCLan motivated 
the investigation of such important bio-catalytic reactions using core-shell superparamagnetic 
nanoparticles as supports for enzymes due to their simple one-step recovery by an external 
magnetic field with maximum efficiency in re-cycling the enzymes.  
Similarly, microbial contamination in food / water samples can have devastating effects upon 
human health. Several reports have come to the public domain related to food poisoning due 
to the contamination by pathogenic bacteria such as Listeria Monocytogenes (LM). 
Salmonella, etc.  Hence, the separation of such microbes from food samples and their rapid 
detection is a key issue for health industries. In this context, past activity at UCLan in 
collaboration with Q-Bioanalytic GmbH, Germany using nanoparticle-based sensors created 
an opportunity for investigating the use of superparamagnetic nanoparticles for such 
purposes. Similarly, the presence of bacteria is the main indication of water contamination in 
the developing world. A survey conducted by the World Health Organization (WHO) showed 
that 80% of total reported diseases are due to contaminated drinking water. Hence, the 
separation of water-borne microbes such as Escherichia Coli (EC) and their rapid detection 
was key for the investigation of EC primer attached superparamagnetic nanoparticles in the 
context of an on-going project between UCLan, Fudan University, China and Feedwater Ltd. 
UK. 
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ABBREVIATIONS AND UNITS 
Abbreviations 
A adenine Glu glutamic acid 
APDS 3-aminopropyl di-
ethoxymethylsilane 
Gly glycine 
APhTS (4-aminophenyl)-trimethoxysilane HBV hepatitis B virus 
APMS 3-aminopropyl mono-
ethoxydimethylsilane 
His 
HIV 
histidine 
human immunodeficiency virus 
APTS 3-aminopropyl tri-ethoxysilane HPBEt (R,S)-2-hydroxy-4-
phenylbutyric acid ethyl ester 
ATP adenosine triphosphate IAC internal amplification control 
BET Brunauer-Emmett-Teller surface area 
analysis 
ICP-MS inductively coupled plasma – 
mass spectrometry 
BSA  Bovine serum albumin IMS immunomagnetic separation 
C cytosine LM Listeria Monocytogenes 
C18T
MS 
n-octadecyltrimethoxysilane LDH L-lactate dehydrogenase 
CA chronoamperometry Lys lysine 
CAL-B Candida Antarctica Lipase-B MCM-
41 
hexagonal array mesoporous 
silica molecular sieve  
CLEA cross-linked enzyme aggregates MNP magnetic nanoparticle 
CLEC cross-linked enzyme crystals 4-NBA 4-nitrobenzaldehyde 
CRL Candida Rugosa lipase PBS phosphate buffered saline 
CTAB cetyltrimethylammonium bromide PCR polymerase chain reaction 
CTAC cetyltrimethylammonium chloride PEG polyethylene glycol 
CV cyclic voltammetry PFL Pseudomonas Fluorescens 
lipase DC critical diameter 
DNA deoxyribonucleic acid PGA phosphoglyceric acid 
dNTP deoxyribonucleotide triphosphate PNP p-nitrophenol 
dUTP deoxyuridine triphosphate PNPB p-nitrophenyl butyrate 
EC Escherichia Coli  PNPP p-nitrophenyl palmitate 
EDTA ethylenediaminetetraacetic acid PPL Porcine Pancreatic Lipase 
EIS electrochemical impedance 
spectroscopy 
PSL Pseudomonas sp. Lipase 
ELISA enzyme-linked immunosorbent assay PVA polyvinyl alcohol 
FID flame ionisation detector qPCR quantitative real-time 
polymerase chain reaction 
G guanine RNA Ribonucleic acid 
GC gas chromatography RT 
RT-PCR 
retention time 
reverse transcriptase 
polymerase chain reaction 
GC-
MS 
gas chromatography – mass 
spectrometry 
Page 8 of 250 
 
Abbreviations continued 
RuBisCO ribulose-1,5-biphosphate 
carboxylase oxygenase 
TEN buffer consisting of Tris-HCl, 
EDTA, sodium chloride and 
water 
SBA-15 hexagonal array mesoporous silica 
molecular sieve  
TEOS tetraethyl orthosilicate 
S.E.M. standard error of the mean TMAOH tetramethylammonium 
hydroxide 
Ser 
SPIONs  
serine 
superparamagnetic iron oxide 
nanoparticles 
TLL Thermomyces lanuginosus 
lipase 
TPRE tri-phasic reverse emulsion 
SSC Buffer consisting of sodium 
chloride, sodium citrate and water 
UNG Uracil-N-glycosylase 
T thymine VSM vibrating sample 
magnetometry 
 
Units 
Å ångström or angstrom = 1×10
-10
 m mins minutes 
º
C degree Celsius mL millilitre (1×10
-3
 L) 
CFU colony forming units mm millimetre (1×10
-3
 m) 
emu electromagnetic units mmol millimoles (1×10
-3
 moles) 
fg femtogram (1×10
-15
 g) µg microgram (1×10
-6
 g) 
g gram µL microlitre (1×10
-6 
L) 
h hour µm micrometre (1×10
-6
 m) 
K degree Kelvin µmol micromoles (1×10
-6
 moles) 
kOe kilooersted (1×10
3
 Oe) nm nanometre (1×10
-9
 m) 
km kilometre (1×10
3
 m) nmol nanomoles (1×10
-9 
moles) 
kV kilovolt (1×10
3
 V) rpm revolutions per minute 
m metre v/v volume per volume 
M molarity (moles per litre) w/v weight per volume 
mg milligram (1×10
-3
 g)   
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1.1 Aims and Objectives of the Project 
The aims of the project were as follows:  
1. Synthesise a range of superparamagnetic magnetite nanoparticles and coat with silica 
to produce amorphous core-shell silica-magnetite nanoparticles. 
2. Use both classical (water method) and novel (TPRE method) techniques to 
functionalise the surface of the nanoparticles using a range of aminosilanes (APTS, 
APDS, APMS). 
3. Fully characterise the materials made in this project both physically and chemically, 
using DNA binding and elution assays, transmission electron microscopy (TEM), 
UV-Visible colorimetric assay of amine density, Brunauer-Emmett-Teller surface 
area analysis (BET), vibrating sample magnetometry (VSM) and X-ray diffraction 
(XRD), where relevant.  
4. Covalently immobilise lipases (CRL and PFL) onto the aminosilane-functionalised 
nanoparticle surface (via the glutaraldehyde coupling method) to produce bio-
catalytically active materials. 
5. Employ the lipase-immobilised nanoparticles for a model catalysis reaction 
(hydrolysis of PNPP), and use the best materials for useful bio-catalytic applications 
including the transesterification of ethyl butyrate and the synthesis of 
pharmaceutically important chiral compounds via selective hydrolysis. 
6. Covalently immobilise specific single-stranded oligonucleotides onto the 
aminosilane-functionalised nanoparticle surface (via glutaraldehyde) to produce 
materials with uses in bio-separation and bio-sensor applications. 
7. Employ the oligonucleotide-grafted nanoparticles for a model hybrid capture assay 
(monitoring the hybridisation and dehybridisation efficiency of complementary 
oligonucleotide sequences using UV-Visible spectroscopy), followed by the specific 
capture and detection of Listeria Monocytogenes (LM) from food samples in 
collaboration with Q-Bioanalytic GmbH, Bremerhaven, Germany, using real-time 
PCR (qPCR). 
8. Employ the oligonucleotide-grafted nanoparticles for a model hybrid capture assay 
(monitoring the hybridisation and dehybridisation efficiency of complementary 
oligonucleotide sequences using UV-Visible spectroscopy), followed by the specific 
capture and detection of Escherichia Coli (EC) from wastewater samples in 
collaboration with Fudan University, Shanghai, China. 
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1.2 Introduction to Nanoparticles and Nanotechnology 
The prefix ‘nano-’ means a billionth, or 1×10-9. Thus, a nanometre (nm) is defined as 1×10-9 
m. Nanotechnology and nanochemistry deal with structures in the size range of around 1-100 
nm. Although the field of nanotechnology is quite new, nanostructures exist in abundance in 
nature, for example in the very hard shell of the abalone mollusc,
1
 upon geckos’ feet to 
enable them to walk on vertical or even upside-down surfaces,
2
 in butterfly wings producing 
bright colours
3
 and in mineralised collagen fibrils; the building blocks of bone.
4
 
Deoxyribonucleic acid (DNA) and proteins are also nanometre-scale materials. Some of the 
earliest reported incidents of humans utilising nanotechnology were in the 4
th
-century A.D., 
when Roman glassmakers produced glasses, containing nanosized metals like gold and silver, 
which could change colour when light was passed through them. Another early use was 
making brightly coloured stained-glass windows in churches and cathedrals; metal 
nanoparticles were present in the glass. Photography (developed in the eighteenth/nineteenth 
century) is dependent on the production of light-sensitive silver nanoparticles from 
decomposing silver halides present in the film.  
The material properties of solids are dependent on the size range in which they are measured. 
Properties observed on traditional size scales (mm – km) have been seen to change when 
measured in the micrometre-nanometre scale (µm – nm), including mechanical, ferroelectric 
and ferromagnetic properties.
5
 Thus, controlling the properties of the nanoscale such as 
particle size, morphology and magnetism enables control of the desired properties of the bulk 
material. Commonly used materials for nanoparticles include metal oxides such as magnetite, 
polymers such as polystyrene, group IV elements like Si or Ge and semiconducting materials 
such as TiO2 and CdS. The preparation of iron, platinum, cadmium, palladium, silver, copper, 
nickel and gold metal nanoparticles has also been reported.
6
 They are typically made via the 
‘top-down’ or ‘bottom-up’ methods. Top-down methods (such as ball-milling) involve 
miniaturising current methods to produce nanostructures, whereas ‘bottom-up’ processes 
(such as molecular self-assembly) involve the construction of nanostructures from smaller 
subunits, as far down as individual atoms.  
An excellent review on the history of nanoparticles was written by Kreuter in 2007.
7
 From 
this review, it can be seen that research into nanoparticles and nanotechnology really took off 
in the mid-to-late 1970’s with scientists such as Birrenbach, Speiser and Kreuter all working 
together; employing various methods to synthesise nanoparticles for applications in drug 
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delivery
8-13
 and later, nucleic acid, DNA fragments and gene delivery,
14
 cancer therapy
15-20
 
and AIDS treatment.
21,22
 Since these early developments, research into nanoparticles and 
their uses has increased significantly in the areas of bio-catalysis, bio-separations, bio-
medicines and bio-sensors.
23
 As with many newer areas in science, long-term safety and bio-
compatibility of many nanoparticles have not yet been fully explored, prompting concerns 
and slight hesitation for society as a whole to fully accept nanotechnology, as outlined in the 
review by Albrecht et al in 2006.
24
 Despite this hesitation, nanotechnology has been hailed as 
revolutionary, with the ability to impact on many areas including the economy, technology 
industries, military fields, medicine fields, sustainable technology development and the 
petrochemical industries.
24
  
1.3 Introduction to Magnetism and Magnetite Nanoparticles 
Magnetic materials have a magnetic field created by the motions of their electrons. A unified 
magnetic field can be produced in materials when the magnetic moments of the electrons 
align with each other. This field has a direction of flow and will attempt to align with an 
externally applied magnetic field. Alignment of magnetic moments in different types of 
magnetic materials can be observed in Figure 1.1, below. 
 
Figure 1.1: Alignment of magnetic moments (without the presence of an external magnetic 
field) in ferromagnetic, ferrimagnetic, paramagnetic and antiferromagnetic materials.
1
 
Diamagnetic materials are omitted as they have no magnetic moment. Superparamagnetic 
materials contain a single magnetic domain, which aligns with an externally applied magnetic 
field. 
A more in-depth explanation of the types of magnetism will be discussed herein. The six 
types of magnetism are:  
 Ferromagnetism – All magnetic moments contribute positively to the net 
magnetisation of the material. All magnetic moments are aligned; the materials possess a 
permanent magnetic field and can exhibit spontaneous magnetisation. They are the most 
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common type of known ‘magnetic material’. Examples of ferromagnetic materials are cobalt, 
iron, nickel and hematite, α-Fe2O3. 
 Ferrimagnetism – Similar to ferromagnetism, but some of the magnetic moments are 
anti-aligned, subtracting from the net magnetisation of the material. They also exhibit 
spontaneous magnetisation and have a permanent magnetic field. Bulk magnetite (Fe3O4) is 
an example of a ferromagnetic material. 
 Paramagnetism – Have close to zero net magnetic moment, but become slightly 
attracted to externally applied magnetic fields. They have randomly oriented magnetic 
moments and retain no magnetisation following the removal of the external magnetic field
25
. 
Most chemical elements are paramagnetic. 
 Diamagnetism – Materials create an opposite magnetic field to one which is 
externally applied and are repelled by them (have no magnetic moment, retain no 
magnetisation following removal of the external magnetic field). Examples of diamagnetic 
materials are quartz, calcite, sodium chloride and water.  
 Antiferromagnetism – Magnetic moments align in regular, opposite fashion (no 
overall bulk spontaneous magnetisation (when an external magnetic field is applied, a small 
amount of ferromagnetic behaviour is observed). Below 250 K, hematite is antiferromagnetic, 
becoming weakly ferromagnetic between 250-948 K and paramagnetic above 948 K.
26
  
 Superparamagnetism – Occurs in ferri- or ferromagnetic nanoparticles. 
Superparamagnetism occurs in nanoparticles; due to their size they are composed of just a 
single magnetic domain, so the entire nanoparticle aligns with the applied field. Magnetic 
moments can flip direction at random, depending on temperature. The time it takes is called 
the Néel relaxation time. Without the presence of an external magnetic field, the Néel 
relaxation time is much shorter than the time used to measure the magnetisation and the net 
magnetisation is observed as zero – this phenomenon is called superparamagnetism. The 
materials can be magnetised via an external field, much more strongly than regular 
paramagnetic materials.
25
 They retain no magnetisation when the external magnetic field is 
removed. Magnetite nanoparticles are an example of a superparamagnetic material, having 
different magnetic properties to bulk magnetite.
27
 
It is crucial to explain why superparamagnetic materials, particularly magnetite nanoparticles, 
are of such interest. An advantage to using magnetic particles in general is that they can 
easily be separated from the reaction mixture by the application of an external magnetic field. 
This makes magnetic supports more attractive from both green chemistry and economical 
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standpoints because of increased recovery, re-usability and lifetime that can be obtained from 
bio-molecules immobilised on superparamagnetic nanoparticles. Their superparamagnetic 
properties allow them to remain relatively dispersed in suspension without being 
magnetically attracted to each other and aggregating.  
The first reported use of magnetic separation was reported in 1973 by Robinson et al,
28
 who 
used silica-coated iron oxide to immobilise α-chymotrypsin and β-galactosidase for 
applications in bio-reactors. Since this first reported use, magnetic separation has become an 
increasingly popular tool for separations involving bio-molecules.
29
 Following this, potential 
applications of magnetic nanoparticles have been explored for over four decades. The 
following paragraph will detail the methods of synthesising magnetite (Fe3O4) nanoparticles, 
as they are the materials I have used and are of most relevance to this project.  
1.4 Synthesis of Magnetite 
Magnetite, Fe3O4, has an inverse-spinel structure. The unit cell consists of thirty-two oxygen 
atoms forming a face-centred-cubic (fcc) closed-packing structure, with iron cations located 
at octahedral and tetrahedral sites.
30,31
 The unit cell edge length is 0.839 nm. The crystal 
structure can be written as Fe
2+
Fe
3+
2O4 where the Fe
2+
 ions and half of the Fe
3+
 ions occupy 
octahedral sites and the second half of the Fe
3+
 ions occupy the tetrahedral sites; i.e. 
[Fe
3+
]Th[Fe
3+
Fe
2+
]OhO4, where Th represents tetrahedral sites and Oh represents octahedral 
sites. The characteristic black colour of magnetite arises from inter-valence charge transfer 
between octahedral Fe
2+
 and Fe
3+
 ions within the crystal structure.
31,32
 The structure is shown 
in Figure 1.2, reproduced from reference 33. 
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Figure 1.2: The crystal structure of magnetite, Fe3O4, reproduced from reference 33. The 
black spheres represent tetrahedral Fe
3+
 ions, red spheres represent octahedral Fe
2+
 or Fe
3+
 
ions and the yellow spheres correspond to oxygen anions.  
Sugimoto and Matijević first reported the synthesis of uniform, spherical magnetite particles 
(30 – 1100 nm diameter) using ferrous hydroxide gels in 1980.34 An example of this is the 
synthesis of magnetite nanoparticles via the oxidative hydrolysis of iron sulphate in alkaline 
media.
29,34
 Since then, many methods of synthesising magnetite have been developed with 
the aim of controlling particle size, morphology, stability and dispersity. These factors have 
been found to be dependent on the reaction temperature, pH, ionic strength of the media, 
ferrous/ferric (Fe
2+
/Fe
3+
) chloride ratio and the type of salts used.
35
  
One simple, convenient method of magnetite synthesis is via co-precipitation of aqueous 
Fe
2+
/Fe
3+
 salt solutions by adding base under inert atmosphere at various temperatures.
29,36-38
 
Materials made using this method tend to be quite poly-dispersed, possibly due to 
uncontrolled growth following nucleation and controlling the growth is crucial in the 
production of mono-dispersed nanoparticles. This can be done by using stabilising agents 
such as polyvinyl alcohol (PVA) .
39
 Recently, studies have shown oleic acid to be the most 
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effective candidate for stabilising magnetite nanoparticles and is widely used for passivation 
of magnetite nanoparticle surfaces, producing mono-dispersed and highly uniform 
nanoparticles.
40
  
Another method of synthesis commonly employed is thermal decomposition of 
organometallic compounds (such as iron choline citrate,
41
 iron carbonate
42
 and iron 
carboxylate
43
) with surfactants in organic media.
35,44
 
An alternative method that allows control of the nanoparticle morphology and size is the 
microemulsion method (water-in-oil), which uses water droplets as nano-reactors in the oil 
phase, with surfactants (used to produce micellisation of the water droplets and dispersion of 
the nanoparticles).
45-47
 Iron precursors are precipitated into the water phase within the 
micelles and not the organic/oil phase, as they are unreactive in the oil phase. Particle size is 
dictated by control of the water droplet size.
44
 
In 2005, Wang et al
48
 reported the hydrothermal synthesis of noble metal, magnetic, 
dielectric, semiconducting and rare-earth fluorescence nanocrystals using a three phase 
liquid-solid-solution (LSS) system. The reaction involved reduction of metal ions by ethanol 
at the interfaces between the solid (metal linoleate), liquid (ethanol-linoleic acid) and solution 
(water-ethanol) phases. The microwave hydrothermal synthesis of magnetite has also been 
reported.
49
 This method produced nanoparticles of various sizes and shapes with extensive 
potential applications. 
Other methods of nanoparticle synthesis include: 
 Sonochemical50 
 Biomimetic51-53 
 Sol-gel54 
 Electrochemical deposition55 
 Physical methods such as aerosols,56 ball milling57 and gas phase deposition.58 
Table 1.1 summarises the most commonly used methods of nanoparticle synthesis outlined 
earlier in this section (modified from Lu et al’s review entitled: Magnetic Nanoparticles: 
Synthesis, Protection, Functionalisation, and Application
35
). 
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For protection against oxidation, erosion by acidic/basic species and for increased stability in 
suspension, nanoparticles are typically either coated by an inorganic component (typically 
silica,
59
 carbon
60
 or precious metals
61,62
) to produce a core-shell structure, or coated with an 
organic shell (surfactants or polymers).
63,64
 Oxidation of the magnetite core can affect the 
magnetic ability of the nanoparticles. The nanoparticles can also be dispersed or embedded 
into a polymer, silica or carbon matrix to form a composite structure. However, the 
nanoparticles are then fixed in the composite matrix and are not freely dispersible in reaction 
media. In the context of this project, silica coatings will be considered and explored. 
 
Table 1.1: Summary of the four most common methods of nanoparticle synthesis outlined in 
this section. 
Synthetic Method  Synthetic Conditions Typical 
Solvent 
Particle Size 
Distribution 
Shape 
Control 
Co-precipitation
29,36-40
 Simple, ambient conditions. 
20-90ºC, reaction time of 
minutes. High yield, able to 
scale-up. 
Water Relatively 
narrow 
Not good 
Thermal 
Decomposition
41-43
 
Complicated, inert 
atmosphere. 100-320ºC, 
reaction time of hours-days. 
High yield, able to scale-up. 
Organic 
compound 
Very narrow Very 
good 
Microemulsion
45-47
 Complicated, ambient 
conditions. 20-50ºC, 
reaction time of hours. 
Relatively low-yielding. 
Organic 
compound 
Relatively 
narrow 
Good 
Hydrothermal 
Synthesis
48,49
 
Simple, high pressure. 
220ºC, reaction time of 
hours-days. Moderate yield.  
Water-
ethanol 
Very narrow Very 
good 
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1.5 Silica Coating on Magnetite Nanoparticles 
Coating magnetic nanoparticles with a silica shell protects the magnetite core from oxidation, 
erosion and unwanted interactions with species that are later linked to the silica surface such 
as bio-molecules. Silica coatings make the nanoparticles stable under aqueous conditions at 
low-neutral pH, bio-compatible, allow simple surface modification, shell thickness control 
and easy control of inter-particle interactions.
35
 The main methods for silica coating are the 
Stӧber method65 and sol-gel methods.36 The Stӧber method (also a sol-gel method) is the 
base-catalysed synthesis of silica particles from alkoxysilanes. In this way, the 
polycondensation/polymerisation of silicic acid to form siloxane (Si-O-Si) bonds generates a 
silica sol (colloidal suspension) which polymerises into a colloidal silica gel when intra-
molecular water is eliminated from the system.
66
 These processes rely on the use of silicon 
alkoxides (such as TEOS) as the silica source; the silica coating is precipitated onto the 
magnetic nanoparticles in a basic ethanol/water mixture in the presence of ammonia.
67,68
 
Ethanol acts as a co-solvent in the reaction, with ammonia acting as morphological catalyst.
69
  
Silica coatings can be either amorphous or mesoporous. Amorphous silica coatings, which 
are non-porous and non-crystalline, first reported by Philipse et al in 1994
36
 via the sol-gel 
method, allow the nanoparticles’ surface to retain a negative charge above silica’s isoelectric 
point (~pH 2). Amorphous coatings are produced if no templating systems are present in the 
coating process. This provides applications in bio-separations by using electrostatic 
interactions to bind bio-molecules. In addition to this, the silica possesses silanol functional 
groups (Si-OH) which can be used to covalently bond to organosilanes in order to further 
functionalise the surface. Another method of amorphous silica-coating is via the deposition of 
silicic acid, which was reported on the large scale by Bruce et al in 2004.
29
 Reverse 
microemulsion methods have been used to produce a coating as thin as 1 nm.
70
 
In order to increase surface area, various routes have been taken to prepare magnetite 
nanoparticles with microporous (zeolites) and mesoporous silica shells. The first reported 
synthesis of mesoporous magnetite nanocomposites particles was reported by Wu et al in 
2004.
71
 They used CTAC micelles as molecular templates. In 2005, Zhao et al produced 
uniform magnetic nanocomposites spheres with a mesoporous silica shell.
72
 They employed 
simultaneous sol-gel polymerisation of a silica source (TEOS) and a surfactant (n-
octadecyltrimethoxysilane (C18TMS)) onto hematite (Fe2O3), followed by removal of the 
organic group. This method produced uniform mesoporous core-shell superparamagnetic 
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nanoparticles (~270 nm diameter) with high surface area and pore volume, which can be used 
for drug delivery applications. The template-assisted preparation of mesoporous silica-
magnetite nanocomposites has been reported.
73
 This was performed by adding a silica source 
(TEOS), a surfactant (CTAB) and a base (NaOH) to magnetite in water at room temperature, 
followed by slow titration to pH 7 with HCl. In 2009, Deng et al
74
 combined sol-gel synthesis 
and vapour-phase transport to produce magnetic zeolites microspheres for the immobilisation 
of trypsin. 
1.5.1 Applications of Silica-coated Magnetite Nanoparticles 
A popular application of both colloidal silica and silica-coated nanoparticles is in the quick 
and efficient purification on DNA and RNA from biological samples.
66,75,76
 At physiological 
pH values, silica is weakly acidic (as its isoelectric point is pH ~2), giving it a weakly 
negative surface charge
77
 (Si-O
-
 as opposed to Si-OH). In the presence of high concentrations 
of chaotropic salts (salts which disrupt and denature the structure of nucleic acids and 
destabilise hydrogen bonds), cations are able to form a stable layer around the negatively 
charged silica surface, effectively giving it a positive charge. DNA is actually quite stable in 
the presence of chaotropic salts and retains its negative charge in aqueous solution.
66
 The 
phosphate groups present in the DNA ‘backbone’ are strongly acidic and are deprotonated in 
aqueous media at physiological pH values, having an overall negatively charged surface. As a 
result of this, DNA can bind effectively via the ‘cation bridge’ to the now positively-charged 
silica surface. The DNA out-competes other molecules to bind to the silica surface and they 
are left in solution. The newly formed DNA-silica complex is washed in either a salt solution 
or an ethanol/water mixture to remove impurities, which aren’t as tightly bound as the 
DNA.
78
 The purified DNA can then be eluted from the silica using a buffer containing low 
salt concentrations, or water. The mechanism is shown in Figure 1.3. 
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Figure 1.3: Purification of DNA using silica-coated nanoparticles under chaotropic salt 
conditions.
66
 (Reproduced with the kind permission of Dr Tapas Sen). 
 In 2007, Deng et al
79
 reported the synthesis of superparamagnetic high-magnetisation 
microspheres with an iron oxide core coated in amorphous silica which was then surrounded 
by a mesoporous SiO2 shell for the removal of microcystins, which are very toxic 
heptapeptides, occurring in eutrophic waters. The microspheres were found to be effective 
absorbents for fast, convenient and efficient removal of microcystins with excellent 
recyclability and activity over at least 8 cycles.
79
 For further applications in bio-catalysis, bio-
separations and bio-sensors, the silica-coated surface can then be functionalised with surface-
activating species (such as organosilanes) via the silanol functionality. Bio-molecules can 
then be immobilised/coupled/adsorbed on the surface of the silica-coated magnetic 
nanoparticles. The functional groups are not entrapped or sterically hindered close to the 
surface and instead they are able to interact with substrate species in the vicinity around the 
external surface. Surface functionalisation of nanoparticles is discussed in the next section.  
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1.6 Introduction to Surface Functionalisation of Core-Shell Nanoparticles 
Manipulating the surface chemistry of any materials can lead to improvements in the way 
they interact with other materials. In the context of this work, organosilanes (particularly 
aminosilanes) are the most useful compounds for the surface functionalisation of silica-
coated magnetic nanoparticles. They are useful as they can conjugate a wide selection of bio-
molecules (such as enzymes, proteins and oligonucleotides) to surfaces which have amine or 
carboxyl groups present.
66
 They are also readily available and easy to use. 
Organosilanes are bi-functional reagents, identified by the chemical formula X-(CH2)n-
SiRn(ORʹ)3-n. X represents the headgroup, (CH2)n is a flexible alkyl chain spacer group and 
the Si(ORʹ)n groups are anchor groups which attach to the silanol hydroxyl groups on the 
silica surface following hydrolysis of the alkoxy (ORʹ) group. Aminosilanes are simply 
organosilanes possessing an amino group as the X functionality. They are commercially 
available and are commonly employed in the silanisation of surfaces by organic phase, 
aqueous phase or chemical vapour deposition processes.
80
 Three commonly used 
aminosilanes for surface functionalisation [(3-aminopropyl)-triethoxysilane (APTS), (3-
aminopropyl)-diethoxymethylsilane (APDS) and (3-aminopropyl)-
monoethoxydimethylsilane (APMS)] are shown in Figure 1.4.  
 
Figure 1.4: APTS = (3-aminopropyl)-triethoxysilane, APDS = (3-aminopropyl)-
diethoxymethylsilane, APMS = (3-aminopropyl)-monoethoxydimethylsilane. 
The headgroup can also be altered to be a vinyl, mercaptan, epoxy or halogen functionality. 
An example of this is a publication by Huang and Hu
81
, who reported that surface 
modification of Si-MNP’s with γ-mercaptopropyltrimethoxysilane can lead to fast, selective 
and efficient solid phase extraction of trace amounts of heavy metals in 
environmental/biological samples, prior to their determination by ICP-MS.
81
 This is essential 
with respect to water purification as heavy metals are severely toxic to living organisms and 
can bio-accumulate in the food chain, so their removal from water and concentration 
measurement is of great importance.
82,83
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As aminosilanes are most commonly used, their mechanism of action will be described in 
further detail. The process of surface functionalisation with aminosilanes depends on two 
simultaneous reactions; (i) the hydrolysis of the n silane alkoxy groups (Si(ORʹ)n) to the 
corresponding reactive silanol species and (ii) the condensation of the resultant silanol 
species with the free hydroxyl groups on the silica surface to form stable Si-O-Si bonds. An 
example of this reaction scheme using APTS is shown in Scheme 1.1 below. 
 
 
Scheme 1.1: Schematic representation of the (i) hydrolysis (ii) subsequent condensation onto 
silanol-functionalised surface and (iii) auto catalysed hydrolysis and polymerisation of APTS 
in water. 
The third reaction (iii) represents the hydrolysis and spontaneous oligomerisation / 
polymerisation of APTS that occurs in water. This is auto-catalysed, due to the basic nature 
of the amino group and is a competing process with the condensation onto the silica-coated 
surface of the nanoparticles. As a result of this, APTS oligomerisation / polymerisation and 
condensation in water is largely uncontrolled and surfaces functionalised by APTS have a 
tendency to be multi-layered and disordered.
84
 This process is much slower in organic 
solvents. The amino groups (either those of the free aminosilane or already bound 
aminosilanes) or silanol headgroups can also hydrogen bond to silanol groups on the 
nanoparticle surface during condensation, decreasing the effective amine density.
66
 APTS 
possesses three alkoxy groups which can anchor to the silanol groups on the nanoparticle 
surface. Due to having three of these groups, APTS is believed to be more susceptible to 
intermolecular cross-linking reactions than both APDS and APMS, which have two and one 
alkoxy groups respectively.
85
 The alkoxysilane groups in these two compounds are replaced 
by unreactive methyl groups, thus less intermolecular cross-linking between aminosilanes is 
achieved. In this way, the aminosilanes can bond to the surface of the nanoparticles in a more 
orderly fashion. Figure 1.5 represents what an ideal aminosilane-functionalised silica-coated 
nanoparticle surface should look like.  
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Figure 1.5: The ‘ideal’ orientation of aminosilanes on the surface of silica-coated 
nanoparticles. (Reproduced with the kind permission of Dr Tapas Sen). 
As flat surfaces have only two dimensions, the surface functionalisation can be more 
controlled (often by ready elimination of water from the surface using a drying step) than in 
the three-dimensional nanoparticles. In the suspension phase, as well as oligomerisation / 
polymerisation of aminosilanes and hydrogen bonding to the surface, other interactions such 
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as nanoparticle aggregation can cause unforeseen problems and reductions in total surface 
amine density. Another competing process to condensation of the aminosilanes to the silica-
surface of the nanoparticles is the multilayer formation of aminosilanes which results in the 
sequestration of amino groups away from the surface, hence making them unavailable for 
bio-molecule binding (shown below in Figure 1.6). Again these issues are prevalent in 
aqueous systems. A monolayer is the ideal scenario (shown above in Figure 1.5), in which 
case all of the aminosilane groups would not be cross-linked, hydrogen bonded or 
sequestered and all of the amino groups would be available to bind to bio-molecules. 
 
Figure 1.6: Demonstrating the sequestration of amino groups in a disordered multilayer 
aminosilane arrangement.
86,87
 The red line represents a spherical nanoparticle surface. 
In 1996, Moon et al
88
 reported the comparison of four different aminosilanes (APTS, APDS, 
APMS and (4-aminophenyl)-trimethoxysilane (APhTS)) for producing uniform aminosilane 
thin layers on the flat surfaces of fused silica and oxidised silicon wafers. They measured the 
relative surface density of amine groups by ellipsometry and via a coupling reaction with 4-
nitrobenzaldehyde (4-NBA) to form imine-bonded species which could be confirmed by UV-
Visible spectroscopy. Following the coupling, the 4-NBA species could be removed by 
hydrolysis, which was also confirmed by UV-Visible spectroscopy. This assay was further 
developed by van de Waterbeemd
86
 et al in 2010. In regard to nanoparticles in suspension, 
ellipsometry cannot be used so along with the detection of reversible coupling and hydrolysis 
of UV-Visible active reagents such as 4-NBA, chemical and elemental combustion analysis 
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methods can be used to provide information about the surface amine density and 
availability
86
 (see Figure 1.7 below).  
 
Figure 1.7: Total amine density, including sequestered amines, on the left side; identified by 
chemical and elemental combustion. The right side shows the surface amines which can be 
identified using the 4-NBA colorimetric assay. Comparison of the results obtained from both 
methods are used to calculate surface amine density and total amine density. (Reproduced 
with the kind permission of Dr Tapas Sen). 
It was the combination of these two methods of analysis that allowed the improved 
understanding of surface and sequestered amino groups on the mono- and multi-layered 
aminosilane functionalised surface of nanoparticles.  
Sen and Bruce recently reported the novel strategy of surface activation of nanoparticulates in 
suspension using a tri-phasic reverse emulsion (TPRE).
87,89
 The TPRE system consisted of 
solid silica-coated magnetite nanoparticles (solid phase), surrounded by a surface water phase 
dispersed within an organic solvent phase (toluene), in the presence of a bio-compatible, non-
ionic surfactant (Triton X-100). APTS was used as aminosilane and was found to be soluble, 
but did not hydrolyse or self-condense in toluene. It can only perform these reactions in the 
presence of water. By having just a small amount of adsorbed water on the nanoparticle 
surface, APTS could react in a much more controlled fashion, producing an ordered uniform 
layer on the surface. Dispersion of the nanoparticles in the TPRE avoids their aggregation 
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and spontaneous and uncontrolled polymerisation of APTS in water is eliminated. Amino-
functionalised nanoparticles prepared by this method exhibited a higher surface to total amine 
density (>80%) than those prepared using bulk water phase surface functionalisation (20%). 
The materials were used for successful DNA grafting and capture in magnetic bio-
separations.  
As bio-molecules frequently possess surface amine groups, to allow for easier conjugation of 
bio-molecules to amino-functionalised surfaces, it is important for coupling reagents to be 
used to allow the coupling of two species. 
1.6.1 Coupling Reagents for Bio-molecule Conjugation 
The crosslinking of enzymes to supports typically happens via the amino groups of enzyme 
residues on the enzyme/protein surface. Coupling reagents such as glutaraldehyde and 
glyoxyl groups are used to change aminosilane-functionalised surfaces to an aldehyde 
functionality, to allow the covalent cross-linking to other amino-groups. Carbodiimide 
reagents can be used to couple surface carboxyl groups with amino groups, producing stable 
secondary amines/amides.
90,91
 They do this by activating carboxyl groups in water, allowing 
them to react with amine groups. Highly reactive groups used to immobilise proteins via 
aldehyde surface modification, such as glutaraldehyde and cyanogen bromide, can bind the 
enzyme to the support in mild conditions (physiological pH, ambient temperature). This 
suggests immobilisation involves exposed residues that are reactive at these pH values such 
as terminal amino groups. Due to their high reactivity, these reagents become unstable at 
alkaline pH values. As a result, proteins are mainly immobilised with these reagents by a 
single point covalent attachment via the terminal amino group at neutral pH. The attachment 
is formed due to formation of an imine bond, or Schiff base (R-CH=N-R′ ).  
Glutaraldehyde is the most popular and widely used reagent for surface activation and 
subsequent bio-molecule immobilisation. It is a linear, 5-carbon di-aldehyde (CHO-(CH2)3-
CHO) homo bi-functional coupling reagent which also converts surface amine groups to 
aldehydes.
92
 It permits cross-linking of the bio-molecule (primarily with terminal amine 
groups
66
) to the support via a single, strong imine bond. Glutaraldehyde can be used at 
slightly acidic and neutral pH values, making it useful and convenient. Examples of 
glutaraldehyde being used as a coupling/crosslinking reagent for immobilising enzymes are 
numerous.
93-98
 Scheme 1.2 shows the cross-linking process using glutaraldehyde to cross-link 
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enzymes onto hierarchically ordered porous magnetic nanocomposites reported by Sen et 
al.
99,100
 The efficient coupling of bio-molecules for various applications can then take place. 
The first of these bio-molecules to be discussed will be enzymes. 
 
Scheme 1.2: The cross-linking process using glutaraldehyde to cross-link enzymes onto 
hierarchically ordered porous magnetic nanocomposites
99,100
.  
In contrast to the reagents which work optimally in neutral pH and ambient conditions is 
glyoxal, a two-carbon di-aldehyde (CHO-CHO), which has also been used to activate support 
surfaces for the immobilisation of various bio-molecules; primarily enzymes.
101-103
 
Immobilisation only proceeds in alkaline conditions and slight changes in pH and 
temperature lead to big reductions in immobilisation rate. The support must be highly 
activated before immobilisation and immobilisation is via multiple points, as the amino-
glyoxyl bond is very weak. Compounds with a single amino group do not undergo a 
significant amount of immobilisation to glyoxyl supports. At alkaline pH values, lysine (Lys) 
residues become more reactive. As Lys residues possess two amine groups, glyoxyl groups 
can immobilise proteins via these points, so they are immobilised in the areas which have the 
highest density of Lys residues on the surface (shown below in Figure 1.8). This can be 
advantageous as immobilisation may be directed towards the area of the enzyme/protein 
where multipoint covalent bonding is most likely and hence, stabilisation can be achieved.
104
 
Conformation and biological activity is preserved as the Lys residues are typically on the 
outer surface of the enzyme structure, away from the active site and thus are not as affected 
by steric hindrances. 
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Figure 1.8: Lysine residue containing the ε- and α-amino groups.  
Imine bonds are quite sensitive to hydrolysis, so stability can be improved by selective 
reduction with sodium cyanoborohydride (NaBH3CN), forming a stable secondary amine
66
. 
As glutaraldehyde possesses the ability to work at acidic-neutral pH values, ambient 
conditions and its commercial availability and ease of use, it is the coupling reagent that I 
have chosen to utilise for the purposes of this study for the immobilisation of both enzymes 
and oligonucleotides. The following section introduces the concepts of enzymes; and their 
applications as bio-catalysts.  
1.7 Introduction to Enzymes and Bio-catalysis 
Enzymes are natural proteins which catalyse chemical reactions. Their molecular weight can 
vary from several thousand to several million, but they can catalyse reactions on molecules as 
small as nitrogen and carbon dioxide.
105
 They catalyse chemical reactions by lowering 
transition-state energies and energetic intermediates by increasing the ground-state energy. 
The initial phase of an enzyme-catalysed reaction is the formation of an enzyme-substrate 
(E·S) complex via binding of the substrate to the catalytic active site (this E·S complex is also 
known as the Michaelis complex).
105
 The active site is made up of around a dozen amino acid 
residues, of which only two or three are directly involved in the substrate binding and 
catalysis of the reaction. It is thought that the rest of the enzyme structure is needed to 
maintain the structural integrity of the active site for optimal substrate binding and catalysis. 
In addition to accelerating the rate of chemical reactions, enzymes are also selective and have 
high specificity. The transition state is extremely short-lived and high-energy. It is bound 
around 10
12
 times more tightly than the substrate or products and once bound, the enzyme 
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catalyses the conversion of substrates to products, forming an enzyme-product (E·P) 
complex, via various mechanisms including approximation, desolvation; as well as covalent, 
electrostatic and general acid/base catalysis.
105
 This is another tightly-bound, high-energy, 
short-lived transition-state complex. Following formation of the E·P complex, the interactions 
present in stabilising the transition-state complexes are no longer present and the now poorly 
bound products are expelled from the active site. This can also be due to repulsive 
interactions between the products and active site residues, triggered by changes in electronic 
distribution due to bond breakage/formation, leading to opening of the active site and product 
expulsion.
106
  
The basic kinetics and mechanism of an enzyme-catalysed reaction is shown in Scheme 1.3.  
 
Scheme 1.3: General mechanism for enzyme-catalysed reactions. E represents the enzyme 
and S represents the substrate. k1 denotes the rate constant of formation of the E·S complex, 
k2 denotes the rate constant of formation of the E·P complex and k-1 denotes the rate constant 
of breakdown of the E·S complex.
105
  
The stability of the E·S complex is related to substrate’s affinity towards the enzyme and is 
measured by its KS value. This is called the dissociation constant of the complex, calculated 
by the equation in Scheme 1.4 below:  
 
Scheme 1.4: Definition of the dissociation constant, KS, of an enzyme-substrate complex.
105
  
If the rate of E·P complex formation is much greater than the rate of dissociation of the E·S 
complex, then k2 can be called kcat (catalytic rate constant) and Ks becomes Km (Michaelis-
Menten constant). The catalytic rate constant, kcat represents the ‘turnover number’: the 
maximum number of substrate molecules converted to product molecules per active site per 
unit time (typically around 10
3
 s
-1
, ~1000 molecules per second are converted to product from 
substrate).
105
 
Enzymes have several important functions in nature. In humans and animals, protein kinases 
and phosphatases are involved in cell regulation and signalling
107
 and myosin enables muscle 
contraction via the hydrolysis of ATP.
108
 In digestion, carbohydrases and amylases break 
down carbohydrates and starch (via hydrolysis of starch chains into smaller molecules which 
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can be absorbed in the intestines), proteases break down proteins into small peptides and 
amino acids (via hydrolysis of peptide bonds in polypeptide chains that link amino acids) and 
lipases break down lipids (via hydrolysis of triglycerides to free fatty acids and glycerol). In 
viruses, integrases are produced to allow the genetic material of the virus to be integrated into 
the infected cell’s DNA.109 Neuraminidase allows the viral release of the influenza virus from 
cells.
110
 Herbivores produce cellulase in their ruminating chambers to allow the breakdown of 
cellulose in plants and grasses to β-glucose. In the second stage of photosynthesis in plants 
(The Calvin Cycle), ribulose-1,5-biphosphate carboxylase oxygenase (RuBisCO) catalyses 
the fixation of atmospheric carbon dioxide (carboxylation) to RuBP, causing its breakdown to 
phosphoglyceric acid (PGA), which is then converted to phosphoglyceraldehyde and is 
further broken down into energy-rich sugars, fatty acids and amino acids.
111
 RuBisCO is 
thought to be the most abundant protein on Earth.  
 
1.7.1 General Applications of Enzymes 
Enzymes are widely used in the chemical industry for homogeneous catalysis as a result of 
their high chemo-, regio- and enantioselectivity. Within the pharmaceutical industry, 
increased demand for new, more potent drugs and medicines has opened the door for the 
exploration of novel methods of efficient stereoselective synthesis and since the mid-to-late 
1990’s,112 bio-catalysis using enzymes has been seen to be the answer. In a review by 
Roberts,
113
 a vast range of useful enzyme-catalysed reactions are explored, such as 
hydrolysis,
93,114,115
 esterifications,
116-118
 oxidations,
119-121
 carbon-carbon bond 
formations
122,123
 and bio-transformations.
124,125
 Roberts also remarked that due to the wide 
variety of enzymes that are readily available and the reactions being relatively easy to scale-
up, the use of enzymes in bio-catalysis is “one of the most powerful techniques for the 
preparation of optically active compounds using asymmetric catalysts.” It is also important to 
mention that as well as being efficient and selective bio-catalysts, enzymes typically require 
mild reaction conditions and produce much less waste and harmful by-products than other 
catalysts, making them a more attractive option for chemical synthesis. The most widely used 
group of enzymes for such applications are lipases, which are discussed in the following 
section. 
1.7.2 Lipases: Structure, Function and Activation 
Lipases, also known as triacylglycerol hydrolases (E.C. 3.1.1.3), are one of the most popular 
classes of enzymes used for bio-transformations and are ubiquitous; found in most living 
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organisms.
126,127
 In nature, they are used to digest, transport and process fats, oils, 
triglycerides and other lipids,
128
 and function by catalysing the hydrolytic cleavage of 
triglycerides into fatty acids and glycerol at water-lipid interfaces. In the weight loss industry, 
lipase-inhibitors such as Orlistat
®
 are used to inhibit gastric and pancreatic lipases in the 
gastrointestinal tract to decrease dietary fat adsorption.
129
 Under micro-aqueous conditions, 
lipases have the unique ability to carry out esterification, alcoholysis and acidolysis reactions 
on various esters at the water-lipid interface.
130
 Table 1.2 below illustrates the reactions that 
lipases catalyse.  
 
Table 1.2: Basic mechanisms of various lipase-catalysed reactions. Reactions (ii)-(v) are 
classified as transesterification reactions. 
Reaction Type Scheme 
(i) Hydrolysis R1COOR2 + H2O                    R1COOH + R2OH  
(ii) Esterification R1COOH + R2OH                   R1COOR2 +  H2O 
(iii) Interesterification R1COOR2 + R3COOR4                    R1COOR4 + R3COOR2  
(iv) Alcoholysis R1COOR2 + R3OH                  R1COOR3 + R2OH  
(v) Acidolysis R1COOR2 + R3COOH             R3COOR2 + R1COOH  
 
Lipases are serine hydrolases belonging to the α/β-hydrolase fold superfamily,131 possessing a 
core structure of a central, mostly parallel β-pleated sheet (consisting of 8 β-strands) flanked 
on each side by α-helices131(only the second β-strand is anti-parallel). They hydrolyse ester 
bonds using a catalytic triad comprising of a nucleophillic residue (serine), an acidic residue 
(aspartate/glutamate) and histidine in the active site. The structure of the α/β-hydrolase fold is 
shown below in Figure 1.9.
132
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Figure 1.9: The structure of the α/β-hydrolase fold. α-helices are shown by cylinders; β-
sheets are shown by arrows. Reproduced from Ollis et al (1992).
131,132
 
The serine residue is located in a highly conserved Gly-X-Ser-X-Gly pentapeptide sequence 
(X = unspecified amino acid residue), forming a sharp turn between the β5-strand and the αC-
helix. As close contact exists between the residues in the highly conserved sequence, one or 
often both of these residues in these positions are small glycine groups. It is this β-strand- 
nucleophile-α-helix arrangement which is termed the ‘nucleophile elbow’.126,133,134 The 
tightness of this arrangement forces the nucleophillic residue (serine) to adopt “energetically 
unfavourable mainchain torsion angles”,135 imposing a steric hindrance on residues in the 
immediate vicinity. The nucleophile elbow’s geometry also aids the formation of the 
‘oxyanion hole’, formed by two backbone nitrogen atoms around the active site which helps 
to stabilise the negatively charged transition state species formed during hydrolysis. In a 
mechanism known as the charge relay system, the nucleophillic serine residue is activated by 
hydrogen bonding to the histidine and aspartate/glutamate residues.
136, 137
 The mechanism for 
the charge relay system is shown in Figure 1.10. 
 
Ser 
Asp/Glu 
His 
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Figure 1.10: Active Site Charge Relay System with Serine activation (adapted from 
reference 136).  
A structural feature found in many lipases is that of a ‘lid’ composed of either one or two 
amphiphillic α-helices that cover the active site, blocking substrate access in its closed 
conformation. The side of the lid facing towards the active site is hydrophobic and the side 
facing away is hydrophilic, stabilised by protein surface interactions.
136
 In the closed 
conformation, the hydrophilic surface is exposed to water solvation and the hydrophobic 
surface facing the active site is hidden by the lid.
137
 Interfacial activation is caused by 
reorientation of the α-helix lid by increasing the hydrophobicity of the surface in the 
immediate area surrounding the active site, exposing a large hydrophobic area which can 
interact with the hydrophobic interface and the catalytic triad becomes accessible to the 
hydrophobic substrate (see Figure 1.11). In 2009, Reis et al published a review which 
addresses the reactions involving lipases which take place at interfaces, interfacial 
engineering and properties, limitations and their bio-catalytic applications.
138
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Figure 1.11: Computer simulations of the open-active and closed-inactive structures of 
Thermomyces lanuginosus lipase (TLL). The left side of the diagram depicts the open-active 
conformation and demonstrates how the lid position changes to expose the catalytic triad of 
the active site (Ser = green, His = yellow, Asp = red). The right side illustrates the closed-
inactive conformation. Surface Lys residues are visualised using a space-filling modality, 
indicating the positions most likely to be involved in covalent binding to functionalised 
supports. Adapted from Hanefield et al’s review on Understanding Enzyme 
Immobilisation.
137
  
Lipases require no cofactors to function, are commercially available and are easy to handle. 
They are typically prepared for commercial use by cultivation of microorganisms or by 
extraction from plant/animal tissue.
139
 Microbial lipases are easier to manipulate via genetic 
engineering (or directed evolution
130
) and can be grown year-round on relatively inexpensive 
media. Their production is convenient, safer and they are more stable than their plant- and 
animal-derived equivalents, making them more desirable.
140
 Bacterial strains are generally 
favoured over yeasts as enzyme sources, offering higher activity, being thermostable and 
having neutral or alkaline pH optima. Microbial cells also have short generation times, simple 
nutritional needs, easy screening for desired characteristics and can be genetically or 
environmentally manipulated to increase their yield and enzyme activity.
140,141
 
 
1.7.3 Bio-catalytic Applications of Lipases 
Lipases are widely used catalysts for the hydrolysis of oils/fats and the synthesis of esters. 
There have been many reviews published on their bio-chemical properties,
130,142
 industrial 
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applications
140
 and overall applications as bio-catalaysts.
132,136,139,143-145
 The following section 
will serve to outline a few of the bio-catalytic applications that utilise lipases. 
 
In the pharmaceutical industry, lipases are commonly used as chiral catalysts in the synthesis 
of fine chemicals and pharmaceutical compounds. An example of this is in the synthesis of 
enantiopure secondary alcohols, which are used as intermediates in the synthesis of many 
drug molecules, such as Dorzolamide, an antiglaucoma drug.
128
 They also exhibit high 
enantioselectivity by successfully recognising enantiomeric molecules/enantiotopic groups on 
prostereogenic molecules,
146
 which is useful as they can be used to kinetically resolve 
racemic chiral compounds with a theoretical yield of 50%. In the case of prochiral 
compounds, they can achieve asymmetrisation with a reasonable yield.
146
 It has been found 
that enantioselectivity of lipases can be improved via crosslinking,
147
 crystallisation,
148
 
organic solvent pre-treatment
149,150
 and lipid coating,
151
 amongst other methods.
152
 
Consequently, due to their high enantioselectivity, lipases are seen as important bio-catalysts 
for enantiopure building blocks in the production of commercially available organic 
compounds.  
 
Two particularly important lipases, with respect to this project, are Candida Rugosa Lipase 
(CRL) and Pseudomonas Fluorescens Lipase (PFL). Candida Rugosa is a non-sporogenic, 
unicellular, non-pathogenic yeast that synthesises and secretes a mixture of at least five iso-
enzymes. Each of the secreted iso-enzymes possesses a single 543-amino acid polypeptide 
chain and a molecular weight of around 60 kDa.
153,154
 It’s active site has been extensively 
studied and characterised and it’s catalytic triad consists of the Ser-209, Glu-341 and His-449 
residues.
155
 CRL claims more applications than any other bio-catalysts and there have been 
many publications concerned with its molecular biology and structure,
154
 catalytic 
mechanism,
156
 interfacial activation,
155
 and bio-catalytic applications (see Table 1.3 and 
following section). 
 
Pseudomonas Fluorescens is a rod-shaped, Gram-negative bacterium that produces 
Pseudomonas Fluorescens Lipase (PFL). Pseudomonas lipases are classed in three groups 
depending on amino acid homology and biological properties.
142,157
 PFL belongs to the sub-
family I.2 of Pseudomonas lipases,
158
 and contains a 475-amino acid polypeptide chain. 
Fernández-Lorente et al have reported that PFL has a molecular weight of 33 kDa at low 
enzyme concentrations, but has a tendency to aggregate into more stable, more 
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enantioselective, but less catalytically active bi-molecular structures of around 66 kDa 
molecular weight.
159
 The reduction in activity of the bi-molecular structure is thought to be 
due to the aggregation occurring between the hydrophobic regions surrounding the active 
centres of the two uni-molecular structures in their open form, suggesting that interfacial 
activation competes with formation of the bi-molecular structure. Though the structure of its 
active site is much less studied than that of CRL, as PFL is also an α/β-hydrolase, the 
catalytic triad is still confirmed to contain the characteristic Ser-His-Asp/Glu residues. 
Literature on PFL is less abundant than that on CRL and although there are publications on 
the structures of other Pseudomonas lipases,
160
 currently the exact 3-dimensional structure of 
PFL is not known.
161
 However, there have been publications regarding its growth and 
isolation,
162,163
 purification and characterisation,
164-166
 physiochemical properties
167
 and bio-
catalytic applications (see Table 1.3 and the following section). 
 
A review by Gandhi in 1997
144
 addressed the many hundreds of catalytic applications that 
lipases have in industry. Some of the applications of free CRL and free PFL have been picked 
out and are described in Table 1.3 below. 
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Table 1.3: A selection of the catalytic applications of CRL and PFL outlined in Gandhi’s 
review
144
. 
Lipase Application Reference 
CRL Hydrolysis of fish oil to concentrate polyunsaturated fatty 
acids 
168 
Enantioselective esterification of racemic ibuprofen 169 
Hydrolysis of milk fat (butter oil) 170 
Kinetic study of the hydrolysis of triacetin 171 
Esterification of sugars in the enzymatic synthesis of 
carbohydrate esters of fatty acids 
172 
Transesterification of vinyl acrylate to produce acrylic esters 173 
Enzymatic hydrolysis of olive oil to produce glycerol and 
fatty acids 
174 
PFL Hydrolysis of racemic methyl-branched octanoic acid 
thioesters to determine stereoselective mechanism of action 
175 
Regioselective deprotection of 3ʹ,5ʹ-O-acylated pyrimidine 
nucleosides 
176 
Synthesis of low molecular weight esters in non-aqueous 
systems (CRL also used in this study) 
177 
Intramolecular esterification (direct lactonisation synthesis 
of cyclopentadecanolide from 15-hydroxypentadecanoic 
acid) 
178 
Regioselective acylation of 2ʹ deoxypyrimidine nucleosides 
with an acid anhydride in dry apolar solvents 
179 
Preparation of a chiral building block based on 1,3-syn-diol 
and its application to the synthesis of a hunger modulator 
180 
 
A further search of the literature reveals that CRL has been used extensively as a bio-catalyst 
for more applications including:  
 Esterification of methyl branched carboxylic acids for the resolution of 
citronellic acid.
181
 
  Hydrolysis of racemic methyl esters (such as naproxen) in supercritical 
CO2.
182
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 Preparation of L-amino acyl esters of various carbohydrates.183 
 Enhancement of enantioselectivity for the chiral resolution of carboxylic acids 
in organic solvents.
184
 
 Stereoselective esterifications of relatively short chain primary alcohols185 and 
hundreds of similar applications to the ones listed.  
 
In addition to the applications reviewed by Gandhi,
144
 PFL has been commonly used in other 
applications such as the enantioselective hydrolysis of a selection of 3-(2-nitrophenoxy) 
butanoates,
186
 exhibiting enantiomeric excesses greater than 99.9%. The use of PFL has been 
reported in the enzymatic resolution of various fluorinated arylethyl chloroacetamides via 
alcoholysis of the chloroacetamide group (using n-amyl alcohol in diisopropyl ether), with 
high enantioselectivity
187
 (E = 25 to >100). This is an important application as the 
trifluoromethyl group is commonly used in organic chemistry due it’s substantial electron-
withdrawing ability and small size combining to stabilise small rings and change the 
reactivity and regioselectivity of substituted compounds.
187
 Intensity and fastness of dyes 
increases in the presence of a –CF3 group and optically active α-trifluoromethlyated amines 
are useful building blocks in the synthesis of pharmaceuticals, so increased yield, resolution 
and rate of reaction inferred by PFL is extremely beneficial to this reaction. Another 
application of PFL has been in the kinetic resolution of phenothiazine-based ethanol 
derivatives, which are pharmaceutically important and are known for their important 
biological activity.
188,189
 Other applications of PFL include (but are not limited to):  
 Preparation of optically active 4,4,4-trifluoro-3-(indole-3-) butyric acid, which 
is a novel plant growth regulator.
190
 
 Selective enrichment of C18-C20 acyl-chain polyunsaturated fatty acids from 
sardine oil.
191
 
 Irreversible and highly enantioselective acylation of 2-halo-1-arylethanols in 
organic solvents.
192
 
 Interesterification of butter fat.193 
 Enantioselective transesterification of 2-methyl-1,3-propanediol derivatives in 
organic solvent.
194
 
CRL and PFL have both been employed to catalyse transesterification synthesis reactions of 
citronellyl esters, which are used as a flavouring agents,
195,196
 giving fruity and floral aromas. 
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The transesterification synthesis of citronellyl acetate, catalysed by CRL, PFL and many 
other enzymes was reported by Xiong et al
196
 and is shown in Scheme 1.5 below. 
 
Scheme 1.5: The transesterification synthesis of citronellyl acetate from citronellol and vinyl 
acetate. PFL obtained yields of up to 99.4% conversion, whereas CRL only achieved up to 
20.4%. 
Another area of developing interest is in the lipase-catalysed production of biodiesel. 
Biodiesel consists of fatty acid methyl esters which are typically derived from the 
transesterification of triglycerides with methanol. In 1999, Ma and Hanna published 
‘Biodiesel production: A review’ which summarised the most common methods of synthesis 
and addressed the emerging use of lipases as bio-catalysts for the application.
197
 In 2001, 
Fukuda et al published an article covering biodiesel production by transesterification of 
oils,
198
 though this was only one of many. This area is attractive to industry as both the fatty 
acid products and glycerol by-products are easy to recover and have commercial 
applications.
199,200
 Kaieda et al have reported that methyl esters synthesised via methanolysis 
of plant oil are potentially important as biodiesel fuels.
201
 They used both CRL and PFL (and 
also Pseudomonas cepacia lipase) to catalyse the methanolysis of soybean oil in aqueous 
conditions, remarking that all lipases exhibited particularly high catalytic ability for the 
application. A general and basic schematic representation of the enzyme-catalysed production 
of biodiesel is shown below in Scheme 1.6. 
 
Scheme 1.6: Lipase-catalysed transesterification of fats and oils with alcohol to produce 
biodiesel and glycerol. 
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In 2007, Al-Zuhair published an article on the ‘Production of biodiesel: possibilities and 
challenges’ which addressed the use of immobilised enzymes to overcome limitations 
regarding enzyme cost, re-usability, recoverability and reductions in activity.
202
 In 2008, 
Fjerbaek et al reviewed the state of biodiesel production using enzyme-catalysed 
transesterification.
203
 It can be seen that the use of lipases to catalyse the production of 
biodiesel is an area that has gained considerable interest in recent years. This could be due to 
optimisation of the process using immobilised enzymes for the many advantages they offer. 
The use of supported enzymes for various applications will be discussed in the following 
section. 
 
As has been explored and discussed, enzymes in their free forms can be used to catalyse a 
vast range of chemically and pharmaceutically important reactions and can be used under 
mild conditions while still producing tremendous chemo-, regio- and enantioselectivity. 
However, the use of free enzymes to catalyse these reactions presents a problem: the enzyme 
cannot be recycled or re-used once it is introduced to the system. Also, enzymes are fairly 
expensive so being able to re-use them is cost effective and would make the system more 
commercially viable. Another problem is that most organic compounds that are of 
commercial interest are often insoluble/partially soluble in water, which requires a lot of 
energy to remove.
204
 A way around this is to use organic solvents, which leads to high 
substrate solubility, higher reaction rates and increased ease of recovery of the enzyme from 
the system. However, a disadvantage of using lipases in organic solvents is that catalytic 
activity can decrease dramatically compared to aqueous systems,
205,206
 due to diffusional 
limitations, enzyme destabilisation and changes in protein flexibility.
204,207,208
 As has been 
previously explained, it has been reported that employing micro-aqueous conditions permits 
interfacial activation and ‘lid-opening’ of the lipase’s active site, which can overcome this 
problem and greatly increase catalytic activity. An effective and convenient solution to these 
problems and limitations is to immobilise the enzymes onto a solid support, which creates a 
heterogeneous system. The supported enzyme can be introduced into the reaction mixture, the 
reaction can be carried out and then the enzyme-immobilised solid support can be recovered, 
washed and re-used for further reactions. Magnetic nanoparticles are particularly useful for 
these applications as they can be easily removed from the reaction mixtures by magnetic 
immobilisation.  
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1.8 Immobilisation of Enzymes 
This section of the introduction will serve to outline the most commonly used support 
materials for enzyme immobilisation, typical enzyme immobilisation strategies and their 
optimisation, as well as some bio-catalytic applications of immobilised enzymes and their 
advantages over free enzymes. 
Mateo et al
209
 explained that in terms of multipoint-covalent binding of the enzyme to the 
support in order to rigidify and stabilise the enzyme structure, certain characteristics must be 
considered when deciding on a suitable support.
209
 These include:  
 The support should have high internal surface areas so that there can be no 
geometrical or steric hindrance to the enzyme. 
 The support surface should provide a high density of reactive groups so an 
intense multipoint covalent attachment can be achieved. 
 The reactive groups should provide minimal steric hindrance during the 
reaction as the attachment requires contact between groups bound to rigid 
structures. 
 The reactive support surface moieties should interact and react with groups 
introduced to the enzyme surface and they should also be stable enough to 
permit lengthy enzyme-support reaction times. 
 Finally, it should not be difficult to get a final inert surface in the support 
following immobilisation without affecting the bound enzyme.
209
  
Support materials that have been found to fulfil many of the criteria are agarose beads,
103,210-
213
 zeolites,
214-216
 amorphous and porous silica supports,
217,218
 epoxy resins
219-221
 and 
magnetic nanoparticles.
222
 Immobilisation of enzymes on agarose beads activated using 
glyoxyl groups only proceeds at alkaline pH and catalytic activity is reported to be pH 
dependent. Enzymes that have been immobilised in this way include alcalase and 
carboxypeptidase A for the hydrolysis of proteins,
212,213
 esterase
103
 and many others.
210,223
 
Zeolites are widely used for a range of bio-catalytic applications, ranging between 
immobilising trypsin for peptide synthesis,
216
 cutinases for alcoholysis reactions
215
 and 
lipases on hydrophilic and hydrophobic zeolites for hydrolysis and esterification reactions.
214
 
Silica supports can undergo surface modification with aminosilanes to permit the formation 
of siloxane bonds to amine residues on the enzyme. An example of this method being used is 
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in the immobilisation of apricot pectinesterase on porous glass following aminosilane surface 
modification, which is then used in the food processing industry.
218
 Sepabeads are 
macroporous epoxy-resins and are an example of a divinylbenzene copolymer.
224
 They are a 
common example of a widely used epoxy support. They are shown to remain very stable 
when obtaining Lipase B from Candida Antarctica in the presence of hydrogen peroxide
220
 as 
well as finding application in hydrolysis of lactose in dairy products via immobilisation of 
thermophilic β-galactosidase on its surface.221 Dyal et al were one of the first groups to report 
the use of enzymes immobilised on magnetic nanoparticles and used CRL immobilised on -
Fe2O3 to catalyse the ester cleavage of p-nitrophenol butyrate (PNPB), reporting the long-
term stability and economic viability of immobilised enzymes for bio-catalysis.
222
  
1.8.1 Porous Supports 
A prevalent method of enzyme stabilisation is by immobilisation on porous silica supports of 
various pore diameters (Å to µm scale). Immobilisation within the porous structure of a solid 
can permit the enzyme to fully disperse and utilise the intended surface area. This means they 
are protected from interactions with external surfaces and molecules, as well as molecules 
from the enzymatic sample which prevents aggregation, autolysis or proteolysis from the 
sample and will be homogenously dispersed throughout the pores.
209
 The enzyme will also be 
protected from external hydrophobic surfaces such as gas bubbles which may inactivate the 
enzyme.
225
 
In the process of immobilisation, the surface of the support should be functionalised via one 
of the methods outlined previously (in the case of this project; amino-silanisation). Following 
this, the surface-functionalised material can be activated (using coupling reagents) to enable 
the efficient conjugation of bio-molecules to the surface. 
1.8.2 Enzyme Immobilisation Strategies and Optimisation 
 Enzymes have been immobilised in many ways, the main methods include adsorption (non-
covalent), binding (covalent), self-immobilisation, entrapment and encapsulation.
226
 An 
important point to consider is choosing the correct support to optimise catalytic activity and 
stability of the enzyme when it is immobilised. Entrapments generally use either an organic 
polymer network or sol-gel matrix and are often performed in situ.
227
 The entrapped enzymes 
are then protected from the effects of gas bubbles, mechanical damage and hydrophobic 
solvents, but entrapped enzymes can suffer from mass transfer limitations and lower enzyme 
loadings
228
 than other immobilisation methods.
229
 Encapsulation is similar to entrapment as 
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the enzyme is protected from many external factors but has limited use in bio-catalysis of 
large substrates due to mass transfer limitations again.
228,229
 Self-immobilisation is commonly 
carried out in the case of carrier-free immobilisation, made possible using a bi-functional 
cross-linking molecule, such as glutaraldehyde, to bind enzymes to each other without 
needing a support.
229
 Examples include cross-linked enzyme crystals (CLEC’s)230 and cross-
linked enzyme aggregates (CLEA’s).231,232 Figure 1.12 below is reproduced from a review 
article by Brady and Jordan on “Advances in Enzyme Immobilisation”, showing the main 
strategies involved.
229
 Figure 1.12 presents the main enzyme immobilisation strategies that 
are commonly employed. 
 
 
Figure 1.12: The main enzyme immobilisation strategies: a) entrapment b) encapsulation c) 
solid support by surface conjugation d) self-immobilisation. Enzymes are represented by the 
green dots in the figure, reproduced from Brady and Jordaan.
229 
An example of various immobilisation methods being used in the same reaction is reported 
with PFL. Immobilisation via adsorption, cross-linked enzyme adsorption and sol-gel 
encapsulation was reported for the kinetic resolution of several 3-aryl-3-
hydroxypropanoates.
233
 Immobilisation was shown to increase stability, activity and re-
usability. The bi-molecular form
159
 exhibited increased thermal stability and activity in 
catalysing the transesterification of olive oil with benzyl alcohol. PFL was also immobilised 
on glyoxyl supports at alkaline pH for the hydrolysis of (R,S)-2-hydroxy-4-phenylbutyric 
acid ethyl ester (HPBEt) in both its mono- and bi-molecular forms.
234
 
1.9 Supported Enzymes as Bio-catalysts 
Advantages of immobilisation such as separability and re-usability are important and allow 
greater control over the reaction process. It is also well documented that enzyme activity 
increases when immobilised on solid supports and enzymes become more robust when 
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supported in solid matrix.
204
 The main focus of this section of the introduction is to explore 
the wide range of solid supports that have been used, various methods of immobilisation and 
the important bio-catalytic applications that these immobilised enzymes (primarily lipases) 
are employed in.  
When covalently immobilised via just a single point to the solid support, immobilised 
enzymes can retain rigidity similar to free soluble enzymes and are much less susceptible to 
aggregation, proteolysis and interaction with other surfaces.
235
 However, it is well 
documented that enzymes attached to the support at many points become more rigid
236
 and 
stabilised against distorting agents, as the relative positions of groups involved in 
immobilisation remain unchanged during any conformational change.
237
 This means they can 
be used in any medium, as opposed to adsorbed enzymes, which can only be used in organic 
solvents/hydrophobic reactants due to problems associated with leaching into the solution.
137
 
It is also thought that immobilisation leads to the enzyme being dispersed over a large surface 
area, enhancing mass transfer and preventing aggregation.
238
 Figure 1.13 presents the effect 
of multipoint immobilisation on enzyme stability. 
 
Figure 1.13: The effect of multipoint immobilisation on enzyme stability. Reproduced from 
Mateo et al.
209
 
1.9.1 Bio-catalytic Applications of Supported Enzymes 
An emerging area of particular importance is the production of fatty acid esters, better known 
as biodiesel (production with free lipases is addressed earlier in Section 1.7.3). CRL 
immobilised on chitosan (a linear polysaccharide) was used to catalyse (and optimise) the 
preparation of biodiesel from rapeseed soapstock using methanol.
239
 This method led to 
methyl conversion of 63.6% and methyl ester (biodiesel) contents of over 95% following 
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molecular distillation. Various lipases (CRL, PFL and others) immobilised on porous 
kaolinite were used for the transesterification synthesis of biodiesel using n-butanol.
240
 PFL 
was observed to have the highest activity and was selected as catalyst for the production of 
propyl- and butyl-oleate esters from triolein. Immobilised PFL exhibited increased activity, 
stability and re-usability over free PFL. Various immobilised and free lipases were compared 
for the enzymatic alcoholysis of sunflower oil with methanol to produce biodiesel.
241
 PFL 
immobilised on polypropylene (EP 100) was found to have the second highest activity after 
24h, giving 72.4% conversion of triolein to fatty acid ester products (Rhizomucor miehei 
immobilised on an ion-exchange resin gave 96.3% conversion in 24 h). Alkali lipase from 
Penicillium expansum immobilised on functionalised ceramic foams have been utilised for 
the hydrolysis of olive oil.
242
 As can be seen from the many reactions outlined for the 
production of biodiesel, enzyme-catalysed synthesis is both widely used and efficient. 
Another reaction class of interest is kinetic resolution of racemic mixtures. The resolution of 
(R,S)-2-octanol with SBA-15 (a hexagonal array mesoporous silica molecular sieve), 
Pseudomonas sp. Lipase (PSL) and vinyl acetate to produce (R)-2-octanol and (R)-2-octanol 
acetate has been reported.
243
 2-octanol, or capryl alcohol, is commonly used as a raw 
material to make caproic acid, which is used as a flavour intermediate, or 2-octanol itself can 
be refined to produce plasticisers.
244
 The reaction is summarised in Scheme 1.7 below. 
 
Scheme 1.7: Lipase-catalysed resolution of (R,S)-2-octanol with vinyl acetate. 
Full resolution of racemic 1-phenylethanol to (R)-1-phenylethanol and (R)-1-phenylethyl 
acetate using immobilised Candida Antarctica lipase B on a modified silica meso-cellular 
foam has been reported.
245
 This is important because chiral alcohols can be used in 
enantioselective organic synthesis. α-Chymotrypsin immobilised on MCM-41 has been 
utilised by Fadnavis et al
246
 in the chiral resolution of (±)-trans-4-methoxy-3-phenylglycidic 
acid methyl ester, shown in Scheme 1.8.  
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Scheme 1.8: Kinetic resolution of (±)-trans-4-methoxy-3-phenylglycidic acid methyl ester 
glycidate with α-Chymotrypsin immobilised on MCM-41. Reproduced from Fadnavis et 
al.
246
 
The resolutions of racemic mixtures explained above have all been catalysed by lipases 
which have been immobilised on silica supports. Other supported lipases used for resolving 
racemic mixtures include: 
 Novozym® 435 (Candida Antarctica Lipase-B (CAL-B) immobilised on acrylic 
resin).
115,247
 
 Magnetic nanoparticles.248-250 
 Celite,251 epoxy resins252 and many others.223  
However, the most widely used support material for enzyme immobilisation is silica. In 
addition to the methods outlined above which are used to produce biodiesels, in 2011 
mesoporous silica prepared via the sol-gel method was used to immobilise cellobiase enzyme 
which was then used in the enzymatic hydrolysis of biomass, generating ethanol for 
biofuels.
253
 In the same year, lipase-immobilised mesoporous silica were used in the 
methanolysis of soybean oil to biodiesel.
254
 These are just a small fraction of the uses of 
porous silica as a support.  
1.9.2 Silica Supports 
Applications of various enzymes immobilised on silica are copious and porous silica has 
found the most applications as a support material. It has been widely used for a long time to 
immobilise various enzymes to carry out a huge range of applications. In 1982, glucoamylase 
was immobilised on various porous silicas’ (macroporous silica gels, silochromes and porous 
glasses) for starch hydrolysis.
255
 In 1984, the kinetics of the hydrolysis of starch, amylase and 
maltose were investigated using glucoamylase immobilised on alkylamine derivatives of 
Ti(IV)-activated porous silica.
256
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More recently, it has been exhibited that enzymes can be immobilised on porous silica (pore 
size ~2 nm) nanotubes with higher catalyst loadings than other mesoporous silica 
materials.
257
 In 2000, porous silica beads with immobilised Porcine Pancreatic Lipase (PPL) 
were used in the enzymatic ring-opening polymerisation of cyclic phosphates.
258
 CRL 
immobilised on amorphous silica nanoparticles has been used to synthesise ethyl isovalerate, 
a flavouring agent commonly found in fruits.
259
 
In an excellent article by Hartmann and Jung, the significant reactions carried using 
immobilised enzymes on mesoporous silica are reviewed;
260
 the three most common being: 
resolutions of racemic mixtures, hydrolysis reactions and selective oxidations.  
1.10 Bio-catalytic Applications of Supported Enzymes on Magnetic 
Nanoparticles 
The area which is of most relevance to this project is the use of silica-coated 
superparamagnetic iron oxide (magnetite, Fe3O4) nanoparticles (SPIONs) as solid supports 
for lipase immobilisation. An excellent review of SPIONs and their development, surface 
modification and applications in chemotherapy can be found in reference 44. Previous work 
in the field has shown that magnetic nanoparticles (MNP’s) coated in amorphous silica217 
have been used in the isolation of bio-molecules, such as genomic
76
 and plasmid
261
 DNA, 
extraction of nucleic acids from soil,
262
 drug delivery
263
 and extraction of phenolic 
compounds from environmental water.
264
 MNP’s coated with mesoporous silica99,265 have 
been found to be useful in controlled drug delivery,
266,267
 hyperthermia,
268
 removal of 
mercury from- and desulfurisation of -industrial effluent,
269
 fluorescence, magnetic resonance 
imaging
270
 and isolation of plasmid and genomic DNA similar to MNP’s coated with 
amorphous silica.  
Certain properties of nanoparticles that make them attractive for use in drug delivery - such 
as high surface area, ability to cross cellular and tissue barriers and resistance to bio-
degradation - have been found to increase their cytotoxic potential relative to the bulk 
material.
271
 Whereas the iron oxide core alone has been associated with causing inflammatory 
responses
274
 and inducing oxidative stress – leading to apoptosis (programmed cell death),272-
274
 silica-coated magnetite nanoparticles are bio-compatible.
275,276
 It is important to assess 
how the drug and shell materials interact with each other to avoid bursting which could lead 
to the formation and release of toxic chemicals in the body.
44
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It has also been found that mesoporous, macroporous and meso-cellular silica foams with 
immobilised enzymes on the surface lack ordering in the pore structure when they were 
studied for bio-catalysis.
94
 In a method to overcome this, Sen et al have reported the template 
assisted fabrication of hierarchically ordered porous magnetic nanocomposites and their 
potential as supports for bio-catalysis.
100
 In their study, they investigated the catalytic activity 
of CRL immobilised on hierarchically ordered porous magnetic nanocomposites to convert p-
nitrophenyl palmitate (PNPP) to palmitic acid and p-nitrophenol via ester hydrolysis. The 
immobilised enzymes were found to exhibit catalytic conversion values of roughly 100 times 
less than that of pure lipase in homogeneous conditions, but retained most of their catalytic 
activity and stability after many cycles, which is impossible using free enzymes in solution as 
they are unrecoverable. This reaction is useful as palmitic acid is a well-known substrate for 
lipase-activity;
277
 was formerly used in napalm synthesis;
278
 its derivatives have been 
investigated for use in anti-psychotic drugs;
279
 and it is one of the major components of palm 
oil found in foods, or used to produce biodiesel.
280
 The reaction is shown below in Scheme 
1.9. 
 
Scheme 1.9: Immobilised lipase-catalysed hydrolysis of PNPP. 
The catalysis of p-nitrophenyl butyrate (PNPB) is much less documented but has been done 
before, using free enzymes,
281
 and recently a study comparing enzyme-immobilisation 
methods on the bio-catalytic hydrolysis of PNPB has been carried out.
282
 The study 
concluded that lipases immobilised on solid supports (zeolites in this case) exhibited higher 
specific activity than cross-linked enzyme aggregates (CLEA’s) and supplied a 
“heterogeneous catalyst with promising catalytic properties”.282 Using the materials produced 
in this project for the catalysis of PNPP hydrolysis, comparisons can be made with previous 
studies.  
 
Magnetic silica nanoclusters (clusters of silica-coated magnetic nanoparticles of roughly 500 
nm) have been used and benefited from increased chemical stability and decreased 
aggregation.
283,284
 It has recently been reported that L-lactate dehydrogenase (LDH), 
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covalently immobilised on silica-coated magnetic nanoclusters, could be suitable for 
catalysing the chiral synthesis of pharmaceutical compounds.
285
 Netto et al
286
 have reported 
that Candida Antarctica lipase (CAL) immobilised on superparamagnetic silica-coated 
nanoparticles can be used to catalyse enantioselective transesterification reactions, such as the 
enantioselective acetylation (and hence kinetic resolution) of alcohols derived from (R,S)-1-
phenylethanol using vinyl acetate as acyl donor.
286
 This group also tested catalytic activity by 
examining the hydrolysis of PNPP. This study is useful to our project as it shows the viability 
of enantioselectively-acylating secondary alcohols using enzymes immobilised on 
superparamagnetic silica-magnetite nanoparticles.  
One reaction that will be performed during the bio-catalysis phase is the use of a selection of 
lipase enzymes (CRL and PFL), immobilised on silica-coated SPION’s for the bio-catalytic 
partial and selective hydrolysis of cis-3,5-diacetoxy-1-cyclopentene (3 in Scheme 1.10, 
shown below) to obtain enantiomerically pure (1S,4R)-cis-4-acetoxy-2-cyclopenten-1-ol and 
its (1R,4S) enantiomer (2a and 2b respectively).  
 
Scheme 1.10: Enzyme-catalysed hydrolytic synthesis of (1S,4R)-cis-4-acetoxy-2-
cyclopenten-1-ol (2a) and its enantiomer (2b). 
Although this reaction has been reported previously, catalysed by lipase from Mucor sp.,
287
 
pancreatin
288
 and immobilised Mucor miehei lipase (Chirazyme
®
),
289
 to the best of my 
knowledge, this reaction has not been carried out using immobilised lipases on magnetic 
nanoparticles. The products are high cost synthetic chiral intermediates which are starting 
materials for the synthesis of carbocyclic nucleoside analogs
290
 (useful immunosuppressants) 
and particularly eicosanoid compounds:
291
 (bio-active lipids derived from 20-carbon 
unsaturated fatty acids
292
 which act as signalling molecules involved in the regulation of 
bodily systems including inflammation, immunity and as messengers in the central nervous 
system
293-295
) specifically prostaglandins, prostacyclins and thromboxanes.
289,296-298
 Figure 
1.14 presents the structure of Prostaglandin E1, pharmaceutically known as the drug 
alprostadil, which is a vasodilator used to treat erectile dysfunction.
299,300
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Figure 1.14: The structure of Prostaglandin E1. 
Considering the high demand for these chiral intermediates, development of economically 
viable enzymatic technology to catalyse their large-scale synthesis is a key synthetic 
objective and one which is currently relevant.  
Another common reaction catalysed by lipase-immobilised magnetic nanoparticles is the 
transesterification (alcoholysis) of short chain alkyl esters. The alcoholysis of ethyl butyrate 
with n-butanol has been previously reported using CRL immobilised on surfactant-, fatty 
acid- and polymer-coated magnetite nanoparticles
301
 along with immobilised Mucor miehei 
(Lipozyme
®
)
302
 and free rape-seedling lipase
303
 (among many others). The mechanism of the 
reaction is shown in Figure 1.15. 
 
Figure 1.15: The mechanism of lipase-catalysed transesterification (alcoholysis) of ethyl 
butyrate with n-butanol. NP denotes surface-functionalised, silica-coated magnetic 
nanoparticles, Enz denotes enzyme, B denotes basic group and Bu denotes butyl group.  
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1.10.1 Bio-catalysis with Supported Enzymes: Summary 
A wide range of enzymes (particularly lipases) immobilised on various support materials 
have been utilised successfully as bio-catalysts. Table 1.4 provides a comprehensive listing of 
the main types of bio-catalytic reactions outlined in Section 1.9, along with the types of 
support used.  
Table 1.4: A summary of the main types of supports and enzymes used.  
Support 
type 
Enzyme(s) Studied Reaction(s) and Reaction 
Class(es) 
Ref. 
Silica Lipases, 
dehydrogenases, 
peroxidases and 
oxidases. 
 
Various including oxidation, hydrolysis, 
esterification and kinetic resolution. 
260 
Agarose 
beads 
Carboxypeptidase A, 
Alcalase, 
Esterases, 
Lipases. 
 
Protein hydrolysis,  
Esterification. 
103,210-
213  
Zeolites Trypsins, 
Cutinases, 
Lipases. 
 
Peptide synthesis, alcoholysis, 
hydrolysis, esterification.  
214-216 
Porous 
glasses 
Apricot 
pectinesterase. 
Hydrolysis of methoxyl groups of 
methylated galacturonic residues in pectin 
molecules. 
 
218 
Epoxy 
resins 
Lipases,  
Β-galactosidase, 
cytosine deaminase, 
5-fluorocytosine. 
Hydrolysis of dairy products, cancer 
chemotherapy.  
 
219-221 
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Table 1.4: Continued 
Support 
type 
Enzyme(s) Studied Reaction(s) and Reaction 
Class(es) 
Ref. 
Magnetic 
NPs 
CRL Hydrolysis of p-nitrophenyl esters, 
esterification synthesis of ethyl 
isovalerate, transesterification of ethyl 
butyrate. 
 
222,259,301 
Silica-
coated 
magnetic 
NPs 
Lipases,  
Dehydrogenases, 
Various others.  
 
Enantioselective esterification, 
hydrolysis, isolation of bio-molecules, 
extraction of nucleic acids, controlled 
drug delivery, water purification, 
fluorescence and magnetic resonance. 
44,73,81, 
217, 261-
263,269,270
279,283, 
284,286,304 
 
1.11 Introduction to Bio-separations and Bio-sensors Using Magnetic 
Nanoparticles 
1.11.1 Bio-separations 
Bio-separation involves the selective separation and purification of target bio-molecules from 
a mixture of biological components. Typical methods used in bio-separations are:
305
 
 Physical and mechanical methods such as various adsorption,306 filtration,307 
centrifugation
308
 and magnetic separation techniques.
309,310
 
 Chemical and thermal methods such as reverse osmosis,311 ion-exchange,312 
chromatography
313
 and electrophoresis
314
 techniques.  
Magnetic nanoparticles and functionalised magnetic nanoparticles have been widely used in 
bio-separations for numerous applications, outlined below: 
 Protein recovery and separation from protein mixtures.315,316 
 Immunomagnetic cell isolation and separation.317,318 
 Immunomagnetic assays, i.e. a chemiluminescence enzyme immunoassay for 
sensitive and rapid detection of immunoglobulin G,
319
 a fluoroimmunoassay for the 
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detection and removal of E.Coli
320
 and an enzyme-linked immunosorbent assay 
(ELISA) for detection of Staphylococcus spp. bacteria in milk.
321
 
1.11.2 Bio-sensors 
Bio-sensors are biological analytical devices that combine a biological recognition element 
with a physicochemical detector (such as a transducer).
322
 They can be classified according to 
the detection methods used and some examples using magnetic nanoparticles are explained in 
detail below. 
Optical bio-sensors: are powerful tools for detection and analysis that have many 
applications in the bio-medical, pharmaceutical and military industries.
323
 Detection is 
typically either fluorescence-based (binding of fluorescence-tagged target or receptor 
molecules resulting in a measurable increase in fluorescence) or label-free (by measuring 
changes in optical properties such as refractive index and optical absorption).  
Optical bio-sensor systems incorporating magnetic nanoparticles have been used for the 
detection of: drugs in human blood serum/plasma and saliva,
324
 antigens related to 
Alzheimer’s disease,325 myocardial infarction diagnosis326 and others,327 food-borne 
pathogens,
328
 DNA, RNA and protein molecules.
329-331
 In 2010, Smith et al reported the 
impact of using magnetic extraction using antibody-conjugated MNP’s labelled with 
fluorescent proteins for both target pre-concentration and integration into immunoassays 
leading to enhanced signal generation.
332
 
Electrochemical bio-sensors: are widely used as they can directly convert a biological 
“event” to an electric signal, i.e. by measuring current (amperometric), charge accumulation 
(potentiometric) or changes in conductive properties between electrodes in a medium 
(conductometric).
322
 They typically employ screen-printed electrodes as both the solid-phase 
for the immunoassay and the electrochemical transducers. Specific enzyme-labelled 
antibodies/antigens are directly immobilised onto the electrode surface and produce 
electroactive products upon binding with their target which can be detected at the electrode 
surface
333
. However, this can lead to problems such as shielding of the surface by the bound 
antibody-antigen complex.  
The use of bio-ligand-functionalised magnetic nanoparticles as the solid phase for the 
reaction leaves the electrode surface free and the product can diffuse onto the bare electrode 
surface without steric hindrances. Typical detection methods are cyclic voltammetry (CV), 
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chronoamperometry (CA), electrochemical impedance spectroscopy (EIS), potentiometry and 
others.
322
 Examples of magnetic nanoparticles being used for electrochemical bio-sensor 
applications are outlined in Table 1.5 below. 
Table 1.5: Examples of electrochemical bio-sensors and their applications.  
Bio-sensor System  Species Detected and Application Ref. 
Screen-printed carbon electrodes 
(SPCEs) coated with ferricyanide 
magnetite, yeast YADH and NAD
+
 
cofactor. 
Ethanol from fermentation and distillation 
processes. 
334 
Glucose oxidase layered on drop-
coated ferricyanide magnetite on 
SPCEs. 
Sensitive detection of glucose as a clinical 
indicator of diabetes and in the food industry. 
 
335 
Laccase immobilised on core-shell 
silica-magnetite nanoparticles, 
attached to a carbon paste electrode. 
Detection of hydroquinone in compost (due to 
being hazardous and degradation-resistant in 
the environment).  
 
336 
Tyrosinase immobilised on magnetic 
MgFe2O4 nanoparticles, attached to a 
carbon paste electrode. 
 
Detection of phenol, a contaminant in ground 
and surface water. 
337 
Glutathione oxidase immobilised on 
chitosan-functionalised gold-coated 
magnetite nanoparticles, attached to a 
modified Pt electrode. 
Detection of glutathione, a human health bio-
marker overexpressed in tumour tissues and 
altered levels in plasma are implicated in 
diagnosis of Alzheimer’s, Parkinson’s, 
diabetes and HIV. 
 
338 
PEGylated arginine functionalised 
magnetite nanoparticles, coated on a 
glassy carbon electrode. 
Detection of dopamine, a neurotransmitter 
that plays an important role in the function of 
the central nervous, renal and hormonal 
systems. Low or abnormal metabolisms of 
dopamine are associated with Parkinson’s, 
schizophrenia, epilepsy and others.  
339 
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The second aim of this project is to develop both bio-separation and bio-sensor systems for 
the detection of pathogenic Listeria Monocytogenes (LM) in real food samples and 
Escherichia Coli (EC) in both food and wastewater. In terms of bio-separation, LM- or EC-
specific oligonucleotides or antibodies will be covalently attached to functionalised magnetic 
nanoparticles for the specific capture of LM or EC from a mixture of bacteria and nucleic 
acids. In the case of oligonucleotide capture, the LM or EC bacteria captured on the 
nanoparticles will be removed by dehybridisation and amplified and quantified using real-
time quantitative PCR. Hence, it is important to discuss why both LM and EC are of such 
interest. 
1.11.2.1 Listeria Monocytogenes (LM) 
Listeria Monocytogenes (LM) is a Gram-positive, rod-shaped facultative anaerobic bacterium 
and is widespread, with the ability to multiply at low temperatures (refrigeration 
temperatures) and within a wide pH range (4.39-9.40).
340,341
 It can contaminate foods such as 
cheeses, raw milk, ice cream, raw and cooked poultry and fish, raw vegetables and raw 
sausages
342
 - causing listeriosis; a severely infectious disease known to cause meningitis, 
septicaemia and spontaneous abortion, as well as fatality in around 30% of all cases.
343,344
 
Therefore, it is important to find suitable materials and processes in order to detect low levels 
of LM in food samples in conjunction with the European quality of safety directly related to 
human health.  
1.11.2.2 Escherichia Coli (EC) 
Escherichia Coli (EC) is a Gram-negative, rod-shaped facultative anaerobic bacterium 
commonly found in the intestinal tract of animals.
345
 Most strains of EC are harmless, but 
some serotypes are inherently pathogenic, leading to infections including urinary tract 
infection [uropathogenic (UPEC)],
346
 meningitis in newborns [newborn-meningitis-causing 
(NMEC)]
346
 and enteric/diarrheal diseases [enterotoxigenic (ETEC), enteroinvasive (EIEC), 
enterohemorrhagic (EHEC), enteropathogenic (EPEC) and enteroaggregative (EAEC)].
347,348
 
EC is serotyped according to its somatic (O), flagellar (H) and capsular (K) surface antigen 
profiles. Enterohemorrhagic EC (EHEC) can be identified as pathogenic and dangerous as it 
produces the major virulence factor, the Shiga toxin, which is cytotoxic.
349
 These strains are 
also known as Shiga toxin-producing Escherichia Coli (STEC) strains and well-known 
outbreaks of contamination have been found to be caused by strains including Escherichia 
Coli O104:H4 (enteroaggregative – causing persistent diarrhea350) and O157:H7 
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(enterohemorrhagic – causing bloody diarrhea350), both found in undercooked ground beef, 
raw milk, cheese, vegetables and water, amongst other things.
346-349,351-353
 These are the 
specific strains that this project will attempt to selectively isolate and detect from real 
samples.  
1.11.2.3 Typical Bacteria Detection Methods 
Typical methods of detection involve placing the bacteria sample in an enrichment broth with 
or without selective agents for around 48 hours. After 24 and 48 hours, the enriched cultures 
are streaked onto Agar plates, which contain selective isolation media to only permit the 
growth of a specific species. The plates are incubated at 30-35ºC for 24-48 hours, depending 
on the media present. The bacteria is then often isolated for analysis and identification
341,354
. 
Following enrichment and culturing, the sample can then be analysed using a range of 
detection methods. There are three main methods of bacteria/microbe capture and detection 
used in industry today.
355
 They are: 
1. Molecular whole-cell and surface recognition methods: This method 
involves binding to molecular structures on the surface or interior structures of 
the target microorganisms (bacteria, viruses, genetic materials). This is 
typically carried out with immunoassay techniques, bacteriophages and 
specific probes (for example ELISA assays and immunomagnetic separations). 
 
2. Enzyme/substrate methods: Based on existing widely-used chromogenic or 
fluorogenic substrate methods, or done by developing new enzyme-substrate 
methods. This method is done by the capture of fluorophore- (or 
chromophore-) tagged growth substrates by the enzyme. This is followed by 
the substrate growth and subsequent enzymatic cleavage of the fluorophore, 
causing an increase in fluorescence which can be detected. Examples include 
agarose gel electrophoresis and Southern blotting. 
 
3. Nucleic acid detection methods: These methods capture target specific 
microorganism nucleic acid sequences, which are then amplified for detection. 
Common methods of amplification include: Polymerase chain reaction (PCR), 
reverse transcriptase PCR (RT-PCR), quantitative PCR (qPCR), nucleic acid 
based amplification and microarrays.  
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The primary method chosen for detection of both LM and EC (following bio-separation) in 
this project is PCR, as it is possible to target specific nucleic acid sequences for amplification 
and detection. It also has the advantage over typical microbiological detection methods as it 
is more sensitive, requiring the culture to be enriched for a shorter time. It can provide rapid, 
accurate results and is a very widely used, efficient method commonly used for bacteria 
detection. For specific LM detection, the virulence protein listeriolysin O, encoded by the 
gene hlyA, is commonly the target of the primers in the PCR reaction,
309,356,357
 although 
others can be targeted.
358
 For specific EC detection, targets include: β-galactosidase, encoded 
by the gene lamB;
359
 β-D-glucoronidase, encoded by the gene uid;360 and the chromosonal 
gene, eae.
361
 Initially separating the target species from a mixture can make detection much 
quicker, efficient and more sensitive. For this reason, bio-separations with magnetic 
nanoparticles for the specific detection of LM or EC will be discussed first.  
1.11.3 Immobilisation of Bio-molecules for the Detection of Specific Target Bacteria 
In PCR, Taq polymerase (a recombinant thermostable DNA polymerase used to catalyse 
DNA synthesis) can suffer from inhibition in the presence of some components of food, 
enrichment media, or particularly large amounts of DNA. As a pre-PCR step, immunological 
techniques such as the enzyme-linked immunosorbent assay (ELISA) can be used alone to 
detect and isolate specific bacterial cells or antigens within samples. However, as they require 
a detection limit of 10
5
-10
7
 colony-forming units per millilitre of reaction medium 
(CFU/mL), they still require lengthy enrichment and plating steps.
362
 Therefore, the use of 
immunological methods combined with separation techniques is useful as a method of 
isolating specific bacteria from enrichment broths and samples before PCR. Immunomagnetic 
separation (IMS) is a commonly used technique that combines both methods; permitting 
specific capture of bacteria/antigens from an enrichment broth, while concentrating the target 
cells and removing PCR-amplification inhibiting species.
341,363
 Immunomagnetic separation 
(IMS) requires specific receptor molecules (typically antibodies) immobilised on magnetic 
solid supports which bind to target molecules (antigens) within the sample.
362,364
 
1.11.3.1 Using Immobilised Antibodies 
Methods involving covalently immobilised antibodies on magnetic nanoparticles have been 
previously reported by many groups
341,365-368
 and when combined with PCR or qPCR, offer 
increased sensitivity of detection over techniques such as classical microbiological 
enrichment and culture plating, gel electrophoresis and Southern blotting. These methods are 
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the basis of immunomagnetic procedures.
369
 In 1993, Fluit et al first reported the use of 
magnetic nanoparticles coated with LM-specific monoclonal antibodies for the detection of 
LM in cheese.
362
 Since this first reported use of immunomagnetic separation, many groups 
have used this method. 
For detection of Listeria, IMS has been popular due to the commercial availability of anti-
Listeria immunomagnetic beads, such as anti-Listeria Dynabeads
®
 (Dynal Biotech 
ASA).
341,363
 However, these beads capture all Listeria species and are not specific for LM 
only. Yang et al reported that carboxyl-modified magnetic nanoparticles with covalently 
immobilised rabbit anti-LM antibodies were used for the IMS and detection of LM in 
artificially contaminated milk.
341
 Their findings confirmed that immobilised rabbit anti-LM 
antibodies on functionalised magnetic nanoparticles afforded higher capture efficiency and 
specificity for the target LM antigen. Reasons for these results could be that the magnetic 
nanoparticles are much smaller (70-100 nm) than the commercial Dynabeads
®
 (which are 
~2.8 µm diameter), having a higher surface-to-volume ratio and efficient diffusion properties, 
facilitating the rapid binding kinetics to target cells within the milk.
341
  
For specific EC detection, IMS methods involving magnetic nanoparticles have been used 
with classical microbiological plating
370,370
 as well as in combination with techniques such as 
chemiluminescence,
371
 electrochemiluminescence,
372
 ELISA,
373
 flow cytometry
374
 and 
others.
375-377
 A good example of IMS combined with another technique is reported by Yu 
and Bruno,
372
 who combined immunomagnetic separation (with antibody-coated magnetic 
beads) with electrochemiluminescent detection to target EC O157:H7 and Salmonella 
typhimurium in both food and environmental water samples. Various IMS assays have also 
been developed for the detection of Salmonella
310,364,378,379
 and others.
380-383
 
1.11.3.2 Using Immobilised Oligonucleotides 
Nucleic acid bio-separation relies on the hybrid capture of a target oligonucleotide sequence 
using a specific complementary oligonucleotide sequence covalently-immobilised on 
functionalised magnetic nanoparticles. The immobilised captured target sequence can then be 
washed to remove impurities from the system before being dehybridised and used for 
amplification and detection using techniques such as qPCR. It is a modification of typical 
IMS techniques and is much less common. By selectively isolating target DNA from a 
complex sample mixture, time-consuming cultural enrichment steps can be avoided and 
shorter specific nucleic acid enrichment periods can be implemented. Total detection time is 
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decreased and PCR sensitivity can be increased due to removal of inhibiting species and non-
target DNA.  
Initial techniques used biotinylated capture probes to capture target DNA from samples, 
followed by immobilisation upon Streptavidin- or avidin-coated magnetic supports, which 
were then actually used in the PCR reaction itself.
384-388
 One of the first reported applications 
of this technique was in 1994, when Heerman et al used hepatitis B virus (HBV) DNA as a 
template nucleic acid for hybrid capture, immobilisation and subsequent PCR amplification 
and detection.
384
 The first step was to chemically denature HBV proteins, the second step was 
to hybridise biotinylated oligonucleotides to the HBV-DNA in the liquid-phase and then the 
final step was to immobilise them onto Streptavidin-coated magnetic nanoparticles. The 
samples were then analysed using PCR. Since this first reported use, the same method has 
been used for capture and detection of chronic enteric pathogens,
385
 mycobacterial DNA (for 
the diagnosis of tuberculosis),
386
 poliovirus,
387
 hepatitis C virus,
388,389
 and others.
390
  
More recently, methods that utilise capture oligonucleotides covalently-immobilised on 
functionalised magnetic nanoparticles have started to gain popularity, particularly for the 
detection of LM.
344,391
 In 2006, Amagliani et al developed a rapid and sensitive method for 
detecting LM in milk samples using a LM-specific, covalently immobilised (via imine bond) 
oligonucleotide (capture probe) on functionalised core-shell silica-magnetite nanoparticles.
344
 
The oligonucleotide sequence was selected from a highly conserved region of the listeriolysin 
O gene (hlyA) and was located outside the desired specific PCR site to avoid cross-
contamination. The captured sequence was then dehybridised and qPCR was used for 
amplification and detection. Scheme 1.11 provides a schematic representation of the 
oligonucleotide capture and dehybridisation sequence.  
 
Scheme 1.11: Schematic representation of target sequence capture by an immobilised capture 
oligonucleotide. 
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In 2010, the same group developed a multiplex magnetic hybrid capture assay for 
simultaneous detection of Salmonella spp. and LM DNA from seafood.
392
 They utilised a 1:1 
mixture of immobilised Salmonella spp. and LM capture probes on functionalised silica-
magnetite nanoparticles for simultaneous and selective isolation of the target DNA sequences 
from samples contaminated with both species. Following isolation of the target species, a 
triplex real-time PCR (qPCR) was carried out in the presence of an Internal Amplification 
Control (IAC) to simultaneously amplify, detect and quantify the amount of the target species 
in each sample. 
In 2012, Zhu et al developed a novel nanomagnetic primer based electrochemiluminescence-
PCR strategy for genome detection and analysis. The process relies on two in situ processes: 
1) PCR on the magnetic nanoparticle surface and 2) Magnetic nanoparticle loading onto a 
magnetic electrochemiluminescence readout platform.
391
 This method was used to rapidly 
and selectively detect LM at limits of 500 fg/µL in 1 hour, a limit comparable to that of 
qPCR. 
Examples of similar methods that use capture oligonucleotides covalently-immobilised onto 
functionalised nanoparticles in the detection of EC are less common than LM, but include: 
 Detection of EC from stool samples using primer-immobilised magnetic nanoparticles 
to detect enterotoxigenic EC (ETEC) using PCR.393 
 Detection of EC O157:H7 using oligonucleotide-functionalised gold nanoparticles in 
combination with piezoelectric bio-sensing.
394
 
  Detection of EC using gold nanoparticles and a thiolated capture oligonucleotide 
(from EC) immobilised into a 3-dimensional mercaptosilane-based sol-gel polymeric 
network, formed onto a screen printed gold electrode surface for electrochemical 
detection.
395
 
 
Further examples of target species that have been detected using oligonucleotide-grafted 
nanoparticles include genetically-modified organisms,
396
 Alexandrium species that cause 
harmful algal blooms in the Mediterranean Sea
397
 and rotavirus (an enteric diarrhoea causing 
pathogen).
398
 It is interesting to note that most of the methods which used PCR as a detection 
method, have used the hybridised capture and target sequences immobilised on the magnetic 
nanoparticles directly in the PCR, without prior dehybridisation of the target sequence from 
the support. This is in contrast to using dehybridised single-stranded DNA, which can avoid 
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slight steric hindrances of DNA and primer target recognition on the nanoparticle surface in 
the PCR reaction. Many new processes are using PCR combined with other detection 
techniques such as electrochemiluminescence to afford quicker and more sensitive 
results.
391,398
  
As has been mentioned previously in this section, following the selective isolation of the 
target species from a sample, the purified or captured materials can then be amplified and 
detected by a variety of methods, leading to accurate quantification of the target species. With 
regards to this project, the most important of these detection methods is the polymerase chain 
reaction (PCR), which will be discussed in detail in the upcoming section.  
1.11.4 Polymerase Chain Reaction (PCR) 
Initially developed in 1983 by Mullis
399
 (later earning him the 1993 Nobel Prize in 
Chemistry), PCR is an in vitro method used for the amplification of DNA. PCR uses two 
oligonucleotides (short lengths of single-stranded DNA, also known as primers) 
complementary to opposite strands of the target DNA, to specifically amplify the regions 
between them in order to direct the target-specific synthesis of new DNA copies (amplicons). 
The primers provide the initiation site for DNA synthesis, catalysed by a thermostable DNA 
polymerase (such as the recombinant thermostable DNA polymerase from the Thermus 
Aquaticus microorganism - Taq polymerase).  
The new DNA which is synthesised by Taq polymerase is then used itself for further 
replication, hence giving rise to a chain reaction in which the target DNA sequence becomes 
exponentially amplified. PCR relies on a three-step thermal cycling method to synthesise new 
DNA sequences from an original DNA template sequence: 
1. Denaturation/melting: The original DNA is heated in order to separate the two 
strands in its double helix. This step is typically around 95ºC, time can vary from 30 
seconds to 10 minutes.  
2. Hybridisation/annealing: Specific oligonucleotide sequences (primers) to each 
strand of the DNA are added in vast excess to the original DNA
400
 (due to the huge 
amount of copies to be made) and are then hybridised (annealed) to the separated 
single-strands at around 40-65ºC for a short time (usually less than 1 minute). The 
temperatures used can vary, but are usually just under the melting point (Tm) of the 
primer-DNA complex. If the primer and DNA sequences are complementary, then 
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stable bonds will form between them and the Taq polymerase then begins to attach 
additional complementary nucleotides at these sites. 
3. Extension/elongation: The temperature is increased to 70-75ºC (typically 72oC) as 
this is close to the optimum working temperature of Taq polymerase, which works by 
adding complementary nucleotides to the developing DNA strands, forming a new 
double stranded DNA molecule. Also, non-complementary bonds between the primer 
and DNA sequence are broken in this step.  
These steps 1-3 are then repeated with the newly formed DNA amplicons for 20-45 cycles. 
The process is shown below in Figure 1.16. 
 
Figure 1.16: Schematic representation of the PCR process. Step 1 is denaturation at around 
95ºC to separate double-stranded DNA to single-stranded DNA. Step 2 is the annealing of 
primers to their complementary target sequences on the single-stranded DNA at around 60ºC. 
Step 3 is the extension phase using Taq polymerase to generate a new sequence of double-
stranded DNA. At the end of the first cycle, the newly formed double-stranded DNA 
sequences are used as templates for subsequent cycles. Figure reproduced and adapted from 
reference 401, which had mixed up the 3ʹ and 5ʹ ends of the primer bound to the upper strand 
of the denatured double-stranded DNA. 
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Following the first cycle, two new DNA amplicons (identical to the target) are formed, but 
without a clearly defined 3ʹ end. They do, however, possess the precisely defined 5ʹ end and 
as the number of cycles increases, newly formed amplicons with more defined lengths are 
used as DNA templates and new DNA amplicons synthesised from these have clearly defined 
lengths limited at either end by the 5ʹ group of the two primers (can be seen in Figure 1.16). 
For example, in the second cycle, a discrete double-stranded product is formed which is 
exactly the length between the primer ends on the original DNA template. Each of these 
strands are complementary to the primers and are used as templates in subsequent cycles to 
produce new double-stranded DNA amplicons with a precisely defined length. After 20 
cycles, around 1 million molecules are cloned from a single segment of the original double-
stranded DNA. In the absence of any inhibiting species in the reaction mixture, the amount of 
DNA copies will approximately double with every cycle. 
1.11.4.1 PCR Optimisation 
In order to work most effectively, PCR requires optimisation of the following: 
 Template DNA sequence 
 Specific primers 
 Thermostable DNA polymerase (such as Taq polymerase) 
 Deoxyribonucleotide triphosphate (dNTP) mixture 
 MgCl2 
 Specific PCR buffer (with K+ ions, usually from KCl) 
The template DNA should be purified and only a small amount is required (0.1-1 µg for 
genomic DNA).
400
 Larger amounts can often contribute to the increased yield of non-specific 
PCR products. Primers are used in great excess to the template DNA (typically around 10
7
 
times) and should have similar melting temperatures (within 5ºC of each other).
400,402
 They 
should not be self-complementary or complementary to other oligonucleotides in the reaction 
mixture to prevent secondary structures from forming, such as primer-dimers and hairpins, 
which lead to decreased availability, efficiency and ability to bind to the target sequence.
403
 
Formation of these undesirable secondary DNA structures competes with synthesis of the 
target DNA and can drastically affect product yields. 
Primers should also be short in length (18-30 nucleotides) and GC content should be 40-
60%
400,404
. Melting temperature can be modified by changing the GC content, as guanine (G) 
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and cyanine (C) share three hydrogen bonds, making the interaction between them more 
stable than that between thymine (T) and guanine (G), which share just two hydrogen bonds. 
Increasing the temperature can decrease non-specific primer annealing. Melting temperature 
(Tm) can be simply estimated from Scheme 1.12 below:
404
 
Tm = 2(A+T) + 4(G+C) 
Scheme 1.12: Estimate of melting temperature (Tm) based on nucleotide composition.  
MgCl2 acts as a co-factor to Taq polymerase and also forms stabilising complexes with the 
original DNA templates, primers and dNTP’s405 (K+ also helps to stabilise the Taq 
polymerase). Its concentration must be optimised (usually 1-3 mM) as too much will increase 
the yield of non-specific products and too little will decrease the yield of specific PCR 
products. The concentration of the Taq polymerase must be optimised as too much can lead 
to the production of non-specific products, which is again undesirable.
406
 The buffer acts to 
help the mixture retain constant pH and salt concentrations, so that the DNA polymerase can 
retain maximum activity throughout the reaction.  
1.11.4.2 Taq Polymerase: Mechanism of Action 
Primers, like DNA, have a 5ʹ and 3ʹ end and the Taq polymerase uses the original single 
strands of DNA to add complementary deoxyribonucleotide triphosphates (dNTPs: better 
known as nucleotide bases A, C, G and T) from the reaction mixture to the 3ʹ end of the 
primer to synthesise a section of double-stranded DNA specific to the region of interest. The 
5ʹ end of the primer remains unchanged as, like in most DNA replication processes, Taq 
polymerase only synthesises new DNA in the 5ʹ → 3ʹ direction (via the 3ʹ-OH group on the 
nucleotide at the end of the oligonucleotide sequence).
407
 It also possesses only 5ʹ→ 3ʹ 
exonuclease activity- meaning that it cleaves 5ʹ terminal oligonucleotides of double-stranded 
DNA and releases mono- and oligonucleotides.
408
 Without 3ʹ → 5ʹ exonuclease activity, Taq 
polymerase lacks proofreading activity (the ability to reverse its direction of synthesis to 
remove an incorrect base pair and replace it with the correct one) and can have a high error 
rate, up to 1 in 10,000 nucleotide mutations per cycle.
409-411
  
dNTP’s are added by the Taq polymerase to the 3ʹ-OH end of the primer (forming a 
phospodiester bond), resulting in the loss of a pyrophosphate group each time a new dNTP is 
added to the extending chain.
412,413
 The active site of Taq polymerase features two metal ions 
which facilitate the binding of dNTPs to the primer strand.
414
 The first metal ion is the 
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nucleotide-binding ion and coordinates the α-, β- and γ-phosphate oxygens of the incoming 
dNTP. The second is the catalytic ion which coordinates the α-phosphate of the dNTP and the 
3ʹ-oxygen of the primer strand. The coordination of the catalytic metal ion to the 3ʹ-oxygen 
on the primer is what facilitates the chemical reaction, which is nucleophillic attack of the 3ʹ-
OH on the dNTP.
414
 The nucleotide-binding metal ion also assists the leaving of 
pyrophosphate from the active site. The two metal ions are commonly Mg
2+
.
415
 Figure 1.17 
below demonstrates the two metal ion catalytic mechanism. 
 
Figure 1.17: The two-metal ion mechanism of DNA polymerase. The two conserved 
aspartate residues D705 and D882 have the E.Coli DNA polymerase I numbers. Taq 
polymerase is homologous to E.Coli DNA Polymerase I,
416
 but in Taq polymerase, the 
aspartate residues are numbered differently (Asp-610 and Asp-785).
416
 Metal ion A can be 
seen to activate the 3ʹ-OH group of the primer for nucleophillic attack on the α-phosphate on 
the dNTP. Metal ion B stabilises the negative charge on the leaving oxygen and chelates the 
β- and γ-phosphates. The figure is reproduced from reference 413. 
1.11.4.3 Post-PCR Processing 
In the initial phases of a PCR, amplification is exponential and the number of amplicons will 
double with every cycle (assuming 100% efficiency). As reagents are consumed and 
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depleted, the PCR slows down and eventually plateaus. Traditionally, it is at this plateau 
phase when traditional PCR can begin to detect the products. The amplified DNA products 
from the PCR can then be analysed using techniques such as: 
 Gel electrophoresis (DNA electrophoresis): DNA molecules are placed into a gel 
matrix and an electric field is applied, moving the anionic DNA molecules through 
the gel matrix. Smaller molecules migrate further than large molecules as they can 
move more easily throughout the pores within the gel matrix. This process is known 
as sieving. The DNA molecules are typically stained with ethidium bromide (or 
SYBR
®
 Green I – an asymmetric fluorescent cyanine dye used for nucleic acid 
staining) which fluoresces under UV light upon intercalation with DNA, making them 
visible when UV light is applied. Common stabilising media used as gels today are 
agarose and polyacrylamide.
417,418
 “Ladders” are solutions of DNA molecules with 
varying known length added into the gel matrix and are used to help approximate the 
size of the DNA molecule of interest.  
 Southern Blotting: Single- or double-stranded DNA molecules undergo gel 
electrophoresis, followed by transfer to a nylon membrane. Double stranded DNA is 
often denatured to produce single-stranded, blotted DNA, which is then heated or 
illuminated under UV light. Solutions that contain single-stranded labelled 
hybridisation probes that are complementary to the target sequences are then added 
under various conditions (i.e. changing temperature and salt concentration) and the 
hybridised DNA-probe complex will remain attached to the nylon membrane 
throughout multiple washing steps. The probes are often radio- or fluorophore-
labelled, allowing the detection of the target sequence by measuring fluorescence, for 
example. This method is up to 100 times more sensitive than gel electrophoresis 
alone, allowing the differentiation between specific and non-specific PCR products.
419
 
 Colorimetric assays, dot-spot analysis, oligomer-restriction and many others.419 
 
Techniques such as gel electrophoresis and Southern blotting are relatively slow, non-
automated, require post-PCR processing, have low sensitivity and precision and rely on 
discrimination of products by size or charge only. They provide qualitative analysis of PCR 
products. Also, as these techniques analyse the amount of DNA following both the 
exponential linear phase of amplification and the plateau phase, it is more difficult to 
determine the original amount of template DNA. However, a technique known as real-time 
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quantitative PCR (qPCR) allows the measurement and quantification of PCR products as they 
accumulate. This permits quantitative analysis of the DNA amplicons at all phases of the 
PCR amplification. This allows for more accurate determination of DNA concentration.
420,421
 
Real-time PCR uses changes in fluorescence to quantify and detect the amount of DNA 
amplicons that have been synthesised in the PCR. Intercalating fluorescent dyes such as 
SYBR
®
 Green I fluoresce when bound to double-stranded DNA, hence fluorescence will 
increase as the number of DNA amplicons increases. This can be detected by the PCR 
instrument which can also quantify the amount of fluorescence emitted. However, this 
method can lack specificity as all DNA in the reaction causes fluorescence of the dye, not just 
the specific required amplicon.
422
 Another method of monitoring the qPCR is with 
fluorescent probes, which are complementary to the target DNA sequence. These probes are 
labelled at one end with a fluorescent reporter (donor) molecule on one end and a quencher 
(acceptor) at the other. In their normal, unbound state, fluorescence of the probe is low as the 
quencher is able to act upon the fluorescent reporter. During PCR, the probe binds to the 
target sequence of interest and is cleaved from this site by the 5ʹ → 3ʹ exonuclease activity of 
Taq polymerase during the elongation step.
408
 At this point, the reporter and quencher 
molecules become separated and fluorescence increases. As more copies of the DNA 
amplicon are made, more of the fluorescent probe molecules bind to the target DNA 
sequence and are cleaved by the Taq polymerase, resulting in an increase in fluorescence.
421
 
A reference dye may also be used to normalise the signal within the instrument and correct 
for any well-to-well changes.
421
 Examples of fluorescent probes are TaqMan
®
 probes and 
molecular beacons.
420,422
 The mechanism of action of a Taqman
®
 probe is shown below in 
Figure 1.18. 
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Figure 1.18: The mechanism of action of a Taqman
®
 probe in real-time PCR. The probe 
sequence is homologous to a region with the target sequence. When the probe is intact, the 
reporter emission is quenched by the quencher molecule. During extension, the probe is 
cleaved via the 5ʹ exonuclease activity of the Taq polymerase, releasing the reporter and 
quencher resulting in an increase in fluorescence, which can be detected and quantified in 
real-time. As amplification continues, the strength of fluorescence will be proportional to the 
amount of PCR product made. Figure reproduced from reference 413. 
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1.12 Summary 
With the current drive for ‘greener’ chemistry, magnetic nanoparticles functionalised with 
bio-molecules can potentially provide the answer, in the fields of bio-catalysis, bio-medicine, 
bio-separation and bio-sensors. Further strategies for immobilisation will emerge due to a 
current emphasis on research into alternative support materials. In terms of enzymes, even 
though extremely effective and applicable, methods that reduce activity such as cross-linking 
could lose focus in the search for methods which can increase catalytic activity while keeping 
the current advantages that enzymes possess.
423
 It is envisaged that strategies to enable 
enzymes to be functional in more harsh conditions such as high/low temperature, pH and 
pressure and various organic solvents will be researched heavily to make them applicable in 
all fields. In the bio-medical industry, bio-functionalised magnetic nanoparticles are finding 
increasing application in areas such as cancer diagnosis, chemotherapy, hyperthermia, 
magnetic resonance imaging (MRI) and many more. In the areas of bio-separations and bio-
sensors, it seems that a combination of effective separation and detection methods could be 
used together in order to provide more rapid and sensitive results. It is the aim of this project 
to immobilise various useful bio-molecules onto silica-coated SPIONs in order to produce 
efficient materials for applications in bio-catalysis, bio-medicine, bio-separation and bio-
sensing with commercial viability. 
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2.1 Chemicals and Bio-molecules 
All reagents employed in this study were available commercially, of highest purity grade and 
used as purchased unless otherwise stated.  
Specialist reagents were obtained as follows: 3-aminopropyl tri-ethoxysilane (APTS) was 
obtained from Sigma-Aldrich, UK; 3-aminopropyl di-ethoxymethylsilane (APDS) and 3-
aminopropyl mono-ethoxydimethylsilane (APMS) were both obtained from ABCR Specialty 
Chemicals, Germany. Lipases [Candida Rugosa (CRL) and Pseudomonas 
Fluorescens(PFL)], bovine serum albumen (BSA), Bradford reagent, salmon sperm DNA, 
glutaraldehyde solution (Grade I, 25% in H2O), 4-nitrobenzaldehyde (4-NBA), p-nitrophenyl 
palmitate (PNPP), p-nitrophenol (PNP), sodium cyanoborohydride and chiral reagents [cis-
3,5-dihydroxycyclopentene, cis-3,5-diacetoxy-1-cyclopentene, (1S,4R)-cis-4-acetoxy-2-
cyclopenten-1-ol and (1R,4S)-cis-4-acetoxy-2-cyclopenten-1-ol] were all purchased from 
Sigma-Aldrich, UK. Ethanol (Absolute, 200 proof, Molecular Biology grade) was purchased 
from Fisher Scientific, UK. Oligonucleotide sequences specific to Listeria Monocytogenes 
(LM), shown in Table 2.1, were purchased from TIB-MOLBIOL, Germany.  
Table 2.1: Single-stranded oligonucleotides specific to Listeria Monocytogenes (LM), used 
in the project.  
Name Oligonucleotide Sequence Concentration 
of Stock 
Solution           
(nmol/mL) 
C6-T1NH2 1.0 OD 5ʹ-NH2-dc6- GGTGGCAAACGGTATTTGGCAT 4.10 
C6-T1NH2  5ʹ-NH2-dc6- GGTGGCAAACGGTATTTGGCAT 41.1 
C12-T1NH2  5ʹ-NH2-dc12- GGTGGCAAACGGTATTTGGCAT 41.1 
C6-T2NH2 1.0 OD 5ʹ-NH2-dc6- CACATTTGTCACTGCATCTCCGTG 4.30 
C6-T2NH2  5ʹ-NH2-dc6- CACATTTGTCACTGCATCTCCGTG 43.1 
C12-T2NH2  5ʹ-NH2-dc12- CACATTTGTCACTGCATCTCCGTG 43.1 
T1-Comp Seq. 5ʹ-ATGCCAAATACCGTTTGCCACC 44.3 
T2-Comp Seq. 5ʹ-CACGGAGATGCAGTGACAAATGTG 35.8 
6F-T1-Comp Seq. 
1.0 OD 
5ʹ-6FAM- ATGCCAAATACCGTTTGCCACC 4.40 
6F- T1-Comp Seq.  5ʹ-6FAM- ATGCCAAATACCGTTTGCCACC 44.4 
6F-T2-Comp Seq. 
1.0 OD 
5ʹ-6FAM- CACGGAGATGCAGTGACAAATGTG 3.60 
6F-T2-Comp Seq.  5ʹ-6FAM- CACGGAGATGCAGTGACAAATGTG 35.9 
 
Page 75 of 250 
 
Oligonucleotide sequences specific to Escherichia Coli (EC), shown in Table 2.2, were also 
purchased from TIB-MOLBIOL, Germany.  
Table 2.2: Single-stranded oligonucleotides specific to Escherichia Coli (EC), used in the 
project.  
Name Oligonucleotide Sequence Concentration of 
Stock Solution         
(nmol/mL) 
EC_541_FOR 5ʹ-NH2-dc6-GGTCATATCTCTAACGCCATCC 45.7 
EC_637_REV 5ʹ-NH2-dc6-TGGCGTCGTGCATTAGTT 54.9 
Comp FOR  5ʹ-GGATGGCGTTAGAGATATGACC 40.0 
Comp REV 5ʹ-AACTAATGCACGACGCCA 49.6 
 
2.2 Solutions and Buffers 
All solutions were made up using E-pure deionised water supplied from a Thermo Scientific 
Barnstead Nanopure Water Deionisation System unless otherwise stated. All stock solutions 
and buffers were typically made up as shown in Table 2.3.  
Table 2.3: Description, use and storage information of solutions and buffers used in the 
project. 
Solution Description Use Storage 
Coupling 
solution 
1 litre of solution was prepared 
containing 0.8% w/v acetic acid 
(glacial) in methanol 
UV-Visible 
colorimetric assays 
and storage of NH2 
modified 
nanoparticles 
 
1 litre capped 
clear glass 
bottle at 25ºC 
 
 
Hydrolysis 
solution 
1:1 mixture of methanol and 
water containing 0.15% acetic 
acid (glacial) 
UV-Visible 
colorimetric assays 
1 litre capped 
clear glass 
bottle at 25ºC 
 
4-NBA  
solution (700 
µg/ml) 
7 mg of 4-NBA was dissolved in 
10 ml coupling solution 
UV-Visible 
colorimetric assays 
Centrifuge 
tubes at 4ºC in 
the dark (used 
on the day of 
production) 
 
Glutaraldehyde 
solution (5% 
w/v) 
10 ml stock solution was 
typically prepared containing 
1.886 ml glutaraldehyde and 
8.114 ml 20×SSC buffer 
 
Conversion of      
surface amine 
groups to aldehydes 
 
Centrifuge 
tubes at -18ºC  
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Table 2.3: Continued. 
Solution Description Use Storage 
NaBH3CN 
solution 
(0.03% w/v) 
Stock solution was made by 
dissolving 3 mg NaBH3CN in 10 
ml 1×SSC buffer 
Reduction of  
C-N bond in 
oligonucleotide 
grafting 
 
Centrifuge 
tubes at 4ºC  
BSA solution 
(0.05% w/v) 
 
 
 
Stock solution was made by 
dissolving 5 mg BSA in 10 ml 
13×SSC buffer 
Blocking solution 
used in hybridisation 
reactions 
Centrifuge 
tubes at 4ºC 
 
 
Salmon 
sperm DNA 
solution (1 
mg/ml) 
 
DNA (10 mg) was dissolved and 
sheared repeatedly with a syringe in 
sterile distilled water (10 ml), 
giving suspension density of 1 
mg/mL 
 
Salmon sperm DNA 
binding and elution 
assays 
Centrifuge 
tubes at -18ºC 
TEN buffer  
  
Stock solution was made by mixing 
Tris-HCl (100 mM), EDTA (50 
mM), NaCl (500 mM) and 100 ml 
distilled water 
 
Salmon sperm DNA 
binding and elution 
assays 
Capped clear 
glass bottle at 
4ºC 
20% PEG/4 
M NaCl 
solution  
Stock solution was made by 
dissolving 40 g polyethylene glycol 
(Mr 8000) in 200 ml NaCl (4 M) 
 
Salmon sperm DNA 
binding and elution 
assays 
Capped clear 
glass bottle at 
4ºC 
20×SSC 
stock buffer  
 
Stock solution was made by 
dissolving 175.3 g NaCl and 88.2 g 
sodium citrate in 1 L water. The pH 
was adjusted to 7.4 
Conversion of      
surface amine 
groups to aldehydes. 
Grafting and hybrid 
capture of 
oligonucleotides 
 
Capped clear 
glass bottle at 
25ºC 
1×SSC and 
13×SSC 
buffer 
solutions 
 
20×SSC stock buffer solution was 
diluted respectively to produce 1× 
and 13×SSC buffers  
Conversion of      
surface amine 
groups to aldehydes. 
Grafting and hybrid 
capture of 
oligonucleotides 
 
Capped clear 
glass bottle at 
25ºC 
Reagent A Gum Arabic (0.0667g), sodium 
deoxycholate (0.267g), Tris-HCl 
(12 mL, 250 mM) was added to 48 
mL deionised water 
Hydrolysis of PNPP 
reaction solvent in 
1:1 mixture with 
isopropanol 
 
Capped clear 
glass bottle at 
25ºC 
PBS Buffer 1×PBS tablet (136 mM NaCl, 3 
mM KCl, 10 mM Na2HPO4, 2 mM 
KH2PO4) dissolved in 200mL water 
Washing and storage 
of lipase- materials. 
Capped clear 
glass bottle at 
25ºC 
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2.3 Synthesis of Magnetite Nanoparticles, Fe3O4  
2.3.1 Co-precipitation of Iron Chloride Solutions in Alkaline Media 
Magnetite was prepared by the co-precipitation of ferrous and ferric chloride solutions in 
alkaline media and was carried out as follows.
424
 Iron(III) chloride hexahydrate (10.8120 g, 
0.04mol) was dissolved in 40 mL distilled, deionised water in a 1 litre round-bottomed flask 
equipped with a magnetic stirrer. To this, iron(II) chloride tetrahydrate (3.9762 g, 0.02 mol) 
dissolved in 10 mL HCl (2 M) was added whilst stirring. The brown/orange solution was 
stirred at room temperature whilst 500 mL of ammonium hydroxide solution (0.7 M) was 
added slowly, turning the solution black. The reaction was allowed to proceed with stirring at 
room temperature for a further 30 minutes. Following this, the reaction mixture was 
transferred to a 1 litre conical flask and the black precipitate was washed to neutral pH with 
distilled, deionised water via magnetic sedimentation and decantation using a slab magnet. 
The product, named R1MA, was observed to be dark red-brown in colour, having a slow 
response to the slab magnet. The supernatant was observed to be brown. The co-precipitation 
reaction is represented by the following Scheme 2.1:
425
  
 
Scheme 2.1: The co-precipitation of iron(II) and iron(III) chloride. 
Due to the weak magnetic response, this material was not used for further silica-coating, or 
for any bio-catalytic, bio-separation or bio-sensor applications.  
2.3.2 Oxidative Hydrolysis of Iron Sulphate 
This method involved the oxidative hydrolysis of iron(II) sulphate heptahydrate as the iron 
source under nitrogen at 90ºC.
29,424
 Iron(II) sulphate heptahydrate (23.60 g, 0.085 mol) was 
dissolved in 220 mL degassed, deionised, distilled water in a 500 mL round-bottomed three-
necked flask equipped with a magnetic stirrer, nitrogen inlet, condenser and thermometer. 
The solution was heated to 90ºC whilst stirring under nitrogen. To the solution, potassium 
nitrate (5.39 g, 0.053 mol) and potassium hydroxide (12.60 g, 0.225 mol) were added to the 
green solution whilst stirring. The resulting jet-black mixture was kept at 90ºC, with stirring 
under nitrogen for a further 4 hours. Subsequently, the mixture was allowed to cool for one 
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hour and was transferred to a 1 litre conical flask. The black precipitate was washed to 
neutral pH with distilled, deionised water via magnetic sedimentation and decantation using a 
slab magnet. The product, named R2MC, was observed to be black and had a strong affinity 
for the slab magnet. The supernatant was clear during storage.  
Large-scale magnetite was prepared using a scaled-up version of the method used to prepare 
R2MC, similar to that reported by Bruce et al.
29
 This method again involved the oxidative 
hydrolysis of iron(II) sulphate heptahydrate as the iron source under nitrogen at 90ºC
29
. 
Iron(II) sulphate heptahydrate (354.20 g, 1.27 mol) was dissolved in 3 litres degassed, 
deionised, distilled water in a 5 litre round-bottomed three-necked flask equipped with a 
magnetic stirrer, nitrogen inlet, condenser and thermometer. The solution was heated to 90ºC 
whilst stirring under nitrogen. Separately, potassium nitrate (80.90 g, 1.25 mol) was dissolved 
into 1 litre of degassed, distilled, deionised water in a 2 litre conical flask and potassium 
hydroxide (188.60 g, 3.36 mol) was added to the dissolved potassium nitrate solution whilst 
stirring. This mixture was heated to 65ºC and degassed with nitrogen for a further 5 minutes, 
before it was added to the iron sulphate solution dissolved previously. The resulting jet-black 
mixture was kept at 90ºC, with stirring under nitrogen for a further 4 hours. Subsequently, the 
mixture was allowed to cool for one hour and was transferred to a 5 litre conical flask. The 
black precipitate was washed to neutral pH with distilled, deionised water via magnetic 
sedimentation and decantation using a slab magnet. The method regularly yielded ~20 g of 
product. The product, QBLSBM, was observed to be black and had a strong affinity for the 
slab magnet. The supernatant was clear during storage. 
The oxidative hydrolysis reaction is represented by Scheme 2.2:
34
 
 
Scheme 2.2: The oxidative hydrolysis of iron(II) sulphate heptahydrate.  
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2.4 Silica-Coating of Magnetite Nanoparticles  
2.4.1 Small-scale Amorphous Coating 
Silica-coated magnetite nanoparticles were prepared via the small scale deposition of silica 
onto magnetite nanoparticles R2MC (see Section 2.3.2), from silicic acid solution at pH 10.
29
 
Aqueous sodium silicate solution, 20.75 g (13.80 mL, 27% SiO2) was dissolved in water to a 
total volume of 500 mL with distilled, deionised water. A column containing 110 g of 
Amberlite IR-120 ion-exchange resin was regenerated with 1 litre each of the following: Hot 
water (70ºC), 3 M HCl and cold water. Sodium silicate solution was passed down the 
column, allowing the first 50 mL to pass uncollected. The subsequent 450 mL of the eluate 
(now in the form of silicic acid) was taken and it’s pH was immediately raised to pH 12 with 
aqueous TMAOH (25%) to prevent homogeneous silica nucleation.
426
 In addition to this, 5 g 
of magnetite suspension (R2MC) was mixed with 225 mL fresh distilled, deionised water and 
titrated to pH 12 with aqueous TMAOH (25%). With continued stirring, the silicic acid eluate 
(at pH 12) was added to the magnetite suspension. The mixture was then slowly titrated to pH 
10.0 using 0.5 M HCl over approximately 1 hour. The mixture at pH 10.0 was stirred for 
another 2 hours at room temperature before transferring to a 2 litre conical flask. The silica-
magnetite nanoparticles were washed once with 1 litre of TMAOH solution at pH 10.0 and 
then many times with 1 litre distilled, deionised water (via magnetic sedimentation) until the 
supernatant reached neutral pH. Four consecutive depositions (as described by the method 
above) were carried out for each material. Between each deposition, the silica-magnetite was 
washed with water until the supernatant reached neutral pH. An aliquot of suspension (20-50 
mL) was retained for analysis following each deposition. The product, CR2MC, was 
observed to be black and had a strong affinity for the slab magnet. The supernatant was clear 
during storage.  
2.4.2 Large-scale Amorphous Coating 
Silica-coated magnetite nanoparticles were prepared via the large scale deposition of silica 
onto magnetite nanoparticle sample QBLSBM (see Section 2.3.2), from silicic acid solution 
at pH 10.
29
 Aqueous sodium silicate solution, 83.0 g (55.2 mL, 27% SiO2) was dissolved in 
water to a total volume of 2 litres with distilled, deionised water. A column containing 110 g 
of Amberlite IR-120 ion-exchange resin was regenerated with 1 litre each of the following: 
Hot water (70ºC), 3 M HCl and cold water. Sodium silicate solution was passed down the 
column, allowing the first 100 mL to pass uncollected. The subsequent 1800 mL of the eluate 
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(now in the form of silicic acid) was taken and its pH was immediately raised to pH 12 with 
aqueous TMAOH (25%) to prevent homogeneous silica nucleation. In addition to this, 20 g 
of magnetite suspension (QBLSBM, see Section 2.3.2) was mixed with 900 mL fresh 
distilled, deionised water and titrated to pH 12 with aqueous TMAOH (25%). With continued 
stirring, the silicic acid eluate (at pH 12) was added to the magnetite suspension. The mixture 
was then slowly titrated to pH 10.0 using 0.5 M HCl over approximately 1 hour. The mixture 
at pH 10.0 was stirred for another 2 hours at room temperature before transferring to a 5 litre 
conical flask. The silica-magnetite nanoparticles were washed once with 2 litres of TMAOH 
solution at pH 10.0 and then many times with 2 litres distilled, deionised water (via magnetic 
sedimentation) until the supernatant reached neutral pH. Four consecutive depositions (as 
described by the method above) were carried out for each material. Between each deposition, 
the silica-magnetite was washed with water until the supernatant reached neutral pH. An 
aliquot of suspension (20-50 mL) was retained for analysis following each deposition. The 
product, QBLSSM, was observed to be black and had a strong affinity for the slab magnet. 
The supernatant was clear during storage. The silicic acid deposition process used for coating 
the magnetite nanoparticles is represented by Figure 2.1. 
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Figure 2.1: Representing the mechanism of the silica-coating process using the silicic acid 
deposition method. Step 1 involves the acidification of sodium silicate using an ion-exchange 
resin (Amberlite IR-120), followed by raising the pH to 12 using TMAOH to avoid 
nucleation of the silicic acid, forming A. Step 2 raises the pH of magnetite nanoparticles 
(forming B) in solution to around 12 so that when they are mixed with the silicic acid 
solution, the deposition and polycondensation of the silica can be controlled. When the 
magnetite nanoparticles and the silicic acid solutions are mixed at pH 12 and the pH is slowly 
adjusted to 10, the controlled and orderly deposition of silica onto the magnetite surface (via 
the Fe-O
-
 groups) takes place, forming product C. As the materials are allowed to mix further, 
polycondensation and polymerisation of silica takes place on the surface via the Si-OH 
groups, as shown by the formation of product D, producing a silica core-shell around the 
magnetite nanoparticles. Products are not drawn to scale and the figure is a schematic 
structural representation.  
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2.5 Surface Functionalisation of Silica-Magnetite Nanoparticles 
2.5.1 ‘Classical’ Silanisation of Silica and Silica-Magnetite Nanoparticles (Water 
Method) 
Surface modification (silanisation) of silica-magnetite nanoparticles using various 
aminosilanes was performed as follows, using a modified method from that developed by 
Bruce et al.
80
 Silica-magnetite nanoparticles (150 mg) were added to a freshly prepared 
solution of 30 mL of aminosilane in water (APTS, APDS or APMS, 2% w/v) in a 50 mL 
screw-capped centrifuge tube. The mixture was allowed to react at 50ºC for 20 hours in an 
incubator with end-over-end rotation at 40 rpm. Silanised silica-magnetite nanoparticles were 
washed with 3×10 mL coupling solution (0.8% v/v glacial acetic acid in methanol) and re-
suspended in 10 mL of the solution at 5ºC. The products TWQB, DWQB and MWQB were 
all prepared from QBLSSM using APTS, APDS and APMS as the aminosilane sources, 
respectively. Surface amine densities were determined by colorimetric assay using 4-
NBA.
88,427
 It was observed in a detailed study by De Waterbeemd
428
 that surface amine 
density suffered substantial decreases after prolonged storage and as a result, fresh batches of 
surface-functionalised nanoparticles were produced every month. 
2.5.2 Tri-phasic Reverse Emulsion (TPRE) Silanisation of Silica and Silica-Magnetite 
Nanoparticles (TPRE method)
87,89
 
Surface modification (silanisation) of silica-magnetite nanoparticles using various 
aminosilanes was performed as follows, using a modified method from Sen and Bruce.
89
 
Silica-magnetite nanoparticles (150 mg) were collected in a 50 mL screw-capped centrifuge 
tube via magnetic separation and to these, 30 mL of toluene and 5 g Triton X-100 were 
added. The mixture was shaken to form a tri-phasic reverse emulsion (TPRE). To this, the 
appropriate aminosilane (APTS, APDS or APMS, 2% w/v) was added to the emulsion and 
the mixture was allowed to react at 50ºC for 20 hours in an incubator with end-over-end 
rotation at 40 rpm. Functionalised silica-magnetite nanoparticles were washed with 3×10 mL 
coupling solution (0.8% v/v glacial acetic acid in methanol) and re-suspended in 10 mL of the 
solution at 5ºC. The products TTQB, DTQB and MTQB were all prepared QBLSSM using 
APTS, APDS and APMS as the aminosilane sources, respectively. Surface amine densities 
were determined by colorimetric assay using 4-NBA.
88,427
 See Figure 1.5 in Section 1.6 for a 
representation of the ideal surface functionalised materials. It was observed in a detailed 
study by De Waterbeemd
428
 that surface amine density suffered substantial decreases after 
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prolonged storage and as a result, fresh batches of surface-functionalised nanoparticles were 
produced every month. 
2.6 Covalent Immobilisation of Lipase on the Functionalised Silica-
Magnetite Nanoparticle Surface for Bio-catalytic Applications 
2.6.1 Conversion of Surface Amine Groups to Aldehyde Groups Using 
Glutaraldehyde
80
 
SSC buffer (20×) was prepared by dissolving sodium chloride (175.3 g) and sodium citrate 
(88.2 g) in 1 litre distilled, deionised water (final pH 7.4). SSC buffer (1×) was prepared by 
diluting 50 mL 20×SSC buffer to 1 litre with distilled, deionised water. Glutaraldehyde 
solutions were prepared immediately prior to their use. Aminosilane-modified silica-
magnetite nanoparticles (50 mg) were washed 3 times with 10 mL 1×SSC buffer and the 
supernatant removed. Subsequently, 4 mL of a 5% w/v glutaraldehyde solution (in 20×SSC 
buffer) was added and the suspension was incubated for 3 hours at 18ºC with end-over-end 
rotation (40 rpm). After 3 hours, the nanoparticles were collected magnetically and the 
supernatant was removed. The nanoparticles were washed 3 times with 5 mL 1×SSC buffer 
to remove excess glutaraldehyde and then washed 3 times with 5 mL of PBS buffer (pH 7.2) 
before immobilisation of lipase. 
2.6.2  Immobilisation of Enzymes 
50 mg of non-functionalised (leading to physical adsorption) or glutaraldehyde-modified 
(covalent immobilisation) nanoparticles were magnetically collected and the supernatant 
removed. To these nanoparticles, 4 mL of lipase solution (CRL or PFL, 1 mg/mL in PBS 
buffer) was added and the reaction mixture was incubated at 18ºC overnight with end-over-
end rotation (40 rpm). The amount of lipase in solution before and after immobilisation was 
calculated by measuring absorption at 595 nm using UV-Visible spectrophotometry using a 
modified version of the Bradford Assay (see Section 2.9.3 for details).
100,429,430
 
The entire process, from surface functionalisation, to glutaraldehyde surface modification and 
enzyme immobilisation is demonstrated in Scheme 2.3. 
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Scheme 2.3: A schematic diagram of surface functionalisation, glutaraldehyde surface 
modification and enzyme immobilisation on core-shell silica-magnetite nanoparticles (see 
Appendix II as reference). 
2.6.3 Model Catalysis Reaction: Ester Hydrolysis: PNPP100,431,432  
Hydrolysis of p-nitrophenyl palmitate (PNPP) was performed using 500 µg of either free 
(crude powder) or immobilised lipase (on non-functionalised (physical adsorption) or 
glutaraldehyde modified surface-functionalised (covalent immobilisation) nanoparticles 
reacting with 1 mL of ester solution (3.74 µmol/mL). The ester solution was prepared in a 1:1 
mixture of isopropanol and reagent A (0.0667 g Gum Arabic + 12 mL of 250 mM Tris-HCl 
buffer, pH 7.8 + 48 mL of deionised water + 0.267 g of sodium deoxycholate) and the 
reaction was incubated for 1 hour at 25ºC with end-over-end rotation (40 rpm). After 1 hour, 
the supernatants were analysed for their absorbance at 410 nm using UV-Visible 
spectrophotometry (see Section 2.9.5 for details). Lipase-immobilised nanoparticles were 
then washed 3 times with 1 mL of the 1:1 mixture of isopropanol and reagent A. The washed 
materials were further used for the hydrolysis of PNPP under identical conditions as above, in 
order to test the catalytic efficiency and re-usability of lipase-immobilised nanoparticles for 
further catalytic cycles. The reaction is demonstrated in Section 1.10. 
2.6.4 Bio-catalytic Application: Transesterification of Ethyl Butyrate 
Initial Method 
This reaction was carried out using a modification of the method described by Solanki and 
Gupta.
301
 Ethyl butyrate (60 mM) and n-butanol (120 mM) were taken in a 1.5 mL screw-cap 
centrifuge tube containing 1 ml of hexane followed by the addition of 500 µg free lipase or 
lipase immobilised nanoparticles containing 500 µg of immobilised lipase. The reaction 
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mixture was incubated for 24 hours at 37ºC with end-over-end rotation (40 rpm). A 5 µL 
aliquot of the reaction mixture was withdrawn and analysed by GC and GC-MS (see Section 
2.9.6 for details). The remaining reaction supernatant was removed from the lipase 
immobilised nanoparticles by magnetic separation and the nanoparticles were washed 3 times 
with 1 mL distilled, deionised water and the reaction was repeated for further cycles under 
identical conditions as above, in order to test the catalytic efficiency and re-usability of 
lipase-immobilised nanoparticles. A control experiment was run in which the non-modified 
nanoparticles (without any lipase) were added. The amount of transesterification product 
(butyl butyrate) resulting from the reaction was calculated from a calibration curve 
constructed from the peak areas, obtained using a series of standard butyl butyrate solutions 
prepared in hexane (see Section 2.9.6). The reaction mechanism is demonstrated in Figure 
1.15 in Section 1.10.  
Optimised Method 
This reaction was carried out using a modification of the method described by Liaquat et 
al
301,303
 and was necessary due to poor results obtained using the initial method above. Ethyl 
butyrate (600 mM) and n-butanol (100 mM) were taken in a 1.5 mL screw-cap centrifuge 
tube containing 1 ml of 10% water/hexane followed by the addition of 500 µg free lipase or 
lipase immobilised nanoparticles containing 500 µg of immobilised lipase. The reaction 
mixture was incubated for 24 hours at 37ºC with end-over-end rotation (40 rpm). A 5 µL 
aliquot of the reaction mixture was withdrawn and analysed by GC and GC-MS (see Section 
2.9.6 for details). The remaining reaction supernatant was removed and the lipase-
immobilised nanoparticles were washed 3 times with 1 mL distilled, deionised water and the 
reaction was repeated for further cycles under identical conditions as above, in order to test 
the catalytic efficiency and re-usability of lipase-immobilised nanoparticles. A control 
experiment was similarly run in which the non-modified nanoparticles (without any lipase) 
were added. The amount of transesterification product (butyl butyrate) resulting from the 
reaction was calculated following the same method described in the initial method.  
 
2.6.5 Bio-catalytic Application: Partial and Selective Hydrolysis of Cis-3,5-diacetoxy-
1-cyclopentene to (1S,4R)-cis-4-acetoxy-2-cyclopenten-1-ol and its Enantiomer 
Cis-3,5-diacetoxy-1-cyclopentene (50 µmol) was taken in a 1.5 mL screw-cap centrifuge tube 
containing 800 µL hexane and 200 µL water (20% water concentration) followed by addition 
of 500 µg free lipase or lipase immobilised nanoparticles containing 500 µg of immobilised 
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lipase. The reaction mixture was typically incubated for up to 48 hours at two different 
temperatures (25ºC and 37ºC) with end-over-end rotation (40 rpm). During the reaction, a 10 
µL aliquot of the reaction mixture (water layer) was withdrawn and analysed by GC and GC-
MS (see Section 2.9.7 for details) at 1 h, 24 h and 48 h for kinetic experiment. The amount of 
hydrolysis reaction products (cis-3,5-dihydroxycyclopentene, (1S,4R)-cis-4-acetoxy-2-
cyclopenten-1-ol and its enantiomer) resulting from the reaction were calculated from pre-
constructed calibration curves using a series of standard solutions (cis-3,5-
dihydroxycyclopentene, (1S,4R)-cis-4-acetoxy-2-cyclopenten-1-ol and its enantiomer) 
prepared in water (see Section 2.9.7). The hexane layer was also analysed to calculate initial 
concentrations of cis-3,5-diacetoxy-1-cyclopentene. The reaction is depicted in Scheme 1.10, 
Section 1.10. The reaction was also repeated using 50% water/hexane (500 µL hexane and 
500 µL water) as the solvent system at 25ºC. 
2.7 Oligonucleotide Grafting and Hybrid Capture Assay for Bio-sensor 
and Bio-separation Applications 
2.7.1 Conversion of Surface Amine Groups to Aldehyde Groups Using Glutaraldehyde 
SSC buffer (20×) was prepared by dissolving sodium chloride (175.3 g) and sodium citrate 
(88.2 g) in 1 litre distilled, deionised water (final pH 7.4). SSC buffer (1×) was prepared by 
diluting 50 mL 20×SSC buffer to 1 litre with distilled, deionised water. Glutaraldehyde 
solutions were prepared immediately prior to their use. Aminosilane-modified silica-
magnetite nanoparticles (50 mg) were washed 3 times with 10 mL 1×SSC buffer and the 
supernatant removed. Subsequently, 4 mL of a 5% w/v glutaraldehyde solution (in 20×SSC 
buffer) was added and the suspension was incubated for 3 hours at 18ºC with end-over-end 
rotation (40 rpm). After 3 hours, the nanoparticles were collected by magnetic separation and 
the supernatant was removed. The nanoparticles were washed 3 times with 5 mL 1×SSC 
buffer to remove excess glutaraldehyde. The reaction can be seen in Scheme 2.3, above in 
Section 2.6.2.  
2.7.2 Oligonucleotide Grafting on Functionalised Nanoparticle Surface 
This method is similar to one previously employed by Bruce et al.
80
 Immediately following 
glutaraldehyde surface modification, a 3.3 µM solution (0.5 mL, 1.65 nmol total) of 5ʹ-
amine-modified oligonucleotides in 1×SSC coupling buffer solution (corresponding to the 
oligonucleotides in Table 2.1 or Table 2.2) was added and the mixture was left incubating 
overnight at 18ºC with end-over-end rotation (40 rpm). The oligonucleotide-modified 
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nanoparticles were then washed once with 1 mL 1×SSC coupling buffer and placed in 0.8 mL 
of NaBH3CN solution [0.1% (w/v) in 1×SSC coupling buffer] for 30 minutes at 18°C with 
end-over-end rotation (40 rpm). The materials were then washed 3 times with 0.8 mL of 
1×SSC coupling buffer and finally re-suspended in 200 µL of the same.  
 
2.7.3 Model Assay: Hybrid Capture of Complementary Oligonucleotide Sequence 
from Solution (Initial Method) 
This method is again similar to one previously employed by Bruce et al.
80
 Oligonucleotide-
grafted particles (1 mg equivalent to 100 µL suspension) were washed twice with 0.5 mL of 
water and heated to 80°C for 4 minutes. The water was removed and a solution of 
complementary oligonucleotide sequence containing 200 µL (equivalent to 1.65 nmol total) 
in 13×SSC coupling buffer / 0.05% BSA at the required concentration (see Table 2.3, Section 
2.2) was added and the suspension was incubated with end-over-end rotation (40 rpm) for 30 
minutes at 18°C. The supernatant was removed and their absorbance at 260 nm was analysed 
by UV-Visible spectrophotometry. After the nanoparticles were washed 3 times with 1 mL of 
13×SSC coupling buffer, 200 µL of water was added and the nanoparticle suspension was 
heated to 85°C for 4 minutes to disassociate the annealed complementary/captured 
sequences. The supernatant was removed and their absorbance at 260 nm was analysed by 
UV-Visible spectrophotometry (see Section 2.9.4 for details).  
 
2.7.4 Model Assay: Hybrid Capture of Complementary Oligonucleotide Sequence 
from Solution (Revised Method in Consultation with Q-Bioanalytic GmbH, 
Germany) 
The oligonucleotide sequences which we used for grafting and capture / dehybridisation were 
specially designed for use in PCR by Q-Bioanalytic GmbH. Oligonucleotide-grafted particles 
(1 mg equivalent to 100 µL suspension) were washed twice with 0.5 mL of water and heated 
to 95°C for 10 minutes. Water was removed and a solution of complementary oligonucleotide 
sequence containing 200 µL (equivalent to 1.65 nmol total) in 13×SSC coupling buffer / 
0.05% BSA at the required concentration (see Table 2.3, Section 2.2) was added and the 
suspension was incubated with end-over-end rotation (40 rpm) for 1 minute at 60°C. The 
supernatant was removed and their absorbance at 260 nm was analysed by UV-Visible 
spectrophotometry. After the nanoparticles were washed 3 times with 1 mL of 13×SSC 
coupling buffer, 200 µL of water was added and the nanoparticle suspension was heated to 
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95°C for 10 minutes to disassociate the annealed complementary/captured sequences. The 
supernatant was removed and their absorbance at 260 nm was analysed by UV-Visible 
spectrophotometry (see Section 2.9.4 for details). The assay can be represented using the 
following Scheme 2.4.  
 
Scheme 2.4: Schematic representation of hybrid capture of target oligonucleotide sequence 
by an immobilised nucleotide of pre-defined sequence and subsequent dehybridisation of the 
captured oligonucleotide. The black spheres represent surface-functionalised core-shell silica-
magnetite nanoparticles. 
 
2.7.5 Extraction of DNA Protocol (Bio-separation) 
1 mL of pre-enrichment culture (in this case either LM, EC, a 1:1 mixture of LM: EC, or 
water as control) was transferred to a sterile 1.5 mL centrifuge tube. The mixture was 
centrifuged at 10,000 rpm for 10 minutes and the supernatant was discarded. 400 µL of lysis 
buffer (100 mM Tris-HCl, 10 mM EDTA, 1 M NaCl, pH 8.0) and 10 µL Proteinase K was 
pipetted onto the centrifuged bacteria pellet and the solution was mixed well. The mixture 
was then incubated for 20 minutes at 65ºC on a thermal mixing block. The mixture was then 
centrifuged again at 10,000 rpm for 5 minutes to remove the matrix and cell debris. The 
clarified supernatant containing the DNA was transferred to a new sterile 1.5 mL centrifuge 
tube. 400 µL of binding buffer [20% PEG (Mr 8000) in 4M NaCl] and 25 µL (equivalent to 
0.5 mg) of silica-magnetite nanoparticles (QBLSSM, suspension density of 20 mg/mL) were 
added to the DNA-containing mixture, which was incubated at room temperature for 5 
minutes. The nanoparticles were magnetically immobilised and the supernatant was removed 
and discarded. The nanoparticles were then washed with 400 µL washing buffer (75% 
ethanol in water). The nanoparticles were magnetically immobilised and the washing buffer 
was removed and discarded. The centrifuge tube containing the nanoparticles was left open at 
room temperature to evaporate the ethanol (but not to complete dryness). The nanoparticles 
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were then re-suspended in 100 µL elution buffer (distilled, deionised water) and incubated for 
5 minutes at 65ºC on a thermal mixing block. Finally, the nanoparticles were magnetically 
immobilised and the supernatant (100 µL, containing eluted DNA) was transferred to a new 
sterile 1.5 mL centrifuge tube for use in the next step (specific capture of bacterial DNA). 
2.7.6 Bio-sensor and Bio-separation Application: Selective detection and 
determination of LM and EC in food samples 
A series of solutions of Listeria Monocytogenes (LM) in peptone water; Escherichia Coli 
(EC) in peptone water and a 1:1 mixture of Listeria Monocytogenes (LM) and Escherichia 
Coli (EC) in peptone water were prepared. The extraction of DNA from the bacterial samples 
was carried out using the DNA Extraction Protocol (see Section 2.7.5), which employs the 
silica-magnetite nanomaterial QBLSSM. The extracted DNA was used for selective detection 
and determination of either LM or EC from inoculated food samples. 
Selective Detection and Determination of Either LM or EC in Food Samples (One-step 
Assay) 
Oligonucleotide-grafted nanoparticles (10 µL equivalent to 100 µg suspension) with specific 
primer sequences (forward and reverse related to PCR) with C6 or C12 spacers were mixed 
with each other (C6-spacer forward primer attached nanomaterials were mixed with C6-spacer 
reverse primer attached nanomaterials only and C12-spacer forward primer attached 
nanomaterials were mixed with C12-spacer reverse primer attached nanomaterials only), 
providing a total of 200 µg of oligonucleotide-grafted nanoparticles. When amine-
functionalised (TTQB) and un-modified silica-magnetite (QBLSSM) nanoparticles were used 
for comparison, 200 µg of each was also used. The nanoparticles were washed once with 0.5 
mL water and 100 µL of extracted bacterial DNA solution obtained from the extraction step 
was added (see Section 2.7.5). 
The mixture containing bacterial DNA and nanoparticles was first incubated for 5 minutes at 
95ºC on a thermal mixing block. The mixture was then instantly transferred to a thermal 
mixing block set at 65ºC for 5 minutes for hybridisation of the complementary sequences in 
the mixture to the oligonucleotide-grafted nanoparticles, or physical adsorption to other 
nanoparticles. The nanoparticles were then magnetically immobilised and the supernatant 
discarded. The nanoparticles were washed twice with 0.5 mL 13×SSC coupling buffer and 
100 µL of distilled / deionised water was added to the washed nanoparticles. The suspension 
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was heated to 95°C for 10 minutes on a thermal mixing block to disassociate the annealed 
complementary/captured sequences. The nanoparticles were then magnetically immobilised 
and the supernatant taken for analysis by quantitative real-time PCR (qPCR) (see Section 
2.9.8 for details).  
Sensitivity of Detection Limits of Either LM or EC in Food Samples (One-step Assay) 
A series of diluted solutions of Listeria Monocytogenes (LM) or Escherichia Coli (EC) in 
peptone water were prepared and the extraction of DNA from the bacterial samples was 
carried out using the protocol described earlier.  
Oligonucleotide-grafted nanoparticles (10 µL equivalent to 100 µg suspension) with specific 
primer sequences (forward and reverse, see Table 2.1 and Table 2.2, Section 2.1) were mixed 
with each other and used for hybrid capture followed by qPCR analysis.  
Two Step Hybrid Capture Assay 
The reaction protocols for selective detection of LM or EC from a mixture (see Section 0) 
and determining the sensitivity of detection of LM or EC (see Section 0) were modified 
slightly by adding the forward and reverse primer-immobilised nanoparticles separately for 
hybridisation, followed by de-hybridisation and qPCR analysis of complementary sequences 
separately. 
2.8 Chemical and Physical Characterisation Methods  
2.8.1 Surface Area Analysis (BET) 
Nanoparticles (500 to 1000 mg) were dried overnight in an oven at 80°C. Prior to analysis, 
bare magnetite and core-shell silica-magnetite nanoparticles were degassed at 100°C for 24 
hours. Analysis was performed using a Micromeritics ASAP 2010 (Accelerated Surface Area 
and Porosimetry System).  
2.8.2 Nanoparticle Size Analysis - Transmission Electron Microscopy (TEM) 
Images of magnetite nanoparticles were obtained by TEM using a JEOL JEM-2000 EX 
electron microscope at 200 kV. Images were processed using Gatan Digital Micrograph 
Software. Prior to analysis nanoparticles suspensions were diluted 50 times in ethanol and 
approximately 2 µL of diluted suspension was placed on a carbon coated copper grid (400 
mesh, Agar Scientific, UK) which was then dried in air for 10 minutes. 
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2.8.3 Iron Oxide Phase Analysis - X-Ray Diffraction (XRD)  
X-ray diffraction (XRD) was used for the confirmation of the identity of magnetite and silica-
coated magnetite nanoparticles. Nanoparticles were dried overnight in an oven at 80ºC and 
then ground to fine powder which was pressed into a clear silicon single crystal low 
background holder (size: 24.5 mm diameter, 1 mm depth). The holder was then mounted in 
the spinning auto sampler of a Bruker D2 Phaser desktop X-ray diffractometer and scanned 
continuously between 5-80º at a scan axis 2θ measuring 3715 steps at 0.9 seconds per step 
(each step size was 0.02º) with a 5
o
 detector window. 
2.8.4 Magnetic Measurements – Vibrating Sample Magnetometry VSM) 
The saturation magnetisation and magnetisation curve measurements were carried out using a 
7 kOe vibrating sample magnetometer (VSM) at room temperature (298 K). Samples of bare 
and silica-coated magnetite nanoparticles were crushed into a fine power before being packed 
into plastic tubes of length ~10 mm and internal diameter ~1.9 mm. This geometry ensures 
that any demagnetisation effects are kept low.
433
 
2.9 Analytical Methods 
2.9.1 Silica Coating Homogeneity Analysis 
Salmon sperm DNA binding and elution assays were used to confirm silica coating on 
magnetite nanoparticles and the method
29
 was as follows. Salmon sperm DNA solution (50 
µL, see Table 2.3, Section 2.2) was mixed with TEN buffer (400 µL, see Table 2.3, Section 
2.2) and PEG/NaCl (400 µL, see Table 2.3, Section 2.2) and its absorbance at 260 nm was 
measured by UV-Visible spectrophotometry using a Jenway 7315 Spectrophotometer (Bibby 
Scientific Limited, Stone, Staffordshire, UK). The solution was then added to either bare or 
silica-coated magnetite nanoparticles [2 mg, previously washed in sterile water (3×1 mL)] 
and the suspension was incubated in a sterile centrifuge tube (1.5 mL capacity) for 5 minutes 
at room temperature with end-over-end rotation (40 rpm). The nanoparticles were then 
collected magnetically, the supernatant retained and analysed at 260 nm and the nanoparticles 
were then washed in 70% aqueous ethanol (1 mL) for 5 minutes to remove any un-bound 
DNA. Adsorbed DNA was subsequently eluted by incubating the nanoparticles in sterile 
water (500 µL) for 5 minutes at room temperature with end-over-end rotation (40 rpm). This 
elution was then repeated one more time and each 500 µL aliquot was assayed independently 
for its absorbance at 260 nm to estimate its DNA content. The amount of DNA present in 
both aliquots was added together to calculate total elution of DNA. The DNA concentrations 
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were determined using a calibration curve constructed from a range of standard DNA 
solutions prepared in water and 1:1 TEN buffer: PEG/4M NaCl solution.  
Figure 2.1 presents two standard curves constructed using a series of dilutions of salmon 
sperm DNA in a 1:1 TEN:PEG solution (see Table 8, Section 2.2) to assess initial and 
adsorbed DNA concentrations and then in water, to assess the eluted DNA concentration. 
Absorbance was measured by UV-Visible spectrophotometry at 260 nm. 
 
Figure 2.1: Salmon sperm DNA calibration curves constructed in a 1:1 mixture of TEN 
buffer: 20% PEG in 4M NaCl (top) and water (bottom). 
Figure 2.1 shows that linearity is observed over the entire range of 0-70 µg/mL in both cases. 
New standard curves were produced every six months using fresh samples to maintain 
reliability and reproducibility.  
2.9.2 Surface Amine Density Assay 
This assay was used for the detection and quantification of surface amine groups on 
aminosilane-functionalised nanoparticles. The method used is a modified version of that 
previously described by Moon et al
88,427
 and is similar to the method used by Bruce and 
Sen.
80
 Aminosilane-functionalised nanoparticles (5 mg) were placed in a 1.5 mL centrifuge 
tube and washed 4 times with 1 mL of coupling solution [0.8% (v/v) glacial acetic acid in dry 
methanol]. Then, 1 mL of 4-NBA (0.7 mg/mL in coupling solution) was added to the 
nanoparticles and the suspension was allowed to react for 3 h with gentle end-over-end 
rotation at room temperature. The supernatant was then magnetically removed from the 
particles and its absorbance was measured at 282 nm by UV-Visible spectrophotometry using 
a Jenway 7315 Spectrophotometer (Bibby Scientific Limited, Stone, Staffordshire, UK). 
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After removal of the supernatant and washing 4 times with 1 mL of coupling solution, 1 mL 
of hydrolysis solution (composition: 75 mL of water, 75 mL of methanol and 0.2 mL of 
glacial acetic acid) was added to the nanoparticles and the tube was incubated for a further 
hour with end-over-end rotation (40 rpm) at room temperature. The supernatant was then 
magnetically removed from the nanoparticles and its absorbance was measured at 282 nm. 
The amount of 4-NBA in the hydrolysis solution was calculated using a calibration curve 
previously constructed from a range of standard 4-NBA solutions prepared in hydrolysis 
solution (see Table 2.3, Section 2.2). Figure 2.2 presents the standard curve constructed using 
a series of dilutions of 4-NBA in hydrolysis solution.  
 
Figure 2.2: Calibration curve for 4-NBA in hydrolysis solution. 
Figure 2.2 shows that linearity is observed over the entire range of 0-75 nmol/mL. For further 
accuracy, samples with A282 nm > 1.500 were diluted for measurement. New standard curves 
were produced every six months using fresh samples to maintain reliability and 
reproducibility. This had to be done because surface amine density has been shown to 
decrease during longer term storage.
428
 The assay can be represented by Scheme 2.5.  
 
 
Scheme 2.5: Schematic representation of the 4-NBA colorimetric surface assay.  
Page 94 of 250 
 
2.9.3 Bradford Assay for Determination of Adsorbed Lipase on Nanoparticles 
This project employed a modified version of the Bradford Assay for quantitative protein 
determination
429,430
 that was used by Sen et al
100
 in 2010. For lipase immobilised via 
chemical conjugation, following glutaraldehyde surface modification of materials, 4 mL of a 
1000 µg/mL solution of free lipase in PBS buffer was added to 50 mg of the glutaraldehyde-
modified materials and the mixture was incubated overnight for 20 hours at 25ºC with end-
over-end rotation at 40 rpm. For lipase immobilised via physical adsorption, 4 mL of a 1000 
µg/mL solution of free lipase in PBS buffer was added to 50 mg of silica-magnetite 
nanoparticles and the mixture was incubated overnight for 20 hours at 25ºC with end-over-
end rotation at 40 rpm. Following the 20 hour incubation period, the amount of lipase 
remaining in the supernatant was calculated using UV-Visible spectrophotometry; by 
measuring it’s absorbance at 595 nm and subtracting the amount remaining in solution from 
the initial amount of lipase added (4000 µg) using standard curves produced from a set of 
standard free lipase solutions of known concentration.  
Standard curves were constructed using a series of dilutions of lipases in PBS buffer (1 mL) 
mixed with Bradford Reagent (1.2 mL). Absorbance was measured by UV-Visible 
spectrophotometry at 595 nm. Figure 2.3 below presents the curves produced for both CRL 
and PFL. In the case of PFL, the entire standard curve obtained was split into 3 separate 
graphs as it remained linear in these sections.  
 
Figure 2.3: Calibration curves for CRL (left) and PFL (right). 
Figure 2.3 shows that in the case of CRL, linearity is observed over the entire range of 0-
1000 µg/mL, with the line equation y = 0.0006x + 0.4196. In the case of PFL, the curve 
produced from the entire range is non-linear, but contains 3 distinct regions of linearity, from 
which concentration could be calculated based on absorbance. The linear range of 0-200 
µg/mL for PFL has the line equation y = 0.0054x +0.4565. The linear range from 200-600 
Page 95 of 250 
 
µg/mL has the line equation y = 0.0009x + 1.288 and the linear range between 600-1000 
µg/mL has the line equation y = 0.0002x + 1.7057. Hence, in order to calculate the amount of 
lipase present in solution, the correct curve had to be selected depending on the absorbance 
value produced at 595 nm. New standard curves were produced every six months using fresh 
samples to maintain reliability and reproducibility. These curves were used to calculate the 
amount of lipase that had been immobilised on glutaraldehyde-modified nanoparticles (see 
Section 3.8). 
2.9.4 UV-Visible Assay for Determination of Oligonucleotide Concentration 
The heterocyclic bases present in nucleic acids are aromatic and absorb light in the UV 
region. The λmax value for these bases lies between 250-280 nm (values provided with the 
oligonucleotides by TIB-MOLBIOL, Germany), therefore by measuring the absorbance of a 
series of aqueous oligonucleotide solutions of known concentration at 260 nm, a set of 
calibration curves was produced. Absorbance was measured by UV-Visible 
spectrophotometry at 260 nm. Figure 2.4, Figure 2.5 and Figure 2.6 below present the curves 
constructed using a series of dilutions of oligonucleotides in water for oligonucleotide 
sequences specific to both Listeria Monocytogenes and Escherichia Coli. 
 
Figure 2.4: Calibration curves for Listeria Monocytogenes-specific forward (top-left with C6-
spacer, bottom-left with C12-spacer) and reverse (top-right with C6-spacer and bottom-right 
with C12-spacer) oligonucleotides. See Table 2.1, Section 2.1, for the full oligonucleotide 
sequences. Values are mean ± S.E.M., n = 3. 
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Figure 2.5: Calibration curves for complementary forward (bottom-left) and reverse (bottom-
right) oligonucleotides. See Table 2.1, Section 2.1, for the full oligonucleotide sequences. 
Values are mean ± S.E.M., n = 3. 
 
Figure 2.6: Calibration curves for Escherichia Coli-specific forward (top-left) and reverse 
(top-right) oligonucleotides and complementary forward (bottom-left) and reverse (bottom-
right) oligonucleotides. See Table 2.2, Section 2.1, for the full oligonucleotide sequences. 
Values are mean ± S.E.M., n = 3. 
Figure 2.4 and Figure 2.5 show that for the oligonucleotides used in the specific Listeria 
Monocytogenes assays, linearity is observed over the entire range of 0 to 5 nmol/mL. Figure 
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2.6, showing the oligonucleotides used in the specific EC assays, shows that linearity is 
observed over the entire range of 0 to 5 nmol/mL. 
2.9.5 UV-Visible Assay for Determination of p-nitrophenol (PNP) Concentration 
A model catalysis reaction was used for the characterisation of lipase immobilised 
nanoparticles as a test for their performance: Hydrolysis of PNPP to produce palmitic acid 
and PNP (see Section 2.6.3). PNP is an UV-Visible active molecule and its absorbance can be 
measured at 410 nm. Hence, standard curves were constructed using a series of dilutions of 
PNP dissolved in a 1:1 mixture of reagent A (see Table 8, Section 2.2) and isopropanol. 
Absorbance was measured by UV-Visible spectrophotometry at 410 nm. Figure 2.7 presents 
the curve constructed using a series of dilutions of PNP in a 1:1 mixture of reagent A: 
isopropanol.  
 
Figure 2.7: Calibration curve for PNP in a 1:1 mixture of reagent A: Isopropanol. 
Figure 2.7 shows that linearity is observed over the entire range of 0-7 µmol/mL for the entire 
range of solutions. As the PNP is UV-active, amounts as low as 1 µmol/mL required dilutions 
up to 20 times. New standard curves were produced every six months using fresh samples to 
maintain reliability and reproducibility. The calibration curve was used to calculate the 
amount of PNP hydrolysed by lipase-immobilised nanoparticles.  
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2.9.6 Gas Chromatography (GC) and Gas Chromatography-Mass Spectrometry (GC-
MS) for the Detection and Quantification of Ethyl Butyrate, n-Butanol and Butyl 
Butyrate in the Transesterification Reaction 
The second bio-catalytic application carried out using lipase-immobilised nanoparticles was 
the transesterification of ethyl butyrate using n-butanol. In similar studies, GC and GC-MS 
have been used to identify and quantify the reaction products.
301,303
 Starting materials and 
products were quantitatively determined using gas-chromatography (GC) on a Varian 
Chrompack CP-3380 Gas Chromatograph using nitrogen as the carrier gas (California, USA) 
and chromatograms were interpreted using Varian Star Integrator software version 4.51. The 
method of analysis involved injecting a 1 µL aliquot of reaction mixture (hexane layer) into 
the GC using a temperature program starting at 50ºC, increasing to 100ºC at 5ºC per minute. 
The column was flushed with hexane after every third sample.  
Selected reaction products were also analysed (where specified) by gas-chromatography - 
mass spectrometry (GC-MS) on a Thermoscientific Trace GC ultra (Milan, Italy), with DSQ 
II Mass Spectrometer (Texas, USA) and a Triplus AS auto-sampler, using helium as the 
carrier gas. Chromatograms were interpreted using Xcalibur software version 2.0.7. The 
method of analysis involved injecting a 1 µL aliquot of reaction mixture (the water layer) into 
the GC using a temperature program starting at 50ºC, increasing to 200ºC at 10ºC per minute. 
The column was flushed with hexane after every third sample.  
The techniques employed a PerkinElmer
®
 Elite-5MS capillary column (length = 30 m, 
internal diameter = 0.25 mm, film thickness 0.25 µm).  
Standard curves were constructed using a series of dilutions of ethyl butyrate, n-butanol and 
butyl butyrate, with hexane chosen as the solvent for the reaction.  
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Figure 2.8: Calibration curves for ethyl butyrate (top left), n-butanol (top right) and butyl 
butyrate (bottom) in hexane. Peak area (%) is calculated from GC chromatograms. 
Figure 2.8 shows that linearity is observed over the appropriate concentration ranges for each 
compound involved in the transesterification reaction. All samples were prepared in 
duplicate; hence the average peak area is presented in the curves. 
2.9.7 Gas Chromatography (GC) and Gas Chromatography-Mass Spectrometry (GC-
MS) for the Detection of Chiral Products in the Partial and Selective Hydrolysis 
of Cis-3,5-diacetoxy-1-cyclopentene  
In similar studies, GC and GC-MS have been used to identify and quantify the reaction 
products; hence this method was chosen for this reaction too. Following preliminary 
experiments into lipase activation (using water) in the transesterification of ethyl butyrate 
(Section 4.3), varying mixtures of water and hexane were chosen as the solvent system for 
the reaction.  
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Starting materials and products were quantitatively determined using GC on a Varian 
Chrompack CP-3380 Gas Chromatograph using nitrogen as the carrier gas (California, USA) 
and chromatograms were interpreted using Varian Star Integrator software version 4.51. The 
method of analysis involved injecting a 1 µL aliquot of reaction mixture (the water layer) into 
the GC using a temperature program starting at 50ºC, increasing to 200ºC at 10ºC per minute.  
Selected reaction products were also analysed (where specified) by GC-MS on a 
Thermoscientific Trace GC ultra (Milan, Italy), with DSQ II Mass Spectrometer (Texas, 
USA) and a Triplus AS auto-sampler, using helium as the carrier gas. Chromatograms were 
interpreted using Xcalibur software version 2.0.7.  
Both techniques employed a Supelco BETA DEX
TM
 110 fused silica capillary column (length 
= 30 m, internal diameter = 0.25 mm, film thickness 0.25 µm), which is specifically produced 
to separate chiral compounds.
434
  
Calibration curves were constructed using a series of dilutions of cis-3,5-
dihydroxycyclopentene, (1S,4R)-cis-4-acetoxy-2-cyclopenten-1-ol and its enantiomer and 
cis-3,5-diacetoxy-1-cyclopentene.  
Calibration curves were constructed in water for (1S,4R)-cis-4-acetoxy-2-cyclopenten-1-ol 
and cis-3,5-dihydroxycyclopentene, as they are both insoluble in hexane. A calibration curve 
for cis-3,5-diacetoxy-1-cyclopentene was constructed in hexane to calculate the exact amount 
of starting material at time = 0 minutes and to monitor the conversion. In the case of the 
compounds calibrated in water, the data were plotted as absolute peak area against 
concentration, instead of the standard peak area % against concentration. This is because 
water does not appear on the chromatogram as a solvent, as in the FID, (which ionises all 
compounds that pass through the hydrogen/air flame), the water is ionised to hydrogen and 
oxygen, which are the components of the flame; hence, they are not detected. As a result of 
this, there is no solvent peak to use as a reference point.  
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Figure 2.9: Calibration curves for (1S,4R)-cis-4-acetoxy-2-cyclopenten-1-ol (left) and cis-
3,5-dihydroxycyclopentene (right) in water. Peak area (%) is calculated from GC 
chromatograms. 
Figure 2.9 shows that linearity is observed over the appropriate concentration ranges for both 
compounds. The calibration curve constructed for (1S,4R)-cis-4-acetoxy-2-cyclopenten-1-ol 
was also used for (1R,4S)-cis-4-acetoxy-2-cyclopenten-1-ol; peak areas were found to be 
equal when a 1:1 mixture of both was injected in water.  
 
Figure 2.10: Calibration curve for cis-3,5-diacetoxy-1-cyclopentene in hexane. 
Figure 2.10 shows that linearity is observed over the entire concentration range for cis-3,5-
diacetoxy-1-cyclopentene. The data is presented as peak area (%) against concentration.  
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2.9.8 Polymerase Chain Reaction (PCR) Analysis of Selective Isolation, Determination 
and Enrichment of LM and EC in Food Samples 
The detections of LM from food samples and EC from food and wastewater samples were 
carried out using real-time quantitative PCR (qPCR) using a Roche LightCycler
®
 480 and all 
data were interpreted using the Light Cycler
®
 480 Software version 1.5.0. The temperature 
program used was as follows: an initial heating phase for 60 seconds at 95ºC, followed by 45 
seconds of denaturation for 20 seconds at 95ºC, annealing for 30 seconds at 60ºC and 
extension for 20 seconds at 72
o
C. The qPCR premaster mixtures were made up as follows: 2 
µL of the extracted DNA sample was added to 15 µL of this mixture for each reaction. Table 
2.4 presents a complete list of components of the qPCR premaster mixes used to analyse 
extracted LM and EC DNA. 
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Table 2.4: Components of the premaster mixes used for the qPCR analysis of extracted LM 
and EC DNA. 
Component of Mixture (LM-
specific) 
Quantity 
per 
Reaction 
(µL) 
Component of Mixture (EC-
specific) 
Quantity 
per 
Reaction 
(µL) 
Forward primer (See T1NH2 in 
Table 2.1, Section 2.1) (no 
spacer or NH2) 100 pmol/µL 
0.075 Forward primer (See 
EC_541_FOR in Table 2.2, 
Section 2.1) (no spacer or NH2) 
100 pmol/µL 
0.070 
Reverse primer (See T2NH2 in 
Table 2.1, Section 2.1) (no 
spacer or NH2) 100 pmol/µL 
0.075 Reverse primer (See 
EC_637_REV in Table 2.2, 
Section 2.1) (no spacer or NH2) 
100 pmol/µL 
0.070 
LM-specific fluorescence probe 
20 pmol/µL 
 
0.075 EC-specific fluorescence probe 
20 pmol/µL 
0.070 
Internal Amplification Control 
(IAC) primers (forward and 
reverse) 100 pmol/µL each 
0.04  
each 
Internal Amplification Control 
(IAC) primers (forward and 
reverse) 100 pmol/µL each 
0.015 
each 
   0.015 
IAC fluorescence probe 10 
pmol/µL 
 
0.04 IAC fluorescence probe 10 
pmol/µL 
0.015 
dUTP’s 0.12 dUTP’s 0.12 
Glycerin 0.12 Glycerin 0.14 
MgCl2 (25 mM) 0.48 MgCl2 (25 mM) 0.38 
pUC19 (Vector-DNA) 0.20 pUC19 (Vector-DNA) 0.20 
Uracil-N-glycosylase (UNG) 
1U/µL 
0.12 Uracil-N-glycosylase (UNG) 1 
U/µL 
0.12 
Taqman
®
 Fast Universal PCR 
Master Mix (2×) (contains 
dNTP’s and Taq Polymerase) 
7.50 Taqman
®
 Fast Universal PCR 
Master Mix (2×) (contains 
dNTP’s and Taq Polymerase) 
7.50 
Water 6.115 Water 6.285 
Total 15.00 Total 15.00 
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        CHAPTER 3
CHARACTERISATION OF 
NANOPARTICLES 
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3.1 Characterisation and Analytical Methods 
The techniques employed in this project have all been commonly used in other studies related 
to this work and are suitable for the physical and chemical characterisation of magnetic 
nanoparticles.  
Transmission Electron Microscopy (TEM) is widely used to determine both the size and 
shape of the nanoparticles.
217,283,424,435,436
 In this project, it has been used to determine the 
size and shape of both bare and silica-coated magnetite nanoparticles. 
X-Ray Diffraction (XRD) is also widely used to study and confirm the crystalline structure of 
nanoparticles.
283,424,425,436-438
 This project has employed XRD on both bare and silica-coated 
magnetite nanoparticles. 
Vibrating Sample Magnetometry (VSM) is less commonly used, but provides saturation 
magnetism and magnetisation curve measurements.
425,439,440
 This method was used on both 
bare and silica-coated magnetite nanoparticles in this project. 
Brunauer–Emmett–Teller (BET) surface area analysis is a technique used to determine the 
surface area of a sample using the adsorption and desorption of known amounts of nitrogen 
gas at low temperatures.
437,438,441
 Again, this method was used on both bare and silica-coated 
magnetite nanoparticles in this project. 
UV-Visible spectrophotometry-based assays have been used for calculating the surface amine 
density,
86,88
 DNA binding and elution efficiency of bare- and silica-coated magnetite 
nanoparticles,
29,78,86
 amount of lipase immobilised on surface-functionalised 
nanoparticles,
429,430
 amount of PNP hydrolysed during model catalysis reactions
432
 and the 
amount of oligonucleotides covalently coupled to surface-functionalised nanoparticles and 
their efficiency in capturing complementary sequences in hybrid capture assay experiments.
80
 
Gas Chromatography (GC) and Gas Chromatography-Mass Spectrometry (GC-MS) have 
both been used to calculate the product conversion in the transesterification and chiral 
compound hydrolysis reactions.  
Table 3.1 provides an outline of the magnetite and silica-coated magnetite materials that have 
been characterised using each method. The best functionalised materials were then used for 
further applications, shown in Table 3.2. 
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Table 3.1: Materials Produced and Characterisation Methods Used. 
Name Details Characterisation Method Application Used For 
 TEM BET XRD VSM DNA Binding 
and Elution 
Bio-catalysis Bio-sensor 
R1MA Small-scale magnetite (see 
Section 2.3.1) 
 √ √ √ √ √ Not used 
further 
Not used 
further 
R2MC Small-scale magnetite (see 
Section 2.3.2) 
 √ √ √ √ √ Not used 
further 
Not used 
further 
QBLSBM Large-scale magnetite (see 
Section 2.3.2) used for 
applications 
 √ √ √ √ √ √ √ 
CR2MC Small-scale amorphous silica-
coated magnetite (see Section 
2.4.1) 
 √ √ √ √ √ Not used 
further 
Not used 
further 
QBLSSM Large-scale amorphous silica-
coated magnetite (see Section 
2.4.1) used for applications 
 √ √ √ √ √ √ √ 
 
Table 3.2 below provides a list of functionalised silica-magnetite nanoparticles, the characterisation techniques used and how they have been 
used for further applications. 
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Table 3.2: Modified and functionalised nanoparticles, characterisation techniques and their uses for further applications  
Name Details Characterisation Method Used Application Used For 
DNA Binding 
and Elution 
UV Colorimetric 
Assay of Surface 
Amine Density 
Bio-catalysis Bio-sensor 
TTQB Amine-functionalised QBLSSM using APTS 
and TPRE method (see Section 2.5.2) 
√ √ √ √ 
TWQB Amine-functionalised QBLSSM using APTS 
and water method (see Section 2.5.1) 
√ √ √ √ 
DTQB Amine-functionalised QBLSSM using APDS 
and TPRE method (see Section 2.5.2) 
√ √ √ N/A 
DWQB Amine-functionalised QBLSSM using APDS 
and water method (see Section 2.5.1) 
√ √ √ N/A 
MTQB Amine-functionalised QBLSSM using APMS 
and TPRE method (see Section 2.5.2) 
√ √ √ N/A 
MWQB Amine-functionalised QBLSSM using APMS 
and water method (see Section 2.5.1) 
√ √ √ N/A 
Note: The letters T, D and M represent the aminosilane used (APTS, APDS and APMS respectively). The next letter T or W represents the surface-functionalisation method 
used: T = TPRE, W = water. QB represents the shortened name of the silica-coated material QBLSSM.  
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3.2 Nanoparticle Size and Surface Coating Homogenity Analysis 
Samples were prepared and images produced using transmission electron microscopy 
according to methods explained in Section 2.8.2. Images for bare magnetites (R1MA, R2MC 
and QBLSSM) and amorphous silica-magnetites (CR2MC and QBLSSM) are presented 
below.  
Bare Magnetite Materials 
 
Figure 3.1: TEM images of the bare magnetite material R1MA. 
Figure 3.1 shows the bare magnetite R1MA, prepared by the small-scale co-precipitation of 
ferrous and ferric chloride solutions in alkaline media. The nanoparticles are shown to be 
spherical and around 10 nm diameter. The size and shape are similar to those reported by Sen 
et al in 2006
424
.  
 
Figure 3.2: TEM images of bare magnetite material R2MC. 
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Figure 3.2 shows the bare magnetite R2MC, prepared by the small-scale oxidative hydrolysis 
of ferrous sulphate. The nanoparticles are shown to be rhombic and quite polymorphic, with 
diameters ranging from 30-200 nm. The size and shape are similar to those reported by Bruce 
et al
29
 in 2004 and again, by Sen et al
424
 in 2006, although some are slightly larger than those 
reported previously. The needle-like structure seen in the top left image is thought to be 
goethite; its presence is also confirmed in the XRD pattern, Figure 3.7, Section 3.3. 
 
Figure 3.3: TEM images of bare magnetite material QBLSBM. 
Figure 3.3 shows the bare magnetite QBLSBM, prepared by the large-scale oxidative 
hydrolysis of ferrous sulphate. The nanoparticles are shown to be rhombic and polymorphic, 
with sizes ranging from 25-200 nm. The size and shape are similar to those reported by Bruce 
et al
29
 in 2004. The images also confirm that scaling-up the synthesis does not significantly 
alter the morphology of the nanoparticles. 
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Amorphous Silica-Coated Magnetite Materials 
 
Figure 3.4: TEM images of small-scale amorphous silica-coated magnetite material CR2MC. 
Figure 3.4 shows the silica-coated magnetite CR2MC, prepared by coating R2MC via silicic 
acid deposition. The larger image on the left of the figure shows a large area of aggregated 
rhombic magnetite nanoparticles (darker), coated by a thin layer of silica (lighter). The upper 
right image shows an enlarged view of the area in the box in the larger image on the left and 
shows a relatively large (80-100 nm size) rhombic magnetite nanoparticle coated with a thin 
silica shell, underneath a much larger spherical silica particle. The silica shell can also be 
seen clearly surrounding a single magnetite nanoparticle (68.5 nm size) in the image in the 
bottom left of the figure. The nanoparticles are shown to be polymorphic in size, ranging 
from 30-200 nm, although larger aggregates can be present due to sample preparation 
techniques involved with TEM. As with R2MC, the size and shape are similar to those 
reported by Bruce et al
29
 in 2004 and Sen et al
424
 in 2006.  
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Figure 3.5: TEM images of large-scale amorphous silica-coated magnetite material 
QBLSSM. 
Figure 3.5 shows the silica-coated magnetite QBLSSM, prepared by coating QBLSBM via 
silicic acid deposition. The nanoparticles are shown to be rhombic and polymorphic, with 
sizes ranging from 25-200 nm, the same as bare QBLSBM, suggesting a thin silica-coating 
around the nanoparticles. The size and shape are similar to those reported by Bruce et al
29
 in 
2004, who also employed a scaled-up version of producing silica-coated magnetite. The 
upper left corner of the image shows the rhombic morphology of the nanoparticles has not 
changed during silica-coating. The other three images show the rhombic magnetite core 
(dark) surrounded by the thin silica-shell (lighter), which is measured to be around 5-15 nm 
from the TEM images. The lower right image shows the silica-coated magnetite nanoparticle 
underneath another nanoparticle.  
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3.3 Iron Oxide Phase Confirmation 
Samples were prepared and X-ray diffraction data were produced according to methods 
explained in Section 2.8.3. 
Bare Magnetite Materials 
 
Figure 3.6: Powder XRD Pattern for R1MA. Peaks are labelled with Miller Indices using 
DIFFRAC.EVA V3.0 Software. 
Figure 3.6 shows the XRD pattern for bare magnetite R1MA. The peaks obtained are in 
accordance with those expected of pure magnetite when compared to standard XRD data for 
magnetite (JCPDS No. 19-0629, from Yu and Kwak
442
 (ESI)) and are also in accordance with 
those reported in the literature.
54,68,424,443
 Many peaks present in hematite can overlap with the 
ones in magnetite, for example (110) in hematite is present at almost the same 2θ value as the 
(311) peak in magnetite. Other peaks that could overlap are the broad (018) peak in hematite, 
present at the same 2θ value as the (511) peak in magnetite and also the (116) peak in 
hematite at the same 2θ value as the (422) peak in magnetite.444,445 The red-brown colour of 
the nanoparticles confirms the presence of an impurity of hematite in the sample. 
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Figure 3.7: Powder XRD Pattern for R2MC. Peaks are labelled with Miller Indices using 
DIFFRAC.EVA V3.0 Software. Peaks denoted with a * represent peaks corresponding to 
goethite, FeO(OH). 
Figure 3.7 shows the XRD pattern for bare magnetite R2MC. The peaks obtained are in 
accordance with those expected of pure magnetite when compared to standard XRD data for 
magnetite (JCPDS No. 19-0629, from Yu and Kwak
442
 (ESI)) and are also in accordance with 
those reported in the literature.
54,68,424,443
 However, peaks denoted with a * represent peaks 
arising from goethite, FeO(OH)
445
. Hence, it can be concluded that R2MC contains an 
impurity of goethite in magnetite.  
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Figure 3.8: Powder XRD Pattern for QBLSBM. Peaks are labelled with Miller Indices using 
DIFFRAC.EVA V3.0 Software. Peaks denoted with a * represent peaks corresponding to 
goethite, FeO(OH) and peaks denoted with a ** represent peaks corresponding to maghemite, 
γ-Fe2O3. 
Figure 3.8 shows the XRD pattern for bare magnetite QBLSBM. The peaks obtained are in 
accordance with those expected of pure magnetite when compared to standard XRD data for 
magnetite (JCPDS No. 19-0629, from Yu and Kwak
442
 (ESI)) and are also in accordance with 
those reported in the literature.
54,68,424,443
 However, peaks denoted with a * represent peaks 
arising from goethite, FeO(OH) and those denoted with a ** represent peaks corresponding to 
maghemite, γ-Fe2O3.
446
 Hence, it can be concluded that R2MC contains a mixture of 
magnetite, goethite and maghemite. However in this case the goethite and magnetite peaks 
are much smaller than the goethite peaks present in sample R2MC and many goethite and 
maghemite peaks are missing, indicating that the sample is primarily magnetite with just a 
small amount of goethite and maghemite impurities.  
Due to the amorphous nature of the silica coating on the silica-magnetite nanoparticles 
CR2MC and QBLSSM, the XRD pattern remains identical to that obtained from the pure 
Page 115 of 250 
 
magnetite materials used for coating (R2MC and QBLSBM respectively). Hence, the XRD 
patterns for these materials are not shown.  
3.4 Magnetic Properties of Nanoparticles Analysis  
Samples were prepared and magnetic data were obtained using vibrating sample 
magnetometry according to methods explained in Section 2.8.4. 
Bare Magnetite Materials 
 
Figure 3.9: Magnetic susceptibility data of small-scale bare magnetite materials R1MA (left) 
and R2MC (right). 
Figure 3.9 shows the magnetisation data for small-scale bare magnetite materials. R1MA, 
prepared by the small-scale co-precipitation of ferrous and ferric chloride solutions in 
alkaline media, exhibits close to no hysteresis, with saturation magnetisation (MS) of 60 
emu/g. R2MC, prepared by the small-scale oxidative hydrolysis of ferrous sulphate, exhibits 
a small amount of hysteresis, with MS = 52 emu/g. The low MS of R1MA and R2MC could 
be explained due to the presence of hematite and goethite in the samples respectively, as seen 
in the XRD patterns (see Figure 3.6 and Figure 3.7, Section 3.3). Hematite and goethite are 
both antiferromagnetic
447,448
 with MS values less than 1 emu/g;
449,450
 therefore its presence 
leads to a decrease in saturation magnetisation of the sample, as the typically reported MS 
value for bulk magnetite of 92 emu/g.
35,451
 
The slight hysteresis present in R2MC may arise from the various sizes of the nanoparticles 
present in the sample. It is well-known that large magnetic particles are multi-domain 
structures; each domain containing regions of uniform magnetisation,
35
 separated by domain 
walls. As the size of the particle decreases towards the nanometre range, it becomes 
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energetically unfavourable to create a domain wall and at this point, the particle becomes a 
single magnetic domain. This is known as the single-domain limit (or critical diameter, DC), 
at which point the particle is uniformly magnetised; all spins aligned in the same direction 
and the material exhibits superparamagnetic properties. It has been reported that magnetite 
has a single-domain size of around 128 nm.
35
 This can explain the superparamagnetic 
behaviour exhibited by R1MA, which is around 10 nm in diameter; well below the single-
domain limit. However, the critical diameter values can only be strictly applied to spherical 
particles; particles of different shapes generally have higher coercivity and significantly 
different DC values. The nanoparticles present in R2MC are rhombic and between 30-200 nm 
in size, hence, most of the nanoparticles present fall below the critical diameter and the 
material exhibits mostly superparamagnetic behaviour. Larger nanoparticles with diameter > 
DC are the cause for the slight hysteresis in the magnetisation curve and hence will exhibit 
ferrimagnetic behaviour instead of superparamagnetic behaviour.  
 
Figure 3.10: Magnetic susceptibility data of large-scale bare magnetite QBLSBM. 
Figure 3.10 shows the magnetisation data for large-scale bare magnetite QBLSBM, prepared 
by the large-scale oxidative hydrolysis of ferrous sulphate. The material exhibits a higher 
saturation magnetisation than the magnetite materials made on the small-scale, MS = 67 
emu/g. Again, there is slight hysteresis, due to the size distribution of the nanoparticles 
present in the sample (25-200 nm size). The presence of other iron oxides in the sample (as 
seen in the XRD pattern, Figure 3.8, Section 3.3) leads to reduced saturation magnetisation 
due to the lower MS values (goethite = less than 1 emu/g
449
, maghemite is around 74-80 
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emu/g.
452,453
 The presence of iron oxide impurities is possible as magnetic measurements 
were carried out on QBLSBM that had been synthesised months earlier and stored in water, 
hence some oxidation of the magnetite is possible.  
Amorphous Silica-Coated Magnetite Materials 
 
Figure 3.11: Magnetic susceptibility data of small-scale amorphous silica-magnetite CR2MC 
(left) and large-scale amorphous silica-magnetite QBLSSM (right). 
Figure 3.11 shows the magnetisation data for amorphous silica coated magnetite materials 
(core-shell nanoparticles) made using the small- and large-scale deposition of silicic acid on 
bare magnetite nanoparticles. Small-scale silica-magnetite CR2MC shows reasonably high 
saturation magnetisation (66 emu/g), which is unexpectedly higher than the bulk magnetite 
(R2MC, MS = 52 emu/g). The same phenomenon is seen in the case of large-scale silica-
magnetite, which again has a higher saturation magnetisation (73 emu/g) than bare magnetite, 
QBLSBM (MS = 67 emu/g). This could be because silica-coating of the nanoparticles 
protects the magnetite core against oxidation during the drying step and whilst in solution.  
The MS values for all materials are lower than the typically reported MS value for bulk 
magnetite of 92 emu/g
35,451
 and are slightly lower than those reported by Bruce et al
29
 (82 
emu/g at 300 K). This can be previously explained partly due to the presence of other iron 
oxides such as hematite, goethite and maghemite as impurities, which have lower MS values 
than magnetite.  
3.5 Surface Area Analysis 
Samples were prepared and surface area analysis data were obtained via nitrogen adsorption 
techniques using Brunauer-Emmett-Teller surface area measurements according to methods 
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explained in Section 2.8.1. Due to the amorphous nature of the materials, it is only relevant to 
present the overall BET surface area values. 
Table 3.3: BET surface area data for bare- and silica-coated magnetite nanoparticles used in 
this project. 
Material Scale Silica Coating BET Surface Area (m
2
 / g) 
R1MA Small None 109.30 
R2MC Small None 27.01 
QBLSBM Large None 15.73 
CR2MC Small Amorphous 23.26 
QBLSSM Large Amorphous 14.66 
 
The bare magnetite R1MA, prepared by the co-precipitation of ferrous and ferric chlorides, 
has a surface area of 109.30 m
2
/g, which is consistent with the value reported by Bruce et al: 
108.81 m
2
/g.
29
 The surface area of 27.01 m
2
/g obtained for R2MC in this study is slightly 
higher than that reported in the same study by Bruce et al: 21.30 m
2
/g. When scaling up the 
preparation of R2MC, to the synthesis of QBLSBM, surface area decreased to 15.73 m
2
/g. 
This is also in agreement with Bruce et al’s results, where scaling-up the synthesis led to the 
surface area decreasing from 21.30 m
2
/g to 14.66 m
2
/g. This is possibly due to an increase in 
aggregation of the nanoparticles as a result of scaling-up the process, arising from a slight 
decrease in precise control over the synthetic conditions.  
Slight decreases are seen in surface area following silica-coating in both the small- and large-
scale. Small-scale silica-magnetite CR2MC decreases from 27.01 m
2
/g as bare magnetite to 
23.26 m
2
/g following silica-coating. Large-scale silica-magnetite QBLSSM decreases from 
15.73 m
2
/g as bare magnetite to 14.66 m
2
/g following silica-coating. A small change in 
surface area is an indication that the materials were un-affected by silica coating and did not 
aggregate upon silica-coating.  
3.6 Surface Amine Density Analysis 
An optimised version of Moon’s assay88 (developed for flat surfaces), later used by Del 
Campo et al
217
 for nanoparticles, was employed in this study (see Section 2.9.2) in order to 
assess the surface amine density of aminosilane-surface-functionalised silica-magnetite 
nanoparticles. The assay involves the coupling of a UV-sensitive molecule (4-NBA) to the 
amine functionality on the nanoparticle bonds to a single surface amine group, the amount of 
surface amine groups can be calculated from the amount of 4-NBA present in solution 
following hydrolysis.  
Page 119 of 250 
 
Table 3.4 shows a range of materials used to study DNA binding and elution.  
Table 3.4: Surface-functionalised silica-magnetite nanoparticles used in the surface amine 
density assay. 
Material Description 
TTQB QBLSSM surface-functionalised via the TPRE-method using APTS as 
the aminosilane source (see Section 2.5.2) 
TWQB QBLSSM surface-functionalised via the water-method using APTS as 
the aminosilane source (see Section 2.5.1) 
DTQB QBLSSM surface-functionalised via the TPRE-method using APDS as 
the aminosilane source (see Section 2.5.2) 
DWQB QBLSSM surface-functionalised via the water-method using APDS as 
the aminosilane source (see Section 2.5.1) 
MTQB QBLSSM surface-functionalised via the TPRE-method using APMS as 
the aminosilane source (see Section 2.5.2) 
MWQB QBLSSM surface-functionalised via the water-method using APMS as 
the aminosilane source (see Section 2.5.1) 
Note: The letters T, D and M represent the aminosilane used (APTS, APDS and APMS respectively). The next 
letter T or W represents the surface-functionalisation method used: T = TPRE, W = water. QB represents the 
shortened name of the silica-coated material QBLSSM. 
The 4-NBA assay was carried out (as explained in Section 2.9.2) on all materials made via 
aminosilane surface-functionalisation. Absorbance was measured by UV-Visible 
spectrophotometry at 282 nm. 
 
Figure 3.12: Surface amine density of materials made using various aminosilanes (APTS, 
APDS and APMS) via two different methods of surface functionalisation (TPRE and water 
method). The materials are explained in Table 3.4. Values are mean ± S.E.M., n = 3. 
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Figure 3.12 shows that materials made using APTS exhibit a much higher surface amine 
density than both APDS and APMS materials. This may be due to more regular condensation 
mechanism as the alkoxy groups can also interact with each other, permitting a more dense 
aminosilicate layer on the surface and thus a higher number of surface amine groups. TPRE 
materials show a higher surface amine density than water materials in all cases, indicating 
that the condensation of the aminosilanes onto the surface silanol groups is more controlled 
using TPRE conditions, whereas self-polymerisation and condensation is harder to control 
using the water method.  
Using the surface area value for the silica-coated magnetite, QBLSSM, which was used to 
prepare all of the surface-functionalised nanoparticles, it is possible to represent the surface 
amine density in terms of NH2-molecules per nm
2
, as it is a standard unit reported by 
others.
86,88,428,454
 The surface amine density values are presented as averages of multiple 
batches of the materials made in the same way each time. As the methods of surface-
functionalisation are the same as those reported by De Waterbeemd,
428
 the values can be 
directly compared.  
Table 3.5: A comparison between surface amine density values obtained in this study with 
those obtained by De Waterbeemd.
428
 
Material* 
Aminosilane 
Used 
Surface 
Functionalisation 
Method 
Surface Amine Density (NH2-
molecules/ nm
2
) 
My Value 
Literature Value 
(De 
Waterbeemd
428
) 
TTQB APTS TPRE 4.34 ~4.1 
TWQB APTS Water 4.06 1.5 
DTQB APDS TPRE 3.28 ~4.1 
DWQB APDS Water 1.39 3.4 
MTQB APMS TPRE 0.49 N/A 
MWQB APMS Water 0.54 0.2 
Note: The letters T, D and M represent the aminosilane used (APTS, APDS and APMS respectively). The next 
letter T or W represents the surface-functionalisation method used: T = TPRE, W = water. QB represents the 
shortened name of the silica-coated material QBLSSM. *See Table 3.4 for material details. 
As can be seen from Table 3.5, in terms of TPRE-functionalised materials, surface amine 
density values are similar. The decrease in surface amine density seen from APTS to APDS 
in my results could be due to more regular ordering leading to a smaller amount of 
sequestration. As can also be seen, De Waterbeemd did not attempt the TPRE surface 
functionalisation using APMS; therefore no comparison can be made. In terms of water-
functionalised materials, a decreasing trend in surface amine density can be seen from APTS 
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to APDS to APMS. The low surface amine density given by APMS materials was observed 
to be similar in both studies. For APTS materials made using both methods and APDS 
materials made using the TPRE method, surface amine density is similar to that of a 
monolayer on a flat surface, reported to be 4.0-5.3 NH2-molecules/nm
2
 by Moon et al.
88
 In 
both studies, materials made using the TPRE-method exhibit higher surface amine density 
than those made using the water-method, possibly due to the more regular condensation onto 
the nanoparticle surface using the more controlled TPRE synthesis – leading to fewer 
sequestered groups. This is apparent in the significant difference between the surface amine 
density values of DTQB (3.28 NH2-molecules per nm
2
) and DWQB (1.39 NH2-molecules per 
nm
2
). Values are similar for materials made using APMS as there is only a single ethoxy 
group present to make inter-aminosilane condensation possible. 
3.7 Silica Coating Homogenity on Magnetite Nanoparticles Analysis 
Salmon sperm DNA binding and elution was used to analyse the surface of bare magnetite, 
silica-magnetite and amine-surface-functionalised silica-magnetite nanoparticles. Both 
magnetite and silica-magnetite nanoparticles possess surface hydroxyl groups that are 
partially ionised at physiological pH values in chaotropic (high salt concentration) conditions. 
At near-neutral or basic pH, the surface of silica is negatively charged due to weakly acidic 
silanol groups. The point of zero charge (pzc, also known as isoelectric point), is the pH at 
which the surface density of positive and negative charges are equal.
455
 For silica, this value 
is around pH 2-3,
435,455,456
 and for magnetite, it is around pH 6.4-7.3,
456-459
 therefore both will 
carry a negative charge at pH 7-8, although that of silica will be much greater than that of 
magnetite. Hence, negatively charged Fe-O
- 
or Si-O
-
 groups will become shielded by positive 
counter-ions from the salt solution (Na
+
), giving an overall slightly positive surface charge, to 
which the negative-charge-holding phosphate di-ester groups of the DNA backbone are 
attracted. Water can be used to break the electrostatic bond formed via the “cation bridge”, 
eluting the DNA as the corresponding salt species as the silica surface and DNA backbone 
electrostatically repel each other. Under the same physiological pH conditions, amine-
functionalised nanoparticles are in equilibrium between the NH2 and NH3
+ 
species which can 
electrostatically attract the negatively-charged phosphate backbone of the DNA.
80,455
 In 
addition, the silica surface that remains un-functionalised by the aminosilane remains 
negatively charged above pH 7, hence can interact electrostatically with the DNA via the 
“cation bridge”.455 
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Table 3.6 below shows which materials were used to study DNA binding and elution.  
Table 3.6: Small- and large-scale bare, silica-coated and surface-functionalised silica-
magnetite nanoparticles used in the DNA binding and elution study. 
Material Description 
QBLSBM Large-scale rhombic magnetite (see Section 2.3.2) 
QBLSSM 2 Coats Large-scale silica-magnetite coated 2 times with amorphous silica via 
silicic acid deposition (see Section 2.4.2) 
QBLSSM 4 Coats 
(QBLSSM) 
Large-scale silica-magnetite coated 4 times with amorphous silica via 
silicic acid deposition (see Section 2.4.2) 
R2MC Small-scale rhombic magnetite (see Section 2.3.2) 
R2MC 2 Coats Small-scale silica-magnetite coated 2 times with amorphous silica via 
silicic acid deposition (see Section 2.4.1) 
R2MC 4 Coats Small-scale silica-magnetite coated 4 times with amorphous silica via 
silicic acid deposition (see Section 2.4.1) 
TTQB QBLSSM surface-functionalised via the TPRE-method using APTS as 
the aminosilane source (see Section 2.5.2) 
TWQB QBLSSM surface-functionalised via the water-method using APTS as 
the aminosilane source (see Section 2.5.1) 
DTQB QBLSSM surface-functionalised via the TPRE-method using APDS as 
the aminosilane source (see Section 2.5.2) 
DWQB QBLSSM surface-functionalised via the water-method using APDS as 
the aminosilane source (see Section 2.5.1) 
MTQB QBLSSM surface-functionalised via the TPRE-method using APMS as 
the aminosilane source (see Section 2.5.2) 
MWQB QBLSSM surface-functionalised via the water-method using APMS as 
the aminosilane source (see Section 2.5.1) 
  
Note: The letters T, D and M represent the aminosilane used (APTS, APDS and APMS respectively). The next 
letter T or W represents the surface-functionalisation method used: T = TPRE, W = water. QB represents the 
shortened name of the silica-coated material QBLSSM.  
Figure 3.13 and Figure 3.14 below show the DNA binding and elution properties of small- 
and large-scale bare and amorphous silica-coated (2 and 4 times) magnetite nanoparticles. 
Figure 3.13 presents the data in terms of µg used, adsorbed and eluted, while Figure 3.14 
presents the same data as percentages of the initial amount of DNA used.  
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Figure 3.13: The amount of DNA initially used, adsorbed and eluted, in µg. The materials 
used are explained in Table 3.6 above. The blue bars represent initial amount of DNA used, 
the red bars represent the amount of DNA adsorbed and the green bars represent the amount 
of DNA eluted. Values are mean ± S.E.M., n = 3. 
 
Figure 3.14: The amount of DNA adsorbed and eluted, as percentages of the initial amount 
of DNA used. The materials used are explained in Table 3.6 above. The blue bars represent 
initial amount of DNA used, the red bars represent DNA adsorbed and the green bars 
represent the eluted DNA. Values are mean ± S.E.M., n = 3. 
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Figure 3.13 and Figure 3.14 indicate that adsorption of DNA is high in the case of all 
materials (89-97%), indicating that adsorption to these materials occurs via a similar 
mechanism, i.e. the “cation-bridge” under chaotropic conditions. Adsorption is slightly higher 
in the case of bare magnetite nanoparticles, possibly because the DNA is adsorbed by a 
different mechanism, as the magnetite surface will not be fully ionised at the neutral pH 
conditions used. Hence, the “cation-bridge” adsorption mechanism may not be as strong in 
the case of bare magnetite and the magnetite surface groups may interact with the DNA via 
other mechanisms such as hydrogen bonding, or by direct electrostatic attraction with 
functional groups present in the DNA. The low elution values of bare magnetite compared to 
those of silica-coated magnetite again may be explained due to the different adsorption 
mechanisms, discussed above. As a result, with less “cation-bridge” interactions occurring in 
the chaotropic conditions, the adsorbed DNA may not be disrupted by altering the ionic 
strength of the system and more of the DNA will remain adsorbed on the magnetite surface. 
However, it can clearly be seen that coating with silica drastically changes the elution 
properties of the material. 
In the case of amorphous silica-coated materials, both small-and large scale materials show 
an increase in elution with further silica-coatings. This follows trends observed by Bruce et 
al,
29
 who reported that DNA can be successfully eluted from silica surfaces due to the 
electrostatic repulsion between ionised silanol groups (Si-O
-
) and the negatively-charged 
phosphate backbone of DNA at low ionic strength, i.e. in water.
80
 Hence, it is shown that 
magnetite coated 4 times produces a more complete core-shell of silica around the magnetite 
nanoparticle.  
Figure 3.15 and Figure 3.16 show the effect that surface-functionalisation using various 
aminosilanes has on the DNA binding and elution properties of the nanoparticles. Figure 3.15 
presents the data in terms of µg used, adsorbed and eluted, while Figure 3.16 presents the 
same data as percentages of the initial amount of DNA used.  
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Figure 3.15: The amount of DNA initially used, adsorbed and eluted, in µg. The materials 
used are explained in Table 3.6 above. The blue bars represent initial amount of DNA used, 
the red bars represent the amount of DNA adsorbed and the green bars represent the amount 
of DNA eluted. Values are mean ± S.E.M., n = 3. 
 
Figure 3.16: The amount of DNA adsorbed and eluted, as percentages of the initial amount 
of DNA used. The materials used are explained in Table 3.6 above. The blue bars represent 
initial amount of DNA used, the red bars represent DNA adsorbed and the green bars 
represent the eluted DNA. Values are mean ± S.E.M., n = 3. 
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Figure 3.15 and Figure 3.16 show that materials functionalised using APTS and APDS both 
adsorb more than silica-coated magnetite, but have very low elution values (lower than bare 
magnetite in both cases). Materials made using APTS and the TPRE-method of surface-
functionalisation elute only 8% of adsorbed DNA, while those made using the water-method 
elute 3 times more DNA at 26%. For APDS materials, there is little difference between the 
DNA elution values of materials made via the TPRE-(15%) or the water-method (18%). 
However, APMS materials, have slightly lower adsorption than other materials, but have high 
elution values. The lower adsorption may be due to a lower surface amine density permitting 
fewer sites for the DNA to interact with.  For APMS materials made via the TPRE- method, 
85% of the DNA adsorbed was then eluted. APMS materials made via the water-method have 
moderately high elution values of 63% compared to APTS and APDS functionalised 
materials.  
High adsorption values of DNA to the amine-surface-functionalised nanoparticles may be 
due to the fact that the aminosilanes are positively charged at pH 7,
80,455
 mediating adsorption 
via electrostatic interactions between positively charged –NH3
+
 groups on the surface and the 
negatively-charged phosphate backbone of DNA.  
Due to decreasing steric hindrance on the silica-coated magnetite surface with a decreasing 
number of alkoxy groups (from APTS to APDS to APMS) (see Figure 1.5, Section 1.6); it 
was shown that APTS gives the greatest density of surface amine groups (see Section 3.6). 
Due to the increased surface amine density provided by APTS, materials made using it can 
adsorb more DNA groups via direct electrostatic attraction to the –NH3
+
 surface groups. This 
can explain why elution is the lowest for APTS materials (the electrostatic interaction is 
unaffected by the change in ionic strength when water is used as an eluent). APDS possesses 
one methyl group and two alkoxy groups and as a result is slightly less ordered around the 
silica surface due to the methyl group blocking some of the inter-aminosilane Si-O-Si bonds. 
In addition to this, oxygen atoms present in the Si (surface)-O-Si (aminosilane) bond will 
electrostatically repel other similar oxygen atoms around the nanoparticle surface; this means 
that the aminosilane molecules cannot pack as closely together. Despite adsorption remaining 
as high as APTS materials, this could be due to there being more space on the silica-surface 
for the DNA to interact via the “cation-bridge” mechanism directly to the silica-surface, 
hence the slightly higher elution values than APTS. In the same trend, APMS has two methyl 
groups and just one alkoxy group, eliminating inter-aminosilane Si-O-Si bonds and greatly 
increasing the amount of space between each group on the surface, as there is no chance to 
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interact with other aminosilanes. Coupled with lower surface amine density values than 
APTS and APDS materials, more DNA could interact via the “cation-bridge” mechanism 
directly to the silica-surface, explaining the high adsorption values and the much higher 
values for elution. The results of the surface amine density assay shown in Section 3.6 help to 
validate these assumptions. 
3.8 Lipase Immobilisation on Amine Functionalised Silica-Magnetite 
Nanoparticles 
For lipase immobilised on surface-functionalised silica-magnetite nanoparticles (see Section 
2.6 for method of immobilisation), enzyme loading was calculated using standard curves 
produced from a set of standard free lipase solutions of known concentration (see Section 
2.9.3). Table 3.7 (see the next page) provides a comprehensive list of all lipase-immobilised 
materials produced for this project and their bio-catalytic applications. 
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Table 3.7: Immobilised and Physically Adsorbed Lipase Materials and their Use in Bio-catalytic Applications 
Name Details Bio-catalytic Application Used For 
 Model Catalysis 
(Hydrolysis of 
PNPP) 
Transesterification 
of Ethyl Butyrate 
Hydrolysis of 
cis-3,5-
diacetoxy-1-
cyclopentene 
PFLITTQB PFL immobilised on TTQB (see Section 2.5.2) √ √ √ 
PFLITWQB PFL immobilised on TWQB (see Section 2.5.1) √ √ N/A 
PFLIDTQB PFL immobilised on DTQB (see Section 2.5.2) √ √ N/A 
PFLIDWQB PFL immobilised on DWQB (see Section 2.5.1) √ √ N/A 
PFLIMTQB PFL immobilised on MTQB (see Section 2.5.2) √ √ N/A 
PFLIMWQB PFL immobilised on MWQB (see Section 2.5.1) √ √ N/A 
CRLITTQB CRL immobilised on TTQB (see Section 2.5.2) √ √ N/A 
CRLITWQB CRL immobilised on TWQB (see section 2.5.1) √ √ √ 
CRLIDTQB CRL immobilised on DTQB (see Section 2.5.2) √ √ N/A 
CRLIDWQB CRL immobilised on DWQB (see Section 2.5.1) √ √ N/A 
CRLIMTQB CRL immobilised on MTQB (see Section 2.5.2) √ √ N/A 
CRLIMWQB CRL immobilised on MWQB (see Section 2.5.1) √ √ N/A 
PFLIQBLSSM PFL physically adsorbed on QBLSSM (see Section 2.6.2) √ √ N/A 
CRLIQBLSSM CRL physically adsorbed on QBLSSM (see Section 2.6.2) √ √ N/A 
Note: PFLI and CRLI represent materials made using PFL and CRL. The letter T, D and M represent the aminosilane used (APTS, APDS and APMS respectively). The next 
letter T or W represents the surface-functionalisation method used: T = TPRE, W = water. QB represents the shortened name of the silica-coated material QBLSSM.  
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Figure 3.17 shows the average enzyme loading data for lipase-immobilised materials made 
using amorphous silica-coated magnetite nanoparticles functionalised by a variety of 
aminosilanes; APTS, APDS and APMS.  
 
Figure 3.17: Lipase (Pseudomonas Fluorescens Lipase: PFL; Candida Rugosa Lipase: CRL) 
loading data for magnetite nanoparticles coated with amorphous silica and functionalised 
using a variety of aminosilanes by water and TPRE methods. See Table 3.7 for explanations 
of the names of materials. Values are mean, ± S.E.M., n ≥3 in all cases. 
From Figure 3.17, the first comparisons to be made were between the water and TPRE 
methods of surface functionalisation. It can be seen that among materials functionalised using 
APTS, there is no significant difference in enzyme loading values between materials made 
using the water (PFLITWQB, CRLITWQB) or TPRE (PFLITTQB, CRLITTQB) methods. 
This can be explained by the similar values for surface amine density of the amine-
functionalised materials made using APTS: TPRE = 4.34 NH2-molecules per nm
2
 and water 
= 4.06 NH2-molecules per nm
2
. For materials functionalised using APDS, in the case of PFL 
immobilisation, the TPRE method produces materials (PFLIDTQB) with around 50% higher 
enzyme loading values than the water method (PFLIDWQB). For CRL, loading values are 
slightly higher than those achieved using APTS-functionalised materials, with no clear 
difference between loading values achieved using the TPRE (CRLIDTQB) or water 
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(CRLIDWQB) method. It was expected that the loading for APDS materials made via the 
TPRE method would be higher than those made by the water method due to the higher 
surface amine density (3.28 NH2-molecules per nm
2
 compared to 1.39 NH2-molecules per 
nm
2
). Finally, for materials functionalised using APMS, in the case of PFL, loading values 
decrease, following the same trend of TPRE-functionalised materials (PFLIMTQB) having 
higher loading than water-functionalised materials (PFLIMWQB). For CRL loaded materials 
functionalised using APMS, loading values decrease significantly compared to APTS- and 
APDS-functionalised materials: by 15-22% in the case of TPRE-functionalised materials 
(CRLIMTQB) and 30-35% in the case of water-functionalised materials (CRLIMWQB). 
Again these lower lipase-loading results for materials functionalised using APMS correlate 
with a decrease in surface amine density due to a lack of inter-aminosilane cross-linking 
around the nanoparticle surface. As a result, there are fewer total surface amine groups where 
the lipase can bind.  
For the physical adsorption of lipases, loading values were much lower for PFL than with 
amine functionalised materials. For CRL, physical adsorption gave similar loading values to 
those obtained using APMS and the water method, which was the lowest loading value 
obtained for all CRL materials. The general trend is that physical adsorption gave much 
lower loading values on average than those immobilised using chemical conjugation.  
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                                             CHAPTER 4
BIO-CATALYTIC APPLICATIONS OF 
LIPASE-IMMOBILISED SILICA-
MAGNETITE NANOPARTICLES 
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4.1 Introduction 
This section of the thesis will outline three bio-catalytic reactions that have been explored in 
this project.  
1. The first application was a model catalysis reaction; the hydrolysis of p-nitrophenyl 
palmitate (PNPP) to palmitic acid and p-nitrophenol (PNP). The hydrolysis of long-
chain p-nitrophenyl esters has been used widely as a model reaction as it can be 
followed easily by UV-Visible spectrophotometry; directly following the hydrolysis 
of PNP by measuring the absorbance at 410 nm.
277,432
 The amount of PNP hydrolysed 
was calculated using calibration curves produced from a set of standard PNP solutions 
of known concentration (see Figure 2.7, Section 2.9.5).  
2. The second application was the transesterification of ethyl butyrate using n-butanol to 
produce butyl butyrate. The reaction is also known as alcoholysis and many studies 
investigating the effect of varying water concentration, solvent conditions and 
enzymes to produce flavour esters in this way have been reported.
301,303
 The reaction 
products were monitored using GC and GC-MS and the conversion of ethyl butyrate 
to butyl butyrate was calculated using calibration curves produced from a set of 
standard solutions of ethyl butyrate, n-butanol and butyl butyrate of known 
concentration (see Figure 2.8, Section 2.9.6).  
3. The final bio-catalytic application was the partial and selective hydrolysis of cis-3,5-
diacetoxy-1-cyclopentene to produce the chiral optical isomer (1S,4R)-cis-4-acetoxy-
2-cyclopenten-1-ol and its enantiomer, with cis-3,5-dihydroxycyclopentene produced 
as a by-product. This reaction has not been reported much in the literature, but the 
chiral products are important pharmaceutical compounds used in the synthesis of 
prostaglandins and thromboxanes.
289,298
 The reaction products were monitored using 
GC and GC-MS and the conversion to (1S,4R)-cis-4-acetoxy-2-cyclopenten-1-ol and 
its (1R,4S)-enantiomer was calculated using calibration curves produced from a set of 
standard solutions of cis-3,5-diacetoxy-1-cyclopentene, (1S,4R)-cis-4-acetoxy-2-
cyclopenten-1-ol and cis-3,5-dihydroxycyclopentene of known concentration (see 
Figure 2.9 and Figure 2.10, Section 2.9.7). 
All of the bio-catalytic applications have been carried out using lipases (both CRL and PFL), 
immobilised on surface-functionalised silica-magnetite nanoparticles as efficient, re-usable 
catalysts, see Section 3.8.  
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4.2 Bio-catalytic Application: Model Catalysis Reaction - Hydrolysis of 
PNPP 
The reaction was carried out according to the method outlined in Section 2.6.3. The amount 
of lipase-immobilised nanoparticles (variable amount, in mg) corresponding to 500 µg 
immobilised lipase was used in each case, except when free lipase was used as catalyst, 500 
µg was used directly as catalyst. This type of reaction has been carried out numerous times 
with both free
277,281,432
 and immobilised lipases (mainly commercial supports).
282,460
 The 
reaction has also been carried out using lipase immobilised on surface-functionalised 
magnetic nanoparticles
100,461,462
 (mainly using APTS), however, to the best of my knowledge 
this reaction has not been carried out in a comparative study using lipase immobilised on 
APTS, APDS and APMS surface-functionalised nanoparticles. Wang et al
463
 have 
investigated the effect of the alkyl chain length of three alkoxy silanes (trimethoxypropyl 
silane, trimethoxyoctyl silane and trimethoxyoctadecyl silane) on immobilised enzyme 
activity using CRL. However, the enzyme was immobilised via hydrophobic interaction and 
not via chemical cross-linking. This study also compares the activity of lipase-immobilised 
materials prepared using both the TPRE and water methods of surface functionalisation.  
The reaction was carried out using two lipases (PFL and CRL) immobilised on TPRE- and 
water-method surface-functionalised nanoparticles using three different aminosilanes: APTS, 
APDS and APMS. Physically adsorbed PFL and CRL on silica-coated magnetite 
nanoparticles and free lipases were used as comparison for the study.  
The main focus of this part of the study is to compare the activity of lipase-immobilised 
nanoparticles made using various aminosilanes and surface-functionalisation methods. The 
first materials to be discussed are the PFL materials. The results are shown in Figure 4.1. 
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Figure 4.1: The catalytic activity (in µmol PNP produced per gram of enzyme used) of free, 
physically adsorbed and chemically conjugated PFL on various surface-functionalised silica-
magnetite nanoparticles. The re-usability of the materials was also tested and the blue bars 
represent catalytic activity for the first one hour cycle, the red bars represent activity for the 
second one hour cycle and the green bars represent activity for the third one hour cycle. See 
Table 3.7 (Section 4.1) for explanations of the names of materials. Values are mean, ± 
S.E.M., n ≥3 in all cases. 
PFL materials made using APTS show similar activity values, regardless of the surface 
functionalisation method. PFLITTQB is shown to retain 84% of its initial activity over 3 
cycles, whilst PFLITWQB retains 78%. PFL materials made using APDS (and show very 
similar trends and activity values, with no real difference between materials made using the 
TPRE (PFLIDTQB) and water (PFLIDWQB) method. However, for PFL materials made 
using APMS, two interesting trends can be observed. The first is that PFLIMTQB is by far 
the most effective catalyst for this reaction, producing 3424 µg of PNP per gram of support, 
which is 1.6-1.75 times more catalytically active than PFL-immobilised on APTS 
(PFLITTQB and PFLITWQB) or APDS (PFLIDTQB and PFLIDWQB) functionalised 
nanoparticles and 1.37 times more active than PFLIMWQB. The second is that there is a 
large, noticeable difference between materials prepared by the TPRE (PFLIMTQB) and water 
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(PFLIMWQB) method. Both materials retain around 80% of their initial activity over 3 
cycles, but PFLIMTQB shows much higher activity over the 3 cycles than PFLIMWQB 
(37% higher for cycle 1 and 41% higher for both cycles 2 and 3). This could be due to lower 
enzyme loading values of materials made using APMS for surface functionalisation leading 
to a decrease in steric hindrance which could be a factor with higher loading values. This may 
also lead to the active site of PFL being more accessible at low enzyme loading under 
hydrophobic surfaces (due to the presence of neighbouring methyl groups). 
Another interesting observation is that the activity of PFL materials made using APMS 
decreases by the largest percentage between the 1
st
 and 2
nd
 cycles (activity decreases 19-21% 
from cycle 1 to cycle 2). This could be due to a decreased steric hindrance around the 
nanoparticle surface permitting a small amount of physical adsorption directly on the silica-
magnetite core-shell, which is then leached into solution in subsequent cycles. This could 
also explain why activity remains almost equal in cycles 2 and 3, when the physically 
adsorbed lipase has leached into solution leaving just the chemically conjugated (covalently-
linked) PFL. Another possible explanation is that the high loading of PFL on APTS and 
APDS surface-functionalised nanoparticles leads to the formation of the bi-molecular form of 
PFL. As immobilisation leads to activation of the lipase and PFL is known to form bi-
molecular aggregates
159,234
 via the hydrophobic regions surrounding its active sites in its open 
form, high loadings could lead to the simultaneous activation and aggregation of PFL due to 
the presence of the hydrophilic surfaces on the nanoparticles, leading to a reduction in 
activity due to competition between the reaction occurring in the active sites and formation of 
the bi-molecular structure with neighbouring PFL active sites. The catalytic activity of 
physically adsorbed PFL (PFLIQBLSSM) was shown to be considerably lower than that of 
chemically conjugated PFL in all cases. This could be caused by the PFL being adsorbed to 
the nanoparticle surface in a manner that inhibits efficient catalytic activity. 
The results of the reaction performed by CRL materials are presented in Figure 4.2.  
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Figure 4.2: The catalytic activity (in µmol PNP produced per gram of enzyme used) of free, 
physically adsorbed and immobilised CRL on various surface-functionalised silica-magnetite 
nanoparticles. The re-usability of the materials was also tested and the blue bars represent 
catalytic activity for the first one hour cycle, the red bars represent activity for the second one 
hour cycle and the green bars represent activity for the third one hour cycle. See Table 3.7 
(Section 4.1) for explanations of the names of materials. Values are mean, ± S.E.M., n ≥3 in 
all cases. 
With regard to CRL materials, APTS surface-functionalised materials made by the TPRE 
method (CRLITTQB) show markedly higher activity over 3 cycles than those made using the 
water (CRLITWQB) method. They both retain around 80% of initial activity over 3 cycles, 
but CRLITTQB shows between 44-53% higher activity per cycle. For materials made using 
APDS, the same trend can be seen, with CRLIDTQB giving up to 93% higher activity per 
cycle than CRLIDWQB. An interesting trend is seen in CRL materials made using APMS. 
CRLIMTQB shows increasing activity over all 3 cycles and higher activity than all other 
CRL materials. CRLIMWQB also shows increased activity compared to other CRL 
materials, retaining 92% of its initial activity over 3 cycles. This could again be due to the 
decreased steric hindrance due to lower enzyme loadings seen in materials prepared using 
APMS. It is possible that in the case of CRLIMTQB, the lower loading enabled the physical 
adsorption of some CRL and as it was leached into the solution over the cycles, the 
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chemically conjugated (covalently linked) CRL became less sterically hindered and more 
active sites become accessible, similar to PFL.  
The final observation that can be made from the results is that all PFL materials (free, 
physically adsorbed and chemically conjugated) exhibit higher activity than all forms of CRL 
materials for this reaction. Free lipases (only run for one cycle due to difficulties in isolating 
the lipase from the reaction mixture) show that PFL is over 2.5 times more active for this 
reaction than CRL. For physically adsorbed materials, again PFL materials give higher 
activity than CRL materials. However, in the case of physically adsorbed materials, activity 
for both materials decreases dramatically for each consecutive cycle. For PFLIQBLSSM, 
activity during the 3
rd
 cycle drops to 65% that of the 1
st
 while for CRLIQBLSSM, activity 
drops to just 34% during the 3
rd
 cycle. This is possibly due to the lipase being leached into 
solution over time during the reaction, as suggested by Sen et al.
100
 
Brief Conclusions 
There are various conclusions which can be drawn from this section of the study. The first is 
that PFL (free, physically adsorbed or chemically conjugated) is a much more catalytically 
active lipase than CRL (all forms) for this particular application. The second is that for 
physically adsorbed lipases (both PFL and CRL), activity decreases by a large margin over a 
number of cycles, possibly due to the lipase leaching into solution. For PFL-immobilised 
(chemically conjugated) nanoparticles, activity for APTS and APDS materials is similar, 
regardless of the surface-functionalisation method used. However, when APMS is used, 
catalytic activity is increased greatly and a big difference can be seen in materials made using 
the TPRE and water methods. This increase could be due to decreased steric hindrances 
leading to more accessible active sites. For CRL-immobilised materials, APTS, APDS and 
APMS surface-functionalised materials made using the TPRE method give higher activity 
than the same materials made using the water method. This could be due to a more ordered 
orientation of the CRL around the nanoparticle surface due to the more ordered amine groups 
given by the TPRE method.
87,89
  
These conclusions can be enhanced by Figure 3.12, Section 3.6, which shows that for APTS 
and APDS materials in particular, the TPRE method affords a higher surface amine density 
than the water method. For APMS materials’, loading is similar for both methods, but the 
values are much lower than both APTS and APDS materials. The physically adsorbed 
enzyme can be leached into solution and will then exhibit behaviour of the free lipase, which 
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for PFL is higher than APTS and APDS functionalised nanoparticles, but lower than those 
made using APMS. For CRL, free lipase exhibits higher activity than all materials. Hence, 
the increased activity of APMS materials in all cases could be due to a combination of 
covalently immobilised lipase benefiting from less steric hindrance than APTS and APDS 
materials (hence having more accessible active sites and higher activity) and physically 
adsorbed lipase being gradually leached into the reaction (exhibiting the increased activity of 
free lipase). This combination can account for the higher activity values obtained and also the 
increase in activity over 3 cycles for CRLIMTQB. 
4.3 Bio-catalytic Application: Transesterification of Ethyl Butyrate 
The amount of lipase-immobilised nanoparticles (variable amount, in mg) corresponding to 
500 µg immobilised lipase was used in each case, except when free lipase was used as 
catalyst, 500 µg was used directly as catalyst. Initially, the reaction was carried out using 
identical conditions to Solanki and Gupta,
301
 who employed surfactant-coated 
superparamagnetic nanoparticles with immobilised CRL for the transesterification of ethyl 
butyrate using n-butanol and anhydrous hexane. As in the transesterification carried out by 
Solanki and Gupta, I initially used a 1:2 ratio of ethyl butyrate (60 mM) to n-butanol (120 
mM), but with the regular 500 µg total lipase, instead of the 1000 µg used in their study. For 
this initial study, the following materials were used as catalysts: PFLITTQB, CRLITTQB, 
PFLIQBLSSM, CRLIQBLSSM, free PFL and free CRL. However, results obtained showed 
almost no butyl butyrate present after 1 hour and 24 hours of reaction time, for any of the 
catalyst materials. It was observed that there was no miscibility between the nanoparticles 
(with just a surface water layer) and the hexane layer. The reaction was repeated in THF, with 
no results either.  
It was later during a literature search I found that lipases are only active in water-immiscible 
solvents, as water miscible solvents extract the water of hydration layer from the enzymes, 
rendering them inactive, hence this was the reason that no reaction had taken place. I also 
learned that esterification success is dependent on water concentration in the system and 
lipase hydration is important, as a minimum amount of water is required to keep it in its’ 
active form.
464
 Also, when hydrophobic solvents are used, they can limit enzyme flexibility, 
so the lipase should be in its active conformation prior to addition of the organic solvent, i.e. 
the lipase should be dissolved in water prior to hexane addition. Finally, it has been 
reported
464
 that lipase stability can also be improved by covalent attachment of PEG to free 
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amino-residues on the lipase, giving them amphiphillic properties and allowing their 
dissolution in organic solvents.
464
 By coating the nanoparticles in surfactants, Solanki and 
Gupta got the transesterification reaction to work without the addition of extra water, hence, I 
decided to investigate the effects of varying water concentration and PEG in order to allow 
the lipase to be in its active conformation throughout the reaction and act as an efficient bio-
catalyst. The investigation into optimising the water concentration is reported in the 
following section.  
4.3.1 Investigation into Varying Water Concentration 
The initial study was to compare the efficiency of the reaction by adding 0.5 and 1% water to 
the system. In order to reduce wastage of my own materials, free lipases (free PFL and free 
CRL) and a commercial supported lipase (PFL immobilised on Immobead support) were used 
for this initial reaction, until the best conditions could be found. Reaction conditions [1:2 
ratio of ethyl butyrate (60 mM) to n-butanol (120 mM) with the regular 500 µg total lipase at 
37ºC] were kept the same as before. 
 
Figure 4.3: Conversion of ethyl butyrate to butyl butyrate after 1 hour using free lipases and 
commercially available PFL immobilised on Immobead 150 (Product number 90678, Sigma-
Aldrich, UK) with 0.5% and 1% water/hexane solvent. 
Figure 4.3 above shows that after 1 hour, conversion is extremely low, with around 0.25% 
being the maximum. It can also be seen that 1% water/hexane gives slightly higher 
conversion values than 0.5% and hence, reactions in 1% water/hexane were decided to be 
continued for a further 21 hours. Note that commercially available PFL immobilised on 
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Immobead 150 did not produce any reaction products (0% conversion) after 1 hour under 
identical reaction conditions.  
 
Figure 4.4: Conversion of ethyl butyrate to butyl butyrate after 22 hours using free lipases 
and commercially available PFL immobilised on Immobead 150 with 1% water/hexane 
solvent. 
Figure 4.4 above shows much higher conversion values for 22 hours reaction time. Free PFL 
shows product conversion of 32.5%, almost 200 times more than that produced after just 1 
hour. Free CRL shows 14.4% conversion, over 50 times the amount of product produced. No 
reaction took place when the reaction was performed without the presence of lipase catalysts 
(blank reaction). As the reaction was more successful using a higher water concentration, I 
decided to perform the reaction using 10% water/hexane as the solvent system. Conditions 
were kept the same as before (1:2 ratio of ethyl butyrate (60 mM) to n-butanol (120 mM), 
with 500 µg total lipase at 37ºC). 
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Figure 4.5: Conversion of ethyl butyrate to butyl butyrate after 24 hours using lipase-
immobilised materials PFLITTQB and CRLITTQB, as well as free lipases with 10% 
water/hexane solvent. 
Figure 4.5 shows that transesterification of ethyl butyrate increases to 50.2% and 23.8% for 
free PFL and CRL respectively when water concentration is increased to 10%. Lipase 
Immobilised materials PFLITTQB (2.2%) and CRLITTQB (3.3%) both showed small 
conversion figures, but the increase in water concentration definitely provided better 
conversion results for free lipases. I decided that 10% water/hexane would be used as the best 
solvent system. As the water content of the system had been decided upon, the next step was 
to investigate the effect of adding PEG as a stabilising agent for the lipase. 
4.3.2 Investigation into Using PEG as Stabilising Agent 
The first step in this case was to test the system using a small amount of PEG in the 10% 
water/hexane system to see if it could improve the conversion. A solution of 1% PEG in 
water was made, to give a final solvent system of 0.1% PEG in 10% water/hexane. The 
reaction was first carried out with free lipases to reduce wastage of lipase-immobilised 
materials. Reaction conditions were kept the same as before (1:2 ratio of ethyl butyrate (60 
mM) to n-butanol (120 mM), with the regular 500 µg total lipase at 37ºC). 
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Figure 4.6: Conversion of ethyl butyrate to butyl butyrate after 24 hours using free lipases 
and commercially available PFL immobilised on Immobead 150 with 0.1% PEG in 10% 
water/hexane solvent. Values are mean, ± S.E.M., n =2. 
Figure 4.6 shows conversion for both free PFL (64.6%) and CRL (38.1%) has been improved 
by the addition of PEG. A reasonable conversion (6%) for PFL immobilised on Immobead 
150 was obtained in the presence of PEG. Following the successful results, I decided that this 
solvent system would be used to test the lipase-immobilised nanoparticles. The reaction was 
repeated for a further 3 identical catalytic cycles, with the lipase-immobilised nanoparticles 
washed magnetically with 3×1 mL PBS buffer and re-dispersed in fresh 0.1% PEG in 10% 
water before addition of a fresh hexane layer and new reactants between cycles. Free lipases 
and the water layer were centrifuged and re-dispersed, before addition of a fresh hexane layer 
and new reactants between cycles.  
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Figure 4.7: Conversion of ethyl butyrate to butyl butyrate over 24 hour reaction (3-4 re-
usable cycles) using lipase-immobilised materials PFLITTQB and CRLITTQB, lipase-
adsorbed materials PFLIQBLSSM and CRLIQBLSSM, free lipases (PFL and CRL) and 
commercially available PFL immobilised on Immobead 150 with 0.1% PEG in 10% 
water/hexane solvent. The blue bars represent cycle 1 conversion values, the red bars 
represent cycle 2, the green bars represent cycle 3 and the purple bars represent cycle 4. See 
Table 4.2, Section 4.3.4 for material names. 
Figure 4.7 above shows the multi-cycle transesterification reaction using a variety of 
materials. Firstly, it can be seen that for free lipases, catalytic activity decreases slightly with 
each cycle, but the overall activity of free lipases is much greater than lipase-immobilised 
materials. However, free lipases proved difficult to recover and re-disperse because of the 
loss of some of the water layer between each cycle. Free PFL retains over 82% of its initial 
catalytic activity in the third cycle of the reaction, dropping from 52.5% conversion to 44.9% 
in cycle 2 and 43.1% in cycle 3. For free CRL, conversion drops from 32.6% in cycle 1 to 
26.1% in cycle 2 and 24.3% in cycle 3, retaining around 74% of its initial activity. The 
activity of PFL immobilised on Immobead 150 actually increased steadily over 3 cycles.  
With regard to lipase-immobilised nanoparticles, conversion is low over all 4 cycles and quite 
irregular. Both PFLITTQB and CRLITTQB exhibited their highest conversion values of 10-
12% in the second cycle, before decreasing for the third cycle. For PFLITTQB, activity was 
the same in cycles 3 and 4, while for CRLITTQB, activity increased again in cycle 4. As with 
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the model catalysis reaction, increases in activity could be due to the enzyme leaching into 
solution after it is washed between cycles. For physically-adsorbed lipase materials, 
PFLIQBLSSM displayed the lowest activity out of all materials for every cycle and steadily 
decreased in activity over all 4 cycles (from 4.8% in cycle 1 to 2.3% in cycle 4). 
CRLIQBLSSM displayed some interesting behaviour, increasing in activity from cycle 1 
(6.0%) to cycle 2 (10.3%) and then increasing a large amount to cycle 3 (29.8%). The large 
conversion exhibited in cycle 3 was higher than free CRL in the same cycle, suggesting 
leaching of the lipase from the support into the solution during the reaction. The activity 
decreased to just 6.3% in cycle 4.  
Due to the somewhat irregular and unexpected erratic nature of the results obtained using the 
PEG/water/hexane system, I attempted to find an explanation in the literature, but found no 
relevant results as the system has not been used (to the best of my knowledge) for this 
application with these types of catalytic materials. However, I came across an interesting 
article by Liaquat et al
303
 who reported the transesterification of ethyl butyrate to butyl 
butyrate catalysed by rape seedling lipase. They also studied the effect of water concentration 
and found that transesterification yield was best with water concentrations between 0.5 and 
20%, decreasing outside of these limits (although the reaction was carried out a 5 mL scale). 
It is worth mentioning that increasing the water concentration from 1% to 20% did not have 
much of an effect on transesterification yield in their study, hence 10% was decided as the 
maximum concentration for this study. They tested the effect of ethyl butyrate to n-butanol 
ratio, concluding that the optimal system was using a 6:1 ratio of ethyl butyrate (600 mM) to 
n-butanol (100 mM). Hence, the next part of the transesterification reaction investigation has 
been focussed on the effect of reactant ratio using the best solvent system.  
4.3.3 Optimising the Solvent System Using a 6:1 Ratio of Ethyl Butyrate to n-Butanol 
With the new ratio of starting materials for the reaction, it was important to decide on the 
correct solvent system to further optimise the reaction for the best results. Therefore, the 
reaction was performed for 24 hours and a variety of solvent systems using free PFL and free 
CRL.  
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Figure 4.8: Conversion of ethyl butyrate to butyl butyrate after 24 hours using free PFL (blue 
bars) and free CRL (red bars) and 3 different solvent systems: 0.5% water/hexane, 10% 
water/hexane and 0.1% PEG in 10% water/hexane. The blue bars represent conversion given 
by free PFL and the red bars represent free CRL. Reactant ratio (ethyl butyrate to n-butanol) 
of 6:1. 
Figure 4.8 shows that 0.5% water/hexane is by far the most ineffective solvent system for the 
reaction and will not be used any further. It can also be seen that PEG does not have a 
considerable effect on the conversion of ethyl butyrate to butyl butyrate. It is worth 
mentioning that the 6:1 ratio of starting materials leads to much higher conversion values for 
free PFL (around 90%) and free CRL (around 65%), compared with the 1:2 ratio and equal 
solvent conditions.  
Table 4.1: Ethyl butyrate to butyl butyrate conversion values given using different ratios of 
ethyl butyrate to n-butanol. Conditions = 10% water/hexane solvent, 37ºC, 24 hours. 
Catalyst Material Conversion of Ethyl Butyrate to Butyl Butyrate (%) 
1:2 ethyl butyrate : n-butanol 6:1 ethyl butyrate : n-butanol 
Free PFL (500 µg) 50.15 88.60 
Free CRL (500 µg) 23.84 64.61 
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4.3.4 Results: Detailed Study on Re-usability and Activity of Lipase-Immobilised 
Nanoparticles for Transesterification of Ethyl Butyrate Using Optimised 6:1 
Ratio of Ethyl Butyrate to n-Butanol and Solvent System 
The reaction was performed as explained in Section 2.6.4. Ethyl butyrate (600 mM) and n-
butanol (100 mM) were added to the amount of lipase-immobilised nanoparticles 
corresponding to 500 µg total lipase. The solvent system used was 10% water/hexane. 
Materials made using a variety of aminosilanes (APTS, APDS and APMS) for surface 
functionalisation followed by lipase (PFL and CRL) immobilisation. Table 4.2 shows the 
materials used for this reaction. 
Table 4.2: Materials used for the transesterification of ethyl butyrate. 
Name Details* Name Details* 
PFLITTQB PFL immobilised on TTQB CRLITTQB CRL immobilised on TTQB 
PFLITWQB PFL immobilised on TWQB CRLITWQB CRL immobilised on TWQB 
PFLIDTQB PFL immobilised on DTQB CRLIDTQB CRL immobilised on DTQB 
PFLIDWQB PFL immobilised on DWQB CRLIDWQB CRL immobilised on DWQB 
PFLIMTQB PFL immobilised on MTQB CRLIMTQB CRL immobilised on MTQB 
PFLIMWQB PFL immobilised on MWQB CRLIMWQB CRL immobilised on MWQB 
Note: PFLI and CRLI represent materials made using PFL and CRL. The letters T, D and M represent the 
aminosilane used (APTS, APDS and APMS respectively). The next letter T or W represents the surface-
functionalisation method used: T = TPRE, W = water. QB represents the shortened form of the silica-coated 
material QBLSSM. *See Table 3.7, Section 4.1 for material details. 
The reaction was carried out for a total of 24 hours and 3 re-cycles. Lipase-immobilised 
nanoparticles were washed magnetically with 3×1 mL PBS buffer and re-dispersed in fresh 
water before addition of fresh hexane and reactants between cycles. 
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Figure 4.9: Conversion of ethyl butyrate to butyl butyrate over 3×24 hour cycles using 
lipase-immobilised materials in 10% water/hexane solvent. See Table 4.2 above for details on 
the materials used. Values are mean, ± S.E.M., n =3 in all cases. 
Results and discussion on PFL-immobilised materials: For materials made using APTS as the 
aminosilane, the trend of increasing activity over all three cycles can be observed for both 
TPRE- (PFLITTQB: 13.8% cycle 1, 15.4% cycle 2, 19.5% cycle 3) and water- (PFLITWQB: 
10.0 % cycle 1, 13.1% cycle 2, 21.0% cycle 3) functionalised materials. For materials made 
using APDS as the aminosilane, water-functionalised (PFLIDWQB) materials show a 
markedly higher activity (45.7% cycle 1, 33.2% cycle 2, 35.2% cycle 3) over all three cycles 
than TPRE-functionalised (PFLIDTQB) materials (17.9% cycle 1, 26.4% cycle 2, 21.8% 
cycle 3). For materials made using APMS as the aminosilane, again materials made using the 
water-method (PFLIMWQB) show a much higher activity (42.3% cycle 1, 51.0% cycle 2, 
31.4% cycle 3) over all three cycles than those made via the TPRE-method (PFLIMTQB: 30. 
5% cycle 1, 31.4% cycle 2, 26.9% cycle 3).  
For APTS-functionalised materials, those made using TPRE-method perform slightly better 
than those made using the water method over the first two cycles, with similar conversions 
for the third. For APDS-functionalised materials, the water-method has a much higher 
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activity over all 3 cycles and is the most suitable for this application. For APMS-
functionalised materials, materials made using the TPRE-method provide more consistent 
activity over the 3 cycles, but materials made using the water-method show much higher 
activity over all 3 cycles.  
Results and discussion using CRL-immobilised materials: As with PFL, for materials made 
using APTS as the aminosilane, the trend of increasing activity over all 3 cycles can be 
observed for both TPRE-(CRLITTQB: 18.4% cycle 1, 38.3% cycle 2, 42.7% cycle 3) and 
water-functionalised (CRLITWQB: 19.0% cycle 1, 27.1% cycle 2, 34.0% cycle 3) materials. 
It can be concluded that in the case of CRL materials made using APTS as the aminosilane, 
that TPRE is the most effective method of surface functionalisation to produce better 
catalytic materials for the transesterification of ethyl butyrate. For materials made using 
APDS as the aminosilane, materials made by the TPRE-method (CRLIDTQB) have some of 
the highest activity out of all of the materials used (37.4% cycle 1, 44.8% cycle 2, 44.6% 
cycle 3). Materials made by the water-method using APDS (CRLIDWQB) are much less 
catalytically active (12.9% cycle 1, 27.2% cycle 2, 24.3% cycle 3). Finally, CRL-
immobilised materials made using APMS as the aminosilane; water-method (CRLIMWQB) 
materials produced higher activity for cycles 1 and 3, but for cycle 2, the materials 
functionalised using the TPRE approach (CRLIMTQB) have the highest activity out of any 
materials used in any cycle (52.7%).  
Brief Conclusions 
Preliminary investigations and a thorough literature search led to initial experiments into 
finding and optimising a suitable solvent system for the reaction. With regard to solvents, 
initial reactions using hexane and THF gave no successful results, which I later found out was 
due to enzyme inactivation. Water was introduced to the system and various water 
concentrations in hexane were tested, with 10% water/hexane (maximum amount of water) 
providing the best results due to successful interfacial activation of the enzyme permitting 
exposure of the active site. Next, PEG was investigated as a stabilising agent for the reaction, 
but conversion of ethyl butyrate to butyl butyrate was not improved significantly, hence, it 
was left out of the later reactions. The final parameter in my study was the ratio of ethyl 
butyrate to n-butanol. Two systems were used: A 1:2 ratio of ethyl butyrate: n-butanol (as 
used by Solanki and Gupta
301
 and a 6:1 ratio of ethyl butyrate: n-butanol (as used by Liaquat 
et al
303
). It was clear to see (see Table 4.1) that the 6:1 ratio of ethyl butyrate to n-butanol led 
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to a dramatic increase in conversion values (at least in the case of free lipase) and hence these 
conditions were used for the detailed investigation into the transesterification using PFL and 
CRL immobilised materials.  
The activity of PFL- and CRL-immobilised materials cannot be compared accurately due to 
the differing trends observed in the results and their different structures. For PFL materials 
made using APTS as the aminosilane, those made using the TPRE method perform slightly 
better over the first two cycles than those made using the water method, while for the third 
cycle, the conversion values are very similar. For APDS-functionalised materials, those made 
using the water method give much higher average conversion values for all three cycles, but 
the values fluctuate a lot between cycles and error is relatively high. For APMS-
functionalised materials, again, those made using the water method provide higher 
conversion values than those made by the TPRE method, but the values fluctuate a lot 
between cycles and error remains relatively high. Also, every material shows at least one 
instance of conversion increasing between cycles, possibly due to leaching of the enzyme into 
solution over the course of the reaction. Interestingly, none of the conversions given by any 
material were as high as that given by free PFL.  
For CRL-immobilised materials, APTS-functionalised materials obtained by the TPRE and 
water method show similar activity in the first cycle, but in the second and third cycles, those 
made using the TPRE-method give higher conversions. In the case of APDS-functionalised 
materials, those made using the TPRE method show drastically higher conversion values (for 
all cycles) than those made using the water method. Finally, for APMS-functionalised 
materials, those made using the water method show slightly higher conversions than those 
made using the TPRE method in the first and third cycles, but both materials show a 
significant increase in conversion for the second cycle, with the TPRE-functionalised 
material giving the higher value. Again, every material shows at least one instance of 
conversion increasing between cycles, possibly due to leaching of the enzyme into solution 
over the course of the reaction. As was the case with PFL, none of the conversions given by 
any material were as high as that given by free CRL, but the values were closer than they 
were with PFL-materials. A possible reason for the fluctuations in catalytic activity between 
cycles is possibly due to leaching of the enzyme into solution.  
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4.4 Bio-catalytic Application: Partial and Selective Hydrolysis of Cis-3,5-
diacetoxy-1-cyclopentene to Synthesise Pharmaceutically Important 
Chiral Intermediates 
The reaction was carried out according to the method outlined in Section 2.6.5. The amount 
of lipase-immobilised nanoparticles (variable amount, in mg) corresponding to 500 µg 
immobilised lipase was used in each case, except when free lipase was used as catalyst, 500 
µg was used directly as catalyst. Initially, the reaction was carried out using THF as reaction 
solvent, but yielded no products (data not included). The reaction was put on hold, until work 
on the transesterification of ethyl butyrate was completed (Section 4.3). It was later decided 
to employ similar solvent conditions for this reaction, in order to activate the immobilised 
lipase and the free lipase in solution. The reaction was carried out using three separate 
conditions: 20% water/hexane solvent system at 25ºC, 20% water/hexane solvent system at 
37ºC and 50% water/hexane solvent system at 25ºC. In this way it was possible to manipulate 
both water concentration and reaction temperature to gain the best results. 20% water in 1 mL 
of total reaction volume was used as a minimum concentration because small aliquots (1 µL) 
of the water layer were to be injected into the GC or GC-MS for analysis at various times, 
hence it was important that enough water should be available to inject for analysis. Due to the 
slight evaporation of low boiling organic solvent (hexane) during the reaction, it proved 
difficult to analyse the reaction conversion using the remaining reactants present in the 
hexane layer. The starting material cis-3,5-diacetoxy-1-cyclopentene is mostly soluble in 
hexane and sparingly soluble in water, whereas the products; (1S,4R)- and (1R,4S)-cis-4-
acetoxy-2-cyclopenten-1-ol and cis-3,5-dihydroxy-1-cyclopentene were only soluble in 
water. Hence I have calculated conversion percentages based on the concentration of the 
reaction products in the water layer.  
During initial experiments, it was found that when PFL was used as catalyst, a single peak is 
observed at the retention time (RT) corresponding to (1S,4R)-cis-4-acetoxy-2-cyclopenten-1-
ol along with cis-3,5-dihydroxy-1-cyclopentene and the reactant cis-3,5-diacetoxy-1-
cyclopentene. Figure 4.10 presents a scanned GC-MS chromatogram of the reaction products 
after 48 hours using immobilised PFL as catalyst. 
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Figure 4.10: Scanned GC chromatogram of the reaction products after 48 hours using 
PFLITTQB as catalyst. Retention time is indicated by RT. 
However, when CRL was used as catalyst, two peaks were seen at the retention time 
corresponding to (1S,4R)-cis-4-acetoxy-2-cyclopenten-1-ol and (1R,4S)-cis-4-acetoxy-2-
cyclopenten-1-ol and the reactant cis-3,5-diacetoxy-1-cyclopentene, shown in Figure 4.11 
below. 
 
Figure 4.11: Scanned GC chromatogram of the reaction products after 48 hours using 
immobilised CRL as catalyst. Retention time is indicated by RT. 
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Using GC-MS, the compound corresponding to the peak at 11.27 mins was found to have the 
same mass as (1S,4R)-cis-4-acetoxy-2-cyclopenten-1-ol. In order to confirm that the peak 
was the (1S,4R)-form, a small amount (~5 µmol) of pure (1S,4R)-cis-4-acetoxy-2-
cyclopenten-1-ol (Sigma-Aldrich cat. No. 446041) was added to the mixture, it was observed 
that only the area of the peak at 11.15 mins (i.e. (1S,4R)-cis-4-acetoxy-2-cyclopenten-1-ol) 
was seen to increase. Similarly, when a small amount (~5 µmol) of pure (1R,4S)-cis-4-
acetoxy-2-cyclopenten-1-ol (Sigma-Aldrich cat. No. 00848) was added to the mixture and it 
was observed that only the area of the peak at 11.27 mins (i.e. (1R,4S)-cis-4-acetoxy-2-
cyclopenten-1-ol) was seen to increase. Hence, it was concluded from this and the GC-MS 
data, that the peak at 11.27 mins did correspond to (1R,4S)-cis-4-acetoxy-2-cyclopenten-1-ol. 
In later experiments, PFL materials were seen to produce the (1R,4S)- enantiomer in minute 
quantities (0-3% conversion). The enantioselective nature of PFL was expected, as 
Pseudomonas lipases are renowned for their enantioselectivity;
161
 previously used for the 
synthesis of chiral intermediates in drug development.
130,465
 
Following this discovery, it was now possible to calculate conversion to both the (1S,4R)- 
and (1R,4S)-forms of the product, as well as the dihydroxy by-product to provide total 
conversion values. As the enantiomers are of equal molecular weight and functionality, the 
same calibration curve can be used to calculate concentration for each.  
A final point of interest is that acetic acid is formed as a by-product of the reaction following 
further hydrolysis of the hydrolysed acetoxy groups. With the increasing concentration of 
acetic acid in the reaction mixture, it is possible that this leads to the acid-catalysed 
hydrolysis of the newly formed mono-acetoxy products to the dihydroxy by-products. This 
process coupled with the further lipase-catalysed hydrolysis of the mono-acetoxy product 
could be an explanation for the increasing amount of undesired dihydroxy by-products 
present in the reaction mixture with time.  
4.4.1 Results: Reaction Using 20% Water/Hexane Solvent System at 25ºC 
Figure 4.12 shows the conversion of cis-3,5-diacetoxy-1-cyclopentene to the three products, 
as well as total conversion over 48 hours.  
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Figure 4.12: Results of the partial and selective hydrolysis of cis-3,5-diacetoxy-1-
cyclopentene using 20% water/hexane at 25ºC for 48 hours. The red squares represent 
conversion to (1S,4R)-cis-4-acetoxy-2-cyclopenten-1-ol, green triangles represent conversion 
to (1R,4S)-cis-4-acetoxy-2-cyclopenten-1-ol, purple crosses represent conversion to cis-3,5-
dihydroxy-1-cyclopentene and the blue crosses represent total conversion to products. Values 
are mean, ± S.E.M., n =2 in all cases. 
From Figure 4.12 it can be seen that CRL materials are successful at producing both 
enantiomers of cis-4-acetoxy-2-cyclopenten-1-ol. Over all timeframes, free CRL provides a 
higher conversion than immobilised CRL. Maximum total conversion is seen at 24 hours 
(57%) for free CRL, plateauing after this. Immobilised CRL reaches the highest conversion 
(14%) after 48 hours. The products are obtained in approximately a 2:1 ratio of the (1S,4R)-
enantiomer to the (1R,4S)-enantiomer, giving roughly 40% enantiomeric excess (ee) of 
(1S,4R)-cis-4-acetoxy-2-cyclopenten-1-ol. As the reaction continues over 24 hours, it can be 
seen that conversion of the mono-acetoxy products to the dihydroxy by-product occurs in 
small amounts (17% of total products for free CRL and 2% for immobilised CRL).  
From Figure 4.12 it can also be seen that initial conversion (after 1 hour) for free PFL is 
much higher than immobilised PFL. Free PFL gives 39% total conversion and immobilised 
PFL gives 2%. For free PFL, maximum conversion to the desired product is seen after 24 
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hours, with overall conversion decreasing after 48 hours. The high maximum total conversion 
value (76%) is due to the increased conversion to the dihydroxy by-product, which becomes 
the most abundant product at 24 hours. The highest conversion to the desired (1S,4R)- 
enantiomer is highest at 1 hour (35%) and decreases steadily at 24 and 48 hours as a result of 
its further hydrolysis to the dihydroxy by-product. For immobilised PFL, conversion to the 
desired products increases steadily up to a maximum of 25% to 48 hours. Immobilised PFL 
offers the advantage of producing relatively small amounts of the dihydroxy by-product: 7% 
of total products compared to free PFL, which produces the dihydroxy by-product as 75% of 
the total products at 48 hours. For both free and immobilised PFL, the (1R,4S)- enantiomer is 
produced as less than 1% of total products in the reaction. 
In terms of comparing CRL and PFL, free CRL offers higher conversion to the desired 
products and lower conversion to the dihydroxy by-product, at 24 and 48 hours. The highest 
conversion to the desired products (24 hours, (1R,4S) = 33%, (1S,4R) = 17%), is higher than 
that given by free PFL at any reaction time. CRL materials (both immobilised and free) 
produce the (1S,4R)-form in roughly 40% ee (around two (1S,4R) molecules to one (1R,4S) 
molecule). In contrast, PFL materials produce the (1S,4R)- enantiomer in 93-100% 
enantiomeric excess (ee) and free PFL achieves its maximum conversion to the desired 
products after just 1 hour [(1R,4S) = 35%)]. However, after this, it produces an increasing 
amount of the undesired dihydroxy by-product. For immobilised lipases, PFL and CRL 
provide similar initial conversion values after 1 hour, but PFL-immobilised nanoparticles 
exhibit higher maximum conversion, higher enantioselectivity and both materials give low 
amounts of the undesired dihydroxy by-product. Larger error bars observed in the case of free 
lipases could be due to issues such as dissolving the lipase in water prior to the reaction and 
also re-dispersing the lipases following centrifugation prior to removing aliquots of the water 
layer for analysis.  
As applications for the (1S,4R)-form of the product are numerous,
298,466-468
 compared with 
those of the (1R,4S)-form (only one could be found in the literature search
469
), the (1S,4R)-
form is the desired reaction product and the (1R,4S)-form can be considered a by-product, 
hence enhancing the effectiveness of PFL over CRL for this application. Additionally, the 
reasonable activities of immobilised lipases coupled with their re-usability and removability 
from the reaction mixture makes them suitable candidates for catalysing the reaction.  
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4.4.2 Results: Reaction Using 20% Water/Hexane Solvent System at 37ºC 
Figure 4.13 shows the conversion of cis-3,5-diacetoxy-1-cyclopentene to the three products, 
as well as total conversion over 48 hours, at 37ºC.  
 
Figure 4.13: Results of the partial and selective hydrolysis of cis-3,5-diacetoxy-1-
cyclopentene using 20% water/hexane at 37ºC for 48 hours. The red squares represent 
conversion to (1S,4R)-cis-4-acetoxy-2-cyclopenten-1-ol, green triangles represent conversion 
to (1R,4S)-cis-4-acetoxy-2-cyclopenten-1-ol, purple crosses represent conversion to cis-3,5-
dihydroxy-1-cyclopentene and the blue crosses represent total conversion to products. Values 
are mean, ± S.E.M., n =2 in all cases. 
CRL materials results and discussion: As previously seen in the reaction at 25ºC, CRL 
materials produce both enantiomers of cis-4-acetoxy-2-cyclopenten-1-ol, in roughly a 2:1 
ratio of the (1S,4R)-enantiomer to the (1R,4S)-enantiomer, giving around 30-40% (ee). 
Again, over the entire reaction, free CRL provides a higher conversion than immobilised 
CRL. Maximum conversion is again seen at 48 hours in both cases (92% for free CRL and 
33% for immobilised CRL). Compared to the reaction at 25ºC, free CRL exhibits similar 
activity after 1 hour (8%), as does immobilised CRL (1% in both cases). This is indicative of 
increased activity of the lipase at higher temperature. In terms of maximum conversion, much 
higher values are obtained at 37ºC (92% free CRL, 33% immobilised CRL) than 25ºC (57% 
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free CRL, 14% immobilised CRL). The dihydroxy by-product was formed in similar 
quantities to those obtained at 25ºC: 19% of the total conversion for free CRL and 4% for 
immobilised CRL. At 25ºC, the values were 17% and 2% respectively. It has been reported 
that free CRL has optimum activity at temperatures of 35-40ºC,
470-472
 whilst it is somewhat 
higher for immobilised CRL (around 45-55ºC, depending on the support type and method of 
immobilisation)
471-473
. This can explain the increase in catalytic activity from 25ºC to 37ºC.  
PFL materials results and discussion: Both free and immobilised PFL reached maximum 
conversion after 48 hours (96% for free PFL, 33% for immobilised PFL). As was the case at 
25ºC, free PFL exhibits high initial conversion to the desired products, but also suffers from 
an increasing amount of undesired dihydroxy by-product over time, which eventually 
becomes the dominant product in the reaction mixture (73% of total products). The highest 
conversion to desired products for free PFL was after 1 hour (25% conversion, 84% of total 
products). Immobilised PFL affords more control over synthesis of the desired product, 
resulting in 33% total conversion with just 11% of total products being the dihydroxy by-
product. Compared to 25ºC, immobilised PFL gives 8% higher total conversion and free PFL 
gives 22% higher maximum conversion, at 37ºC. Free PFL shows optimum activity in 
literature of around 30-40ºC,
474,475
 increasing to 60-70ºC when immobilised.
240,474
 This can 
again be used to explain the increase in catalytic activity when temperature is increased from 
25ºC to 37ºC. 
To compare results between CRL and PFL, free CRL and PFL offer similar maximum 
conversion values (92 and 97% respectively) at 48 hours. Both free and immobilised PFL 
produce the (1S,4R)- enantiomer in 94-100% ee, while both free and immobilised CRL 
produce the (1S,4R)- enantiomer in 30 and 40 % ee, respectively. 
The conclusions to this part of the study are very similar to those where the reaction was 
carried out at 25ºC. PFL materials remain highly enantioselective (94-100% ee) and CRL 
materials produce the (1S,4R)-form 60-70% (roughly 30-40% ee). However, in this case (at 
37ºC), conversions were much higher and over the entire 48 hour reaction, free PFL proved 
to be the most effective catalyst, giving an overall conversion of 97%. Free CRL gave 92% 
conversion after 48 hours and both free lipases gave high amounts of the undesired dihydroxy 
by-product. This could be due to increasing amounts of acetic acid in the system, as 
explained in the previous section. Increases in activity were seen in both immobilised lipases 
Page 157 of 250 
 
coupled with low amounts of the dihydroxy by-product; immobilised PFL provided the 
highest conversion values.  
It is possible that activity of the immobilised lipases is lower than free lipases because the 
optimum temperatures for immobilised lipases are slightly higher than those for free lipases 
(explained earlier in this section).  
4.4.3 Results: Reaction Using 50% Water/Hexane Solvent System at 25ºC 
Figure 4.14 shows the conversion of cis-3,5-diacetoxy-1-cyclopentene to the three products, 
as well as total conversion over 48 hours, at 25ºC.  
 
Figure 4.14: Results of the partial and selective hydrolysis of cis-3,5-diacetoxy-1-
cyclopentene using 50% water/hexane at 25ºC for 48 hours. The red squares represent 
conversion to (1S,4R)-cis-4-acetoxy-2-cyclopenten-1-ol, green triangles represent conversion 
to (1R,4S)-cis-4-acetoxy-2-cyclopenten-1-ol, purple crosses represent conversion to cis-3,5-
dihydroxy-1-cyclopentene and the blue crosses represent total conversion to products. Values 
are mean, ± S.E.M., n =2 in all cases. 
CRL materials results and discussion: As was the case in the reactions employing 20% 
water/hexane solvent conditions, CRL materials produce both enantiomers of cis-4-acetoxy-
2-cyclopenten-1-ol, in roughly a 2:1 ratio of the (1S,4R)-enantiomer to the (1R,4S)-
enantiomer, giving roughly 40% ee. After 1 hour, total conversion is 22% for free CRL, 2 
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times higher than using 20% water/hexane at the same temperature. Immobilised CRL is 
similar to that obtained at 20% water/hexane (1-1.7%). The maximum conversion values are 
achieved at 24 hours for free CRL (88%), but immobilised CRL reaches its maximum (42%) 
at 48 hours. Total conversion for free CRL drops to 69% between 24 and 48 hours. In terms 
of production of the undesired dihydroxy by-product, both free and immobilised CRL 
produce less than 2% of total products. Maximum conversion for free CRL is much higher 
than at 20% water/hexane at the same temperature. For immobilised CRL, 50% water/hexane 
produces the highest maximum conversion (42%), compared to 20% water/hexane at 25ºC 
(14%) and 37ºC (33%). 
PFL materials results and discussion: Free PFL reaches its maximum after 24 hours (91%) 
and decreases slightly thereafter to 79% after 48 hours. Immobilised PFL has reasonably high 
initial activity (11% total conversion after 1 hour) and increases to its maximum (48% total 
conversion) at 48 hours. After 48 hours, free PFL produces the dihydroxy by-product as 40% 
of the total products, whereas immobilised PFL produces it as 14%. The highest conversion 
to the desired products [(1S,4R)-cis-4-acetoxy-2-cyclopenten-1-ol and (1R,4S)-cis-4-acetoxy-
2-cyclopenten-1-ol] was 24 hours (66%) for free PFL and 48 hours for immobilised PFL 
(42%). Hence, it could be beneficial to stop the reaction using free PFL after 24 hours to 
obtain the maximum amount of desired product with the minimum amount of undesired by-
product. Again, PFL materials are more enantioselective in this reaction, producing the 
(1S,4R)-enantiomer in 97-98% ee.  
Higher conversions given using 50% water/hexane compared to 20% water/hexane at 25ºC 
could be due to a higher interfacial area produced between the water and hexane and also due 
to the lipase being able to dissolve more easily.  
4.4.4 Results: Testing the Re-usability of Lipase-Immobilised Nanoparticles Using 
20% Water/Hexane Solvent System at 25ºC 
CRL- and PFL-immobilised nanoparticles were used to assess their re-usability for the 
reaction using 20% water/hexane at 25ºC. The reaction was carried out as described in 
Section 2.6.5; a single aliquot was withdrawn from the water layer after 24 hours for analysis. 
The lipase-immobilised nanoparticles were then washed with 3×1 mL distilled/deionised 
water and the reaction was repeated for 4×24 hour cycles.  
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Figure 4.15: Testing the re-usability of lipase-immobilised nanoparticles for the partial and 
selective hydrolysis of cis-3,5-diacetoxy-1-cyclopentene using 20% water/hexane at 25ºC for 
4×24 hour cycles. Red bars represent the conversion (1S,4R)-cis-4-acetoxy-2-cyclopenten-1-
ol, green bars represent conversion to (1R,4S)-cis-4-acetoxy-2-cyclopenten-1-ol and purple 
bars represent conversion to cis-3,5-dihydroxy-1-cyclopentene. 
Figure 4.15 shows that for both CRL- and PFL-immobilised materials, activity is highest in 
the first 24 hour cycle. CRL-immobilised materials give 12% conversion of cis-3,5-
diacetoxy-1-cyclopentene to (1S,4R)- and (1R,4S)- cis-4-acetoxy-2-cyclopenten-1-ol in cycle 
1, decreasing slightly to 9% in cycle 2, 7% in cycle 3 and 8% in cycle 4. The (1S,4R)- 
enantiomer is produced in 70-74% ee. Small amounts of the dihydroxy by-product are seen in 
cycles 2, 3 and 4 (less than 0.2%). It is possible that the first cycle exhibits higher total 
conversion than subsequent cycles as in cycles 2, 3 and 4 some of the active sites may 
become blocked, or some lipase can be washed away from the nanoparticle surface during 
either the reaction or washing steps between cycles. In total, CRL-immobilised materials 
retained 63% of their activity after 4 catalytic cycles of the reaction. 
For PFL-immobilised materials, a similar trend is seen in that initial conversion is highest and 
subsequent cycles show slightly decreasing total conversion values. The (1S,4R)- enantiomer 
is produced in 98-99% ee and the dihydroxy by-product is produced as less than 0.7% of total 
products. The activity in cycles 1, 2 and 3 is almost equal (15, 14 and 14% respectively), 
suggesting that PFL-immobilised materials possibly do not suffer from leaching of the lipase 
into solution during the reaction or washing steps. Cycle 4 sees total conversion decrease to 
12%, which is the same as the maximum total conversion achieved by CRL-immobilised 
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materials in cycle 1. PFL-immobilised materials retained 80% of the their activity after 4 
catalytic cycles of the reaction. 
Brief Conclusions 
In terms of temperature, when 20% water/hexane was used as solvent, 37ºC provided higher 
conversion values than 25ºC for both free and immobilised lipases, as this is within the 
optimal activity temperature range for free lipases and closer to the optimal range for 
immobilised lipases, which is slightly higher on average.  
For immobilised lipases, 50% water/hexane proved to be the most successful solvent system, 
giving highest activity values for both PFL and CRL. For free lipases, 20% water/hexane at 
37ºC proved to be the most optimal conditions, as conversion increased to the maximum 
values obtained in the study at 48 hours for both PFL and CRL. 
PFL was shown to be more enantioselective bio-catalyst, producing the desired (1S,4R)-
enantiomer of the product in roughly 93-100% ee, but suffered from relatively high 
production of the undesired dihydroxy by-product due to further hydrolysis of the mono-
acetoxy product (possibly due to production of acetic acid, leading to acid-catalysed 
hydrolysis of the mono-acetoxy product). At both temperatures and solvent conditions, CRL 
was shown to produce both enantiomers in roughly a 2:1 ratio [(1S:4R): (1R,4S)] and 
produced less of the dihydroxy by-product.  
Free lipases provided much higher conversions than immobilised lipases, but immobilised 
lipases produced much higher ratios of the desired products to by-products; it can be said that 
immobilised lipases afforded more control over the formation of the desired products. In 
addition, free PFL reached its maximum conversion to desired products typically after 24 
hours (48 hours at 37ºC); predominantly producing the dihydroxy by-product after this. 
Hence, it can be concluded that immobilised lipases gave reasonable conversion values with 
excellent control over the desired products, along with re-usability and easy separability from 
the reaction mixture.  
In terms of re-usability, both CRL- and PFL-immobilised materials were shown to retain 
most of their activity over 4×24 hour cycles at 25ºC using 20% water/hexane as solvent. 
CRL-immobilised materials retained 63% and PFL-immobilised materials retained 80% of 
their activity over 4×24 hour cycles. It can be concluded that lipase-immobilised 
nanoparticles are suitable and re-usable catalysts for this application.  
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High amounts of the dihydroxy by-product obtained in the reactions can be explained by the 
reasonably high water concentrations used. The hydrolysis of the diacetoxy starting material 
to the desired mono-acetoxy product is catalysed by the lipase active site.
476
 However, the 
hydrolysed acetoxy group remains bound to amino acid residues in the active site as an acyl-
enzyme intermediate complex (see Scheme 4.1). 
 
Scheme 4.1: Hydrolysis of cis-3,5-diacetoxy-cyclopentene to (1R,4S)-cis-4-acetoxy-2-
cyclopenten-1-ol (as an example). Enz denotes the enzyme active site. The reactants and 
products are marked in red. Figure expanded and adapted from reference 476. 
The cis-3,5-diacetoxy-cyclopentene forms a tetrahedral intermediate complex with the 
catalytic triad of the lipase active site (Asp/Glu-His-Ser) and the mono-acetoxy product is 
hydrolysed from the active site. The hydrolysed acetoxy group from the diacetoxy reactant 
remains bound to the serine residue in the active site as an acyl-enzyme intermediate 
complex. After the acyl-enzyme intermediate is formed, water hydrolyses the acetoxy group, 
forming acetic acid in the reaction mixture, which enables the acid-catalysed hydrolysis of 
the mono-acetoxy product to the dihydroxy by-product.  
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5.1 Introduction 
The following section will present the bio-separation and bio-sensor applications that have 
been explored as part of the project. The first section involved the bio-separation application 
of silica-coated core-shell nanoparticles (QBLSSM). The nanoparticles were used to extract 
DNA (via non-specific physical adsorption) from real food samples and the extraction 
efficiency was compared with a classical thermal lysis extraction technique. The silica-coated 
nanoparticles were subsequently employed by Q-Bioanalytic GmbH as part of their 
commercial DNA Extraction Kit.  
The second section focussed on Listeria Monocytogenes (LM) and the use of a previously-
established model hybrid capture assay.
80,89
 The assay employed in this project utilised LM-
specific amine-modified oligonucleotides (primers) grafted onto surface-functionalised silica-
coated magnetite nanoparticles using glutaraldehyde as a coupling reagent. The 
oligonucleotide-grafted nanoparticles were used to capture LM-specific complementary 
oligonucleotides from a buffer solution (bio-separation), which were then dehybridised at 
high temperature. The capture and dehybridisation of the complementary sequence was 
followed using UV-Visible spectrophotometry, measuring absorbance at 260 nm (bio-
sensing). Following optimisation of the hybrid capture assay to produce the best results, the 
oligonucleotide-grafted nanoparticles were then used at Q-Bioanalytic, Germany, for the 
specific detection of LM in real food samples and then finally to explore the sensitivity of 
detection of LM.  
The third section of this application focussed on Escherichia Coli (EC) and again the initial 
use of a hybrid capture assay. EC-specific primers were grafted in the same way as the LM-
specific amine-modified primers onto the functionalised nanoparticles. The EC-grafted 
materials were then used in the previously optimised hybrid capture assay conditions and 
complementary sequence capture and dehybridisation was monitored using UV-Visible 
spectrophotometry, measuring absorbance at 260 nm. Again, samples were used at Q-
Bioanalytic, Germany for the specific detection of EC in food samples, to explore the 
sensitivity of detection of EC and were also used in collaboration with Fudan University, 
China, for the detection of EC in wastewater samples.  
Table 5.1 below presents the materials used in this part of the project and the applications 
they were used for. 
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Table 5.1: Materials used in bio-separation and bio-sensor applications. 
Name Details Bacteria 
Detected 
 Application 
DNA 
Extraction 
Hybrid 
Capture 
Assay 
Specific 
Detection 
from a 
Mixture 
Sensitivity 
of 
Detection 
Limits 
TTQB-C6-
T1NH2  
TTQB with oligonucleotide sequence C6-T1NH2 covalently 
attached to the surface*  
LM N/A √ √ √ 
TTQB-C12-
T1NH2  
TTQB with oligonucleotide sequence C12-T1NH2 covalently 
attached to the surface* 
LM N/A √ √ √ 
TTQB-C6-
T2NH2  
TTQB with oligonucleotide sequence C6-T2NH2 covalently 
attached to the surface*  
LM N/A √ √ √ 
TTQB-C12-
T2NH2  
TTQB with oligonucleotide sequence C12-T2NH2 covalently 
attached to the surface*  
LM N/A √ √ √ 
TTQB-
EC_541_FOR 
TTQB with oligonucleotide sequence EC_541_FOR 
covalently attached to the surface** 
EC 
 
N/A √ √ √ 
TTQB-
EC_637_REV 
TTQB with oligonucleotide sequence EC_637_REV 
covalently attached to the surface** 
EC N/A √ √ √ 
QBLSSM Large-scale silica-coated core-shell magnetite nanoparticles N/A 
 
√ N/A N/A N/A 
*See Table 2.1, Section 2.1 for LM-specific oligonucleotide sequences. 
**See Table 2.2, Section 2.1 for EC-specific oligonucleotide sequences.
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5.2 Bio-separation Application: DNA Extraction Using Silica-Coated 
Core-Shell Nanoparticles 
DNA extraction was carried out according to the method in Section 2.7.5. DNA concentration 
was calculated using a NanoDrop 2000 UV-Visible spectrophotometer (Thermo Scientific, 
Germany). 
 
Figure 5.1: Comparison of total DNA extracted from a real food sample using silica-coated 
core-shell nanoparticles (QBLSSM) and a classical thermal lysis method. Values are mean, ± 
S.E.M., n = 6 in all cases. 
Figure 5.1 shows that silica-coated core-shell nanoparticles (QBLSSM) provide similar 
values of total DNA extracted compared to the thermal lysis method. As the thermal lysis 
method uses high temperature to lyse the nucleic acids from the matrix, it can be considered 
that thermal lysis extracts 100% of total nucleic acids present. Hence, in this experiment, 
QBLSSM was shown to extract around 91% of total DNA from the matrix. However, nucleic 
acids extracted using thermal lysis may be contaminated with PCR-inhibiting species. Prior 
to extraction using the nanoparticles, the sample is enzymatically pre-digested in Proteinase 
K and lysis buffer to lyse the nucleic acids from the sample. The nanoparticles are then 
introduced to extract the DNA in the presence of a binding buffer. The bound DNA is 
purified by washing with aqueous ethanol (70% v/v) and eluted in distilled / deionised water. 
The purified DNA can then be used directly for qPCR. Small error bars demonstrate the 
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reliability of the materials for the application. The silica-coated nanoparticles (QBLSSM) 
were subsequently employed by Q-Bioanalytic GmbH as part of their commercial DNA 
Extraction Kit. 
5.3 Bio-separation and Bio-sensing Applications of Nanoparticles Grafted 
with Listeria Monocytogenes-Specific Primers 
5.3.1 Coupling of 5ʹ-amine-modified oligonucleotides to Nanoparticles 
5ʹ-amine-modified LM-specific oligonucleotides (primers) (see Table 2.1, Section 2.1) were 
grafted (or coupled) onto the glutaraldehyde-modified nanoparticle surface according to the 
method in Section 2.7. Figure 5.2 and Figure 5.3 below present the average coupling data of 
forward (T1NH2) and reverse (T2NH2) primers (with different spacers: C6 and C12) on 
functionalised nanoparticles. 
 
Figure 5.2: Average coupling values of LM-specific oligonucleotides to surface-
functionalised nanoparticles, in nmol of oligonucleotide coupled per mg of nanoparticles. 
Values are mean, ± S.E.M., n ≥6 in all cases. 
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Figure 5.2 shows that primers functionalised with a C12-spacer have a higher coupling (via 
chemical conjugation between surface –CHO groups with 5ʹ-NH2 groups of oligonucleotide 
primers) than those functionalised with the C6-spacer. However, it can be seen from Figure 
5.3 that there is no major difference in the percentage of oligonucleotide coupled. However, 
coupling efficiency in all cases is high, ranging from 78-85%.  
 
Figure 5.3: Average amount of LM-specific oligonucleotide coupled to surface-
functionalised nanoparticles, as a percentage of initial oligonucleotide concentration. Values 
are mean, ± S.E.M., n ≥6 in all cases. 
The initial amount of oligonucleotide used for coupling was supposed to 1.65 nmol, however, 
fresh solutions were made up prior to each batch and the concentration calculated using UV-
Vis spectrophotometry (see Section 2.9.4), hence a small deviation in initial oligonucleotide 
concentration has been observed. As a result of the high coupling efficiency, this method was 
used on every batch of new primer-grafted nanoparticles that were made for either hybrid 
capture testing (model assay) or real-world applications (microbial detection in food at Q-
Bioanalytic GmbH, Germany). 
5.3.2 Hybrid Capture Assay 
The hybrid capture assay was used to capture complementary oligonucleotides from a 
solution in the same way as PCR. The hybrid capture assay consisted of three key stages that 
are similar to those used in PCR. The first was the stretching phase (used to denature double-
stranded DNA to produce single-stranded DNA in PCR), where the sample was placed at 
Page 168 of 250 
 
high temperatures to ensure that the primers were not bound to each other or forming 
secondary structures (such as primer-dimers or hairpins). The second stage was the 
capture/hybridisation (known as annealing in PCR), performed at lower temperatures than the 
stretching/denaturation phase (a few degrees lower than the melting point of the primers), 
where the grafted-oligonucleotides hybridised to the complementary oligonucleotides in 
solution. The amount of oligonucleotide captured was determined by measuring the 
absorbance at 260 nm of the initial solution and the solution after hybridisation. In order to 
reduce the non-specific binding of both complementary primers and other species in the 
solution to surface aldehyde groups (which would be a problem in the specific capture of 
DNA from a mixture), BSA was used as a blocking agent; acting as a competitor by blocking 
the surface-modified aldehyde groups.
80
 The captured complementary sequence (now in 
duplex form with the grafted oligonucleotide) was then washed with buffer solution to 
remove the BSA and weakly bound non-specific species. The third and final stage of the 
hybrid capture assay was the dehybridisation step, performed again at high temperature to 
denature the double-stranded oligonucleotides formed via the hybridisation of the 
complementary sequence. The amount of oligonucleotide dehybridised was again calculated 
by measuring the absorbance at 260 nm. The amount of oligonucleotide dehybridised was 
also used to calculate the hybrid capture efficiency of the material, as the oligonucleotide that 
was dehybridised was assumed to have been captured specifically. Glutaraldehyde-modified 
materials without grafted-oligonucleotides were used to calculate the non-specific capture of 
complementary oligonucleotides.  
5.3.3 Initial Conditions 
The reaction was carried out according to the method outlined in Section 2.7.3. Figure 5.4 
presents the results of the using just TTQB-C6-T1NH2. Capture was found to be high at 
around 55%, but dehybridisation was shown to be low, with only 27% of the hybridised 
oligonucleotides being dehybridised.  
Page 169 of 250 
 
 
Figure 5.4: Initial hybrid capture assay using just TTQB-C6-T1NH2 and identical conditions 
to Bruce and Sen
80
. Values are mean, ± S.E.M, n =2. 
As 1.65 nmol was the maximum amount of 5ʹ-NH2 oligonucleotides which could have been 
coupled (conjugated) to the glutaraldehyde-modified nanoparticles in the grafting step, 
capture (%) has been calculated as a percentage of the total complementary oligonucleotides 
available for capture in the solution (1.65 nmol).  
Due to the low dehybridisation values, I decided to repeat the dehybridisation stage a number 
of times to determine if more of the hybridised primer and non-specifically physically 
adsorbed primers could be dehybridised in this way. Figure 5.5 below presents the results of a 
further 5 consecutive repeats of the dehybridisation step. 
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Figure 5.5: Overall dehybridisation of the complementary oligonucleotide sequence captured 
by TTQB-C6-T1NH2 using successive cycles of heating at 85ºC for 4 minutes in water. 
From Figure 5.5 it can be seen that it took 6×4 minute dehybridisation cycles at 85ºC to 
remove almost 100% of the hybridised complementary oligonucleotide. Following on from 
this, it could therefore be concluded that the assay was not currently optimised for the 
materials and primers being used in this study. The following conditions have later been 
adopted based on the suggestion of Q-Bioanalytic GmbH, Germany as a part of PCR 
analysis: stretching/denaturation at 95ºC for 5 minutes with stirring, capture/hybridisation at 
60ºC for 5 minutes with stirring and dehybridisation at 95ºC for 5 minutes with stirring. Due 
to unavailability of a thermomixer at UCLan to stir the samples whilst maintaining a high 
temperature, I have decided to increase the stretching and dehybridisation steps to 10 minutes 
each, including a 10 second vortex step halfway through each phase. The 
capture/hybridisation at 60ºC has been carried out using a rotator within an incubator 
(maximum temperature 70ºC). 
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5.3.4 Optimised Conditions 
The hybrid capture assay was carried out from this point forward using the new conditions as 
described above (see details in Section 2.7.4). The first set of results is the capture of 
complementary oligonucleotides from solution, representing the second stage of the hybrid 
capture assay (following initial stretching).  
 
Figure 5.6: Capture of complementary oligonucleotide sequences from solution during the 
hybrid capture assay, in terms of nmol oligonucleotide captured per mg of LM-specific 
oligonucleotide-grafted nanoparticles. Values are mean, ± S.E.M, n =3. 
Figure 5.6 shows the amount of complementary oligonucleotides captured in nmol mg
-1
 of 
oligonucleotide-grafted nanoparticles. Materials TTQB-Blank + T1Comp and TTQB-Blank + 
T2Comp represent the non-specific capture of glutaraldehyde-modified nanoparticles in the 
assay. As can be seen, there is no significant difference between materials possessing the C12-
spacer or the C6-spacer. The values for all oligonucleotide-grafted nanoparticles are quite 
close, between 0.43 – 0.46 nmol mg-1, except for the material TTQB-C6T2NH2, which has a 
low capture value of 0.33 nmol mg-1. The non-specific capture of the blank materials is 0.22 
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nmol mg
-1
 for T1Comp and 0.11 nmol mg
-1
 for T2Comp. Table 5.2 shows the capture as a 
percentage of the covalently coupled oligonucleotide concentration.  
Table 5.2: Capture of complementary oligonucleotides from solution as a percentage of the 
covalently coupled LM-specific oligonucleotide concentration (see Table 5.1, Section 5.1 for 
material names). 
Oligonucleotide-
Grafted Material 
Complementary 
Oligonucleotide 
Captured 
Capture  
(nmol mg
-1
) 
Capture % (in 
terms of nmol 
captured per 
nmol coupled) 
Specific 
Capture 
(%) 
TTQB-C6T1NH2 T1Comp 0.46 70.29 52.17 
TTQB-C6T2NH2 T2Comp 0.33 47.57 33.33 
TTQB-C12T1NH2 T1Comp 0.46 65.90 52.17 
TTQB-C12T2NH2 T2Comp 0.43 55.93 48.84 
TTQB-Blank-F  T1Comp 0.22 12.47 0 
TTQB-Blank-R  T2Comp 0.11 7.29 0 
Note: Specific capture (%) is calculated from the difference between capture (%) using 
oligonucleotide-grafted materials and capture (%) using glutaraldehyde-modified materials without 
grafted-oligonucleotides. TTQB-Blank-F is the blank glutaraldehyde-modified material used to 
capture the forward complementary oligonucleotide and TTQB-Blank-R is the blank glutaraldehyde-
modified material used to capture the reverse complementary oligonucleotide. 
 In terms of percentages, oligonucleotide-grafted nanoparticles were shown to capture 
between 47% and 70% of complementary oligonucleotides from the solution. The 
glutaraldehyde-functionalised materials gave non-specific capture values of 12% and 7% for 
T1Comp and T2Comp respectively. This was calculated as a percentage of total 
oligonucleotides available for capture in the solution. The reasonably high non-specific 
capture values may be because the BSA was not used at quite a high enough concentration to 
block all of the surface aldehyde groups in the blank materials and is something that could be 
evaluated in future experiments. From these values, it can be deduced that all of the 
nanoparticles grafted with oligonucleotides captured around 33-52% specifically by the 
hybridisation mechanism. The spacer group used did not exhibit any effect on the capture 
efficiency. The final stage of the hybrid capture assay was the dehybridisation step, where the 
complementary oligonucleotide that was captured in the previous step is removed at high 
temperature.  
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Figure 5.7: Total dehybridisation of captured oligonucleotides (in nmol) per mg of LM-
specific oligonucleotide-grafted nanoparticles (top) and the dehybridisation as a percentage of 
total captured oligonucleotides (bottom). Values are mean, ± S.E.M, n =3. 
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In terms of total dehybridisation, it can be seen from Figure 5.7 that dehybridisation of both 
specifically- and non-specifically-captured oligonucleotides is high: oligonucleotide-grafted 
nanoparticles dehybridised 72-97% of captured oligonucleotides and glutaraldehyde-
modified materials without grafted-oligonucleotides dehybridised 59-100% of physically 
adsorbed (non-specifically captured) oligonucleotides. Oligonucleotide-grafted materials 
possessing the C6-spacer show higher dehybridisation of captured oligonucleotides. Figure 
5.8 presents a summary of the hybrid capture assay data.  
 
Figure 5.8: Summary of the materials used in the Listeria Monocytogenes hybrid capture 
assay and the complementary oligonucleotides they have captured and dehybridised. The blue 
bars represent the initial LM-specific oligonucleotide present on the nanoparticles after the 
glutaraldehyde coupling reaction, the red bars represent the total amount of complementary 
oligonucleotides captured/physically adsorbed during the hybridisation step and the green 
bars represent the total amount of captured oligonucleotides dehybridised (specific capture by 
hybrid capture mechanism). Values are mean, ± S.E.M, n =3. 
In conclusion, it can be seen from the above results of the hybrid capture assay that all 
materials exhibit high coupling values, typically over 80% of the initial oligonucleotide 
concentration present in the solution during the coupling reaction. Oligonucleotide-grafted 
nanoparticles exhibit both specific and non-specific capture of complementary 
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oligonucleotide sequences from solution. Dehybridisation is shown to be high for both 
specifically captured (72-97%) and non-specifically adsorbed (59-100%) oligonucleotides. 
5.4 Bio-separation and Bio-sensing Applications of Nanoparticles Grafted 
with Escherichia Coli -Specific Primers 
5.4.1 Coupling of 5ʹ-amine-modified oligonucleotides to Nanoparticles 
5ʹ-Amine-modified EC-specific oligonucleotides (primers) (see Table 2.2, Section 2.1) were 
grafted (or coupled) onto the glutaraldehyde-modified nanoparticle surface according to the 
method in Section 2.7.2. Figure 5.9 below presents the average coupling data of forward 
(EC_541_FOR) and reverse (EC_637_REV) primers with C6-spacers on functionalised 
nanoparticles. 
 
Figure 5.9: Average coupling values of EC-specific oligonucleotides to surface-
functionalised nanoparticles, in nmol of oligonucleotide coupled per mg of nanoparticles 
(left) and the average amount of oligonucleotide coupled to surface-functionalised 
nanoparticles, as a percentage of initial oligonucleotide concentration (right). Values are 
mean, ± S.E.M., n=3 in all cases. 
Figure 5.9 shows that coupling is very high for both forward (EC_541_FOR) and reverse 
(EC_637_REV) primers, over 96% and 97% respectively. Hence, it can be concluded that 
glutaraldehyde-modified surface-functionalised materials are very efficient for the grafting of 
these particular EC-specific primers. Due to the high coupling efficiency, these materials 
were then used for the hybrid capture assay, using the same optimised conditions from the 
LM hybrid capture assay in Section 2.7.4.  
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5.4.2 Hybrid Capture Assay 
The conditions for the hybrid capture assay were kept the same as those used for the LM-
specific hybrid capture assay. 
 
Figure 5.10: Capture of complementary EC-specific oligonucleotide sequences from solution 
during the hybrid capture assay, in terms of nmol oligonucleotide captured per mg of 
oligonucleotide-grafted nanoparticles. Values are mean, ± S.E.M, n =3. 
Figure 5.10 shows the amount of complementary oligonucleotides captured in nmol mg
-1
 of 
oligonucleotide-grafted nanoparticles. Materials TTQB-Blank + Comp_FOR and TTQB-
Blank + Comp_Rev represent the non-specific capture of glutaraldehyde-modified 
nanoparticles in the assay. It can be seen that oligonucleotide-grafted nanoparticles capture 
much more (0.40 nmol mg
-1
 for forward primer immobilised nanoparticles and 0.34 nmol 
mg
-1
 for reverse primer immobilised nanoparticles) than the glutaraldehyde-modified 
materials (0.16 nmol mg
-1
 for non-specific capture of the forward complementary sequence 
and 0.14 nmol mg
-1
 for non-specific capture of the reverse complementary sequence), 
confirming the specific capture of the complementary oligonucleotides from the solution. 
Table 5.3 below shows the capture as a percentage of the covalently coupled oligonucleotide 
concentration.  
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Table 5.3: Capture of complementary oligonucleotides from solution as a percentage of the 
covalently coupled EC-specific oligonucleotide concentration (see Table 5.1, Section 5.1 for 
material names). 
Oligonucleotide-
Grafted Material 
Complementary 
Oligonucleotide 
Captured 
Capture 
 (nmol mg
-1
) 
Capture % (in 
terms of nmol 
captured per 
nmol coupled) 
Specific 
Capture 
(%) 
TTQB_EC_541_FOR Comp FOR 0.40 54.95 60.00 
TTQB_EC_637_REV Comp Rev 0.34 48.80 58.82 
TTQB-Blank-F Comp FOR 0.16 10.60 0 
TTQB-Blank-R Comp Rev 0.14 8.94 0 
Note: Specific capture (%) is calculated from the difference between capture (%) using 
oligonucleotide-grafted materials and capture (%) using glutaraldehyde-modified materials without 
grafted-oligonucleotides. TTQB-Blank-F is the blank glutaraldehyde-modified material used to 
capture the forward complementary oligonucleotide and TTQB-Blank-R is the blank glutaraldehyde-
modified material used to capture the reverse complementary oligonucleotide. 
For the immobilised forward primer (TTQB_EC_541_FOR), 60% of the capture is specific. 
For the immobilised reverse primer (TTQB_EC_637_REV), around 59% of the capture is 
specific. As with LM-specific materials, capture is reasonably high, 55% and 49% for 
forward and reverse oligonucleotide-grafted nanoparticles respectively.  
The final stage of the hybrid capture assay was the dehybridisation step, where the 
complementary oligonucleotide that was captured in the previous step is removed at high 
temperature. Figure 5.11 presents total dehybridisation of captured EC-specific 
oligonucleotides in nmol mg
-1
 oligonucleotide-grafted nanoparticles. 
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Figure 5.11: Total dehybridisation of captured EC-specific oligonucleotides (in nmol) per mg 
oligonucleotide-grafted nanoparticles. Values are mean, ± S.E.M, n =3. 
Figure 5.12 presents total dehybridisation of captured EC-specific oligonucleotides in nmol 
mg
-1
 oligonucleotide-grafted nanoparticles as a percentage of total captured oligonucleotides.  
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Figure 5.12: Total dehybridisation of captured EC-specific oligonucleotides as a percentage 
of total captured oligonucleotides. Values are mean, ± S.E.M, n =3. 
Figure 5.12 shows that dehybridisation of specifically captured sequences is highly efficient; 
87% for forward oligonucleotide-grafted nanoparticles and 86% for reverse oligonucleotide-
grafted nanoparticles. In comparison, only around 28-42% of non-specifically adsorbed 
oligonucleotides are dehybridised, making this assay efficient at specific hybrid capture and 
dehybridisation. Figure 5.13 presents a summary of the EC hybrid capture data.  
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Figure 5.13: Summary of the materials used in the Escherichia Coli hybrid capture assay and 
the complementary oligonucleotides they have captured and dehybridised. The blue bars 
represent the initial EC-specific oligonucleotide present on the nanoparticles after the 
glutaraldehyde coupling reaction, the red bars represent the total amount of complementary 
oligonucleotides captured during the hybridisation step and the green bars represent the total 
amount of captured oligonucleotides dehybridised (specific capture by hybrid capture 
mechanism). Values are mean, ± S.E.M, n =3. 
In conclusion, it can be seen from results of the hybrid capture assay that all materials exhibit 
very high coupling values, typically over 96% of the initial oligonucleotide concentration. 
Oligonucleotide-grafted nanoparticles exhibit both specific and non-specific capture of 
complementary oligonucleotide sequences from solution, but the majority (over 59% in all 
cases) is specific. Dehybridisation of specifically captured oligonucleotides is especially high 
(85-88%) compared to non-specifically adsorbed oligonucleotides (28-42%), suggesting that 
those adsorbed non-specifically may be bound to the surface functional groups and that the 
interaction is not fully disrupted by dehybridisation in water at 95ºC.  
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5.5 Bio-sensor Application: Selective Determination of Listeria 
Monocytogenes (LM) from a mixture of LM and EC in collaboration 
with Q-Bioanalytic GmbH, Germany 
Initially the reaction has been carried out using LM-specific oligonucleotide-grafted 
nanoparticles (using C6 or C12 spacers), aminosilane-functionalised nanoparticles (TTQB) 
and silica-coated core-shell nanoparticles (QBLSSM) for the specific capture of LM from a 
1:1 mixture of LM and EC, as described in Section 2.7.6. In the amplification curve, there is a 
horizontal line (corresponding to a certain fluorescence value, not shown) called the crossing 
threshold, that when passed, confirms the presence of amplified DNA within the sample. The 
point at which the amplification plot crosses the crossing threshold is called the crossing 
point (Cp) and is presented as a cycle number (see Figure 5.14). A lower Cp value signifies a 
higher amount of amplified DNA in the sample. Due to the nature of the PCR amplification 
process, each cycle produces approximately double the amount of previously amplified DNA, 
therefore a sample with Cp = 23 will contain 32 times (2
5
) more DNA than a sample with Cp = 
28. 
 
Figure 5.14: qPCR amplification curves for selective capture of LM from a mixture of LM 
and EC (first testing of materials).  
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Figure 5.14 presents the qPCR amplification curve for LM-specific materials, aminosilane-
functionalised nanoparticles (TTQB) and silica-coated core-shell nanoparticles (QBLSSM). 
The green lines represent the background experiments ran using only water. Table 5.4 shows 
the Cp values for the materials used in the reaction. Experiments performed using water as the 
target mixture are omitted as fluorescence does not exceed the crossing threshold in all cases, 
except where contamination has taken place.  
Table 5.4: Cp values for LM-specific oligonucleotide-grafted nanoparticles for specific 
detection of LM from a 1:1 mixture of LM and EC. 
Sample Details Target Mixture Cp 
Value 
Positive/Negative 
Result (P/N) 
TTQB-C6T1NH2 + TTQB-C6T2NH2 LM only 28.69 P 
  28.60 P 
  34.52 P 
  33.95 P 
TTQB-C6T1NH2 + TTQB-C6T2NH2 1:1 mixture LM/EC 24.92 P 
  24.87 P 
  22.64 P 
  22.71 P 
TTQB-C12T1NH2 + TTQB-C12T2NH2 LM only 26.66 P 
  26.83 P 
  26.87 P 
  26.96 P 
TTQB-C12T1NH2 + TTQB-C12T2NH2 1:1 mixture LM/EC 25.10 P 
  25.10 P 
  26.92 P 
  27.00 P 
 
Table 5.4 shows that LM-specific oligonucleotide-grafted nanoparticles are successful at 
capturing LM from a solution containing LM only and also from a solution containing LM 
and EC.  
The reaction was also performed using a two-step hybrid capture assay (see Section 0) where 
the forward-specific oligonucleotide-grafted nanoparticles were used first for hybridisation 
and the reaction mixture was subsequently added to reverse-specific oligonucleotide-grafted 
nanoparticles. The captured complementary sequences were then dehybridised separately and 
amplified separately for qPCR.  
For the capture of LM from the 1:1 mixture of LM and EC, no capture was observed at all 
using LM-specific materials. For the capture of EC from the mixture using EC-specific 
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materials, only the material grafted with the reverse-specific oligonucleotide exhibited 
positive results (Cp = 39.80). 
5.6 Bio-sensor Application: Determining the Sensitivity of Detection of 
LM from a Dilution Series using LM-specific oligonucleotide-grafted 
nanoparticles in collaboration with Q-Bioanalytic GmbH, Germany 
The hybrid capture reaction was performed using real food samples inoculated with either 
LM or EC as described in Section 2.7.6. For LM-specific oligonucleotide-grafted 
nanoparticles, capture was shown to be successful for detecting LM in an undiluted mixture 
(see Table 5.4). The reaction was performed with new batches of oligonucleotide-grafted 
nanoparticles using a 2-step hybrid capture assay (see Section 2.7.6).  
 
Figure 5.15: qPCR amplification curves for determining the sensitivity of detection for 
capture of LM from a dilution series of LM in peptone water using the two-step hybrid 
capture mechanism. 
Figure 5.15 shows that for the two-step hybrid capture assay using LM-specific nanoparticles, 
no detection was observed within the dilution series. The only positive results obtained were 
for blank glutaraldehyde-modified TTQB nanoparticles, which detected LM at standard 
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concentration (without dilution), giving CP values of 27.70 and 27.41. The curves appearing 
with CP values of around 19 correspond to positive control samples of LM. 
5.7 Bio-sensor Application: Determining the Sensitivity of Detection of EC 
from a Dilution Series using EC-specific oligonucleotide-grafted 
nanoparticles in collaboration with Q-Bioanalytic GmbH, Germany 
The hybrid capture reaction was performed using real food samples inoculated with either 
LM or EC as described in Section 2.7.6. The reaction was performed with new batches of 
oligonucleotide-grafted nanoparticles using a 2-step hybrid capture assay (see Section 2.7.6).  
 
Figure 5.16: qPCR amplification curves for determining the sensitivity of detection for 
capture of EC from a dilution series of EC in peptone water using the two-step hybrid capture 
mechanism. 
Error! Reference source not found. shows that for EC-specific nanoparticles positive 
esults were obtained for nanoparticles grafted with the forward oligonucleotide 
(EC_541_FOR) at standard concentration (without dilution), CP = 38.78 and 35.13. The 
curves appearing with CP values of around 15 correspond to positive control samples of EC.  
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                     CHAPTER 6
CONCLUSIONS AND FUTURE WORK  
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The work presented in this thesis has been carried out in order to explore the various 
applications of functionalised magnetic nanoparticles with bio-molecules on the surface. The 
materials were then used to investigate their applications in two main areas: Bio-catalysis and 
bio-separation/bio-sensing. 
6.1 Synthesis and Characterisation of Magnetite and Silica-Magnetite 
nanoparticles 
Magnetite nanoparticles were produced using two popular synthetic methods: the chemical 
co-precipitation of ferrous and ferric chloride solutions in alkaline media and the oxidative 
hydrolysis of ferrous sulphate. Magnetite nanoparticles made via the co-precipitation method 
were found to be spherical, around 10nm in diameter, with reasonably high saturation 
magnetisation (MS) and high surface area. However, they were dark red-brown possibly due 
to the presence of hematite and had seemingly slow response to a bar magnet and hence were 
not used for further applications. Nanoparticles made via the oxidative hydrolysis method 
were jet-black in colour with rhombic (25-200 nm size) morphology. The synthesis method 
was scaled up successfully to produce the materials in a larger amount with no significant 
change in the size, shape or magnetic response. Surface areas for the nanoparticles made on 
the small-scale were around two times greater than that observed for large-scale materials, 
perhaps due to the aggregation of the nanoparticles during storage.  
Following the production of silica-coated core-shell nanoparticles, TEM images show an 
amorphous silica-coating surrounding both individual nanoparticles and small aggregates of 
nanoparticles. Magnetic measurements show an interesting trend; silica-coated nanoparticles 
have higher saturation magnetisation than bare magnetite nanoparticles. BET surface area 
results show that the surface area of silica-coated nanoparticles is slightly lower than those 
obtained from bare magnetite. The homogeneity of the silica core-shell coating was proven 
using a salmon sperm DNA binding and elution assay. Binding was shown to be high in all 
materials (bare magnetite and silica-coated magnetite) whereas elution behaviour was 
different depending on the number of silica coating steps or bare magnetite. Elution was 
shown to increase with an increase in silica-coatings hence proving the homogeneity of the 
silica shell on core-magnetite due to the presence of a “cation-bridge” bonding system 
between the surface silanol groups, sodium cations present in the salt buffer and the 
negatively charged phosphate groups on the DNA backbone. 
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6.2 Surface Functionalisation of Silica-Coated Magnetite Nanoparticles 
Following silica-coating, the nanoparticles were functionalised using a variety of 
aminosilanes (APTS, APDS and APMS) and two different functionalisation methods – a 
classical method in water and a recently-developed TPRE method using toluene and a non-
ionic surfactant.  
Materials made using TPRE methods gave higher surface amine density values than those 
made using the classical water method, when the same aminosilane was used. Also, surface 
amine density was highest using APTS and decreased when APDS and APMS were used. 
This is possibly due to APTS molecules forming a more ordered monolayer around the silica-
coated surface, with less steric hindrances than the other aminosilanes (due to the presence of 
‘capped’ methyl groups in APDS and APMS). The surface amine density values given by 
APTS- and APDS-functionalised materials are comparable to the values obtained for that of a 
monolayer on a flat surface, reported by Moon et al.
88
  
Glutaraldehyde was used as a cross-linking reagent to attach the surface amine groups of the 
aminosilane-functionalised nanoparticles covalently to the amine groups on the bio-molecule 
surface – lipases for bio-catalysis and amine functionalised oligonucleotides for bio-sensing.  
6.3 Bio-catalytic Applications of Lipase-Immobilised Nanoparticles 
Enzyme Loading 
Two lipases – CRL and PFL – were immobilised onto various glutaraldehyde-modified 
surface-functionalised nanoparticles for use as bio-catalysts; on average, PFL materials 
showed slightly lower loading values than CRL materials. APTS and APDS-functionalised 
materials exhibited higher loadings (65-80 µg/mg) than those made using APMS (35-60 
µg/mg) for both CRL and PFL. One of the reasons for this is possibly that APTS and APDS 
materials have higher surface amine density values than APMS materials on average and 
have more possible binding sites. Physical adsorption of both lipases onto silica-coated non-
functionalised nanoparticles was also performed, giving lower loading values when compared 
to immobilisation via chemical conjugation. In addition, physically adsorbed lipases could 
also leach into solution during a reaction, whereas immobilised lipases remained attached to 
the nanoparticle surface.  
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Model Catalysis Reaction: Hydrolysis of PNPP to PNP and Palmitic Acid 
The hydrolysis of p-nitrophenyl palmitate (PNPP) to p-nitrophenol (PNP) and the 
corresponding acid is a widely used reaction to determine the hydrolytic activity of lipases 
and lipase-immobilised materials.  
For PFL-immobilised materials, those made using APTS and APDS showed no significant 
differences in activity over three catalytic cycles, regardless of whether the TPRE or water 
method was used for surface functionalisation. When APMS was used for surface 
functionalisation, catalytic activity increased greatly and was higher than when free PFL was 
used. There was also a significant difference in activity of materials made using the TPRE 
and water methods; activity of the TPRE materials being much higher. Free PFL gave higher 
activity than PFL-immobilised materials made using APTS and APDS for surface 
functionalisation, but was lower than those made using APMS. 
For CRL-immobilised materials, APTS, APDS and APMS surface-functionalised materials 
made using the TPRE method give higher activity than the same materials made using the 
water method. Free CRL was seen to have higher activity than all CRL-immobilised 
materials. Materials made using APMS were seen to exhibit the highest catalytic activity 
values again, despite having the lowest loading values. 
For both lipases, the increased activity of APMS functionalised materials over the others is 
possibly due to lower surface amine density leading to decreased steric hindrance around the 
nanoparticle surface and therefore more accessible active sites. 
In the case of physically adsorbed lipases, activity was seen to be much lower, initially, than 
that of immobilised-lipases and activity decreased greatly with subsequent cycles, due to the 
lipase leaching from the nanoparticle surface into the reaction mixture. For free lipases, PFL 
was notably more catalytically active than CRL, producing around 2.5 times more PNP than 
CRL.  
Transesterification of Ethyl Butyrate and n-Butanol to Butyl Butyrate 
The first step of this application involved testing various reaction conditions to optimise the 
reaction. For PFL-immobilised materials, those made using the water method of surface 
functionalisation gave higher conversion values than those made using the TPRE method, 
except when APTS was used as the aminosilane, in which case the conversion values were 
similar regardless of the method used. This trend is opposite to that observed in the model 
Page 189 of 250 
 
catalysis reaction, where PFL materials made using the TPRE and water methods had similar 
catalytic activity. This suggests that the PFL reacts differently to the different reaction 
conditions and performs differently for hydrolysis and transesterification reactions. For CRL-
immobilised materials, those made using the TPRE method performed slightly better on 
average than those made using the water method. Materials made using APMS as the 
aminosilane source provided the highest conversion values overall. These trends for CRL 
materials were similar to those observed in the hydrolysis of PNPP reaction, suggesting that 
CRL performs in a similar way for both reactions. Both free lipases gave higher conversion 
values than all of the corresponding lipase-immobilised materials, with free PFL giving the 
highest overall conversion at around 90% and free CRL at around 65% conversion.  
Partial and Selective Hydrolysis of Cis-3,5-diacetoxy-1-cyclopentene to Synthesise 
Pharmaceutically Important Chiral Intermediates 
A variety of temperatures and solvent conditions were investigated for this reaction in order 
to produce the best results. PFL- and CRL-immobilised nanoparticles made using APTS as 
the aminosilane source and the TPRE method were used for the reaction due to their high 
enzyme loading and reproducibility of results in other applications. Free lipases were also 
used for comparison. 
For free lipases, the highest total conversion values were given at 37ºC using 20% 
water/hexane as the solvent. For immobilised lipases, the highest conversions were obtained 
at 25ºC using 50% water/hexane as the solvent. This could be because 50% water/hexane 
permits a larger interfacial area for the reaction to take place. When free lipases are used in 
50% water/hexane, maximum conversion to desired products is reached after 24 hours. After 
this, conversion to the desired products is seen to decrease and production of the dihydroxy 
by-product increases significantly. At 25
º
C and 37
º
C using 20% water/hexane and free PFL, 
the dihydroxy becomes the dominant product at 24 hours, suggesting that the desired mono-
acetoxy products are hydrolysed further.  
In all cases, immobilised enzymes reach maximum conversion values at 48 hours and 
conversion to the dihydroxy by-product is always very low (under 5% of total products). It 
can be concluded that the re-usability and separability advantages offered by lipase-
immobilised nanoparticles coupled with low amounts of by-products formed makes them 
suitable catalysts for this reaction.  
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6.4 Bio-sensor Applications of Oligonucleotide-Grafted Nanoparticles 
Oligonucleotide Grafting  
Amine-functionalised oligonucleotide sequences specific to either LM or EC were conjugated 
onto glutaraldehyde-modified nanoparticles. LM-specific forward and reverse 
oligonucleotides modified with C6 or C12 spacers were used; conjugation was high in all cases 
(78-85%) and no significant differences were seen, regardless of the spacer group. For EC-
specific primers (with only C6 spacer group), conjugation for the forward and reverse primers 
was extremely high at 96-97%. 
Hybrid Capture Assay: Capture of Complementary Oligonucleotide Sequences Using 
LM-Specific Oligonucleotide-Grafted Nanoparticles 
Initial conditions led to reasonable capture values of 58%, but only 27% of those captured 
oligonucleotides were dehybridised. The assay conditions were then optimised based on 
actual qPCR conditions used by Q-Bioanalytic GmbH and the results were improved. 
Using the optimised conditions, capture was observed to be relatively high as a percentage of 
nmol complementary sequence captured per nmol of sequence grafted for materials 
containing both C6 and C12 spacers (48-70% capture). Non-specific capture using 
glutaraldehyde modified nanoparticles was found to be low (7 to 12%) for the 
complementary forward and reverse sequences. Of the oligonucleotides captured using 
oligonucleotide-grafted nanoparticles, 33-52% were deemed to be via specific hybridisation.  
There was no significant difference in dehybridisation values for oligonucleotide-grafted 
materials possessing the C6-spacer and the C12-spacer group (72-97%). Dehybridisation of 
non-specifically adsorbed sequences using glutaraldehyde modified nanoparticles was also 
high at 59-100%. Optimising the conditions to suit the oligonucleotides used in the assay led 
to a significant increase in capture and dehybridisation efficiency and it can be concluded that 
the oligonucleotide-grafted nanoparticles are efficient for the specific capture and 
dehybridisation of complementary oligonucleotides from a buffer solution.  
Hybrid Capture Assay: Capture of Complementary Oligonucleotide Sequences Using 
EC-Specific Oligonucleotide-Grafted Nanoparticles 
Again, capture using the new, optimised conditions was observed to be relatively high as a 
percentage of nmol complementary sequence captured per nmol of sequence grafted (coupled 
via glutaraldehyde modification): 55% and 49% for forward and reverse oligonucleotide-
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grafted nanoparticles respectively. Capture was observed to be low (9-11%) for the materials 
without attached primers (only glutaraldehyde modified nanoparticles). Of the total capture, 
59-60% was determined to be via specific hybridisation between the grafted and 
complementary oligonucleotides. 
In terms of dehybridisation, oligonucleotide-grafted nanoparticles dehybridised 85-88% of 
captured complementary sequences, whereas glutaraldehyde-functionalised nanoparticles 
without the primers (only glutaraldehyde modified nanoparticles) dehybridised only 28-42% 
of physically captured sequences. It can be concluded that the oligonucleotide-grafted 
nanoparticles are efficient for the specific hybrid capture from a buffer solution. 
In terms of hybrid capture efficiency for both LM and EC specific primer functionalised 
nanoparticles, a better negative control would be to test the capture of non-specific 
oligonucleotide sequences from solution, rather than using glutaraldehyde-functionalised 
nanoparticles. The glutaraldehyde functional groups on the nanoparticles’ surface may 
promote capture of the non-specific nucleotide sequences, giving a less accurate indicator of 
non-specific capture from the solution.  
6.5 DNA Extraction Using Silica-Coated Core-Shell Nanoparticles 
Silica-coated core-shell nanoparticles (QBLSSM) were shown to exhibit similar efficiency 
for extraction of DNA from a food matrix when compared to total DNA extracted using a 
classical thermal lysis method. However, DNA extracted using the nanoparticles can be 
purified by washing and then eluted for direct use in qPCR, whereas DNA extracted from the 
thermal lysis method can contain many PCR-inhibiting species. The silica-coated 
nanoparticles (QBLSSM) were subsequently employed by Q-Bioanalytic GmbH as part of 
their commercial DNA Extraction Kit. 
6.6 Selective Determination of Listeria Monocytogenes or Escherichia Coli 
from a Mixture of Both 
Using a one-step hybrid capture mechanism (see Section 2.7.3) involving LM-specific 
forward and reverse oligonucleotide-grafted nanoparticles, the nanoparticles (containing both 
C6 and C12 spacers) were shown to be successful for the detection of LM from mixtures 
containing a 1:1 mixture of LM and EC.  
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Later, in testing a two-step hybrid capture mechanism in which forward and reverse 
oligonucleotide-grafted nanoparticles were employed separately for capture and 
dehybridisation, only the material grafted with the EC-specific reverse-oligonucleotide was 
successful for detection of EC.  
6.7 Determining the Sensitivity of Detection of Listeria Monocytogenes 
from a Dilution Series 
Using a one-step hybrid capture mechanism (see Section 2.7.6), LM-specific forward and 
reverse oligonucleotide-grafted nanoparticles were successful at detecting LM in undiluted 
samples. The capture and detection was unsuccessful using the two-step hybrid capture 
mechanism. 
6.8 Determining the Sensitivity of Detection of Escherichia Coli from a 
Dilution Series 
Using only a two-step hybrid capture mechanism ((see Section 2.7.6), EC-specific forward 
oligonucleotide-grafted nanoparticles were successful at detecting EC in undiluted samples. 
EC-specific reverse oligonucleotide-grafted nanoparticles were unsuccessful at detecting EC 
in the samples. 
6.9 Future Work 
This work has presented the synthesis and characterisation of rhombic magnetite and silica-
coated magnetite nanoparticles, on the small and large scale, and their subsequent uses for 
immobilising bio-molecules for further applications. In future, it would be worth comparing a 
range of morphologies with a narrow size distribution. 
In terms of bio-catalytic applications such as (i) the transesterification of ethyl butyrate and 
(ii) the partial and selective hydrolysis of cis-3,5-diacetoxy-1-cyclopentene, it would be 
interesting to scale-up the reaction to investigate a wider range of water concentrations; to 
avoid issues dissolving the free lipase in minute quantities of water. This is more of an issue 
in the partial and selective hydrolysis of cis-3,5-diacetoxy-1-cyclopentene as the products are 
formed in the water layer, from which aliquots are withdrawn for analysis. In this reaction, as 
the by-products become the predominant product in some cases, it would be interesting to 
carry out a full kinetic study to pinpoint the exact moment when the production of desired 
products is highest compared to undesired products. Due to the formation of acetic acid in the 
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reaction leading to hydrolysis of the desired reaction products, addition of small amounts of 
base to the reaction to neutralise the acid could lead to higher ratios of desired products to 
undesired by-products.  
For bio-sensor applications, optimising the protocols for the specific capture of bacteria from 
real food samples is a priority. A two-step protocol could be employed, where nanoparticles 
grafted with the forward-specific oligonucleotide could be used for capture first, followed by 
those grafted with the reverse-specific oligonucleotide. The dehybridisation of captured 
complementary sequences could be carried out separately and the two could be mixed before 
amplification by PCR. This would overcome problems associated with non-specific capture 
of sequences from the mixture. Incorporating BSA into the buffer system during the specific 
capture of bacteria from real food samples would also help to block the non-specific nucleic 
acids from binding to the un-grafted glutaraldehyde groups on the surface of the 
nanoparticles. Also, assessing the capture of non-specific oligonucleotides using 
oligonucleotide-grafted nanoparticles would be a better negative control experiment as the 
glutaraldehyde-functionalised nanoparticles possess different surface properties to 
oligonucleotide-grafted nanoparticles and may facilitate the non-specific capture. Due to 
some successful results, with some assay optimisation, the nanoparticles could be grafted 
with oligonucleotides specific to other strains of pathogenic bacteria and also allergens in 
food.  
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Abstract. Superparamagnetic iron oxide nanoparticles (SPIONs) have been fabricated and modified 
with silica shell followed by functionalization with aminosilanes. The non-functionalised core-shell 
and amino-functionalized SPIONs were used for the immobilisation of lipase enzymes (Candida 
Rugosa Lipase:CRL and Pseudomonas Fluorescens Lipase:PFL). The materials have been used for 
the hydrolysis of p-nitrophenyl palmitate (PNPP) to palmitic acid and p-nitrophenol (PNP) under the 
heterogeneous condition. PFL immobilised SPIONs were observed to be highly reactive compared to 
CRL immobilised SPIONs. Similarly chemically conjugated lipases via glutaraldehyde modification 
to the amino-functionalised SPIONs were reactive and stable up to 3 recycles compared to physically 
adsorbed lipase immobilised SPIONs. 
Introduction 
Enzymes are widely used in the chemical industry for homogeneous catalysis as a result of their 
high chemo-, regio- and enantioselectivity [1]. Since mid-to-late 1990’s, bio-catalysis using enzymes 
has been extensively used in the pharmaceutical industry due to increased demand for new, more 
potent drugs and medicines [2]. It is also important to mention that enzymes typically require mild 
reaction conditions and produce much less waste and harmful by-products than other catalysts, 
making them an even more attractive option for chemical synthesis. However, the use of free enzymes 
presents a problem such as they can’t be recycled or reused once introduced into the reaction system. 
Also, enzymes are fairly expensive so being able to reuse them is cost effective and would make the 
system more commercially viable. Another problem is that most organic compounds that are of 
commercial interest are often insoluble/partially soluble in water. A way around this is to use organic 
solvents, which leads to high substrate solubility, higher reaction rates and increased ease of recovery 
of the enzyme from the system. However, a disadvantage of using lipases in organic solvents is that 
catalytic activity can decrease dramatically compared to aqueous systems [3], due to diffusional 
limitations, enzyme destabilisation and changes in protein flexibility [4,5].  
A solution to these problems is to immobilise the enzymes onto a solid support, which would 
create a heterogeneous system where the supported enzyme can be introduced into the reaction 
mixture. The enzyme immobilised solid supports can be recovered by simple filtration and reused for 
further reactions. It is also well documented that enzyme activity increases when immobilised on solid 
supports matrix [4] especially when interfacially adsorbed on hydrophobic supports [6]. This occurs 
because the hydrophobicity of the support surface promotes interfacial activation of the lipase. The 
strong adsorption on the hydrophobic surfaces produces conformational changes that favour the more-
stable “open” form of the enzyme i.e. catalytically active centres are more exposed, leading to 
greater catalytic activity. 
Immobilisation of enzymes on magnetisable solid supports has added advantage as they can be 
separated by applying an external magnetic field. Dyal et al [7] first reported the immobilisation of 
candida rugosa lipase (CRL) on magnetic (maghemite) nanoparticles for the hydrolysis of p-
Page 203 of 250 
 
nitrophenyl palmitate. Sen et al [8] have later reported a novel materials “hierarchically ordered 
porous magnetic nanocomposites” for the same reaction under heterogeneous medium. Netto et al [9] 
have reported superparamagnetic silica-coated nanoparticles for immobilisation of Candida 
Antarctica lipase (CAL) for enantioselective transesterification reactions. In the context of our 
manuscript, both Candida Rugosa lipase (CRL) and Pseudomonas Fluorescence lipase (PFL) were 
employed under homogeneous condition for the enantiomeric synthesis of citronellyl butyrate, a 
flavouring agent i.e. a fruity and floral aroma [10]. 
Herein we report the immobilisation of CRL and PFL on the silica coated superparamagnetic iron 
oxide nanoparticles (SPIONs) by (i) physical adsorption and (ii) chemical conjugation via surface 
functionalisation using aminosilanes for the hydrolysis of p-nitrophenyl palmitate (PNPP) to p-
nitrophenol and palmitic acid under heterogeneous condition and efficient reusability by simple 
magnetic separation.  
Materials and methods 
All chemicals were purchased from Sigma-Aldrich and used without further purification. 
Superparamagnetic iron oxide nanoparticles (SPIONs) were synthesised by earlier published protocol 
[11]. In an actual process ferrous sulphate (23.60 g), potassium nitrate (5.39 g) and potassium 
hydroxide (12.60 g) were mixed and dissolved in 220 mL deionised water. The mixture was stirred 
for 4 hours under nitrogen atmosphere at 90
º
C. The black materials obtained were washed with 
deionised water by magnetic separation using a bench top flat magnet until the pH 7. The core 
SPIONs were coated with a thin layer of amorphous silica by reported protocol [11] using silicic acid 
at alkaline pH.  
The silica coated magnetite nanoparticles were used for the immobilisation of CRL and PFL by two 
different methods: 
Physical adsorption: Silica-coated SPIONs (50 mg) and 4 mL of a 1 mg/mL solution of either 
CRL or PFL in PBS buffer were mixed in 25 mL falcon tubes and the reactions were allowed to 
proceed for 20 hours at 25
º
C (temperature programmed incubator) with gentle end-over-end rotation.  
Chemical conjugation: Silica coated magnetite nanoparticles were functionalized using 
aminopropyl triethoxy silane (APTS) in water at 50
º
C for 24hrs following the reported protocol [12].  
The surface amine density was 
determined by standard 
colorimetric assay [13] before 
treatment with glutaraldehyde for 
the conversion of surface amine to 
aldehyde (see Fig.1). The 
glutaraldehyde modified SPIONs 
(50 mg) were used for 
immobilisation of lipase enzymes 
following the same protocol 
described earlier in the physically 
adsorption route. 
Analysis of enzymes 
immobilisation on the surface of SPIONs: 1 mL of the supernatant from each reactions were removed 
(using magnetic separator) and recorded the absorbance at 595nm (A595) by UV-Vis 
spectrophotometer. The amounts of CRL and PFL immobilised on SPIONs were determined by 
calculating the concentrations using a pre-established standard curves (data not shown). The lipase-
immobilised nanoparticles were then washed with PBS buffer (4×5mL) and finally resuspended in 
PBS buffer for use as bio-catalysts.  
Bio-catalysis: The required amount of enzyme immobilised SPIONs containing 500 µg lipases 
were used for each reaction. A 3.74 µmol/mL (1 mL total volume) solution of para-nitro phenyl 
palmitate (PNPP) in a 1:1 mixture of reagent A (0.0667 g Gum Arabic, 0.267 g sodium deoxycholate, 
12 mL of 250 mM Tris-HCl buffer at pH 7.8 + 48mL deionised water) and isopropanol was added to 
the lipase-immobilised nanoparticles. The reactions were allowed to proceed with gentle end-over-end 
rotation at 25
º
C for 1 hour. After 1 hour, the absorbance at 410nm (A410) was recorded by UV-Vis 
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spectrophotometer to calculate the concentration of para-nitrophenol (PNP) in solution using a pre-
established standard curve (data not shown). The lipase-immobilised nanoparticles were then washed 
in PBS buffer (4×1mL) and the reactions were repeated for 3 cycles in total to assess catalytic 
efficiency and reusability over time. 
Fig.2 presents the reaction scheme 
with magnetic separation of reaction 
products. 
Results and Discussion 
The silica coated SPIONs were 
rhombic in morphology of sizes 
around 30 to 150nm from 
Transmission Electron Microscope 
(data not shown). The materials 
were observed to be 
superparamagnetic in nature with saturation magnetization of ~80 Emu/G (see Fig.3). Fig.4 presents 
the amount of lipase immobilised by physical adsorption and chemically conjugated routes. 
Chemically conjugated route produced highest lipase immobilisation for both CRL and PFL 
compared to physically adsorbed route. PFL immobilisation was lowest (~4µg/mg of solid) in value 
when physically adsorbed on SPIONs. The highest values of PFL immobilisation was ~70µg/mg of 
solid when chemically conjugated route was used. Similarly the value of CRL immobilisation 
was~65µg/mg of solid when the chemically conjugated route was used. 
When the materials were used for bio-catalysis, the chemically conjugated PFL immobilised 
SPIONs exhibited the highest catalytic activity (see C1 to C3 in Fig.5) compared to other materials 
including the free enzymes. It is noteworthy to mention that free PFL also exhibited a high catalytic 
activity however we could not reuse for cycles 2 and 3 due to the difficulty involved in separation 
from the reaction mixture. In was clearly observed that PFL immobilised SPIONs exhibited nearly 6 
folds increase in catalytic activity (see C1 in Fig.5) compared to CRL immobilised SPIONs (see A1 in 
Fig.5). Free CRL exhibited 3 folds higher catalytic activity (see D1 in Fig.5) compared to chemically 
conjugated (see A1 in Fig.5) or physically adsorbed (see B1 in Fig.5) CRL immobilised SPIONs.    
Both PFL and CRL immobilised SPIONs by physically adsorbed route showed a gradual reduction in 
catalytic activity during reusable cycles (1 to 3) however, the catalytic activity nearly unchanged (in 
case of CRL) or increased in values (in case of PFL) when chemically conjugated route was used for 
the immobilisation. The loss of catalytic activity for physically adsorbed lipases could be due to the 
leaching of enzymes from the surface of SPIONs to the reaction mixture. However, enzymes 
immobilised by chemically conjugated route produced a stable catalyst for the hydrolysis of PNPP 
with efficient reusability. The increase in catalytic activity in the case of chemically conjugated PFL 
immobilised SPIONs could be due to the exposure of active sites of the enzymes with different cycles. 
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Summary 
Both PFL and CRL enzymes were successfully immobilised on the surface of superparamagnetic iron 
oxide nanoparticles (SPIONs). Chemical conjugation route produced novel enzyme immobilised 
magnetic nanoparticles which exhibited a high catalytic activity with an efficient reusability. We have 
also identified that PFL is the best enzyme for hydrolysis of PNPP. 
Acknowledgement 
Authors thank to Dr Tim Mercer for helping BH during the magnetic measurement study. BH would 
like to thank Q-Bioanalytic GmbH, Germany for a partial funding to his PhD study and the Centre for 
Materials Science, School of Forensic and Investigative Science for an additional funding. 
References 
[1] S. M. Roberts: J. Chem. Soc. Perkin Trans. Vol. 1 (2000), p.611 
[2] R. S. Rogers: Chem. Eng. News. Vol. 77 (1999), p. 87. 
[3] H. Kitaguchi, P. A. Fitzpatrick, J. E. Huber, A. M. Klibanov: J. Am. Chem. Soc. Vol.111 (1989), 
p.3094. 
[4] Y. Z. Chen, C. B. Ching, R. Xu: Process Biochem. Vol. 44 (2009), p.1245. 
[5] R. Fernandez-Lafuente, P. Armisn, P. Sabuquillo, G. Fernadez-Lorente, M. Guisin: Chem. Phys. 
Lipids. Vol. 93 (1998), p.185. 
[6] G. Fenandez-Lorente, J. M. Palomo, M. Fuentes, C. Mateo, J. M. Guisin, R. Fernandez-Lafuente: 
Biotechol. Bioeng. Vol. 82 (2003), p.232. 
[7] A. Dyal, K. Loos, M. Noto, S. W. Chang, C. Spagnoli, R. A. Gross: J. Am. Chem. Soc. Vol. 125 
(2003), p.1684. 
[8] T. Sen, I. J. Bruce, T. Mercer: Chem. Commun. Vol. 46 (2010), p.6807. 
[9] C. G. C. M. Netto, L. H. Andrade, H. E. Toma: Tet. Lett. Vol. 20 (2009), p. 2299. 
[10] Cargill Aroma Chemicals 2009 information on 
http://www.cargill.com/food/wcm/groups/public/@cseg/@food/@all/documents/document/na30
24026.pdf  
[11] I. J. Bruce, J. Taylor, M. Todd, M. J. Davies, E. Borioni, T. Sen: J. Magn. Magn. Mater.Vol. 284 
(2004), p.145. 
[12] I. J. Bruce, T. Sen: Langmuir Vol. 21 (2005), p.7029. 
[13] J. H. Moon, J. W. Shin, S. Y. Kim, J. W. Park: Langmuir Vol.12 (1996), p.4621. 
 
 
 
 
 
 
 
 
 
 
Page 206 of 250 
 
Reference List 
 1.  Poole Jr., C. P.; Owens, F. J. Introduction to Nanotechnology. In 
Introduction to Nanotechnology, John Wiley & Sons, Inc: Hoboken, New 
Jersey, 2003; pp 1-7. 
 2.  Tian, Y.; Pesika, N.; Zeng, H.; Rosenberg, K.; Zhao, B.; McGuiggan, P.; 
Autumn, K.; Israelachvili, J. Adhesion and Friction in Gecko Toe Attachment 
and Detachment. Proc Natl Acad Sci USA 2006, 103 (51), 19320-19325. 
 3.  Huang, J.; Wang, X.; Wang, Z. L. Controlled Replication of Butterfly 
Wings for Achieving Tunable Photonic Properties. Nano Letters 2006, 6 (10), 
2325-2331. 
 4.  Buehler, M. J. Molecular Nanomechanics of Nascent Bone: Fibrillar 
Toughening by Mineralization. Nanotechnology 2007, 18 (29), 1-9. 
 5.  Poole Jr., C. P.; Owens, F. J. Introduction to Physics of the solid State. In 
Introduction to Nanotechnology, John Wiley & Sons, Inc: Hoboken, New 
Jersey, 2003; pp 8-34. 
 6.  Capek, I. Preparation of Metal Nanoparticles in Water-in-Oil (w/o) 
Microemulsions. Advances in Colloid and Interface Science 2004, 110, 49-74. 
 7.  Kreuter, J. Nanoparticles - A Historical Perspective. International 
Journal of Pharmaceuticals 2007, 331, 1-10. 
 8.  Birrenbach, G.; Spesier, P. P. Polymerized Micelles and their Use as 
Adjuvants in Immunology. J. Pharm. Sci. 1976, 65, 1763-1766. 
 9.  Kramer, P. A. Albumin Microspheres As Vehicles for Achieving 
Specificity in Drug Delivery. J. Pharm. Sci. 1974, 1646-1647. 
 10.  Kreuter, J. Nanoparticles and Nanocapsules - New Dosage Forms in 
Nanometer Size Range. Pharm. Acta Helv. 1978, 53, 33-39. 
 11.  Kreuter, J. Evaluation of Nanoparticles as Drug Delivery Systems. 
Habilitationsschrift, ETH Zurich, Nr. 5417 1981. 
 12.  Kreuter, J. Evaluation of nanoparticles as drug delivery systems I: 
Preparation methods. Pharm. Acta Helv. 1983, 58, 196-209. 
 13.  Marty, J. J.; Oppenheim, R. C. Colloidal Systems for Drug Delivery. 
Aust. J. Pharm. Sci. 1977, 6, 65-76. 
Page 207 of 250 
 
 14.  Bertling, W. M.; Gareis, M.; Paspaleeva, V.; Zimmer, A.; Kreuter, J.; 
Nurnberg, E.; Harrer, P. Use of Liposomes, Viral Capsids, and Nanoparticles as 
DNA Carriers. Biotech. Appl. Biochem. 1991, 13, 390-405. 
 15.  Sugibayashi, K.; Morimoto, Y.; Nadai, T.; Kato, Y.; Hasegawa, A.; Arita, 
T. Drug-carrier property of albumin microspheres in chemotherapy.II. 
Preparation and tissue distribution in mice of microsphere-entrapped 5-
fluorouracil. Chem. Pharm. Bull. 1979, 27, 204-209. 
 16.  Widder, K. J.; Morris, R. M.; Poore, G. A.; Howard, D. P.; Senyei, A. E. 
Selective targeting of magnetic albumin microspheres containing low-dose 
doxorubicin:Total remission in Yoshida Sarcoma-bearing rats. Eur. J. Cancer 
1983, 19, 135-139. 
 17.  Widder, K. J.; Marino, P. A.; Morris, R. M.; Howard, D. P.; Poore, G. A.; 
Senyei, A. E. Selective targeting of magnetic albumin microspheres to the 
Yoshida Sarcoma: Ultrastructural evaluation of microsphere disposition. Eur. J. 
Cancer 1983, 19, 141-147. 
 18.  Brasseur, F.; Couvreur, P.; Kante, B.; Deckers-Passau, L.; Roland, M.; 
Deckers, C.; Speiser, P. P. Actinomycin D adsorbed on 
polymethylcyanoacrylate nanoparticles: Increased efficiency against an 
experimental tumor; 16 ed.; 1980.pp. 1441-1445. 
 19.  Guiot, P.; Couvreur, P. Polymeric Nanoparticles and Microspheres; CRC 
Press: Boca Raton, 1986.pp. 27-93. 
 20.  Kattan, J.; Droz, J. P.; Couvreur, P.; Marino, J.-P.; Boutan-Laroze, A.; 
rougier, P.; Brault, P.; Vranckx, H.; Grognet, J.-M.; Morge, X.; Sancho-Garnier, 
H. Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried 
by polyisohexylcyanoacrylate nanoparticles. Invest. New Drugs 1992, 10, 191-
199. 
 21.  Lobenberg, R.; Kreuter, J. Macrophage targeting of azidothymidine: A 
promising strategy for AIDS therapy. AIDS Res. Hum. Retroviruses 1996, 12, 
1709-1715. 
 22.  Lobenberg, R.; Araujo, L.; von Briesen, H.; Rodgers, E.; Kreuter, J. Body 
distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after 
i.v. injection to rats. J. Control. Rel. 1998, 50, 21-30. 
 23.  Pankhurst, Q. A.; Connolly, J.; Jones, S. K.; Dobson, J. Applications of 
magnetic nanoparticles in biomedicine. J. Phys. D: Appl. Phys. 2003, 36, 167-
181. 
Page 208 of 250 
 
 24.  Albrecht, M. A.; Evans, C. W.; Raston, C. L. Green Chemistry and the 
Health Implications of Nanoparticles. Green Chem. 2006, 8, 417-432. 
 25.  Thorek, D. L. J.; Chen, A. K.; Czupryna, J.; Tsourkas, A. 
Superparamagnetic Iron Oxide Nanoparticle Probes for Molecular Imaging. 
Annals of Biomedical Engineering 2006, 34 (1), 23-38. 
 26.  Dzyaloshinsky, I. A Thermodynamic Theory of "Weak" Ferromagnetism 
of Antiferromagnetics. Journal of Physics and Chemistry of Solids 1958, 4 (4), 
241-255. 
 27.  Kodama, R. H. Magnetic Nanoparticles. Journal of Magnetism and 
Magnetic Materials 1999, 200, 359-372. 
 28.  Robinson, P. J.; Dunnill, P.; Lilly, M. D. The properties of magnetic 
supports in relation to immobilized enzyme reactors. Biotechnol. Bioeng. 1973, 
15 (3), 603-606. 
 29.  Bruce, I. J.; Taylor, J.; Todd, M.; Davies, M. J.; Borioni, E.; Sangregorio, 
C.; Sen, T. Synthesis, characterisation and application of silica-magnetite 
nanocomposites. Journal of Magnetism and Magnetic Materials 2004, 284, 
145-160. 
 30.  Thapa, D.; Palkar, V. R.; Kurup, M. B.; Malik, S. K. Properties of 
magnetite nanoparticles synthesized through a novel chemical route. Materials 
Letters 2004, 58 (21), 2692-2694. 
 31.  Roonasi, P. Adsorption and surface reaction properties of synthesized 
magnetite nano-particles. PhD Lulea University of Technology, 2007. 
 32.  Fleet, M. E. The structure of magnetite. Acta Crystallographica Section 
B: Structural Crystallography and Crystal Chemistry 1981, 37 (4), 917-920. 
 33.  Sorescu, M. Phase transformations induced in magnetite by high energy 
ball milling. Journal of materials science letters 1998, 17 (13), 1059-1061. 
 34.  Sugimoto, T.; Matijevic, E. Formation of Uniform Spherical Magnetite 
Particles by Crystallization from Ferrous Hydroxide Gels. Journal of Colloid 
and Interface Science 1980, 74 (1), 227-243. 
 35.  Lu, A.-H.; Salabas, E. L.; Schuth, F. Magnetic Nanoparticles: Synthesis, 
Protection, Functionalization, and Application. Angewandte Chemie 
International Edition 2007, 46, 1222-1244. 
Page 209 of 250 
 
 36.  Philipse, A. P.; van Bruggen, M. P. B.; Pathmamanoharan, C. Magnetic 
Silica Dispersions: Preparation and Stability of Surface-Modified Silica 
Particles with a Magnetic Core. Langmuir 1994, 10, 92-99. 
 37.  Massart, R. Preparation iof Aqueous Magnetic Liquids in Alkaline and 
Acidic Media. IEEE Transactions on Magnetics 1981, 17 (2), 1247-1248. 
 38.  Kang, Y. S.; Risbud, S.; Rabolt, J. F.; Stroeve, P. Synthesis and 
Characterization of Nanometer-Size Fe3O4 and -Fe2O3 Particles. Chem. Mater. 
1996, 8, 2209. 
 39.  Lee, J.; Isobe, T.; Senna, M. Magnetic properties of ultrafine magnetite 
particles and their slurries prepared via in-situ precipitation. Colloid Surface A 
1996, 109, 121-127. 
 40.  Willis, A. L.; Turro, N. J.; O'Brien, S. Spectroscopic Characterization of 
the Surface of Iron Oxide Nanocrystals. Chem. Mater. 2005, 17, 5970-5975. 
 41.  Grzeta, B.; Ristic, M.; Nowik, I.; Music, S. Formation of nanocrystalline 
magnetite by thermal decomposition of iron choline citrate. Journal of Alloys 
and Compounds 2002, 334, 304-312. 
 42.  Narasimhan, B. R. V.; Prabhakar, S.; Manohar, P.; Gnanam, F. D. 
Synthesis of gamma ferric oxide by direct thermal decomposition of iron 
carboxylate salts. Materials Letters 2002, 52 (4-5), 295-300. 
 43.  Yu, W. W.; Falkner, J. C.; Yavuz, C. T.; Colvin, V. L. Synthesis of 
monodisperse iron oxide nanocrystals by thermal decomposition of iron 
carboxylate salts. Chem. Commun. 2004, 20, 2306-2307. 
 44.  Mahmoudi, M.; Sant, S.; Wang, B.; Laurent, S.; Sen, T. 
Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface 
modification and applications in chemotherapy. Advanced Drug Delivery 
Reviews 2010, 63 (1-2), 24-46. 
 45.  Inouye, K.; Endo, R.; Otsuka, Y.; Miyashiro, K.; Kaneko, K.; Ishikawa, 
T. Oxygenation of Ferrous-Ions in Reversed Micelle and Reversed Micro-
Emulsion. The Journal of Physical Chemistry 1982, 86 (8), 1465-1469. 
 46.  Muller, B. W.; Muller, R. H. Particle-size distributions and particle-size 
alterations in microemulsions. Journal of Pharmaceutical Sciences 1984, 73 (7), 
919-922. 
 47.  Sun, S.; Zeng, H. Size-Controlled Synthesis of Magnetite Nanoparticles. 
J. Am. Chem. Soc. 2002, 124, 8204-8205. 
Page 210 of 250 
 
 48.  Wang, X.; Peng, Q.; Li, Y. A General Strategy for Nanocrystal Synthesis. 
Nature 2005, 437, 121-124. 
 49.  Khollam, Y. B.; Dhage, S. R.; Potdar, H. S.; Deshpande, S. B.; Bakare, P. 
P.; Kulkarni, S. D.; Date, S. K. Microwave hydrothermal preparation of 
submicron-sized spherical magnetite (Fe3O4) powders. Materials Letters 2002, 
56 (4), 571-577. 
 50.  Vijayakumar, R.; Koltypin, Y.; Felner, I.; Gedanken, A. Sonochemical 
Synthesis and Characterization of Pure Nanometer-Sized Fe3O4 Particles. 
Mater. Sci. Eng. 2000, 286, 101. 
 51.  Amemiya, Y.; Arakaki, A.; Staniland, S. S.; Tanaka, T.; Matsunaga, T. 
Controlled formation of magnetite crystal by partial oxidation of ferrous 
hydroxide in the presence of recombinant magnetotactic bacterial protein 
Mms6. Biomaterials 2007, 28 (35), 5381-5389. 
 52.  Coker, V. S.; Telling, N. D.; van der Laan, G.; Pattrick, R. A. D.; Pearce, 
C. I.; Arenholz, E.; Tuna, F.; Winpenny, R. E. P.; Lloyd, J. R. Harnessing the 
extracellular bacterial production of nanoscale cobalt ferrite with exploitable 
magnetic properties. ACS Nano 2009, 3 (7), 1922-1928. 
 53.  Bharde, A.; Rautaray, D.; Bansal, V.; Ahmad, A.; Sarkar, I.; Yusuf, S. 
M.; Sanyal, M.; Sastry, M. Extracellular biosynthesis of magnetite using fungi. 
Small 2006, 2 (1), 135-141. 
 54.  Itoh, H.; Sugimoto, T. Systematic control of size, shape, structure, and 
magnetic properties of uniform magnetite and maghemite particles. Journal of 
Colloid and Interface Science 2003, 265 (2), 283-295. 
 55.  Pascal, C.; Pascal, J. L.; Favier, F.; Moubtassim, M. L. E.; Payen, C. 
Electrochemical synthesis for the control of -Fe2O3 nanoparticle 
size.Morphology,microstructure, and magnetic behavior. Chem. Mater. 1999, 
11 (1), 141-147. 
 56.  Stark, W. J.; Pratsinis, S. E. Aerosol Flame Reactors for Manufacture of 
Nanoparticles. Powder Technology 2002, 126 (2), 103-108. 
 57.  Salavati-Niasari, M.; Javidi, J.; Dadkhah, M. Ball Milling Synthesis of 
Silica Nanoparticle form Rice Husk Ash for Drug Delivery Application. Comb 
Chem High Throughput Screen 2012, Epub Ahead of Print. 
 58.  Kim, J. H.; Sohn, Y.; Kim, I.; Han, B.; Shin, W. G. Electron Beam 
Assisted Gas Phase Synthesis of SiO2 Nanoparticles in an Ambient Condition. 
Aerosol and Air Quality Research 2012, 12, 1467-1471. 
Page 211 of 250 
 
 59.  Kobayashi, Y.; Horie, M.; Konno, M.; Rodriguez-Gonzalez, B.; Liz-
Marzan, L. M. Preparation and properties of silica-coated cobalt nanoparticles. 
J. Phys. Chem. B. 2003, 107, 7420-7425. 
 60.  Lu, A.-H.; Li, W.; Matoussevich, N.; Spliethoff, B.; Bonneman, H.; 
Schuth, F. Highly stable carbon-protected cobalt nanoparticles and graphite 
shells. Chem. Commun. 2005, 98 (1), 98-100. 
 61.  Sobal, N. S.; Hilgendorff, M.; Moehwald, H.; Giersig, M.; Spasova, M.; 
Radetic, T.; Farle, M. Synthesis and Structure of Colloidal Bimetallic 
Nanocrystals: The Non-Alloying System Ag/Co. Nano Letters 2002, 2, 621-
624. 
 62.  Liu, Q.; Xu, Z.; Finch, A. J.; Egerton, R. A novel two-step silica-coating 
process for engineering magnetic nanocomposites. Chem. Mater. 1998, 10, 
3936-3940. 
 63.  Liu, X.; Guan, Y.; Ma, Z.; Liu, H. Surface modification and 
characterization of magnetic polymer nanospheres prepared by microemulsion 
polymerization. Langmuir 2004, 20, 10278-10282. 
 64.  Hong, R.; Fischer, N. O.; Emrick, T.; Rotello, V. M. Surface PEGylation 
and Ligand Exchange Chemistry of FePt Nanoparticles for Biological 
Applications. Chem. Mater. 2005, 17, 4617-4621. 
 65.  Stober, W.; Fink, A.; Bohn, E. Controlled growth of monodisperse silica 
spheres in the micron size range . Journal of Colloid and Interface Science 
1968, 26 (1), 62-69. 
 66.  Rother, D.; Sen, T.; East, D.; Bruce, I. J. Silicon, silica and its surface 
patterning/activation with alkoxy- and amino-silanes for nanomedical 
applications. Nanomedicine 2011, 6, 281-300. 
 67.  van Ewijk, G. A.; Vroege, G. J.; Philipse, A. P. Convenient Preparation 
Methods for Magnetic Colloids. Journal of Magnetism and Magnetic Materials 
1999, 201, 31-33. 
 68.  Deng, Y. H.; Wang, C.-C.; Hu, J.-H.; Yang, W.-L.; Fu, S.-K. 
Investigation of formation of silica-coated magnetite nanoparticles via sol-gel 
approach. Colloids and Surfaces A: Phtsiochem. Eng. Aspects 2005, 262, 87-93. 
 69.  Slowing, I. I.; Vivero-Escoto, J. L.; Wu, C.-W.; Lin, V. S. Y. Mesoporous 
silica nanoparticles as controlled release drug delivery and gene transfection 
carriers. Advanced Drug Delivery Reviews 2008, 60, 1278-1288. 
Page 212 of 250 
 
 70.  Gupta, A. K.; Wells, S. Surface-modified superparamagnetic 
nanoparticles for drug delivery: preparation, characterization, and cytotoxicity 
studies. IEEE Transactions on Nanobioscience 2004, 3 (1), 66-73. 
 71.  Wu, P.; Zhu, J.; Xu, Z. Template-Assisted Synthesis of Mesoporous 
Magnetic Nanocomposite Particles. Advanced Functional Materials 2004, 14 
(4), 345-351. 
 72.  Zhao, W.; Gu, J.; Zhang, L.; Chen, H.; Shi, J. Fabrication of Uniform 
Magnetic Nanocomposite Spheres with a Magnetic Core/Mesoporous Silica 
Shell Structure. J. Am. Chem. Soc. 2005, 127, 8916-8917. 
 73.  Sen, T.; Sebastianelli, A.; Bruce, I. J. Mesoporous SilicaMagnetite 
Nanocomposite: Fabrication and Applications in Magnetic Bioseparations. J. 
Am. Chem. Soc. 2006, 128 (22), 7130-7131. 
 74.  Deng, Y.; Deng, C.; Qi, D.; Liu, C.; Liu, J.; Zhang, X.; Zhao, D. 
Synthesis of Core/Shell Colloidal Magnetic Zeolite Microspheres for the 
Immobilization of Trypsin. Advanced Materials 2009, 21 (13), 1377-1382. 
 75.  Vogelstein, B.; Gillespie, D. Preparative and Analytical Purification of 
DNA from Agarose. Proc. Natl. Acad. Sci. USA 1979, 76 (2), 615-619. 
 76.  Taylor, J. I.; Hurst, C. D.; Davies, M. J.; Sachsinger, N.; Bruce, I. J. 
Application of magnetite and silica-magnetite composites to the isolation of 
genomic DNA. Journal of Chromatography A 2000, 890 (1), 159-166. 
 77.  Goloub, T. P.; Koopal, L. K.; Bijsterbosch, B. H.; Sidorova, M. P. 
Adsorption of Cationic Surfactants on Silica. Surface Charge Effects. Langmuir 
1996, 12 (13), 3188-3194. 
 78.  Melzak, K. A.; Sherwood, C. S.; Turner, R. F. B.; Haynes, C. A. Driving 
Forces for DNA Adsorption to Silica in Perchlorate Solutions. Journal of 
Colloid and Interface Science 1996, 181 (2), 635-644. 
 79.  Deng, Y.; Qi, D.; Deng, C.; Zhang, X.; Zhao, D. Superparamagnetic 
High-Magnetization Microspheres with an Fe3O4@SiO2 Core and 
Perpendicularly Aligned Mesoporous SiO2 Shell for Removal of Microcystins. 
J. Am. Chem. Soc. 2007, 130 (1), 28-29. 
 80.  Bruce, I. J.; Sen, T. Surface Modification of Magnetic Nanoparticles with 
Alkoxysilanes and Their Application in Magnetic Bioseparations. Langmuir 
2005, 21, 7029-7035. 
 
Page 213 of 250 
 
  81.  Huang, C.; Hu, B. Silica-coated magnetic nanoparticles modified with -
mercaptopropyltrimethoxysilane for fast and selective solid phase extraction of 
trace amounts of Cd, Cu, Hg, and Pb in environmental and biological samples 
prior to their determination by inductively coupled plasma mass spectrometry. 
Spectrochimica Acta Part B: Atomic Spectroscopy 2008, 63 (3), 437-444. 
 82.  Antochshuk, V.; Jaroniec, M. 1-Allyl-3-propylthiourea modified 
mesoporous silica for mercury removal. Chem. Commun. 2002, (3), 258-259. 
 83.  Hultberg, B.; Andersson, A.; Isaksson, A. Alterations of tiol metabolism 
in human cell lines induced by low amounts of copper, mercury or cadmium 
ions. Toxicology 1998, 126 (3), 203-212. 
 84.  Zhao, J.; Li, Y.; Guo, H.; Gao, L. Relative surface density and stability of 
the amines on the biochip. Chinese Journal of Analytical Chemistry 2006, 34 
(9), 1235-1238. 
 85.  Metwalli, E.; Haines, D.; Becker, O.; Conzone, S.; Pantano, C. G. Surface 
characterizations of mono-, di-, and tri-aminosilane treated glass substrates. 
Journal of Colloid and Interface Science 2006, 298 (2), 825-831. 
 86.  De Waterbeemd, M. V.; Sen, T.; Biagini, S.; Bruce, I. J. Surface 
functionalisation of magnetic nanoparticles: Quantification of surface to bulk 
amine density. Micro & Nano Letters, IET 2010, 5 (5), 282-285. 
 87.  Sen, T.; Bruce, I. J. Surface engineering of nanoparticles in suspension 
for particle based bio-sensing. Sci. Rep. 2012, 2. 
 88.  Moon, J. H.; Shin, J. W.; Kim, S. Y.; Park, J. W. Formation of Uniform 
Aminosilane Thin Layers: An Imine Formation To Measure Relative Surface 
Density of the Amine Group. Langmuir 1996, 12 (20), 4621-4624. 
 89.  Sen, T.; Bruce, I. J. A generalized approach for the surface engineering of 
nanoparticles in suspension for highly efficient hybrid capture of bio-molecules. 
In Nanotechnology 2010: Advanced Materials, CNTs, Particles, Films and 
Composites, CRC press, Taylor & Francis group.: 2010; pp 596-599. 
 90.  Nakajima, N.; Ikada, Y. Mechanism of Amide Formation by 
Carbodiimide for Bioconjugation in Aqueous Media. Bioconjugate Chem. 1995, 
6 (1), 123-130. 
 91.  Hermanson, G. T. Zero-Length Crosslinkers. In Bioconjugate 
Techniques, 3 ed.; Hermanson, G. T., Ed.; Academic Press, Elsevier: London, 
UK, 2013; pp 259-274. 
Page 214 of 250 
 
 92.  Ducker, R. E.; Montague, M. T.; Leggetta, G. J. A Comparative 
investigation for methods for protein immobilization on self-assembled 
monolayers using glutaraldehyde, carbodiimide and anhydride reagents. 
Biointerphases 2008, 3 (3), 59-65. 
 93.  Jones, M. M.; Williams, J. M. J. Dynamic kinetic resolution in the 
hydrolysis of an alpha-bromo ester. Chem. Commun. 1998, 22, 2519-2520. 
 94.  Kim, J.; Lee, J.; Na, H.B.; Kim, B.-C.; Youn, J.K.; Kwak, J.H.; 
Moon, K.; Lee, E.; Kim, J.; Park, J.; Dohnalkova, A.; Park, H.G.; Gu, M.B.; 
Chang, H.N.; Grate, J.W.; Hyeon, T. A Magnetically Separable, Highly 
Stable Enzyme System Based on Nanocomposites of Enzymes and Magnetic 
Nanoparticles Shipped in Hierarchically Ordered, Mesocellular, Mesoporous 
Silica. Small 2005, 1 (12), 1203-1207. 
 95.  López-Gallego, F.; Betancor, L.; Mateo, C.; Hidalgo, A.; Alonso-
Morales, N.; Dellamora-Ortiz, G.; Guisán; J.M.; Fernández-Lafuente, R. 
Enzyme stabilization by glutaraldehyde crosslinking of adsorbed proteins on 
aminated supports. Journal of Biotechnology 2005, 119 (1), 70-75. 
 96.  Fernández-Lafuente, R.; Rosell, C. M.; Rodriguez, V.; Guisán, J. M. 
Strategies for enzyme stabilization by intramolecular crosslinking with 
bifunctional reagents. Enzyme and Microbial Technology 1995, 17 (6), 517-523. 
 97.  Kennedy, J. F.; Kalogerakis, B.; Cabral, J. M. S. Surface immobilization 
and entrapping of enzymes on glutaraldehyde crosslinked gelatin particles. 
Enzyme and Microbial Technology 1984, 6 (3), 127-131. 
 98.  Zhou, Q. Z. K.; Dong Chen, X. Immobilization of -galactosidase on 
graphite surface by glutaraldehyde. Journal of Food Engineering 2001, 48 (1), 
69-74. 
 99.  Sen, T. Novel Nanocomposites: Hierarchically Ordered Porous Silica for 
the Immobilisation of Enzyme as Bio-catalyst. In NSTI-Nanotech 2010, CRC 
Press, Taylor & Francis Group: 2010; pp 784-787. 
 100.  Sen, T.; Bruce, I. J.; Mercer, T. Fabrication of novel hierarchically 
ordered porous magnetic nanocomposites for bio-catalysis. Chem. Commun. 
2010, 46 (36), 6807-6809. 
 101.  Alvaro, G.; Blanco, R. M.; Fernandez-Lafuente, R.; Guisán, J. M. 
Immobilization-Stabilization of Penicillin G Acylase from Escherichia Coli. 
Appl. biochem. Biotechnol. 1990, 26, 210-214. 
Page 215 of 250 
 
 102.  Pedroche, J.; Yust, M. M.; Giron-Calle, J.; Vioque, J.; Alaiz, M.; Mateo, 
C.; et al. Stabilization–immobilization of carboxypeptidase a to aldehyde-
agarose gels. A practical example in the hydrolysis of casein. Enzyme and 
Microbial Technology 2002, 31, 711-718. 
 103.  Fernández-Lafuente, R.; Cowan, D. A.; Wood, A. N. P. 
Hyperstabilization of a Thermophilic Esterase by Multipoint Covalent 
Attachment. Enzyme and Microbial Technology 1995, 17, 366-372. 
 104.  Mateo, C.; Palomo, J. M.; Fuentes, M.; Betancor, L.; Grazu, V.; López-
Gallego, F.; Pessela, B. C. C.; Hidalgo, A.; Hidalgo, A.; Hernández-Lorente, G.; 
Fernández-Lafuente, R.; Guisán, J. M. Glyoxyl agarose: A fully inert and 
hydrophilic support for immobilization and high stabilization of proteins. 
Enzyme and Microbial Technology 2006, 39 (2), 274-280. 
 105.  Silverman, R. B. Enzymes As Catalysts. In The Organic Chemistry of 
Enzyme-Catalyzed Reactions, Revised ed.; Academic Press: 2002; pp 1-38. 
 106.  Schramm, V. L. Enzymatic Transition States and Transition State Analog 
Design. Annu. Rev. Biochem. 1998, 67, 693-720. 
 107.  Hunter, T. Protein Kinases and Phosphatases: The Yin and Yang of 
Protein Phosphorylation and Signaling. Cell 1995, 80 (2), 225-236. 
 108.  Berg, J. S.; Powell, B. C.; Cheney, R. E. A millenial Myosin Consensus. 
Mol Biol Cell 2001, 12 (4), 780-794. 
 109.  Chiu, T. K.; Davies, D. R. Structure and Function of HIV-1 Integrase. 
Curr Top Med Chem 2004, 4 (9), 965-977. 
 110.  von Itzstein, M. The War Against Influenza: Discovery and Development 
of Sialidase Inhibitors. Nature Reviews Drug Discovery 2007, 6, 967-974. 
 111.  Ellis, R. J. The Most Abundant Protein in the World. Trends in 
Biochemical Sciences 1979, 4 (11), 241-244. 
 112.  Rogers, R. S. Companies Turn To Biocatalysis. Chemical & Engineering 
News 1999, 77 (29), 87-91. 
 113.  Roberts, S. M. Preparative biotransformations. J. Chem. Soc. , Perkin 
Trans. 1 2000, (5), 611-633. 
 114.  Cipiciani, A.; Cittadini, M.; Fringuelli, F. Improving the 
enantioselectivity of Candida rugosa lipase in the kinetic resolution of racemic 
methyl 2-(2,4-dichlorophenoxy)propionate. Tetrahedron 1998, 54 (27), 7883-
7890. 
Page 216 of 250 
 
 115.  Katayama, S.; Ae, N.; Nagata, R. Enzymatic resolution of 2-substituted 
tetrahydroquinolines. Convenient approaches to tricyclic quinoxalinediones as 
potent NMDA-glycine antagonists. Tetrahedron: Asymmetry 1998, 9 (24), 
4295-4299. 
 116.  Chillemi, R.; Russo, D.; Sciuto, S. Chemoenzymatic Synthesis of 
Lysophosphatidylnucleosides. The Journal of Organic Chemistry 1998, 63 (10), 
3224-3229. 
 117.  Ferraboschi, P.; Rezaelahi, S.; Verza, E.; Santaniello, E. Lipase-catalyzed 
resolution of stereogenic centers in steroid side chains by transesterification in 
organic solvents: the case of a 26-hydroxycholesterol. Tetrahedron: Asymmetry 
1998, 9 (13), 2193-2196. 
 118.  Yoshida, N.; Kamikubo, T.; Ogasawara, K. Lipase-mediated kinetic 
resolution of a synthetic equivalent of 2-hydroxymethylcyclopentadien-5-ol. 
Tetrahedron: Asymmetry 1998, 9 (18), 3325-3329. 
 119.  Aitken, J.; Grogan, G.; Chow, Y.; Turner, J.; Flitsch, L. 
Biohydroxylations of Cbz-protected alkyl substituted piperidines by Beauveria 
bassiana ATCC 7159. J. Chem. Soc. , Perkin Trans. 1 1998, (20), 3365-3370. 
 120.  Fritz-Langhals, E.; Kunath, B. Synthesis of aromatic aldehydes by 
laccase-mediator assisted oxidation. Tetrahedron Letters 1998, 39 (33), 5955-
5956. 
 121.  Pchelka, K.; Gelo-Pujic, M.; Guibe-Jampel, E. Chemoenzymatic 
autocatalytic Baeyer-Villiger oxidation. J. Chem. Soc. , Perkin Trans. 1 1998, 
(17), 2625-2628. 
 122.  Han, S.; Lin, G.; Li, Z. Synthesis of (R)-cyanohydrins by crude (R)-
oxynitrilase-catalyzed reactions in micro-aqueous medium. Tetrahedron: 
Asymmetry 1998, 9 (11), 1835-1838. 
 123.  Sheflyan, G. Y.; Howe, D. L.; Wilson, T. L.; Woodard, R. W. Enzymatic 
Synthesis of 3-Deoxy-d-manno-octulosonate 8-Phosphate, 3-Deoxy-d-altro-
octulosonate 8-Phosphate, 3,5-Dideoxy-d-gluco(manno)-octulosonate 8-
Phosphate by 3-Deoxy-d-arabino-heptulosonate 7-Phosphate Synthase. J. Am. 
Chem. Soc. 1998, 120 (43), 11027-11032. 
 124.  Bisht, K. S.; Deng, F.; Gross, R. A.; Kaplan, D. L.; Swift, G. Ethyl 
Glucoside as a Multifunctional Initiator for Enzyme-Catalyzed Regioselective 
Lactone Ring-Opening Polymerization. J. Am. Chem. Soc. 1998, 120 (7), 1363-
1367. 
Page 217 of 250 
 
 125.  Yuan, D. Q.; Dong, S. D.; Breslow, R. Cyclodextrin-based class I 
aldolase enzyme mimics to catalyze crossed aldol condensations. Tetrahedron 
Letters 1998, 39 (42), 7673-7676. 
 126.  Jaeger, K. E.; Ransac, S.; Dijkstra, B. W.; Colson, C.; van Heuvel, M.; 
Misset, O. Bacterial lipases. FEMS Microbiology Reviews 1994, 15 (1), 29-63. 
 127.  Gilbert, E. J. Pseudomonas lipases: Biochemical properties and molecular 
cloning. Enzyme and Microbial Technology 1993, 15 (8), 634-645. 
 128.  Turcu, M. C. Lipase-Catalyzed Approaches Towards Secondary 
Alcohols: Intermediates For Enantiopure Drugs. University of Turku, Finland, 
2010. 
 129.  Heck, A. M.; Yanovski, J. A.; Calis, K. A. Orlistat, a New Lipase 
Inhibitor for the Management of Obesity. Pharmacotherapy: The Journal of 
Human Pharmacology and Drug Therapy 2000, 20 (3), 270-279. 
 130.  Gupta, R.; Gupta, N.; Rathi, P. Bacterial Lipases: An Overview of 
Production, Purification and Biochemical Properties. Applied Microbiology and 
Biotechnology 2004, 64 (6), 763-781. 
 131.  Ollis, D. L.; Cheah, E.; Cygler, M.; Dijkstra, B.; Frolow, F.; Franken, S. 
M.; Harel, M.; Remington, S. J.; Silman, I.; Schrag, J.; Sussman, J. L.; 
Verschueren, K. H. G.; Goldman, A. The  Hydrolase Fold. Protein 
Engineering 1992, 5 (3), 197-211. 
 132.  Jaeger , K. E.; Dijkstra, B. W.; Reetz, M. T. Bacterial Biocatalysts: 
Molecular Biology, Three-Dimensional Structures and Biotechnological 
Applications of Lipases. Annu. Rev. Microbiol. 1999, 53, 315-351. 
 133.  Pascale, D.; Cusano, A.; Autore, F.; Parrilli, E.; Prisco, G.; Marino, G.; 
Tutino, M. L. The cold-active Lip1 lipase from the Antarctic bacterium 
Pseudoalteromonas haloplanktis TAC125 is a member of a new bacterial 
lipolytic enzyme family. Extremophiles 2008, 12 (3), 311-323. 
 134.  Akoh, C. C.; Lee, G. C.; Liaw, Y. C.; Huang, T. H.; Shaw, J. F. GDSL 
family of serine esterases/lipases. Progress in Lipid Research 2004, 43 (6), 534-
552. 
 135.  Nardini, M.; Dijkstra, B. W.  Hydrolase fold enzymes: the family 
keeps growing. Curr Opin Struct Biol. 1999, 9 (6), 732-737. 
Page 218 of 250 
 
 136.  Yahya, A. R. M.; Anderson, W. A.; Moo-Young, M. Ester synthesis in 
lipase-catalyzed reactions. Enzyme and Microbial Technology 1998, 23 (78), 
438-450. 
 137.  Hanefield, U.; Gardossi, L.; Magner, E. Understanding enzyme 
immobilisation. Chemical Society Reviews 2009, 38, 453-468. 
 138.  Reis, P.; Holmberg, K.; Watzke, H.; Leser, M. E.; Miller, R. Lipases at 
Interfaces: A Review. Advances in Colloid and Interface Science 2009, 147-
148, 237-250. 
 139.  Schmid, R. D.; Verger, R. Lipases: Interfacial Enzymes with Attractive 
Applications. Angewandte Chemie International Edition 1998, 37 (12), 1608-
1633. 
 140.  Hasan, F.; Shah, A. A.; Hameed, A. Industrial applications of microbial 
lipases. Enzyme and Microbial Technology 2006, 39 (2), 235-251. 
 141.  Demain, A. L. Overproduction of microbial metabolites and enzymes due 
to alteration of regulation. In Advances in Biochemical Engineering, Volume 1, 
1 ed.; Springer Berlin Heidelberg: 1971; pp 113-142. 
 142.  Arpigny, J. L.; Jaeger, K. E. Bacterial lipolytic enzymes: classification 
and properties. Biochem. J. 1999, 343 (1), 177-183. 
 143.  Murty, V. R.; Bhat, J.; Muniswaran, P. K. A. Hydrolysis of Oils by Using 
Immobilized Lipase Enzyme: A Review. Biotechnol. Bioprocess. Eng. 2002, 7, 
57-66. 
 144.  Gandhi, N. Applications of lipase. J Amer Oil Chem Soc 1997, 74 (6), 
621-634. 
 145.  Sharma, R.; Chisti, Y.; Banerjee, U. C. Production, Purification, 
Characterization, and Applications of Lipases. Biotechnology Advances 2001, 
19, 627-662. 
 146.  Berglund, P. Controlling lipase enantioselectivity for organic synthesis. 
Biomolecular Engineering 2001, 18 (1), 13-22. 
 147.  Lalonde, J. J.; Govardhan, C.; Khalaf, N.; Martinez, A. G.; Visuri, K.; 
Margolin, A. L. Cross-Linked Crystals of Candida rugosa Lipase: Highly 
Efficient Catalysts for the Resolution of Chiral Esters. J. Am. Chem. Soc. 1995, 
117 (26), 6845-6852. 
 148.  Margolin, A. L. Novel crystalline catalysts. Trends in Biotechnology 
1996, 14 (7), 223-230. 
Page 219 of 250 
 
 149.  Kim, M. G.; Lee, E. G.; Chung, B. H. Improved enantioselectivity of 
Candida rugosa lipase towards ketoprofen ethyl ester by a simple two-step 
treatment. Process Biochemistry 2000, 35 (9), 977-982. 
 150.  Colton, I. J.; Ahmed, S. N.; Kazlauskas, R. J. A 2-Propanol Treatment 
Increases the Enantioselectivity of Candida rugosa Lipase toward Esters of 
Chiral Carboxylic Acids. The Journal of Organic Chemistry 1995, 60 (1), 212-
217. 
 151.  Okahata, Y.; Mori, T. Lipid-coated enzymes as efficient catalysts in 
organic media. Trends in Biotechnology 1997, 15 (2), 50-54. 
 152.  Giorno, L.; Drioli, E. Biocatalytic membrane reactors: applications and 
perspectives. Trends in Biotechnology 2000, 18 (8), 339-349. 
 153.  Lotti, M.; Tramontano, A.; Longhi, S.; Fusetti, F.; Brocca, S.; Pizzi, E.; 
Alberghina, L. Variability within the Candida rugosa Upases family. Protein 
Engineering 1994, 7 (4), 531-535. 
 154.  Benjamin, S.; Pandey, A. Candida rugosa lipases: Molecular biology and 
versatility in biotechnology. Yeast 1998, 14 (12), 1069-1087. 
 155.  Grochulski, P.; Li, Y.; Schrag, J. D.; Bouthillier, F.; Smith, P.; Harrison, 
D.; Rubin, B.; Cygler, M. Insights into interfacial activation from an open 
structure of Candida rugosa lipase. Journal of Biological Chemistry 1993, 268 
(17), 12843-12847. 
 156.  Monecke, P.; Friedemann, R.; Naumann, S.; Csuk, R. Molecular 
Modelling Studies on the Catalytic Mechanism of Candida rugosa Lipase. J 
Mol Model 1998, 4 (12), 395-404. 
 157.  Zhang, A.; Gao, R.; Diao, N.; Xie, G.; Gao, G.; Cao, S. Cloning, 
expression and characterization of an organic solvent tolerant lipase from 
Pseudomonas fluorescens JCM5963. Journal of Molecular Catalysis B: 
Enzymatic 2009, 56 (23), 78-84. 
 158.  Salis, A.; Bhattacharyya, M. S.; Monduzzi, M.; Solinas, V. Role of the 
support surface on the loading and the activity of Pseudomonas fluorescens 
lipase used for biodiesel synthesis. Journal of Molecular Catalysis B: 
Enzymatic 2009, 57 (14), 262-269. 
 159.  Fernández-Lorente, G.; Palomo, J. M.; Fuentes, M.; Mateo, C.; Guisán, J. 
M.; Fernández-Lafuente, R. Self-assembly of Pseudomonas fluorescens lipase 
into bimolecular aggregates dramatically affects functional properties. 
Biotechnology and Bioengineering 2003, 82 (2), 232-237. 
Page 220 of 250 
 
 160.  Schrag, J. D.; Li, Y.; Cygler, M.; Lang, D.; Burgdorf, T.; Hecht, H. J.; 
Schmid, R.; Schomburg, D.; Rydel, T. J.; Oliver, J. D.; Strickland, L. C.; 
Dunaway, C. M.; Larson, S. B.; Day, J.; McPherson, A. The open conformation 
of a Pseudomonas lipase. Structure 1997, 5 (2), 187-202. 
 161.  Reetz, M. T.; Jaeger, K. E. Overexpression, immobilization and 
biotechnological application of Pseudomonas lipases. Chemistry and Physics of 
Lipids 1998, 93 (12), 3-14. 
 162.  Cadirci, B. H.; Yasa, I. An organic solvents tolerant and thermotolerant 
lipase from Pseudomonas fluorescens P21. Journal of Molecular Catalysis B: 
Enzymatic 2010, 64 (34), 155-161. 
 163.  Burini, J. F.; Gugi, B.; Merieau, A.; Guespin-Michel, J. F. Lipase and 
acidic phosphatase from the psychrotrophic bacterium Pseudomonas 
fluorescens: Two enzymes whose synthesis is regulated by the growth 
temperature. FEMS Microbiology Letters 1994, 122 (12), 13-18. 
 164.  Kojima, Y.; Yokoe, M.; Mase, T. Purification and Characterization of an 
Alkaline Lipase from Pseudomonas fluorescens AK102. Bioscience, 
Biotechnology, and Biochemistry 1994, 58 (9), 1564-1568. 
 165.  Kojima, Y.; Shimizu, S. Purification and characterization of the lipase 
from Pseudomonas fluorescens HU380. Journal of Bioscience and 
Bioengineering 2003, 96 (3), 219-226. 
 166.  Kim, K. R.; Kwon, D. Y.; Yoon, S. H.; Kim, W. Y.; Kim, K. H. 
Purification, refolding, and characterization of recombinant Pseudomonas 
fluorescens lipase. Protein Expression and Purification 2005, 39 (1), 124-129. 
 167.  Sugiura, M.; Oikawa, T. Physicochemical properties of a lipase from 
Pseudomonas fluorescens. Biochim Biophys Acta 1977, 489 (2), 262-268. 
 168.  Hoshino, T.; Yamana, T.; Shimizu, S. Selective Hydrolyis of Fish Oil by 
Lipase to Concentrate n-3 Polyunsaturated Fatty Acids. Agric. Biol. Chem. 
1989, 54 (6), 1459-1467. 
 169.  Hedström, G.; Backlund, M.; Slotte, J. P. Enantioselective synthesis of 
ibuprofen esters in AOT/isooctane microemulsions by Candida cylindracea 
lipase. Biotechnol. Bioeng. 1993, 42 (5), 618-624. 
 170.  Garcia, H. S.; Malcata, F. X.; Hill, J.; Amundson, C. H. Use of Candida 
rugosa lipase immobilized in a spiral wound membrane reactor for the 
hydrolysis of milkfat. Enzyme and Microbial Technology 1992, 14 (7), 535-545. 
Page 221 of 250 
 
 171.  Guit, R. P. M.; Kloosterman, M.; Meindersma, G. W.; Mayer, M.; Meijer, 
E. M. Lipase kinetics: Hydrolysis of triacetin by lipase from Candida 
cylindracea in a hollow-fiber membrane reactor. Biotechnol. Bioeng. 1991, 38 
(7), 727-732. 
 172.  Seino, H.; Uchibori, T.; Nishitani, T.; Inamasu, S. Enzymatic synthesis of 
carbohydrate esters of fatty acid (I) esterification of sucrose, glucose, fructose 
and sorbitol. J Am Oil Chem Soc 1984, 61 (11), 1761-1765. 
 173.  Ikeda, I.; Tanaka, J.; Suzuki, K. Synthesis of acrylic esters by lipase. 
Tetrahedron Letters 1991, 32 (47), 6865-6866. 
 174.  Tsai, S. W.; Wu, G. H.; Chiang, C. L. Kinetics of enzymatic hydrolysis of 
olive oil in biphasic organic-aqueous systems. Biotechnol. Bioeng. 1991, 38 (7), 
761-766. 
 175.  Sonnet, P.; Baillargeon, M. Methyl-branched octanoic acids as substrates 
for lipase-catalyzed reactions. Lipids 1991, 26 (4), 295-300. 
 176.  Uemura, A.; Nozaki, K.; Yamashita, J. i.; Yasumoto, M. Regioselective 
deprotection of 3',5'-O-acylated pyrimidine nucleosides by lipase and esterase. 
Tetrahedron Letters 1989, 30 (29), 3819-3820. 
 177.  WELSH, F. W.; WILLIAMS, R. E.; DAWSON, K. H. Lipase Mediated 
Synthesis of Low Molecular Weight Flavor Esters. Journal of Food Science 
1990, 55 (6), 1679-1682. 
 178.  Yamane, T.; Kojima, Y.; Ichiryu, T.; Nagata, M.; Shimizu, S. 
Intramolecular esterification by lipase powder in microaqueous benzene: Effect 
of moisture content. Biotechnol. Bioeng. 1989, 34 (6), 838-843. 
 179.  Uemura, A.; Nozaki, K.; Yamashita, J. i.; Yasumoto, M. Lipase-catalyzed 
regioselective acylation of sugar moieties of nucleosides. Tetrahedron Letters 
1989, 30 (29), 3817-3818. 
 180.  Xier, Z. F.; Sakai, K. Preparation of a chiral building block based on 1,3-
syn-diol using Pseudomonas fluorescens lipase and its application to the 
synthesis of a hunger modulator. Chem. Pharm. Bull. 1989, 37, 1650-1652. 
 181.  Nguyen, B. V.; Hedenström, E. Candida rugosa lipase as an 
enantioselective catalyst in the esterification of methyl branched carboxylic 
acids: resolution of rac-3,7-dimethyl-6-octenoic acid (citronellic acid). 
Tetrahedron: Asymmetry 1999, 10 (9), 1821-1826. 
 
Page 222 of 250 
 
 182.  SalgIn, U.; SalgIn, S.; Serpil, T. The enantioselective hydrolysis of 
racemic naproxen methyl ester in supercritical CO2 using Candida rugosa 
lipase. The Journal of Supercritical Fluids 2007, 43 (2), 310-316. 
 183.  Lohith, K.; Divakar, S. Candida rugosa lipase catalysed preparation of L-
prolyl, L-phenylalanyl, L-tryptophanyl and L-histidyl esters of carbohydrates. 
Biochemical Engineering Journal 2007, 34 (1), 28-43. 
 184.  Persichetti, R. A.; Lalonde, J. J.; Govardhan, C. P.; Khalaf, N. K.; 
Margolin, A. L. Candida rugosa lipase: Enantioselectivity enhancements in 
organic solvents. Tetrahedron Letters 1996, 37 (36), 6507-6510. 
 185.  Hedenström, E.; Edlund, H.; Lund, S. Stereoselective esterification of 
2,6-dimethyl-1,7-heptanedioic acid, catalysed by Candida rugosa lipase. 
Journal of Molecular Catalysis B: Enzymatic 2003, 23 (1), 53-59. 
 186.  Knezovic, S.; Sunjic, V.; Lévai, A. Enantioselective hydrolysis of some 
3-(2-nitrophenoxy) butanoates catalyzed by Pseudomonas fluorescens and 
Pseudomonas sp. lipase. Tetrahedron: Asymmetry 1993, 4 (3), 313-320. 
 187.  Kato, K.; Gong, Y.; Saito, T.; Yokogawa, Y. Enzymatic resolution of 
2,2,2-trifluoro-1-arylethylamine derivatives by Pseudomonas fluorescens lipase 
in organic solvents. Journal of Molecular Catalysis B: Enzymatic 2004, 30 (2), 
61-68. 
 188.  Brem, J.; Tosa, M. I.; Paizs, C.; Munceanu, A.; Matkovic-Calogovic, D.; 
Irimie, F. D. Lipase-catalyzed kinetic resolution of racemic 1-(10-alkyl-10H-
phenothiazin-3-yl)ethanols and their butanoates. Tetrahedron: Asymmetry 2010, 
21 (16), 1993-1998. 
 189.  Lin, G.; Midha, K. K.; Hawes, E. M. Synthesis of the piperidinone 
metabolites of piperidine type phenothiazine antipsychotic drugs via ruthenium 
tetroxide oxidation. Journal of Heterocyclic Chemistry 1991, 28 (2), 215-219. 
 190.  Kato, K.; Katayama, M.; Fujii, S.; Kimoto, H. Effective preparation of 
optically active 4,4,4-trifluoro-3-(indole-3-)butyric acid, a novel plant growth 
regulator, using lipase from Pseudomonas fluorescens. Journal of Fermentation 
and Bioengineering 1996, 82 (4), 355-360. 
 191.  Chakraborty, K.; Paul Raj, R. Selective enrichment of n3 
polyunsaturated fatty acids with C1820 acyl chain length from sardine oil 
using Pseudomonas fluorescens MTCC 2421 lipase. Food Chemistry 2009, 114 
(1), 142-150. 
Page 223 of 250 
 
 192.  Hiratake, J.; Inagaki, M.; Nishioka, T.; Oda, J. Irreversible and highly 
enantioselective acylation of 2-halo-1-arylethanols in organic solvents catalyzed 
by a lipase from Pseudomonas fluorescens. The Journal of Organic Chemistry 
1988, 53 (26), 6130-6133. 
 193.  Kalo, P.; Huotari, H.; Antila, M. Pseudomonas fluorescens Lipase-
catalysed Interesterification of Butter Fat. Fett/Lipid 1989, 91 (7), 276-281. 
 194.  Grisenti, P.; Ferraboschi, P.; Manzocchi, A.; Santaniello, E. 
Enantioselective transesterification of 2-methyl-1,3-propanediol derivatives 
catalyzed by Pseudomonas fluorescens lipase in an organic solvent. 
Tetrahedron 1992, 48 (18), 3827-3834. 
 195.  Dahlan, I.; Harun, A.; Najafpour, G. D. Free Candida rugosa Lipase-
Catalyzed Synthesis of Citronelly Butyrate in n-Hexane By Direct 
Esterification: Effect of Reaction Parameters. Jurnal Teknologi 2009, 50, 29-40. 
 196.  Xiong, J.; Huang, Y. J.; Zhang, H. Lipase-catalyzed transesterification 
synthesis of citronellyl acetate in a solvent-free system and its reaction kinetics. 
Eur Food Res Technol 2012, 235 (5), 907-914. 
 197.  Ma, F.; Hanna, M. A. Biodiels Production: A Review. Bioresource 
Technology 1999, 70, 1-15. 
 198.  Fukuda, H.; Kondo, A.; Noda, H. Biodiesel fuel production by 
transesterification of oils. Journal of Bioscience and Bioengineering 2001, 92 
(5), 405-416. 
 199.  Molinari, F.; Solange Cavenago, K.; Romano, A.; Romano, D.; Gandolfi, 
R. Enantioselective hydrolysis of (RS)-isopropylideneglycerol acetate with 
Kluyveromyces marxianus. Tetrahedron: Asymmetry 2004, 15 (12), 1945-1947. 
 200.  Sauvageot, N.; Gouffi, K.; Laplace, J. M.; Auffray, Y. Glycerol 
metabolism in Lactobacillus collinoides: production of 3-
hydroxypropionaldehyde, a precursor of acrolein. Int. J. Food Microbiol. 2000, 
55 (1-3), 167-170. 
 201.  Kaieda, M.; Samukawa, T.; Kondo, A.; Fukuda, H. Effect of Methanol 
and water contents on production of biodiesel fuel from plant oil catalyzed by 
various lipases in a solvent-free system. Journal of Bioscience and 
Bioengineering 2001, 91 (1), 12-15. 
 202.  Al-Zuhair, S. Production of biodiesel: possibilities and challenges. 
Biofuels, Bioprod. Bioref. 2007, 1 (1), 57-66. 
Page 224 of 250 
 
 203.  Fjerbaek, L.; Christensen, K. V.; Norddahl, B. A Review of the Current 
State of Biodiesel Production Using Enzymatic Transesterification. Biotechnol. 
Bioeng. 2008, 102 (5), 1298-1315. 
 204.  Chen, Y. Z.; Ching, C. B.; Xu, R. Lipase immobilization on modified 
zirconia nanoparticles: Studies on the effects of modifiers. Process 
Biochemistry 2009, 44 (11), 1245-1251. 
 205.  Clark, S. D. Characteristics of nearly dry enzymes in organic solvents: 
implications for biocatalysis in the absence of water. Phil. Trans. R. Soc. Lond. 
B 2004, (359), 1299-1307. 
 206.  Kitaguchi, H.; Fitzpatrick, P. A.; Huber, J. E.; Klibanov, A. M. Enzymic 
resolution of racemic amines: crucial role of the solvent. J. Am. Chem. Soc. 
1989, 111 (8), 3094-3095. 
 207.  Dodson, G.; Verma, C. Protein flexibility: its role in structure and 
mechanism revealed by molecular simulations. Cellular and Molecular Life 
Sciences 2006, 63 (2), 207-219. 
 208.  Klibanov, A. M. Why are enzymes less active in organic solvents than in 
water? Trends in Biotechnology 1997, 15 (3), 97-101. 
 209.  Mateo, C.; Palomo, J. M.; Fernandez-Lorente, G.; Guisan, J. M.; 
Fernandez-Lafuente, R. Improvement of enzyme activity, stability and 
selectivity via immobilization techniques. Enzyme and Microbial Technology 
2007, 40 (6), 1451-1463. 
 210.  Hidalgo, A.; Betancor, L.; Lopez-Gallego, F.; Moreno, R.; Berenguer, J.; 
Fernández-Lafuente, R.; Guisan, J. M. Design of an immobilized preparation of 
catalase from Thermus thermophilus to be used in a wide range of conditions.: 
Structural stabilization of a multimeric enzyme. Enzyme and Microbial 
Technology 2003, 33 (2-3), 278-285. 
 211.  Palomo, J. M.; Munoz, G.; Fernández-Lorente, G.; Mateo, C.; Fernandez-
Lafuente, R.; Guisan, J. M. Interfacial adsorption of lipases on very 
hydrophobic support (octadecyl-Sepabeads): immobilization, hyperactivation 
and stabilization of the open form of lipases. Journal of Molecular Catalysis B: 
Enzymatic 2002, 19-20, 279-286. 
 212.  Tardioli, P. W.; Fernandez-Lafuente, R.; Guisan, J. M.; uisan, J. M.; 
ordano, R. L. C. Design of New Immobilized-Stabilized Carboxypeptidase A 
Derivative for Production of Aromatic Free Hydrolysates of Proteins. 
Biotechnol Progress 2003, 19 (2), 565-574. 
Page 225 of 250 
 
 213.  Tardioli, P. W.; Pedroche, J.; Giordano, R. L. C.; Fernandez-Lafuente, R.; 
Guisan, J. M. Hydrolysis of Proteins by Immobilized-Stabilized Alcalase-
Glyoxyl Agarose. Biotechnol Progress 2003, 19 (2), 352-360. 
 214.  Lie, E.; Molin, G. Hydrolysis and esterification with immobilized lipase 
on hydrophobic and hydrophilic zeolites. Journal of Chemical Technology and 
Biotechnology 1991, 50 (4), 549-553. 
 215.  Serralha, F. N.; Lopes, J. M.; Lemos, F.; Prazeres, D. M. F.; Aires-
Barros, M. R.; Cabral, J. M. S.; Ramoa Ribeiro, F. Zeolites as supports for an 
enzymatic alcoholysis reaction. Journal of Molecular Catalysis B: Enzymatic 
1998, 4 (5-6), 303-311. 
 216.  Xing, G. W.; Li, X. W.; Tian, G. L.; Ye, Y. H. Enzymatic Peptide 
Synthesis in Organic Solvent with Different Zeolites as Immobilization 
Matrixes. Tetrahedron 2000, 56 (22), 3517-3522. 
 217.  del Campo, A.; Sen, T.; Lellouche, J. P.; Bruce, I. J. Multifunctional 
magnetite and silica-magnetite nanoparticles: Synthesis, surface activation and 
applications in life sciences. Journal of Magnetism and Magnetic Materials 
2005, 293 (1), 33-40. 
 218.  Karakus, E.; PekyardImcI, S. Immobilization of apricot pectinesterase 
(Prunus armeniaca L.) on porous glass beads and its characterization. Journal 
of Molecular Catalysis B: Enzymatic 2009, 56 (1), 13-19. 
 219.  Katsuragi, T.; Sakai, T.; Tonomura, K. Implantable enzyme capsules for 
cancer chemotherapy from bakers' yeast cytosine deaminase immobilized on 
epoxy-acrylic resin and urethane prepolymer. Appl. biochem. Biotechnol. 1987, 
16, 61-69. 
 220.  Hernandez, K.; Fernandez-Lafuente, R. Lipase B from Candida 
antarctica immobilized on octadecyl Sepabeads: A very stable biocatalyst in the 
presence of hydrogen peroxide. Process Biochemistry 2011, 46 (4), 873-878. 
 221.  Pessela, B. C. C.; Mateo, C.; Fuentes, M.; Vian, A.; Garcia, J. L.; 
Carrascosa, A. V.; Guisan, J. M.; Fernandez-Lafuente, R. The immobilization of 
a thermophilic -galactosidase on Sepabeads supports decreases product 
inhibition: Complete hydrolysis of lactose in dairy products. Enzyme and 
Microbial Technology 2003, 33 (2-3), 199-205. 
 222.  Dyal, A.; Loos, K.; Noto, M.; Chang, S. W.; Spagnoli, C.; Shafi, K. V. P. 
M.; Ulman, A.; Cowman, M.; Gross, R. A. Activity of Candida rugosa Lipase 
Immobilized on -Fe2O3 Magnetic Nanoparticles. J. Am. Chem. Soc. 2003, 125 
(7), 1684-1685. 
Page 226 of 250 
 
 223.  Palomo, J. M.; Fernández-Lorente, G.; Mateo, C.; Fuentes, M.; 
Fernández-Lafuente, R.; Guisan, J. M. Modulation of the enantioselectivity of 
Candida antarctica B lipase via conformational engineering. Kinetic resolution 
of (±)--hydroxy-phenylacetic acid derivatives. Tetrahedron: Asymmetry 2002, 
13 (12), 1337-1345. 
 224.  Soylak, M.; Tuzen, M. Sorbent extraction of rubeanic acid-metal chelates 
on a new adsorbent: Sepabeads SP70. Journal of Hazardous Materials 2006, 
138 (1), 195-200. 
 225.  Bommarius, A. S.; Karau, A. Deactivation of Formate Dehydrogenase 
(FDH) in Solution and at Gas-Liquid Interfaces. Biotechnol Progress 2005, 21 
(6), 1663-1672. 
 226.  Cao, L. Immobilised enzymes: science or art? Current Opinion in 
Chemical Biology 2005, 9 (2), 217-226. 
 227.  Sheldon, R. A. Enzyme Immobilization: The Quest for Optimum 
Performance. Adv. Synth. Catal. 2007, 349 (8-9), 1289-1307. 
 228.  Lalonde, J.; Margolin, A. Immobilization of Enzymes; Wiley-VCH Verlag 
GmbH: 2002.pp. 163-184. 
 229.  Brady, D.; Jordaan, J. Advances in enzyme immobilisation. 
Biotechnology Letters 2009, 31 (11), 1639-1650. 
 230.  St.Clair, N. L.; Navia, M. A. Cross-linked enzyme crystals as robust 
biocatalysts. J. Am. Chem. Soc. 1992, 114 (18), 7314-7316. 
 231.  Sheldon, R. A. Cross-linked enzyme aggregates (CLEAs): stable and 
recyclable biocatalysts. Biochem. Soc. Trans. 2007, 35, 1583-1587. 
 232.  Sheldon, R. A.; Schoevaart, R.; Van Langen, L. M. Cross-linked enzyme 
aggregates (CLEAs): A novel and versatile method for enzyme immobilization 
(a review). Biocatalysis and Biotransformation 2005, 23 (3-4), 141-147. 
 233.  Brem, J.; Turcu, M. C.; Paizs, C.; Lundell, K.; Tosa, M.-L.; Irimie, F. D.; 
Kanerva, L. T. Immobilization to improve the properties of Pseudomonas 
fluorescens lipase for the kinetic resolution of 3-aryl-3-hydroxy esters. Process 
Biochemistry 2012, 47 (1), 119-126. 
 234.  de Lima, L. N.; Aragon, C. C.; Mateo, C.; Palomo, J. M.; Giordano, R. L. 
C.; Tardioli, P. W.; Guisan, J. M.; Fernandez-Lorente, G. Immobilization and 
stabilization of a bimolecular aggregate of the lipase from Pseudomonas 
fluorescens by multipoint covalent attachment. Process Biochemistry 2013, 48 
(1), 118-123. 
Page 227 of 250 
 
 235.  Bolivar, J. M.; Wilson, L.; Ferrarotti, S. A.; Fernandez-Lafuente, R.; 
Guisan, J. M.; Mateo, C. Stabilization of a Formate Dehydrogenase by Covalent 
Immobilization on Highly Activated Glyoxyl-Agarose Supports. 
Biomacromolecules 2006, 7 (3), 669-673. 
 236.  Klibanov, A. M. Enzyme stabilization by immobilization. Analytical 
Biochemistry 1979, 93, 1-25. 
 237.  Bolivar, J. M.; López-Gallego, F.; Godoy, C.; Rodrigues, D. S.; 
Rodrigues, R. C.; Batalla, P.; Rocha-Martin, J.; Mateo, C.; Giordano, R. L. C.; 
Guisan, J. M. The presence of thiolated compounds allows the immobilization 
of enzymes on glyoxyl agarose at mild pH values: New strategies of 
stabilization by multipoint covalent attachment. Enzyme and Microbial 
Technology 2009, 45 (6-7), 477-483. 
 238.  Nagayama, K.; Yamasaki, N.; Imai, M. Fatty acid esterification catalyzed 
by Candida rugosa lipase in lecithin microemulsion-based organogels. 
Biochemical Engineering Journal 2002, 12 (3), 231-236. 
 239.  Shao, P.; Meng, X.; He, J.; Sun, P. Analysis of immobilized Candida 
rugosa lipase catalyzed preparation of biodiesel from rapeseed soapstock. Food 
and Bioproducts Processing 2008, 86 (4), 283-289. 
 240.  Iso, M.; Chen, B.; Eguchi, M.; Kudo, T.; Shrestha, S. Production of 
biodiesel fuel from triglycerides and alcohol using immobilized lipase. Journal 
of Molecular Catalysis B: Enzymatic 2001, 16 (1), 53-58. 
 241.  Soumanou, M. M.; Bornscheuer, U. T. Improvement in lipase-catalyzed 
synthesis of fatty acid methyl esters from sunflower oil. Enzyme and Microbial 
Technology 2003, 33 (1), 97-103. 
 242.  Huang, L.; Cheng, Z. M. Immobilization of lipase on chemically 
modified bimodal ceramic foams for olive oil hydrolysis. Chemical Engineering 
Journal 2008, 144 (1), 103-109. 
 243.  Yu, D.; Wang, Z.; Zhao, L.; Cheng, Y.; Cao, S. Resolution of 2-octanol 
by SBA-15 immobilized Pseudomonas sp. lipase. Journal of Molecular 
Catalysis B: Enzymatic 2007, 48 (3-4), 64-69. 
 244.  Polytrans.Alcohols: 2-Octanol. 
http://www.polytrans.be/p_alcohols_octanol.htm . 2011. 5-5-2011.  
 
 245.  Han, Y.; Lee, S. S.; Ying, J. Y. Pressure-Driven Enzyme Entrapment in 
Siliceous Mesocellular Foam. Chemistry of Materials 2006, 18 (3), 643-649. 
Page 228 of 250 
 
 246.  Fadnavis, N.; Bhaskar, V.; Kantam, M. L.; Choudary, B. M. Highly 
Efficient Tight Fit Immobilization of -Chymotrypsin in Mesoporous MCM-
41: A Novel Approach Using Precursor Immobilization and Activation. 
Biotechnol Progress 2003, 19 (2), 346-351. 
 247.  Overmeyer, A.; Schrader-Lippelt, S.; Kasche, V.; Brunner, G. Lipase-
catalysed kinetic resolution of racemates at temperatures from 40
o
C to 160
o
C in 
supercritical CO2. Biotechnology Letters 1999, 21 (1), 65-69. 
 248.  Rebelo, L. P.; Netto, C. G. C. M.; Toma, H. E.; Andrade, L. H. 
Enzymatic kinetic resolution of (RS)-1-(Phenyl)ethanols by Burkholderia 
cepacia lipase immobilized on magnetic nanoparticles. Journal of the Brazilian 
Chemical Society 2010, 21, 1537-1542. 
 249.  Andrade, L. H.; Rebelo, L. P.; Netto, C. G. C. M.; Toma, H. E. Kinetic 
resolution of a drug precursor by Burkholderia cepacia lipase immobilized by 
different methodologies on superparamagnetic nanoparticles. Journal of 
Molecular Catalysis B: Enzymatic 2010, 66 (12), 55-62. 
 250.  Fu, Y.; Huang, T.; Chen, B.; Shen, J.; Duan, X.; Zhang, J.; Li, W. 
Enantioselective resolution of chiral drugs using BSA functionalized magnetic 
nanoparticles. Separation and Purification Technology 2013, 107 (0), 11-18. 
 251.  Ziegler, T.; Jurisch, C. Chemoenzymatic synthesis of enantiomerically 
enriched aminoalkenols and glycosides thereof. Tetrahedron: Asymmetry 2000, 
11 (16), 3403-3418. 
 252.  Yang, G.; Wu, J.; Xu, G.; Yang, L. Enantioselective resolution of 2-(1-
hydroxy-3-butenyl)-5-methylfuran by immobilized lipase. Appl Microbiol 
Biotechnol 2009, 81 (5), 847-853. 
 253.  Das, S.; Berke-Schlessel, D.; Ji, H. F.; McDonough, J.; Wei, Y. 
Enzymatic hydrolysis of biomass with recyclable use of cellobiase enzyme 
immobilized in sol-gel routed mesoporous silica. Journal of Molecular 
Catalysis B: Enzymatic 2011, 70 (1-2), 49-54. 
 254.  Ahn, K. W.; Ye, S. H.; Chun, W. H.; Rah, H.; Kim, S. G. Yield and 
component distribution of biodiesel by methanolysis of soybean oil with lipase-
immobilized mesoporous silica. Microporous and Mesoporous Materials 2011, 
142 (1), 37-44. 
 255.  Lomako, O. V.; Menyailova, I. I.; Nakhapetyan, L. A.; Nikitin, Y.; 
Kiselev, A. V. Immobilization of glucoamylase on porous silicas. Enzyme and 
Microbial Technology 1982, 4 (2), 89-92. 
Page 229 of 250 
 
 256.  Cabral, J. M. S.; Cardoso, J. P.; Novais, J. M.; Kennedy, J. F. A simple 
kinetic model for the hydrolysis of -glucans using glucoamylase immobilized 
on titanium (IV) activated porous silica. Enzyme and Microbial Technology 
1984, 6 (8), 365-370. 
 257.  Ding, H.; Wen, L.; Chen, J. Porous silica nano-tube as host for enzyme 
immobilization. China Particuology 2004, 2 (6), 270-273. 
 258.  He, F.; Zhuo, R. X.; Liu, L. J.; Jin, D. B.; Feng, J.; Wang, X. L. 
Immobilized lipase on porous silica beads: preparation and application for 
enzymatic ring-opening polymerization of cyclic phosphate. Reactive and 
Functional Polymers 2001, 47 (2), 153-158. 
 259.  Dandavate, V.; Keharia, H.; Madamwar, D. Ethyl isovalerate synthesis 
using Candida rugosa lipase immobilized on silica nanoparticles prepared in 
nonionic reverse micelles. Process Biochemistry 2009, 44 (3), 349-352. 
 260.  Hartmann, M.; Jung, D. Biocatalysis with enzymes immobilized on 
mesoporous hosts: the status quo and future trends. J. Mater. Chem. 2010, 20, 
844-857. 
 261.  Chiang, C. L.; Sung, C. S.; Chen, C. Y. Application of silica-magnetite 
nanocomposites to the isolation of ultrapure plasmid DNA from bacterial cells. 
Journal of Magnetism and Magnetic Materials 2006, 305 (2), 483-490. 
 262.  Sebastianelli, A.; Sen, T.; Bruce, I. J. Extraction of DNA from soil using 
nanoparticles by magnetic bioseparation. Letters in Applied Microbiology 2008, 
46 (4), 488-491. 
 263.  Son, S. J.; Reichel, J.; He, B.; Schuchman, M.; Bai, X.; Lee, S. B. 
Magnetic-field-assisted bioseparation and drug delivary by magnetic 
silica/magnetite composite nanotubes. Abstracts of Papers of the American 
Chemical Society 2005, 230, 152. 
 264.  Zhao, X.; Shi, Y.; Wang, T.; Cai, Y.; Jiang, G. Preparation of silica-
magnetite nanoparticle mixed hemimicelle sorbents for extraction of several 
typical phenolic compounds from environmental water samples. Journal of 
Chromatography A 2008, 1188 (2), 140-147. 
 265.  Sen, T.; Bruce, I. J. Mesoporous silica-magnetite nanocomposites: 
Fabrication, characterisation and applications in biosciences. Microporous and 
Mesoporous Materials 2009, 120 (3), 246-251. 
Page 230 of 250 
 
 266.  Souza, K.; Ardisson, J.; Sousa, E. Study of mesoporous silica/magnetite 
systems in drug controlled release. Journal of Materials Science: Materials in 
Medicine 2009, 20 (2), 507-512. 
 267.  Yang, P.; Quan, Z.; Hou, Z.; Li, C.; Kang, X.; Cheng, Z.; Lin, J. A 
magnetic, luminescent and mesoporous core-shell structured composite material 
as drug carrier. Biomaterials 2009, 30 (27), 4786-4795. 
 268.  Martín-Saavedra, F. M.; Ruíz-Hernández, E.; Boré, A.; Arcos, D.; Vallet-
Regí, M.; Vilaboa, N. Magnetic mesoporous silica spheres for hyperthermia 
therapy. Acta Biomaterialia 2010, 6 (12), 4522-4531. 
 269.  Qu, L.; Tie, S. Mesoporous silica-coated superparamagnetic magnetite 
functionalized with CuO and its application as a desulfurizer. Microporous and 
Mesoporous Materials 2009, 117 (1-2), 402-405. 
 270.  Kim, J.; Kim, H.-S.; Lee, N.; Kim, T.; Kim, H.; Yu, T.; Song, I.-C.; 
Moon, W.K.; Hyeon, T. Multifunctional Uniform Nanoparticles Composed of 
a Magnetite Nanocrystal Core and a Mesoporous Silica Shell for Magnetic 
Resonance and Fluorescence Imaging and for Drug Delivery. Angewandte 
Chemie International Edition 2008, 47 (44), 8438-8441. 
 271.  Shubayev, V. I.; Pisanic II, T. R.; Jin, S. Magnetic nanoparticles for 
theragnostics. Advanced Drug Delivery Reviews 2009, 61 (6), 467-477. 
 272.  Naqvi, S.; Samim, M.; Abdin, M.; Ahmed, F. J.; Maitra, A.; Prashant, C.; 
Dinda, A. K. Concentration-dependent toxicity of iron oxide nanoparticles 
mediated by increased oxidative stress. Int J Nanomedicine 2010, 5, 983-989. 
 273.  Park, E. J.; Kim, H.; Kim, Y.; Yi, J.; Choi, K.; Park, K. Inflammatory 
responses may be induced by a single intratracheal instillation of iron 
nanoparticles in mice. Toxicology 2010, 275 (1), 65-71. 
 274.  Ramesh, V.; Ravichandran, P.; Copeland, C. L.; Gopikrishnan, R.; 
Biradar, S.; Goornavar, V.; Ramesh, G. T.; Hall, J. C. Magnetite induces 
oxidative stress and apoptosis in lung epithelial cells. Molecular and cellular 
biochemistry 2012, 363 (1-2), 225-234. 
 275.  Sun, C.; Lee, J. S. H.; Zhang, M. Magnetic nanoparticles in MR imaging 
and drug delivery. Advanced Drug Delivery Reviews 2008, 60 (11), 1252-1265. 
 276.  Singh, R. K.; Kim, T. H.; Patel, K. D.; Knowles, J. C.; Kim, H. W. 
Biocompatible magnetite nanoparticles with varying silica-coating layer for use 
in biomedicine: Physicochemical and magnetic properties, and cellular 
compatibility. J. Biomed. Mater. Res. 2012, 100A (7), 1734-1742. 
Page 231 of 250 
 
 277.  Teng, Y.; Xu, Y. A modified para-nitrophenyl palmitate assay for lipase 
synthetic activity determination in organic solvent. Analytical Biochemistry 
2007, 363 (2), 297-299. 
 278.  Abdullah, A. A. B. A. H. The Biopetrol Synthesis from Palmitic Acid - 
Heterogenous Catalytic Cracking with Zeolite Catalyst. PhD  Universiti 
Malaysia Panang, 2010. 
 279.  Baldessarini, R. J.; Campbell, A.; Webb, N. L.; Swindell, C. S.; Flood, J. 
G.; Shashoua, V. E.; Kula, N. S.; Hemamalini, S.; Bradley, M. O. Fatty Acid 
Derivatives of Clozapine: Prolonged Antidopaminergic Activity of 
Docosahexaenoylclozapine in the Rat. Neuropsychopharmacology 2001, 24 (1), 
55-65. 
 280.  Kalam, M. A.; Masjuki, H. H. Biodiesel from palmoilan analysis of its 
properties and potential. Biomass and Bioenergy 2002, 23 (6), 471-479. 
 281.  Lima, V. M. G.; Krieger, N.; Mitchell, D. A.; Baratti, J. C.; Filippis, I. d.; 
Fontana, J. D. Evaluation of the potential for use in biocatalysis of a lipase from 
a wild strain of Bacillus megaterium. Journal of Molecular Catalysis B: 
Enzymatic 2004, 31 (13), 53-61. 
 282.  Costa, L.; Brissos, V.; Lemos, F.; Ribeiro, F.; Cabral, J. Comparing the 
effect of immobilization methods on the activity of lipase biocatalysts in ester 
hydrolysis. Bioprocess and Biosystems Engineering 2008, 31 (4), 323-327. 
 283.  Santra, S.; Tapec, R.; Theodoropoulou, N.; Dobson, J.; Hebard, A.; Tan, 
W. Synthesis and Characterization of Silica-Coated Iron Oxide Nanoparticles in 
Microemulsion: The Effect of Nonionic Surfactants. Langmuir 2001, 17 (10), 
2900-2906. 
 284.  Lu, Y.; Yin, Y.; Mayers, B. T.; Xia, Y. Modifying the Surface Properties 
of Superparamagnetic Iron Oxide Nanoparticles through A SolGel Approach. 
Nano Letters 2002, 2 (3), 183-186. 
 285.  Yusdy; Patel, S. R.; Yap, M. G. S.; Wang, D. I. C. Immobilization of L-
lactate dehydrogenase on magnetic nanoclusters for chiral synthesis of 
pharmaceutical compounds. Biochemical Engineering Journal 2009, 48 (1), 13-
21. 
 286.  Netto, C. G. C. M.; Andrade, L. H.; Toma, H. E. Enantioselective 
transesterification catalysis by Candida antarctica lipase immobilized on 
superparamagnetic nanoparticles. Tetrahedron: Asymmetry 2009, 20 (19), 2299-
2304. 
Page 232 of 250 
 
 287.  Theil, F.; Schick, H.; Weichert, D.; Tannenberger, K.; Klappach, G. 
Enzymes in Organic Synthesis. Part 6. Enzyme-catalyzed Synthesis of (1S,4R)-
()-4-Hydroxycyclopent-2-enyl Acetate and its (+)-Antipode - an Improved 
Procedure Using Lipase from Mucor sp. J. Prakt. Chem. 1991, 333 (3), 497-
499. 
 288.  Theil, F.; Schick, H.; Lapitskaya, M. A.; Pivnitsky, K. K. Enzymes in 
organic synthesis, 4. Investigation of the pancreatin-catalyzed acylation of cis-
cyclopent-2-ene-1,4-diol with various trichloroethyl and vinyl Alkanoates. 
Liebigs Ann. Chem. 1991, 1991 (3), 195-200. 
 289.  Ghorpade, S. R.; Kharul, R. K.; Joshi, R. R.; Kalkote, U. R.; 
Ravindranathan, T. Desymmetrization of meso-cyclopenten-cis-1,4-diol to 4-
(R)-hydroxycyclopent-2-en-1-(S)-acetate by irreversible transesterification 
using Chirazyme.  Tetrahedron. Asymm. 1999, 10, 891. 
 290.  Borcherding, D. R.; Edwards III, C. K.; Esser, R. E.; Cole, D. L. 
Carbocyclic nucleoside analogs useful as immunosuppressants. US5470857 A, 
1997. 
 291.  Beare-Rogers, J.; Dieffenbacher, A.; Holm, J. V. Lexicon of Lipid 
Nutrition. Pure Appl. Chem. 2001, 73 (4), 685-744. 
 292.  Roy Baker, R. The eicosanoids: A historical overview. Clinical 
Biochemistry 1990, 23 (5), 455-458. 
 293.  Nicolaou, A. Eicosanoids in skin inflammation. Prostaglandins, 
Leukotrienes and Essential Fatty Acids 2013, 88 (1), 131-138. 
 294.  Kendall, A. C.; Nicolaou, A. Bioactive lipid mediators in skin 
inflammation and immunity. Progress in Lipid Research 2013, 52 (1), 141-164. 
 295.  Harizi, H.; Corcuff, J. B.; Gualde, N. Arachidonic-acid-derived 
eicosanoids: roles in biology and immunopathology. Trends in Molecular 
Medicine 2008, 14 (10), 461-469. 
 296.  Harre, M.; Raddatz, P.; Walenta, R.; Winterfeldt, E. 4-Oxo-2-
cyclopentenyl Acetate A Synthetic Intermediate. Angew. Chem. Int. Ed. Engl. 
1982, 21 (7), 480-492. 
 297.  Noyori, R.; Suzuki, M. Prostaglandin Syntheses by Three-Component 
Coupling. Angew. Chem. Int. Ed. 1984, 23, 847. 
Page 233 of 250 
 
 298.  Danishefsky, S. J.; Cabal, M. P.; Choe, K. Novel stereospecific silyl 
group transfer reactions: Practical routes to the prostaglandins. J. Am. Chem. 
Soc. 1989, 111, 3456-3457. 
 299.  Padma-Nathan, H.; Hellstrom, W. J. G.; Kaiser, F. E.; Labasky, R. F.; 
Lue, T. F.; Nolten, W. E.; Norwood, P. C.; Peterson, C. A.; Shabsigh, R.; Tam, 
P. Y.; Place, V. A.; Gesundheit, N.; Cowley, C.; Nemo, K. J.; Spivack, A. P.; 
Stephens, D. E.; Todd, L. K. Treatment of Men with Erectile Dysfunction with 
Transurethral Alprostadil. N Engl J Med 1997, 336 (1), 1-7. 
 300.  Cawello, W.; Leonhardt, A.; Schweer, H.; Seyberth, H. W.; Bonn, R.; 
Lomeli, A. L. Dose proportional pharmacokinetics of alprostadil (prostaglandin 
E1) in healthy volunteers following intravenous infusion. British journal of 
clinical pharmacology 1995, 40 (3), 273-276. 
 301.  Solanki, K.; Gupta, M. N. Simultaneous purification and immobilization 
of Candida rugosa lipase on superparamagnetic Fe3O4 nanoparticles for 
catalyzing transesterification reactions. New J. Chem. 2011, 35, 2551-2556. 
 302.  Paiva, A. L.; van Rossum, D.; Malcata, F. X. Kinetics of Lipase-mediated 
Synthesis of Butyl Butyrate in n-hexane. Biocatal Biotransformation 2002, 20 
(1), 43-51. 
 303.  Liaquat, M.; Khan, S.; Aslam, S.; Khan, A.; Khan, H.; Khan, S. M.; Ali, 
S.; Wahad, S.; Bhatti, H. N. Rape Seedling Lipase Catalyzed Synthesis of 
Flavor Esters Through Transesterification in Hexane. J. Chem. Soc. Pak. 2012, 
34 (1), 144-150. 
 304.  Sen, T.; Tiddy, G. J. T.; Casci, J. L.; Anderson, M. W. Meso-cellular 
silica foams, macro-cellular silica foams and mesoporous solids: a study of 
emulsion-mediated synthesis. Microporous and Mesoporous Materials 2005, 78 
(2-3), 255-263. 
 305.  Keller, K.; Friedmann, T.; Boxman, A. The bioseparation needs for 
tomorrow. Trends in Biotechnology 2001, 19 (11), 438-441. 
 306.  Ghosh, R. Separation of human albumin and IgG by a membrane-based 
integrated bioseparation technique involving simultaneous precipitation, 
microfiltration and membrane adsorption. Journal of Membrane Science 2004, 
237 (12), 109-117. 
 307.  Sii, D.; Sadana, A. Bioseparation using affinity techniques. Journal of 
Biotechnology 1991, 19 (1), 83-98. 
Page 234 of 250 
 
 308.  Leung, W. W.-F. 6 - Commercial Applications of Centrifugation in 
Biotechnology. In Centrifugal Separations in Biotechnology, Academic Press: 
Oxford, 2007; pp 109-128. 
 309.  Bilir Ormanci, F. S.; Erol, I.; Ayaz, N. D.; Iseri, O.; Sariguzel, D.  
Immunomagnetic separation and PCR detection of Listeria monocytogenes in 
turkey meat and antibiotic resistance of the isolates. British Poultry Science 
49[5], 560-565. 2008.  
 
 310.  Cudjoe, K. S.; Hagtvedt, T.; Dainty, R. Immunomagnetic separation of 
Salmonella from foods and their detection using immunomagnetic particle 
(IMP)-ELISA. International Journal of Food Microbiology 1995, 27 (1), 11-25. 
 311.  Soltanieh, M.; Sahebdelfar, S. Interaction effects in multicomponent 
separation by reverse osmosis. Journal of Membrane Science 2001, 183 (1), 15-
27. 
 312.  Käppler, T. E.; Hickstein, B.; Peuker, U. A.; Posten, C. Characterization 
of magnetic ion-exchange composites for protein separation from 
biosuspensions. Journal of Bioscience and Bioengineering 2008, 105 (6), 579-
585. 
 313.  Fiedler, E.; Fiedler, M.; Proetzel, G.; Scheuermann, T.; Fiedler, U.; 
Rudolph, R. Affilin Molecules: Novel Ligands for Bioseparation. Food and 
Bioproducts Processing 2006, 84 (1), 3-8. 
 314.  Singh, P. C.; Singh, R. K. Choosing an appropriate bioseparation 
technique. Trends in Food Science & Technology 1996, 7 (2), 49-58. 
 315.  Gu, H.; Xu, K.; Xu, C.; Xu, B. Biofunctional magnetic nanoparticles for 
protein separation and pathogen detection. Chem. Commun. 2006, 0 (9), 941-
949. 
 316.  Bucak, S.; Jones, D. A.; Laibinis, P. E.; Hatton, T. A. Protein Separations 
Using Colloidal Magnetic Nanoparticles. Biotechnol Progress 2003, 19 (2), 
477-484. 
 317.  Saiyed, Z.; Telang, S.; Ramchand, C. Application of magnetic techniques 
in the field of drug discovery and biomedicine. Biomagn Res Technol 2003, 1 
(1), 2. 
 318.  Jing, Y.; Moore, L. R.; Williams, P. S.; Chalmers, J. J.; Farag, S. S.; 
Bolwell, B.; Zborowski, M. Blood progenitor cell separation from clinical 
leukapheresis product by magnetic nanoparticle binding and magnetophoresis. 
Biotechnol. Bioeng. 2007, 96 (6), 1139-1154. 
Page 235 of 250 
 
 319.  Matsunaga, T.; Kawasaki, M.; Yu, X.; Tsujimura, N.; Nakamura, N. 
Chemiluminescence Enzyme Immunoassay Using Bacterial Magnetic Particles. 
Analytical chemistry 1996, 68 (20), 3551-3554. 
 320.  Nakamura, N.; Burgess, J. G.; Yagiuda, K.; Kudo, S.; Sakaguchi, T.; 
Matsunaga, T. Detection and removal of Escherichia coli using fluorescein 
isothiocyanate conjugated monoclonal antibody immobilized on bacterial 
magnetic particles. Analytical chemistry 1993, 65 (15), 2036-2039. 
 321.  Pour Yazdankhah, S.; Hellemann, A. L.; Rønningen, K.; Olsen, E. Rapid 
and sensitive detection of Staphylococcus species in milk by ELISA based on 
monodisperse magnetic particles. Veterinary Microbiology 1998, 62 (1), 17-26. 
 322.  Xu, Y.; Wang, E. Electrochemical biosensors based on magnetic 
micro/nano particles. Electrochimica Acta 2012, 84 (0), 62-73. 
 323.  Fan, X.; White, I. M.; Shopova, S. I.; Zhu, H.; Suter, J. D.; Sun, Y. 
Sensitive optical biosensors for unlabeled targets: A review. Analytica Chimica 
Acta 2008, 620 (12), 8-26. 
 324.  Bruls, D. M.; Evers, T. H.; Kahlman, J. A. H.; Van Lankvelt, P. J. W.; 
Ovsyanko, M.; Pelssers, E. G. M.; Schleipen, J. J. H. B.; De Theije, F. K.; 
Verschuren, C. A.; Van Der Wijk, T. Rapid integrated biosensor for multiplexed 
immunoassays based on actuated magnetic nanoparticles. Lab Chip 2009, 9 
(24), 3504-3510. 
 325.  Haes, A. J.; Chang, L.; Klein, W. L.; Van Duyne, R. P. Detection of a 
Biomarker for Alzheimer's Disease from Synthetic and Clinical Samples Using 
a Nanoscale Optical Biosensor. J. Am. Chem. Soc. 2005, 127 (7), 2264-2271. 
 326.  Tang, L.; Casas, J.; Venkataramasubramani, M. Magnetic Nanoparticle 
Mediated Enhancement of Localized Surface Plasmon Resonance for 
Ultrasensitive Bioanalytical Assay in Human Blood Plasma. Analytical 
chemistry 2012, 85 (3), 1431-1439. 
 327.  Wang, L.; Sun, Y.; Wang, J.; Wang, J.; Yu, A.; Zhang, H.; Song, D. 
Preparation of surface plasmon resonance biosensor based on magnetic 
core/shell Fe3O4/SiO2 and Fe3O4/Ag/SiO2 nanoparticles. Colloids and Surfaces 
B: Biointerfaces 2011, 84 (2), 484-490. 
 328.  Ravindranath, S. P.; Mauer, L. J.; Deb-Roy, C.; Irudayaraj, J. 
Biofunctionalized Magnetic Nanoparticle Integrated Mid-Infrared Pathogen 
Sensor for Food Matrixes. Analytical chemistry 2009, 81 (8), 2840-2846. 
Page 236 of 250 
 
 329.  Dubus, S.; Gravel, J. F.; Le Drogoff, B.; Nobert, P.; Veres, T.; Boudreau, 
D. PCR-Free DNA Detection Using a Magnetic Bead-Supported Polymeric 
Transducer and Microelectromagnetic Traps. Analytical chemistry 2006, 78 
(13), 4457-4464. 
 330.  Wang, Y.; Dostalek, J.; Knoll, W. Magnetic nanoparticle-enhanced SPR 
biosensor. Procedia Engineering 2010, 5 (0), 1017-1020. 
 331.  Sun, Y.; Bai, Y.; Song, D.; Li, X.; Wang, L.; Zhang, H. Design and 
performances of immunoassay based on SPR biosensor with magnetic 
microbeads. Biosensors and Bioelectronics 2007, 23 (4), 473-478. 
 332.  Smith, J. E.; Sapsford, K. E.; Tan, W.; Ligler, F. S. Optimization of 
antibody-conjugated magnetic nanoparticles for target preconcentration and 
immunoassays. Analytical Biochemistry 2011, 410 (1), 124-132. 
 333.  Centi, S.; Laschi, S.; Mascini, M. Improvement of analytical 
performances of a disposable electrochemical immunosensor by using magnetic 
beads. Talanta 2007, 73 (2), 394-399. 
 334.  Liao, M. H.; Guo, J. C.; Chen, W. C. A disposable amperometric ethanol 
biosensor based on screen-printed carbon electrodes mediated with ferricyanide-
magnetic nanoparticle mixture. Journal of Magnetism and Magnetic Materials 
2006, 304 (1), e421-e423. 
 335.  Lu, B. W.; Chen, W. C. A disposable glucose biosensor based on drop-
coating of screen-printed carbon electrodes with magnetic nanoparticles. 
Journal of Magnetism and Magnetic Materials 2006, 304 (1), e400-e402. 
 336.  Zhang, Y.; Zeng, G. M.; Tang, L.; Huang, D. L.; Jiang, X. Y.; Chen, Y. 
N. A hydroquinone biosensor using modified coreshell magnetic nanoparticles 
supported on carbon paste electrode. Biosensors and Bioelectronics 2007, 22 
(910), 2121-2126. 
 337.  Liu, Z.; Liu, Y.; Yang, H.; Yang, Y.; Shen, G.; Yu, R. A phenol biosensor 
based on immobilizing tyrosinase to modified core-shell magnetic nanoparticles 
supported at a carbon paste electrode. Analytica Chimica Acta 2005, 533 (1), 3-
9. 
 338.  Chauhan, N.; Narang, J.; Meena; Pundir, C. S. An amperometric 
glutathione biosensor based on chitosaniron coated gold nanoparticles 
modified Pt electrode. International Journal of Biological Macromolecules 
2012, 51 (5), 879-886. 
Page 237 of 250 
 
 339.  Chandra, S.; Arora, K.; Bahadur, D. Impedimetric biosensor based on 
magnetic nanoparticles for electrochemical detection of dopamine. Materials 
Science and Engineering: B 2012, 177 (17), 1531-1537. 
 340.  Uyttendaele, M.; De Troy, P.; Debevere, J. Incidence of Salmonella, 
Campylobacter jejuni, Campylobacter coli, and Listeria monocytogenes in 
poultry carcasses and different types of poultry products for sale on the Belgian 
retail market. Journal of Food Protection 1999, 62 (7), 735-740. 
 341.  Yang, H.; Qu, L.; Wimbrow, A. N.; Jiang, X.; Sun, Y. Rapid detection of 
Listeria monocytogenes by nanoparticle-based immunomagnetic separation and 
real-time PCR. International Journal of Food Microbiology 2007, 118 (2), 132-
138. 
 342.  Walker, K. R. Rapid Detection of Listeria monocytogenes in Salad by 
Polymerase Chain Reaction. Auburn University, Alabama, 2005. 
 343.  Sutherland, P. S.; Porrit, R. J. Listeria monocytogenes. In Food-borne 
Microorganisms of Public Health Significance, Hocking, A. D., Ed.; Food 
Microbiology Group: Syndney, Australia, 1997; pp 333-378. 
 344.  Amagliani, G.; Omiccioli, E.; del Campo, A.; Bruce, I. J.; Brandi, G.; 
Magnani, M. Development of a magnetic capture hybridization-PCR assay for 
Listeria monocytogenes direct detection in milk samples. Journal of Applied 
Microbiology 2006, 100 (2), 375-383. 
 345.  Furchtgott, L.; Wingreen, N. S.; Huang, K. C. Mechanisms for 
maintaining cell shape in rod-shaped Gram-negative bacteria. Molecular 
Microbiology 2011, 81 (2), 340-353. 
 346.  Antaoa, E. M.; Laturnusa, C.; Diehla, I.; Gloddea, S.; Homeier, T.; 
Bohnke, U.; Steinruck, H.; Philipp, H. C.; Wieler, L. H. Avian pathogenic, 
uropathogenic, and newborn meningitis-causing Escherichia coli: how closely 
related are they? International Journal of Medical Microbiology 2007, 297, 
163-176. 
 347.  Todar, K.  Pathogenic E. coli. Todar's Online Textbook of Bacteriology , 
1-4. 2012. 14-6-2013.  
Ref Type: Online Source 
 348.  Nataro, J. P.; Kaper, J. B. Diarrheagenic escherichia coli. Clinical 
microbiology reviews 1998, 11 (1), 142-201. 
Page 238 of 250 
 
 349.  Muniesa, M.; Hammerl, J. A.; Hertwig, S.; Appel, B.; Brüssow, H. Shiga 
toxin-producing Escherichia coli O104: H4: a new challenge for microbiology. 
Appl. Environ. Microbiol. 2012, 78 (12), 4065-4073. 
 350.  RobinsBrowne, R. M.; Hartland, E. L. Escherichia coli as a cause of 
diarrhea. Journal of gastroenterology and hepatology 2002, 17 (4), 467-475. 
 351.  Varshney, M.; Yang, L.; Su, X.-L.; Li, Y. Magnetic Nanoparticle-
Antibody Conjugates for the Separation of Escherichia coli O157:H7 in Ground 
Beef. Journal of Food Protection 2005, 68, 1804-1811. 
 352.  Mora, A.; Herrera, A.; López, C.; Dahbi, G.; Mamani, R.; Pita, J. M.; 
Alonso, M. P.; Llovo, J.; Bernárdez, M. I.; Blanco, J. E.; Blanco, M.; Blanco, J. 
Characteristics of the Shiga-toxin-producing enteroaggregative Escherichia coli 
O104:H4 German outbreak strain and of STEC strains isolated in Spain. Int 
Microbiol 2011, 14 (3), 121-141. 
 353.  Vogt, R. L.; Dippold, L. Escherichia coli O157: H7 outbreak associated 
with consumption of ground beef, June-July 2002. Public Health Reports 2005, 
120 (2), 174. 
 354.  Donnelly, C. W.  Detection and Isolation of Listeria monocytogenes from 
Food Samples: Implications of Sublethal Injury. Journal of AOAC International 
85[2], 495-500. 2002.  
 
 355.  Noble, R. T.; Weisberg, S. B. A review of technologies for rapid 
detection of bacteria in recreational waters. J. Water Health 2005, 3 (4), 381-
392. 
 356.  Scheu, P.; Gasch, A.; Berghof, K. Rapid detection of Listeria 
monocytogenes by PCR-ELISA. Letters in Applied Microbiology 1999, 29 (6), 
416-420. 
 357.  Norton, D. M.  Polymerase Chain Reaction-Based Methods for Detection 
of Listeria monocytogenes: Toward Real-Time Screening for Food and 
Environmental Samples. Journal of AOAC International 85[2], 505-515. 2002.  
Ref Type: Abstract 
 358.  O'Grady, J.; Sedano-Balbás, S.; Maher, M.; Smith, T.; Barry, T. Rapid 
real-time PCR detection of Listeria monocytogenes in enriched food samples 
based on the ssrA gene, a novel diagnostic target. Food Microbiology 2008, 25 
(1), 75. 
Page 239 of 250 
 
 359.  Bej, A. K.; Steffan, R. J.; DiCesare, J.; Haff, L.; Atlas, R. M. Detection of 
coliform bacteria in water by polymerase chain reaction and gene probes. Appl. 
Environ. Microbiol. 1990, 56 (2), 307-314. 
 360.  Iqbal, S.; Robinson, J.; Deere, D.; Saunders, J. R.; Edwards, C.; Porter, J. 
Efficiency of the polymerase chain reaction amplification of the uid gene for 
detection of Escherichia coli in contaminated water. Letters in Applied 
Microbiology 1997, 24 (6), 498-502. 
 361.  Gannon, V. P.; Rashed, M.; King, R. K.; Thomas, E. J. Detection and 
characterization of the eae gene of Shiga-like toxin-producing Escherichia coli 
using polymerase chain reaction. Journal of clinical microbiology 1993, 31 (5), 
1268-1274. 
 362.  Fluit, A. C.; Torensma, R.; Visser, M. J.; Aarsman, C. J.; Poppelier, M. 
J.; Keller, B. H.; Klapwijk, P.; Verhoef, J. Detection of Listeria monocytogenes 
in cheese with the magnetic immuno-polymerase chain reaction assay. Appl. 
Environ. Microbiol. 1993, 59 (5), 1289-1293. 
 363.  Hudson, J. A.; Lake, R. J.; Savill, M. G.; Scholes, P.; McCormick, R. E. 
Rapid detection of Listeria monocytogenes in ham samples using 
immunomagnetic separation followed by polymerase chain reaction. Journal of 
Applied Microbiology 2001, 90 (4), 614-621. 
 364.  Skjerve, E.; Rørvik, L. M.; Olsvik, O. Detection of Listeria 
monocytogenes in foods by immunomagnetic separation. Appl. Environ. 
Microbiol. 1990, 56 (11), 3478-3481. 
 365.  Bickley, J.; Short, J. K.; McDowell, D. G.; Parkes, H. C. Polymerase 
chain reaction (PCR) detection of Listeria monocytogenes in diluted milk and 
reversal of PCR inhibition caused by calcium ions. Letters in Applied 
Microbiology 1996, 22 (2), 153-158. 
 366.  Choi, W. S.; Hong, C. H. Rapid enumeration of Listeria monocytogenes 
in milk using competitive PCR. International Journal of Food Microbiology 
2003, 84 (1), 79-85. 
 367.  Nogva, H. K.; Rudi, K.; Naterstad, K.; Holck, A.; Lillehaug, D. 
Application of 5'-nuclease PCR for quantitative detection of Listeria 
monocytogenes in pure cultures, water, skim milk, and unpasteurized whole 
milk. Appl. Environ. Microbiol. 2000, 66 (10), 4266-4271. 
  
Page 240 of 250 
 
368.  Wernars, K.; Heuvelman, C. J.; Chakraborty, T.; Notermans, S. H. W. 
Use of the polymerase chain reaction for direct detection of Listeria 
monocytogenes in soft cheese. Journal of Applied Bacteriology 1991, 70 (2), 
121-126. 
 369.  Safarik, I.; Safarikova, M. Magnetic nano- and microparticles in 
biotechnology. Chem. Pap. 2009, 63 (5), 497-505. 
 370.  Wright, D. J.; Chapman, P. A.; Siddons, C. A. Immunomagnetic 
separation as a sensitive method for isolating Escherichia coli O157 from food 
samples. Epidemiol Infect 1994, 113 (1), 31-39. 
 371.  Pappert, G.; Rieger, M.; Niessner, R.; Seidel, M. Immunomagnetic 
nanoparticle-based sandwich chemiluminescence-ELISA for the enrichment and 
quantification of E.coli. Microchimica Acta 2010, 168 (1), 1-8. 
 372.  Yu, H.; Bruno, J. G. Immunomagnetic-electrochemiluminescent detection 
of Escherichia coli O157 and Salmonella typhimurium in foods and 
environmental water samples. Appl. Environ. Microbiol. 1996, 62 (2), 587-592. 
 373.  Bennett, A. R.; MacPhee, S.; Betts, R. P. The isolation and detection of 
Escherichia coli O157 by use of immunomagnetic separation and immunoassay 
procedures. Letters in Applied Microbiology 1996, 22 (3), 237-243. 
 374.  Seo, K. H.; Brackett, R. E.; Frank, J. F.; Hilliard, S. Immunomagnetic 
Separation and Flow Cytometry for Rapid Detection of Escherichia coli 
O157:H7. Journal of Food Protection 1998, 61 (7), 812-816. 
 375.  Radke, S. M.; Alocilja, E. C. A high density microelectrode array 
biosensor for detection of E. coli O157:H7. Biosensors and Bioelectronics 
2005, 20 (8), 1662-1667. 
 376.  Liu, Y.; Li, Y. Detection of Escherichia coli O157:H7 using 
immunomagnetic separation and absorbance measurement. Journal of 
Microbiological Methods 2002, 51 (3), 369-377. 
 377.  Boyaci, I. H.; Aguilar, Z.; Hossain, M.; Halsall, H. B.; Seliskar, C.; 
Heineman, W. Amperometric determination of live Escherichia coli using 
antibody-coated paramagnetic beads. Anal Bioanal Chem 2005, 382 (5), 1234-
1241. 
 378.  Yang, Y.; Xu, F.; Xu, H.; Aguilar, Z. P.; Niu, R.; Yuan, Y.; Sun, J.; You, 
X.; Lai, W.; Xiong, Y.; Wan, C.; Wei, H. Magnetic nano-beads based 
separation combined with propidium monoazide treatment and multiplex PCR 
assay for simultaneous detection of viable Salmonella Typhimurium, 
Page 241 of 250 
 
Escherichia coli O157:H7 and Listeria monocytogenes in food products. Food 
Microbiology 2013, (0). 
 379.  Favrin, S. J.; Jassim, S. A.; Griffiths, M. W. Application of a novel 
immunomagnetic separationbacteriophage assay for the detection of 
Salmonella enteritidis and Escherichia coli O157:H7 in food. International 
Journal of Food Microbiology 2003, 85 (12), 63-71. 
 380.  Dye, M. The enrichment of Rhizobium from a model system using 
immunomagnetic separation. Journal of Microbiological Methods 1994, 19 (3), 
235-245. 
 381.  de Len, L.; Siverio, F.; Rodriguez, A. Detection of Clavibacter 
michiganensis subsp. michiganensis in tomato seeds using immunomagnetic 
separation. Journal of Microbiological Methods 2006, 67 (1), 141-149. 
 382.  Yang, W.; Gu, A. Z.; Zeng, S. y.; Li, D.; He, M.; Shi, H. c. Development 
of a combined immunomagnetic separation and quantitative reverse 
transcription-PCR assay for sensitive detection of infectious rotavirus in water 
samples. Journal of Microbiological Methods 2011, 84 (3), 447-453. 
 383.  Chakraborty, R.; Hazen, T. C.; Joyner, D. C.; Kusel, K.; Singer, M. E.; 
Sitte, J.; Torok, T. Use of immunomagnetic separation for the detection of 
Desulfovibrio vulgaris from environmental samples. Journal of Microbiological 
Methods 2011, 86 (2), 204-209. 
 384.  Heermann, K. H.; Hagos, Y.; Thomssen, R. Liquid-phase hybridization 
and capture of hepatitis B virus DNA with magnetic beads and fluorescence 
detection of PCR product. Journal of virological methods 1994, 50 (1), 43-57. 
 385.  Millar, D. S.; Withey, S. J.; Tizard, M. L. V.; Ford, J. G.; Hermontaylor, 
J. Solid-Phase Hybridization Capture of Low-Abundance Target DNA 
Sequences: Application to the Polymerase Chain Reaction Detection of 
Mycobacterium paratuberculosis and Mycobacterium avium subsp. silvaticum. 
Analytical Biochemistry 1995, 226 (2), 325-330. 
 386.  Mangiapan, G.; Vokurka, M.; Schouls, L.; Cadranel, J.; Lecossier, D.; 
Van Embden, J.; Hance, A. J. Sequence capture-PCR improves detection of 
mycobacterial DNA in clinical specimens. Journal of clinical microbiology 
1996, 34 (5), 1209-1215. 
 387.  Regan, P. M.; Margolin, A. B. Development of a nucleic acid capture 
probe with reverse transcriptase-polymerase chain reaction to detect poliovirus 
in groundwater. Journal of virological methods 1997, 64 (1), 65-72. 
Page 242 of 250 
 
 388.  Miyachi, H.; Masukawa, A.; Ohshima, T.; Hirose, T.; Impraim, C.; Ando, 
Y. Automated specific capture of hepatitis C virus RNA with probes and 
paramagnetic particle separation. Journal of clinical microbiology 2000, 38 (1), 
18-21. 
 389.  Tanaka, M.; Fujiyama, S.; Tanaka, M.; Itoh, K.; Matsushita, K.; 
Matsushita, K.; Matsuyama, K.; Kakuda, H.; Tomita, K. Clinical Usefulness of 
a New Hepatitis C Virus RNA Extraction Method Using Specific Capture Probe 
and Magnetic Particle in Hemodialysis Patients. Therapeutic Apheresis and 
Dialysis 2004, 8 (4), 328-334. 
 390.  Maibach, R. C.; Dutly, F.; Altwegg, M. Detection of Tropheryma 
whipplei DNA in feces by PCR using a target capture method. Journal of 
clinical microbiology 2002, 40 (7), 2466-2471. 
 391.  Zhu, X.; Zhou, X.; Xing, D. Nano-magnetic primer based 
electrochemiluminescence-polymerase chain reaction (NMPE-PCR) assay. 
Biosensors and Bioelectronics 2012, 31 (1), 463-468. 
 392.  Amagliani, G.; Omiccioli, E.; Brandi, G.; Bruce, I. J.; Magnani, M. A 
multiplex magnetic capture hybridisation and multiplex Real-Time PCR 
protocol for pathogen detection in seafood. Food Microbiology 2010, 27 (5), 
580-585. 
 393.  Paripurana, P.; Pinsaeng, S.; Polpanich, D.; Tangboriboonrat, P.; 
Jangpatarapongsa, K. Primer-immobilized Magnetic Nanoparticle for Bacterial 
DNA separation. IACSIT Press: Singapore, 2012; pp 152-155. 
 394.  Chen, S. H.; Wu, V. C. H.; Chuang, Y. C.; Lin, C. S. Using 
oligonucleotide-functionalized Au nanoparticles to rapidly detect foodborne 
pathogens on a piezoelectric biosensor. Journal of Microbiological Methods 
2008, 73 (1), 7-17. 
 395.  Redondo-Marugan, J.; Petit-Dominguez, M. D.; Casero, E.; Vázquez, L.; 
García, T.; Parra-Alfambra, A. M.; Lorenzo, E. Solgel derived gold 
nanoparticles biosensing platform for Escherichia coli detection. Sensors and 
Actuators B: Chemical 2013, 182 (0), 307-314. 
 396.  Mariotti, E.; Minunni, M.; Mascini, M. Surface plasmon resonance 
biosensor for genetically modified organisms detection. Analytica Chimica Acta 
2002, 453 (2), 165-172. 
 397.  Galluzzi, L.; Bertozzini, E.; del Campo, A.; Penna, A.; Bruce, I. J.; 
Magnani, M. Capture probe conjugated to paramagnetic nanoparticles for 
Page 243 of 250 
 
purification of Alexandrium species (Dinophyceae) DNA from environmental 
samples. Journal of Applied Microbiology 2006, 101 (1), 36-43. 
 398.  Zhan, F.; Zhou, X.; Xing, D. Rapid and sensitive 
electrochemiluminescence detection of rotavirus by magnetic primer based 
reverse transcription-polymerase chain reaction. Analytica Chimica Acta 2013, 
761 (0), 71-77. 
 399.  Bartlett, J. M. S.; Stirling, D. A Short History of the Polymerase Chain 
Reaction. PCR Protocols 2003, 226, 3-6. 
 400.  Coen, D. M. The Polymerase Chain Reaction. In Current Protocols in 
Molecular Biology, John Wiley & Sons, Inc.: 2001. 
 401.  Yang, S.; Rothman, R. E. PCR-based diagnostics for infectious diseases: 
uses, limitations, and future applications in acute-care settings. The Lancet 
Infectious Diseases 2004, 4 (6), 337-348. 
 402.  Dieffenbach, C. W.; Lowe, T. M. J.; Dveksler, G. S. General Concepts 
for PCR Primer Design. In PCR Primer: A Laboratory Manual, Dieffenbach, C. 
W., Dveksler, G. S., Eds.; Cold Spring Harbor Laboratory Press: New York, 
1995; pp 133-155. 
 403.  Singh, V. K.; Govindarajan, R.; Naik, S.; Kumar, A. The Effect of 
Hairpin Structure on PCR Amplification Efficiency. Molecular Biology 
Today 2000, 1 (3), 67-69. 
 404.  Abd-Elsalam, K. A. Bioinformatic tools for PCR primer design. African 
Journal of Biotechnology 2003, 2 (5), 91-95. 
 405.  Tuffaha, M. S. A. Molecular Diagnosis of Tumors. In Phenotypic and 
Genotypic Diagnosis of Malignancies, Wiley-VCH Verlag GmbH & Co. 
KGaA: 2008; pp 81-250. 
 406.  Tuffaha, M. Phenotypic and Genotypic Diagnosis of Malignancies: An 
Immunohistochemical and Molecular Approach; Wiley-VCH: 2008. 
 407.  Yang, W.; Lee, J. Y.; Nowotny, M. Making and Breaking Nucleic Acids: 
Two-Mg
2+
-Ion Catalysis and Substrate Specificity. Molecular Cell 2006, 22 (1), 
5-13. 
 408.  Holland, P. M.; Abramson, R. D.; Watson, R.; Gelfand, D. H. Detection 
of specific polymerase chain reaction product by utilizing the 5' -* 3' 
exonuclease activity of Thermus aquaticus DNA polymerase. Proc. Natl. Acad. 
Sci. USA 1991, 88, 7276-7280. 
Page 244 of 250 
 
 409.  Tindall, K. R.; Kunkel, T. A. Fidelity of DNA synthesis by the Thermus 
aquaticus DNA polymerase. Biochemistry 1988, 27 (16), 6008-6013. 
 410.  Zhou, Y.; Zhang, X.; Ebright, R. H. Random mutagenesis of gene-sized 
DNA molecules by use of PCR with Taq DNA polymerase. Nucleic Acids 
Research 1991, 19 (21), 6052. 
 411.  Saiki, R. K.; Gelfand, D. H.; Stoffel, S.; Scharf, S. T.; Higuchi, R.; Horn, 
G. T.; Mullis, K. B.; Ehrlich, H. A. Primer-directed enzymatic amplification of 
DNA. Science 1988, 239, 487-491. 
 412.  Ronaghi, M.; Karamohamed, S.; Pettersson, B.; Uhlén, M.; Nyrén, P. 
Real-time DNA sequencing using detection of pyrophosphate release. 
Analytical Biochemistry 1996, 242 (1), 84-89. 
 413.  Steitz, T. A. DNA polymerases: structural diversity and common 
mechanisms. Journal of Biological Chemistry 1999, 274 (25), 17395-17398. 
 414.  Yang, L.; Arora, K.; Beard, W. A.; Wilson, S. H.; Schlick, T. Critical role 
of magnesium ions in DNA polymerase 's closing and active site assembly. J. 
Am. Chem. Soc. 2004, 126 (27), 8441-8453. 
 415.  Berg, J. M.; Tymoczko, J. L.; Stryer, L. DNA Polymerases Require a 
Template and a Primer. In Biochemistry, 5th ed.; W H Freeman: New York, 
2002. 
 416.  Eom, S. H.; Wang, J.; Steitz, T. A. Structure of Taq polymerase with 
DNA at the polymerase active site. Nature 1996, 382 (6588), 278-281. 
 417.  Nellemann, L. J.; Frederiksen, J.; Morling, N. PCR typing of DNA 
fragments of the two short tandem repeat (STR) systems upstream of the human 
myelin basic protein (MBP) gene in Danes and Greenland Eskimos. Forensic 
Science International 1996, 78 (2), 139-156. 
 418.  Taylor, C. Y.; Guillén, I. A.; Nazabal, M.; Fernández, J. R.; Silva, J. A. 
Electrophoretic techniques applied to the detection and analysis of the human 
microsatellite DG10s478. Journal of biomolecular techniques: JBT 2007, 18 
(5), 298. 
 419.  Van Pelt-Verkuil, E. Analysis of PCR Amplification Products. In 
Principles and Technical Aspects of PCR Amplification, Springer Netherlands: 
2008; pp 141-182. 
 420.  Heid, C. A.; Stevens, J.; Livak, K. J.; Williams, P. M. Real time 
quantitative PCR. Genome Res 1996, 6 (10), 986-994. 
Page 245 of 250 
 
 421.  Dorak, M. T. Real-time PCR; Taylor & Francis: New York, NY., 
2006.pp. 2-12. 
 422.  Holst-Jensen, A.; Berdal, K. G.; Thorstensen, T.; Tengs, T.; Bøydler, C. 
Equal Performance of TaqMan, MGB, Molecular Beacon, and SYBR Green-
Based Detection Assays in Detection and Quantification of Roundup Ready 
Soybean. J. Agric. Food Chem. 2006, 54 (26), 9658-9663. 
 423.  Spahn, C.; Minteer, S. D. Enzyme Immobilization in Biotechnology. 
Recent Patents on Engineering 2008, 2, 195-200. 
 424.  Sen, T.; Magdassi, S.; Nizri, G.; Bruce, I. J. Dispersion of magnetic 
nanoparticles in suspension. Micro & Nano Letters 2006, 1 (1), 39-42. 
 425.  Petcharoen, K.; Sirivat, A. Synthesis and characterization of magnetite 
nanoparticles via the chemical co-precipitation method. Materials Science and 
Engineering: B 2012, 177 (5), 421-427. 
 426.  Wijnen, P. W.; Beelen, T. P.; van Santen, R. A. Silica Gels from Aqueous 
Silicate Solutions. The Colloid Chemistry of Silica 1994, 517-531. 
 427.  Moon, J. H.; Kim, J. H.; Kim, K.-J.; Kang, T.-H.; Kim, B.; Kim, C.-H.; 
Hahn, J. H.; Park, J. W. Absolute Surface Density of the Amine Group of the 
Aminosilylated Thin Layers: Ultraviolet-Visible Spectroscopy, Second 
Harmonic Generation, and Synchrotron-Radiation Photoelectron Spectroscopy 
Study. Langmuir 1997, 13, 4305-4310. 
 428.  De Waterbeemd, M. V. Silane Condensation to Nanoparticles in 
Suspension. PhD The University of Kent, 2009. 
 429.  Kruger, N. J. The Bradford Method for Protein Quantitation. In The 
Protein Protocols Handbook, 2 ed.; Walker, J. M., Ed.; Humana Press: Totowa, 
NJ, 2002; pp 15-21. 
 430.  Bradford, M. M. A rapid and sensitive method for the quantitation of 
microgram quantities of protein utilizing the principle of protein-dye binding. 
Analytical Biochemistry 1976, 72 (1), 248-254. 
 431.  Brady, D.; Jordaan, J.; Simpson, C.; Chetty, A.; Arumugam, C.; 
Moolman, F. Spherezymes: A novel structured self-immobilisation enzyme 
technology. BMC Biotechnol 2008, 8 (1), 1-11. 
 432.  Gupta, N.; Rathi, P.; Gupta, R. Simplified para-nitrophenyl palmitate 
assay for lipases and esterases. Analytical Biochemistry 2002, 311 (1), 98-99. 
Page 246 of 250 
 
 433.  Jiles, D. Introduction to Magnetism and Magnetic Materials; 1 ed.; 
Chapman and Hall Publishers: 1991. 
 434.  Sigma-Aldrich . Supelco DEX Chiral Columns. 
http://www.sigmaaldrich.com . 2013. 10-9-2013.  
 
 435.  Liang, S.; Wang, Y.; Zhang, C.; Liu, X. Synthesis of amino-modified 
magnetite nanoparticles coated with Hepama-1 and radiolabeled with 
188
Re for 
bio-magnetically targeted radiotherapy. Journal of Radioanalytical and Nuclear 
Chemistry 2006, 269 (1), 3-7. 
 436.  Yi, D. K.; Selvan, S. T.; Lee, S. S.; Papaefthymiou, G. C.; Kundaliya, D.; 
Ying, J. Y. Silica-coated nanocomposites of magnetic nanoparticles and 
quantum dots. J. Am. Chem. Soc. 2005, 127 (14), 4990-4991. 
 437.  Setyawan, H.; Fajaroh, F.; Widiyastuti, W.; Winardi, S.; Lenggoro, I. W.; 
Mufti, N. One-step synthesis of silica-coated magnetite nanoparticles by 
electrooxidation of iron in sodium silicate solution. Journal of Nanoparticle 
Research 2012, 14 (4), 1-9. 
 438.  Mürbe, J.; Rechtenbach, A.; Tõpfer, J. Synthesis and physical 
characterization of magnetite nanoparticles for biomedical applications. 
Materials Chemistry and Physics 2008, 110 (2), 426-433. 
 439.  Liu, Z. L.; Wang, H. B.; Lu, Q. H.; Du, G. H.; Peng, L.; Du, Y. Q.; 
Zhang, S. M.; Yao, K. L. Synthesis and characterization of ultrafine well-
dispersed magnetic nanoparticles. Journal of Magnetism and Magnetic 
Materials 2004, 283 (23), 258-262. 
 440.  Ditsch, A.; Laibinis, P. E.; Wang, D. I.; Hatton, T. A. Controlled 
clustering and enhanced stability of polymer-coated magnetic nanoparticles. 
Langmuir 2005, 21 (13), 6006-6018. 
 441.  Zhao, W.; Gu, J.; Zhang, L.; Chen, H.; Shi, J. Fabrication of Uniform 
Magnetic Nanocomposite Spheres with a Magnetic Core/Mesoporous Silica 
Shell Structure. J. Am. Chem. Soc. 2005, 127 (25), 8916-8917. 
 442.  Yu, B. Y.; Kwak, S. Y. Assembly of magnetite nanocrystals into 
spherical mesoporous aggregates with a 3-D wormhole-like pore structure. 
Journal of Materials Chemistry 2010, 20 (38), 8320-8328. 
 443.  Ma, M.; Zhang, Y.; Yu, W.; Shen, H. y.; Zhang, H. q.; Gu, N. Preparation 
and characterization of magnetite nanoparticles coated by amino silane. 
Colloids and Surfaces A: Physicochemical and Engineering Aspects 2003, 212 
(23), 219-226. 
Page 247 of 250 
 
 444.  Chernyshova, I. V.; Hochella Jr, M. F.; Madden, A. S. Size-dependent 
structural transformations of hematite nanoparticles. 1. Phase transition. 
Physical Chemistry Chemical Physics 2007, 9 (14), 1736-1750. 
 445.  Mahadevan, S.; Gnanaprakash, G.; Philip, J.; Rao, B. P. C.; Jayakumar, 
T. X-ray diffraction-based characterization of magnetite nanoparticles in 
presence of goethite and correlation with magnetic properties. Physica E: Low-
dimensional Systems and Nanostructures 2007, 39 (1), 20-25. 
 446.  Thünemann, A. F.; Schütt, D.; Kaufner, L.; Pison, U.; Möhwald, H. 
Maghemite Nanoparticles Protectively Coated with Poly (ethylene imine) and 
Poly (ethylene oxide)-block-poly (glutamic acid). Langmuir 2006, 22 (5), 2351-
2357. 
 447.  Llavona, A.; Prados, A.; Velasco, V.; Crespo, P.; Sanchez, M. C.; Perez, 
L. Electrochemical synthesis and magnetic properties of goethite single crystal 
nanowires. CrystEngComm 2013, 15 (24), 4905-4909. 
 448.  Lin, S. T. Magnetic Properties of Hematite Single Crystals. I. 
Magnetization Isotherms, Antiferromagnetic Susceptibility, and Weak 
Ferromagnetism of a Natural Crystal. Physical Review 1959, 116 (6), 1447. 
 449.  Martin-Hernandez, F.; Garcìa-Hernández, M. M. Magnetic properties and 
anisotropy constant of goethite single crystals at saturating high fields. 
Geophysical Journal International 2010, 181 (2), 756-761. 
 450.  Kletetschka, G.; Wasilewski, P. J.; Taylor, P. T. Hematite vs. magnetite 
as the signature for planetary magnetic anomalies? Physics of the Earth and 
Planetary Interiors 2000, 119 (3), 259-267. 
 451.  Guardia, P.; Batlle-Brugal, B.; Roca, A. G.; Iglesias, O.; Morales, M. P.; 
Serna, C. J.; Labarta, A.; Batlle, X. Surfactant effects in magnetite nanoparticles 
of controlled size. Journal of Magnetism and Magnetic Materials 2007, 316 (2), 
e756-e759. 
 452.  Goss, C. J. Saturation magnetisation, coercivity and lattice parameter 
changes in the system Fe3O4-Fe2O3, and their relationship to structure. Phys 
Chem Minerals 1988, 16 (2), 164-171. 
 453.  Kanazawa, T.; Liu, X.; Morisako, A. Structure and magnetic properties of 
-Fe2O3-multi walled carbon nanotubes nanocomposites prepared by sol-gel 
method. IOP Publishing: 2011; p 012071. 
 454.  Ek, S.; Iiskola, E. I.; Niinistö, L. Gas-phase deposition of 
aminopropylalkoxysilanes on porous silica. Langmuir 2003, 19 (8), 3461-3471. 
Page 248 of 250 
 
 455.  Carré, A.; Lacarrière, V.; Birch, W. Molecular interactions between DNA 
and an aminated glass substrate. Journal of Colloid and Interface Science 2003, 
260 (1), 49-55. 
 456.  Sun, Y.; Duan, L.; Guo, Z.; DuanMu, Y.; Ma, M.; Xu, L.; Zhang, Y.; Gu, 
N. An improved way to prepare superparamagnetic magnetite-silica core-shell 
nanoparticles for possible biological application. Journal of Magnetism and 
Magnetic Materials 2005, 285 (1), 65-70. 
 457.  Tewari, P. H.; McLean, A. W. Temperature dependence of point of zero 
charge of alumina and magnetite. Journal of Colloid and Interface Science 
1972, 40 (2), 267-272. 
 458.  Marmier, N.; Delisée, A.; Fromage, F. Surface Complexation Modeling 
of Yb(III), Ni(II), and Cs(I) Sorption on Magnetite. Journal of Colloid and 
Interface Science 1999, 211 (1), 54-60. 
 459.  Yean, S.; Cong, L.; Yavuz, C. T.; Mayo, J. T.; Yu, W. W.; Kan, A. T.; 
Colvin, V. L.; Tomson, M. B. Effect of magnetite particle size on adsorption 
and desorption of arsenite and arsenate. Journal of Materials Research 2005, 20 
(12), 3255-3264. 
 460.  Krakowiak, A.; Trzcinska, M.; Sieliwanowicz, B.; Sawicka-Zukowska, 
R.; Jedrychowska, B.; Ajzenberg, V. Properties of immobilised and free lipase 
from Rhizopus cohnii. Polish journal of food and nutrition sciences 2003, 12 
(3), 39-44. 
 461.  Ranjbakhsh, E.; Bordbar, A. K.; Abbasi, M.; Khosropour, A. R.; Shams, 
E. Enhancement of stability and catalytic activity of immobilized lipase on 
silica-coated modified magnetite nanoparticles. Chemical Engineering Journal 
2012, 179 (0), 272-276. 
 462.  Kalantari, M.; Kazemeini, M.; Arpanaei, A. Evaluation of Biodiesel 
Production Using Lipase Immobilized on Magnetic Silica Nanocomposite 
Particles of Various Structures. Biochemical Engineering Journal (0). 
 463.  Wang, J.; Meng, G.; Tao, K.; Feng, M.; Zhao, X.; Li, Z.; Xu, H.; Xia, D.; 
Lu, J. R. Immobilization of Lipases on Alkyl Silane Modified Magnetic 
Nanoparticles: Effect of Alkyl Chain Length on Enzyme Activity. PLoS ONE 
2012, 7 (8), e43478. 
 464.  Kuo, T. M.; Gardner, H. W. Lipases: Structures, function and properties. 
In Lipid Biotechnology, Taylot & Francis Inc: New York, 2002; pp 417-418. 
Page 249 of 250 
 
 465.  Xie, Z. F.; Suemune, H.; Sakai, K. Synthesis of chiral building blocks 
using Pseudomonas Fluorescens lipase catalyzed asymmetric hydrolysis of 
Meso diacetates. Tetrahedron: Asymmetry 1993, 4 (5), 973-980. 
 466.  Henegar, K. E. Process for preparing enantiomerically enriched (1S,4R) 
1-acetoxy-4-hydroxycyclopent-2-ene . EP1587937 A1, 2005. 
 467.  Deardorff, D. R.; Linde, R. G.; Martin, A. M.; Shulman, M. J. 
Enantioselective preparation of functionalized cyclopentanoids via a common 
chiral (pi-allyl) palladium complex. The Journal of Organic Chemistry 1989, 54 
(11), 2759-2762. 
 468.  Kitade, Y.; Kojima, H.; Zulfiqur, F.; Kim, H. S.; Wataya, Y. Synthesis of 
2-fluoronoraristeromycin and its inhibitory activity against Plasmodium 
falciparum S-Adenosyl-L-homocysteine hydrolase. Bioorganic & Medicinal 
Chemistry Letters 2003, 13 (22), 3963-3965. 
 469.  Gurjar, M. K.; Nageswar Reddy, C.; Kalkote, U. R.; Chorghade, M. S. 
Studies toward the total synthesis of carba analogue of motif C of M. Tb cell 
wall Ag complex. Heterocycles 2009, 77 (2), 909-925. 
 470.  Santos, J. C.; Nunes, G. F.; Moreira, A. B.; Perez, V. H.; de Castro, H. F. 
Characterization of Candida rugosa Lipase Immobilized on Poly (N
methylolacrylamide) and Its Application in Butyl Butyrate Synthesis. Chemical 
Engineering & Technology 2007, 30 (9), 1255-1261. 
 471.  Soares, C. M.; De Castro, H.; Moraes, F. F.; Zanin, G. Characterization 
and utilization of Candida rugosa lipase immobilized on controlled pore silica. 
Appl Biochem Biotechnol 1999, 79 (1-3), 745-757. 
 472.  Ozmen, E. Y.; Sezgin, M.; Yilmaz, M. Synthesis and characterization of 
cyclodextrin-based polymers as a support for immobilization of Candida rugosa 
lipase. Journal of Molecular Catalysis B: Enzymatic 2009, 57 (14), 109-114. 
 473.  Pereira, E. B.; de Castro, H. F.; De Moraes, F. F.; Zanin, G. M. Kinetic 
studies of lipase from Candida rugosa. Applied Biochemistry and Biotechnology 
2001, 91 (1-9), 739-752. 
 474.  Boscolo, B.; Trotta, F.; Ghibaudi, E. High catalytic performances of 
Pseudomonas fluorescens lipase adsorbed on a new type of cyclodextrin-based 
nanosponges. Journal of Molecular Catalysis B: Enzymatic 2010, 62 (2), 155-
161. 
Page 250 of 250 
 
 475.  Salis, A.; Pinna, M.; Monduzzi, M.; Solinas, V. Comparison among 
immobilised lipases on macroporous polypropylene toward biodiesel synthesis. 
Journal of Molecular Catalysis B: Enzymatic 2008, 54 (12), 19-26. 
 476.  Raza, S.; Fransson, L.; Hult, K. Enantioselectivity in Candida antarctica 
lipase B: a molecular dynamics study. Protein Science 2001, 10 (2), 329-338. 
 
 
